Note: Descriptions are shown in the official language in which they were submitted.
CA 02450698 2003-12-23
DE~VIA,NDES OU BREVETS VOLUMINEUX
LA PRESENTE PARTIE DE CETTE DEMANDE OU CE BREVETS
COMPREND PLUS D'UN TOME.
CECI EST LE TOME I DE
NOTE: Pour les tomes additionels, veillez contacter 1e Bureau Canadien des
Brevets.
JUMBO APPLICATIONS / PATENTS
THIS SECTION OF THE APPLICATION l PATENT CONTAINS MORE
THAN ONE VOLUME.
THIS IS VOLUME ~ OF
NOTE: For additional volumes please contact the Canadian Patent Office.
CA 02450698 2003-12-23
A METHOD for extracting quantitative information relating to an influence on a
cellular re-
spouse
FIELD OF INVENTION
5 The present invention relates to a method and tools for extracting
Quantitative information
relating to an influence, on a cellular response, in particular an influence
caused by contac-
ting or incubating the cell with a substance influencing a cellular response,
where the cellular
response is manifested in redistribution of at least one component in the
cell. In particular,
the invention relates to a method for extracting quantitative information
relating to an influen-
10 re on an intracellular pathway involving redistribution of at least one
component associated
with the pathway. The method of the invention may be used as a very efficient
procedure for
testing or discovering the influence of a substance on a physiological
process, for example in
connection with screening for new drugs, testing of substances for toxicity,
identifying drug
targets for known or novel drug: Other valuable uses of the method and
technology of the
~ 5 invention wilt be apparent to the skilled person on the basis of the
following disclosure. In a
particular embodiment of the invention, the present invention relates to a
method of detec-
ting intracellular transiocation or redistribution of biologically active
polypeptides, preferably
an enzyme, affecting intracellular processes, and a DNA construct and a cell
for use in the
method.
20
BACKGROUND OF THE INVENTION
Intracellular pathways are tightly regulated by a cascade of components that
undergoes
modulation in a temporally and spatially characteristic manner. Several
disease states can
be attributed to altered activity of individual signalling components (i.e.
protein kinases, pro-
25 tein phosphatases, transcription factors). These components therefore
render themselves as
attractive targets for therapeutic intervention.
Protein kinases and phosphatases are well described components of several
intracellular
signalling pathways. The catalytic activity of protein kinases and
phosphatases are assumed
to play a role in virtually all regulatable cellular processes. Although the
involvement of pro-
30 tein kinases in cellular signalling and regulation have been subjected to
extensive studies,
detailed knowledge on e.g. the exact timing and spatial characteristics of
signalling events is
often difficult to obtain due to lack of a convenient technology.
CA 02450698 2003-12-23
2
Novel ways of monitoring specific modulation of intracellular pathways in
intact, living cells are
assumed to provide new opportunities in drug discovery, functional genomics,
toxicology,
patient monitoring etc.
The spatial orchestration of protein kinase activity is likely to be essential
for the high degree
of specificity of individual protein kinases. The phosphorylation mediated by
protein kinases
is balanced by phosphatase activity. Also within the family of phosphatases
transiocation has
been observed, e.g. translocation of PTP2C to membrane ruffles [{Cossette ef
a1.1996)], and
likewise is likely to be indicative of phosphatase activity.
Protein kinases often show a specfic intracellular distribution before, during
and after activa-
tion. Monitoring the translocation processes andfor redistribution of
individual protein kinases
or subunits thereof is thus likely to be indicative of their functional
activity, A connection be-
tween translocation and catalytic activation has been shown for protein
kinases like the dia-
cyl glycerol (DAG)-dependent protein kinase C (PKC), the CAMP-dependent
protein kinase
(PKA) [(DeBernardi et a1.1996)] and the mitogen-activated-protein kinase Erk-1
[(Sano et
ei.1995)].
Commonly used methods of detection of intracellular localisation/activity of
protein kinases
and phosphatases are immunoprecipitation, Western blotting and
immunocytochemical de-
tection.
Taking the family of diacyl glycerol (DAG)-dependent protein kinase Cs (PKCs)
as an exam-
ple, it has been shown that individual PKC isoforms that are distributed among
different tis-
sues and cells have different activator requirements and undergo differential
translocation in
response to activation. Catalytically inactive DAG-dependent PKCs are
generally distributed
throughout the cytoplasm, whereas they upon activation translocate to become
associated
with different cellular components, e.g. plasma membrane [(Farese,
1992),(Fulop Jr. et
25 aL1995)] nucleus [(Khalil et a1.1992)], cytoskeleton [(globe et a1.1996)].
The translocation
phenomenon being indicative of PKC activation has been monitored using
different ap-
proaches: a) immunocytochemistry where the localisation of individual isoforms
can be de-
tected after permeabilisation and fixation of the cells [(Khalil ef aL1992));
and b) tagging all
DAG-dependent PKC isofortns with a fluorescently labelled phorbol myristate
acetate (PMA)
30 [(Godson et a1.1996)]; and c) chemical tagging PKC b1 with the fluorophore
Cy3 [(Bastiaens
8 Jovin 1996)] and d) genetic tagging of PKCa ([Schmidt e! al. 1997]) and of
PKCy and PKC
a ([Sakai et al. 1996]). The first method does not provide dynamic information
whereas the
tatter methods will. Tagging PKC with fluorescently labelled phorbol myristate
acetate cannot
CA 02450698 2003-12-23
3
distinguish between different DAG~ependent isofom~s of PKC but will label and
show
movement of all isoforms. Chemical and genetic labelling of speafic DAG-
dependent PKCs
confirmed that they in an isofortn specific manner upon activation move to
cell periphery or
nucleus.
In an alternative method, protein kinase A activity has been measured in
living cells by
chemical labelling one of the kinase's subunits(Adams et al. 1991 ). The basis
of the method-
ology is that the regulatory and catalytic subunit of purified protein kinase
A is labelled with
fluorescein and rhodamine, respectively. At low CAMP levels protein kinase A
is assembled
in a heterotetrameric form which enables fluorescence resonance energy
transfer between
10 the two fluorescent dyes. Activation of protein kinase A leads to
dissociation of the complex,
thereby eliminating the energy transfer. A disadvantage of this technology is
that the labelled
protein kinase A has to be microinjected into the cells of interest. This
highly invasive tech-
nique is cumbersome and not applicable to large scale screening of
biologically acfrve sub-
stances. A further disadvantage of this technique as compared to the presented
invention is
15 that the labelled protein kinase A cannot be inserted into
organisms/animals as a transgene.
Recently it was discovered that Green Fluorescent Protein (GFP) expressed in
many differ-
ent cell types, including mammalian cells, became highly fluorescent ((Chalfie
ei aL1994)].
W095107463 describes a oell capable of expressing GFP and a method for
detecting a pro-
tein of interest in a cell based on introducing into a cell a DNA molecule
having DNA se-
20 quanta encoding the protein of interest linked to DNA sequence encoding a
GFP such that
the protein produced by the DNA molecule will have the protein of interest
fused to the GFP,
then culturing the cells in conditions permitting expression of the fused
protein and detecting
the location of the fluorescence in the cell, Thereby localizing the protein
of interest in the
cell. However, examples of such fused proteins are not provided, and the use
of fusion pro-
25 teins with GFP for detection or quantitation of translocation or
redistribution of biologically
active polypeptides affecting intracellular processes upon activation, such as
proteins in-
volved in signalling pathways, e.g. protein kinases or phosphatases, has not
been sug-
gested. WO 95/07463 further describes cells useful for the detection of
molecules, such as
hormones or heavy metals, in a biological sample, by operatively linking a
regulatory ele-
30 ment of the gene which is affected by the molecule of interest to a GFP,
the presence of the
molecules will affect the regulatory element which in turn will affect the
expression of the
GFP. In this way the gene encoding GFP is used as a reporter gene in a cell
which is con-
strutted for monitoring the presence of a specific molecular identity.
CA 02450698 2003-12-23
4
Green Fluorescent Protein has been used in an assay for the detection of
translocation of the glucocorticoid receptor (GR) [Caret', KL et al., The
Journal
of Cell Biology, Vol. 133, No. 5, P. 985-996 (1996)). A GR-S65TGFP fusion
has been used to study the mechanisms involved in translocation of the
glucocorticoid receptor (GR) in response to the agonist dexamethasone from
the cytosol, where it is present in the absence of a ligand, through the
nuclear
pore to the nucleus where it remains after ligand binding. The use of a GR-
GFP fusion enables real-time imaging and quantitation of nuclear/cytoplasmic
ratios of the fluorescence signal.
Many currently used screening programmes designed to find compounds that
affect protein kinase activity are based on measurements of kinase
phosphorylation of artificial or natural substrates, receptor binding and/or
reporter gene expression.
In accordance with one embodiment of the present invention, there is
provided an assay for cAMP, based on PKA activation, comprising the steps
of:
(a) culturing at least one cell containing a nucleotide sequence
coding for a hybrid polypeptide comprising a fluorophore N- or
C-terminally tagged, optionally through a linker, to the catalytic
subunit of cAMP dependent protein kinase (PKAc) under
conditions permitting expression of the nucleotide sequence;
(b) incubating the at least one cell with a substance to be tested for
biological function or biological effect, and
(c) measuring the fluorescence produced by the incubated at least
one cell and determining the result or variation with respect to
the fluorescence, such result or variation being indicative of the
translocation of PKAc and thereby indicative of an altered
concentration of cAMP.
DISCLOSURE OF THE INVENTION
The present invention provides an important new dimension in the
investigation of cellular systems involving redistribution in that the
invention
provides quantification of the redistribution responses or events caused by an
influence, typically contact with a chemical substance or mixture of chemical
CA 02450698 2003-12-23
4a
substances, but also changes in the physical environment. The quantification
makes it possible to set up meaningful relationships, expressed numerically,
or as curves or graphs, between the influences (or the degree of influences)
on cellular systems and the redistribution response. This is highly
advantageous because, as has been found, the quantification can be
achieved in both a fast and reproducible manner, and - what is perhaps even
more important - the systems which become quantifiable utilizing the method
of the invention are systems from which enormous amounts of new
information and insight can be derived.
The present screening assays have the distinct advantage over other
screening assays, e.g., receptor binding assays, enzymatic assays, and
reporter gene assays, in providing a system in which biologically active
substances with completely novel modes of action, e.g. inhibition or promotion
of redistribution/translocation of a biologically active polypeptide as a way
of
regulating its action rather than inhibitionlactivation of enzymatic activity,
can
be identified in a way that insures very high selectivity to the particular
isoform
of the biologically active polypeptide and further development of compound
selectivity versus other isoforms of
CA 02450698 2003-12-23
the same biologically active polypeptide or other components of the same
signalling pa-
thway.
In its broadest aspect, the invention relates to a method for extracting
quantitative informati-
on relating to an influence on a cellular response, the method comprising
recording variation,
caused by the influence on a mechanically intact living cell or mechanically
intact frying cells,
in spatially distributed light emitted from a luminophore, the luminophore
being present in the
cell or cells and being capable of being redistributed in a manner which is
related with the
degree of the influence, and/or of being modulated by a component which is
capable of be-
ing redistributed in a manner which is related to the degree of the influence,
the association
1o resulting in a modulation of the luminescence characteristics of the
luminophore, detecting
and recording the spatially distributed light from the luminophore, and
processing the recur
dad variation in the spatially distributed tight to provide quantitative
information correlating
the spatial distribution or change in the spatial distribution to the degree
of the influence. In a
preferred embodiment of the invention the luminophore, which is present in the
cell or cells,
is capable of being redistributed by modulation of an intracellular pathway,
in a manner'
which is related to the redistribution of at least one component of the
intracellular pathway. In
another preferred embodiment of the invention, the luminophore is a
fluorophore.
The cells
In the invention the cell andlor cells are mechanically intact and alive
throughout the experi-
ment. In another embodiment of the invention, the cell or cells is/are fixed
at a point in time
after the application of the influence at which the response has been
predetermined to be
significant, and the recording is made at an arbitrary later time.
The mechanically intact living cell or cells could be selected from the group
consisting of
fungal tail or cells, such as a yeast cell or cells; invertebrate cell or
cells including insect cell
or cells; and vertebrate cell or cells, such as mammalian cell or cells. This
cell or these cells
is/are incubated at a temperature of 30°C or above, preferably at a
temperature of from 32°C
to 39°C, more preferably at a temperature of from 35°C to
38°C, and most preferably at a
temperature of about 37°C during the time period over which the
influence is observed. In
one aspect of the invention the mechanically intact living cell is part of a
matrix of identical or
non-identical cells.
CA 02450698 2003-12-23
A cell used in the present invention should contain a nucleic acid construct
encoding a fusion
polypeptide as defined herein and be capable of expressing the sequence
encoded by the
construct. The cell is a eukaryotic cell selected from the group consisting of
fungal cells,
such as yeast cells; invertebrate cells including insect cells; vertebrate
cells such as mam-
malian cells. The preferred cells are mammalian cells.
In another aspect of the invention the cells could be from an organism
carrying in at least
one of its component cells a nucleic acid sequence encoding a fusion
polypeptide as defined
herein and be capable of expressing said nucleic acid sequence. The organism
is selected
from the group consisting of unicellular and multicellufar organisms, such as
a mammal.
1o
The luminophore
The luminophore is the component which allows the redistribution to be
visualised and/or
recorded by emitting light in a spatial distribution related to the degree of
influence. In one
embodiment of the invention, the luminophore is capable of being redistributed
in a manner
15 which is physiologically relevant to the degree of the influence. In
another embodiment, the
luminophore is capable of associating with a component which is capable of
being redistri-
buted in a manner which is physiologically relevant to the degree of the
influence. In another
embodiment, the luminophore correlation between the redistribution of the
luminophore and
the degree of the influence could be determined experimentally. In a preferred
aspect of the
20 invention, the luminophore is capable of being redistributed in
substantially the same manner
as the at least one component of an intracellular pathway. In yet another
embodiment of the
invention, the luminophore is capable of being quenched upon spatial
association with a
component which is redistributed by modulation of the pathway, the quenching
being measu-
red as a change in the intensity of the luminescence.
25 The luminophore could be a fluorophore. In a preferred embodiment of the
invention, the lu-
minophore could be a polypeptide encoded by and expressed from a nucleotide
sequence
harboured in the cell or cells. The luminophore could be a hybrid polypeptide
comprising a
fusion of at least a portion of each of two polypeptides one of which
comprises a luminescent
polypeptide and the other one of which comprises a biologically active
polypeptide, as defi-
30 ned herein.
The luminescent polypeptide could be a GFP as defined herein or could be
selected from the
group consisting of green fluorescent proteins having the Ffi4l mutation as
defined herein
CA 02450698 2003-12-23
7
such as F64L-GFP, F64L-Y66H-GFP, F64L-S65T-GFP, and EGFP. The GFP could be N-
or
C-terminally tagged, optionally via a peptide linker, to the biologically
active polypeptide or a
part or a subunit thereof. The fluorescent probe could be a component of a
intracellular sig-
nalling pathway. The probe is coded for by a nucleic acid construct.
The pathway of investigation in the present invention could be an
intracellular signalling pa-
thway.
The influence
In a preferred embodiment of the invention, the influence could be contact
between the me-
chanically intact living cell or the group of mechanically intact frying cells
with a chemical
substance and/or incubation of the mechanically intact living cell or the
group of mechani-
cally intact living ce8s with a chemical substance. The influence will
modulate the intracellular
processes. In one aspect the modulation could be an activation of the
intracellular proces-
ses. In another aspect the modulation could be an deactivation of the
intracellular processes.
~5 In yet another aspect, the influence could inhibit or promote the
redistribution without directly
affecting the metabolic activity of the component of the intracellular
processes.
In one embodiment the invention is used as a basis for a screening program,
where the ef
feet of unknown influences such as a compound library, can be compared to
influence of
known reference compounds under standardised conditions.
The recording
In addition to the intensity, there are several parameters of fluorescence or
luminescence
which can be modulated by the effect of the influence on the underlying
cellular phenomena,
and can therefore be used in the invention. Some examples are resonance energy
transfer,
fluorescence lifetime, polarisation, wavelength shift. Each of these methods
requires a parti-
velar kind of filter in the emission light path to select the component of the
light desired and
reject other components. The recording of property of light could be in the
form of an ordered
array of values such as a CCD array or a vacuum tube device such as a vidicon
tube.
In one embodiment of the invention, the spatially distributed light emitted by
a luminophore
could be detected by a change in the resonance energy transfer between the
luminophore
and another luminescent entity capable of delivering energy 1o the
luminophore, each of
CA 02450698 2003-12-23
8
which has been selected or engineered to become part of, bound to or
associated with parti-
cular components of the intracellular pathway. In this embodiment, either the
fuminophore or
the luminescent entity capable of delivering energy to the luminophore
undergoes redisMbu-
tion in response to an influence. The resonance energy transfer would be
measured as a
change in the intensity of emission from the luminophore, preferably sensed by
a single
channel photodetector which responds only to the average intensity of the
luminophore in a
non-spatially resolved fashion.
in one embodiment of the invention, the recording of the spatially distributed
light could be
made at a single point in time after the application of the influence. In
another embodiment,
the recording could be made at two points in time, one point being before, and
the other
point being after the application of the influence. The result or variation is
determined from
the change in fluorescence compared to the fluorescence measured prior to the
influence or
modulation. In another embodiment of the invention, the recording could be
performed at a
series of points in time, in which the application of the influence occurs at
some time after
the first time point in the series of recordings, the recording being
pertorrned, e.g., with a
predetermined time spacing of from 0.1 seconds to 1 hour, preferably from 1 to
60 seconds,
more preferably from 1 to 30 seconds, in particular from 1 to 10 seconds, over
a time span
of from 1 second to 12 hours, such as from 10 seconds to 12 hours, e.g., from
10 seconds to
one hour, such as from 60 seconds to 30 minutes or 20 minutes. The result or
variation is
determined from the change in fluorescence over time. The result or variation
could also be
determined as a change in the spatial distribution of the fluorescence over
time.
Apparatus
The recording of spatially distributed luminescence emitted from the
luminophore is perfor-
med by an apparatus for measuring the distribution of fluorescence in the cell
or cells, and
thereby any change in the distribution of fluorescence in the cell or cells,
which includes a1 a
minimum the following component parts: (a) a light source, (b) a method for
selecting the
wavelengths) of light from the source which will excite the fluorescence of
the protein, (c) a
device which can rapidly block or pass the excitation light into the rest of
the system, (d) a
series of optical elements for conveying the excitation light to the specimen,
collecting the
emitted fluorescence in a spatially resolved fashion, and forming an image
from this fluore-
scence emission, (e) a bench or stand which holds the container of the cells
being measured
in a predetermined geometry with respect to the series of optical elements,
(f) a detector to
CA 02450698 2003-12-23
9
record the spatially resolved fluorescence in the form of an image, (g) a
computer or electro-
nic system and associated software to acquire and store the recorded images,
and to com-
pute the degree of redistribution from the recorded images.
In a preferred embodiment of the invention the apparatus system is automated.
In one em-
bodiment the components in d and a mentioned above comprise a fluorescence
microscope.
In one embodiment the component in f mentioned above is a CCD camera.
In one embodiment the image is formed and recorded by an optical scanning
system.
In one embodiment a liquid addition system is used to add a known or unknown
compound
to any or all of the cells in the cell holder at a time determined in advance.
Preferably, the
liquid addition system is under the control of the computer or electronic
system. Such an
automated system can be used for a screening program due to its ability to
generate results
from a larger number of test compounds than a human operator could generate
using the
apparatus in a manual fashion.
~luantitation of the influence
The recording of the variation or result with respect to light emitted from
the luminophore is
performed by recording the spatially distributed light as one or more digital
images, and the
processing of the recorded variation to reduce it to one or more numbers
representative of
the degree of redistribution comprises a digital image processing procedure or
combination
2o of digital image processing procedures. The quantitative information which
is indicative of the
degree of the cellular response to the influence or the result of the
influence on the intracel-
lular pathway is extracted from the recording or recordings according to a
predetermined ca-
libration based on responses or results, recorded in the same manner, to known
degrees of
a relevant speck influence. This calibration procedure is developed according
to principles
described below (Developing an Image-based Assay Technique). Specific
descriptions of the
procedures for particular assays are given in the examples.
While the stepwise procedure necessary to reduce the image or images to the
value repre-
sentative of the is particular to each assay, the individual steps are
generally well-known
methods of image processing. Some examples of the individual steps are point
operations
3o such as subtraction, ratioing, and thresholding, digital filtering methods
such as smoothing,
sharpening, and edge detection, spatial frequency methods such as Fourier
filtering, image
cross-correlation and image autocorrelation, object finding and classification
(blob analysis),
CA 02450698 2003-12-23
and colour space manipulations for visualisation. In addition to the
algorithmic procedures,
heuristic methods such as neural networks may also be used.
Nucleic acid constructs
The nucleic acid constructs used in the present invention encode in their
nucleic acid sequ-
ences fusion polypeptides comprising a biologically active polypeptide that is
a component of
an intracellular signalling pathway, or a part thereof, and a GFP, preferably
an F64L mutant
of GFP, N- or C-terminally fused, optionally via a peptide linker, to the
biologically active po-
lypeptide or part thereof.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a protein kinase or a phosphatase.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a transcription factor or a part thereof which changes cellular
localisation upon activation.
fn one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a protein, or a part thereof, which is assoaated with the cytoskeletal
network and which
changes cellular localisation upon activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a protein kinase or a part thereof which changes cellular localisation upon
activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a serine/threonine protein kinase or a part thereof capable of changing
intracellular locali-
sation upon activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a tyrosine protein kinase or a part thereof capable of changing
intracellular localisation
upon activation.
In one embodiment the biologically active polypep6de encoded by the nucleic
aad constnret
is a phospholipid-dependent serine/threonine protein kinase or a part thereof
capable of
changing intracellular localisation upon activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid construct
is a CAMP-dependent protein kinase or a part thereof capable of changing
cellular localisati-
on upon activation. In a preferred embodiment the biologically active
polypeptide encoded by
the nucleic acid construct is a PKAc-F64L-S65T-GFP fusion.
CA 02450698 2003-12-23
11
In one embodiment the biologically active polypeptide encoded by the nucleic
acid
construct is a cGMP-dependent protein kinase or a part thereof capable of
changing
cellular localisation upon activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid
construct is a calmodulin-dependent serine/threonine protein kinase or a part
thereof
capable of changing cellular localisation upon activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid
construct is a mitogen-activated serine/threonine protein kinase or a part
thereof
capable of changing cellular localisation upon activation. In preferred
embodiments,
the biologically active polypeptide encoded by the nucleic acid constructs is
an
ERK1-F64L-S65T-GFP fusion or an EGFP-ERK1 fusion.
IS In one embodiment the biologically active polypeptide encoded by the
nucleic acid
construct is a cyclin-dependent serinelthreonine protein kinase or a part
thereof
capable of changing cellular localisation upon activation.
In one embodiment the biologically active polypeptide encoded by the nucleic
acid
construct is a protein phosphatase or a part thereof capable of changing
cellular
localisation upon activation.
In one preferred embodiment of the invention the nucleic acid constructs may
be
DNA constructs.
In one embodiment the gene encoding GFP in the nucleic acid construct is
derived
from Aequorea victoria. In a preferred embodiment the gene encoding GFP in the
nucleic acid construct is EGFP or a GFP variant selected from F64L-GFP, F64L-
Y66H-GFP and F64L-S65T-GFP.
In preferred embodiments of the invention the DNA constructs which can be
identified by any of the DNA sequences shown in SEQ ID NO: 38, 40, 42, 44, 46,
48,
50, 52, 54, 56, 58,60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 108, 100, 112, 114,
116,
118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142 or are
variants of
these sequences capable of encoding the same fusion polypeptide or a fusion
polypeptide which is biologically equivalent thereto, e.g. an isoform, or a
splice
variant or a homologue from another species.
CA 02450698 2003-12-23
12
Screening Program
The present invention relates to a method that may be used to establish a
screening
program for the identification of biologically active substances that directly
or
indirectly affect intracellular signalling pathways and because of this
property are
potentially useful as medicaments. Based on measurements in living cells of
the
redistribution of spatially resolved luminescence from luminophores which
undergo a
change in distribution upon activation or deactivation of an intracellular
signalling
pathway the result of the individual measurement of each substance being
screened
indicates its potential biological activity.
In one embodiment of the invention the screening program is used for the
identification of a biologically toxic substance as defined herein that exerts
its toxic
effect'by interfering with an intracellular signalling pathway. Based on
measurements
in living cells of the redistribution of spatially resolved luminescence from
luminophores which undergo a change in distribution upon activation or
deactivation
of an intracellular signalling pathway the result of the individual
measurement of each
substance being screened indicates its potential biologically toxic activity.
In one
embodiment of a screening program a compound that modulates a component of an
intracellular pathway as defined herein, can be found and the therapeutic
amount of
the compound estimated by a method according to the invention. In a preferred
embodiment the present invention leads to the discovery of a new way of
treating a
condition or disease related to the intracellular function of a biologically
active
polypeptide comprising administration to a patient suffering from said
condition or
disease of an effective amount of a compound which has been discovered by any
method according to the invention. fn another preferred embodiment of the
invention
a method is established for identification of a new drug target or several new
drug
targets among the group of biologically active polypeptides which are
components of
intracellular signalling pathways.
In another embodiment of the invention an individual treatment regimen is
established for the selective treatment of a selected patient suffering from
an ailment
where the available medicaments used for treatment of the ailment are tested
on a
relevant primary cell or cells obtained from said patient from one or several
tissues,
using a method comprising transfecting the cell or cells with at least one DNA
sequence encoding a fluorescent probe according to the invention, transferring
the
transfected cell or cells back the said patient, or culturing the cell or
cells under
CA 02450698 2003-12-23
12a
conditions permitting the expression of said probes and exposing it to an
array of the
available medicaments, then comparing changes in fluorescence patterns or
redistribution patterns of the fluorescent probes in the intact living cell or
cells to
CA 02450698 2003-12-23
13
detect the cellular response to the specific medicaments (obtaining a cellular
action profile),
then selecting one or more medicament or medicaments based on the desired
activity and
acceptable level of side effects and administering an effective amount of
these medicaments
to the selected patient.
Back-tracking of a signal transduction pathway
The present invention describes a method that may be used to establish a
screening pro-
gram for back-tracking signal transduction pathways as defined herein. In one
embodiment
the screening program is used to establish more precisely at which level one
or several
compounds affect a specific signal transduction pathway by successively or in
parallel test-
ing the influence of the compound or compounds on the redistribution of
spatially resolved
luminescence from several of the luminophores which undergo a change in
distribution upon
activation or deactivation of the intracellular signalling pathway under
study.
Construction and testing of probes
In general, a probe, i.e. a "GeneX"-GFP fusion or a GFP-"GeneX" fusion, is
constructed
using PCR with "GeneX"-specific primers followed by a cloning step to fuse
"GeneX" in
frame with GFP. The fusion may contain a short vector derived sequence between
"GeneX"
and GFP (e.g. part of a multiple cloning site region in the plasmid) resulting
in a peptide lin-
ker between "GeneX" and GFP in the resulting fusion protein.
Detailed ste wise orocedure~
- Identifying the sequence of the gene. This is most readily done by searching
a depository
of genetic information, e.g. the GenBank Sequence Database, which is widely
available and
routinely used by molecular biologists. In the specific examples below the
GenBank Acces-
sion number of the gene in question is provided.
- Design of gene-specific primers. Inspection of the sequence of the gene
allows design of
gene-specific primers to be used in a PCR reaction. Typically, the top-strand
primer en-
30 compasses the ATG start codon of the gene and the following approx. 20
nucleotides, while the
bottom-strand primer encompasses the stop codon and the approx. 20 preceding
nucleotides, if
CA 02450698 2003-12-23
14
the gene is to be fused behind GFP, i.e. a GFP-"GeneX" fusion. if the gene is
to be fused in
front of GFP, i.e. a "GeneX"-GFP fusion, a stop codon must be avoided.
Optionally, the full
length sequence of GeneX may not be used in the fusion, but merely the part
which localizes
and redistributes like GeneX in response to a signal.
In addition to gene-specific sequences, the primers contain at least one
recognition sequen-
ce for a restriction enzyme, to allow subsequent cloning of the PCR product.
The sites are
chosen so that they are unique in the PCR product and compatible with sites in
the cloning
vector. Furthermore, it may be necessary to include an exact number of
nucleotides betv~en
the restriction enzyme site and the gene-specific sequence in order to
establish the correct
reading frame of the fusion gene and/or a translation initiation consensus
sequence. Lastly,
the primers always contain a few nucleotides in front of the restriction
enzyme site to allow
efficient digestion with the enzyme.
-Identifying a source of the gene to be amplified. In order for a PCR reaction
to produce a
product with gene-speafic primers, the gene-sequence must initially be present
in the reacti-
on, e.g. in the form of cDNA. Information in GenBank or the scientific
literature will usually
indicate in which tissues) the gene is expressed, and cDNA libraries from a
great variety of
tissues or cell types from various species are commercially available, e.g.
from Clontech
(Palo Alto), Stratagene (La Jolla) and Invitrogen (San Diego). Many genes are
also available
in cloned form from The American Type Tissue Collection (Virginia).
- Optimizing the PCR reaction. Several factors are known to influence the
efficiency and
speaficity of a PCR reaction, including the annealing temperature of the
primers, the con-
centration of ions, notably Mgr' and K'', present in the reaction, as well as
pH of the reaction.
If the result of a PCR reaction is deemed unsatisfactory, it might be because
the parameters
mentioned above are not optimal. Various annealing temperatures should be
tested, e.g. in a
PCR machine with a built-in temperature gradient, available from e.g.
Stratagene (La Jotla),
andlor various buffer compositions should be tried, e.g. the OptiPrime buffer
system from
3o Stratagene (La Jolla).
CA 02450698 2003-12-23
- Cloning the PCR product. The vector into which the amplified gene product
will be cloned
and fused with GFP will already have been taken into consideration when the
primers were
designed. When choosing a vector, one should at least consider in which cell
types the pro-
be subsequently will be expressed, so that the promoter controlling expression
of the probe
is compatible with the cells. Most expression vectors also contain one or more
selective
markers, e.g. conferring resistance to a drug, which is a useful feature when
one wants to
make stable transfectants. The selective marker should also be compatible with
the cells to
be used.
10 The actual cloning of the PCR product should present no difficulty as it
typically will be a
one-step cloning of a fragment digested with two different restriction enzymes
into a vector
digested with the same two enzymes. If the cloning proves to be problematic,
it may be be-
cause the restriction enzymes did not work well with the PCR fragment. In this
case one
could add longer extensions to the end of the primers to overcome a possible
difficulty of di-
15 gestion close to a fragment end, or one could introduce an intermediate
cloning step not ba-
sed on restriction enzyme digestion. Several companies offer systems for this
approach, e.g.
Invitrogen (San Diegv) and Clontech (Palo Alto).
Once the gene has been cloned and, in the process, fused with the GFP gene,
the resulting
product, usually a plasmid, should be carefully checked to make sure it is as
expected. The
most exact test would be to obtain the nucleotide sequence of the fusion-gene.
Once a DNA construct for a probe has been generated, its functionality and
usefulness may
be tested by subjecting it to the following tests:
Transfecting it into cells capable of expressing the probe. The fluorescence
of the cell is
inspected soon after, typically the next day. At this point, two features of
cellular fluorescen
ce are noted: the intensity and the sub-cellular localization.
3A
CA 02450698 2003-12-23
~s
The intensity should usually be at least as strong as that of unfused GFP in
the cells. If it is
not, the sequence or quality of the probe-DNA might be faulty, and should be
carefully
checked.
The sub-cellular localization is an indication of whether the probe is likely
to perform well. If it
localizes as expected for the gene in question, e.g. is excluded from the
nucleus, it can im-
mediately go on to a functional test. If the probe is not localized soon after
the transfection
procedure, it may be because of overexpression at this point in time, as the
cell typically will
have taken of very many copies of the plasmid, and localization will occur in
time, e.g. within
~0 a few weeks, as plasmid copy number and expression level decreases. If
localization does
not occur after prolonged time, it may be because the fusion to GFP has
destroyed a locali-
zation function, e.g. masked a protein sequence essential for interaction with
its normal cel-
lular anchor-protein. In this case the opposite fusion might work, e.g. if
GeneX-GFP does not
work, GFP-GeneX might, as two different parts of GeneX will be affected by the
proximity to
t5 GFP. If this does not work, the proximity of GFP at either end might be a
problem, and it
could be attempted to increase the distance by incorporating a longer linker
between GeneX
and GFP in the DNA construct.
If there is no prior knowledge of localization, and no localization is
observed, it may be be-
cause the probe should not be localized at this point, because such is the
nature of the pro-
2o tein fused to GFP. It should then be subjected to a functional test.
In a functional test, the cells expressing the probe are treated with at least
one compound
known to perturb, usually by activating, the signalling pathway on which the
probe is expec-
ted to report by redistributing itself within the cell. If the redistribution
is as expected, e.g. if
prior knowledge tell that it should translocate from location X to location Y,
it has passed the
25 first critical test. In this case it can go on to further characterization
and quantification of the
response.
If It does not perform as expected, it may be because the cell lacks at least
one component
of the signalling pathway, e.g. a cell surface receptor, or there is species
incompatibility, e.g.
if the probe is modelled on sequence information of a human geneproduct, and
the cell is of
30 hamster origin. In both instances one should identify other cell types for
the testing process
where these potential problems would not apply.
CA 02450698 2003-12-23
1T
If there is no prior knowledge about the pattern of redistribution, the
analysis of the redistri-
bution will have to be done in greater depth to identify what the essential
and indicative fea-
tures are, and when this is clear, it can go on to further characterization
and quantification of
the response. If no feature of redistribution can be identified, the problem
might be as menti-
oned above, and the probe should be retested under more optimal cellular
conditions.
If the probe does not perform under optimal cellular conditions it's back to
the drawing board.
Developing an Image-based assay technique
The process of developing an image-based redistribution assay begins with
either the un-
to planned experimental observation that a redistribution phenomenon can be
visualised, or the
design of a probe specifically to follow a redistribution phenomenon already
known to occur.
In either event, the first and best exploratory technique is for a trained
scientist or technician
to observe the phenomenon. Even with the rapid advances in computing
technology, the
human eye-brain combination is still the most powertul pattern recognition
system known,
15 and requires no advance knowledge of the system in order to detect
potentially interesting
and useful patterns in raw data. This is especially if those data are
presented in the form of
images, which are the natural "data type" for human visual processing. Because
human vi-
sual processing operates most effectively in a relatively narrow frequency
range, i.e., we
cannot see either very fast or very slow changes in our visual field, it may
be necessary to
20 record the data and play it back with either time dilation or time
compression.
Some luminescence phenomena cannot be seen directly by the human eye. Examples
in-
clude polarization and fluorescence lifetime. However, with suitable filters
or detectors, these
signals can be recorded as images or sequences of images and displayed to the
human in
the fashion just described. In this way, patterns can be detected and the same
methods can
25 be applied.
Once the redistribition has been determined to be a reproducible phenomenon,
one or more
data sets are generated for the purpose of developing a procedure for
extracting the quanti-
tative information from the data. In parallel, the biological and optical
conditions are determi-
ned which will give the best quality raw data for the assay. This can become
an iterative pro-
30 cess; it may be necessary to develop a quantitative procedure in order to
assess the effect
on the assay of manipulating the assay conditions.
CA 02450698 2003-12-23
18
The data sets are examined by a person or persons with knowledge of the
biological phe-
nomenon and skill in the application of image processing techniques. The goal
of this exerci-
se is to determine or at least propose a method which wilt reduce the image or
sequence of
images constituting the record of a "response" to a value corresponding to the
degree of the
response. Using either interactive image processing software or an image
processing tool-
box and a programming language, the method is encoded as a procedure or
algorithm which
takes the image or images as input and generates the degree of response (in
any units) as
its output. Some of the criteria for evaluating the validity of a particular
procedure are:
Does the degree of the response vary in a biologically significant fashion,
i.e., does it
show the known or putative dependence on the concentration of the stimulating
agent or condition?
~ Is the degree of response reproducible, i.e., does the same concentration or
level of
stimulating agent or condition give the same response with an acceptable
variance?
~ Is the dynamic range of the response sufficient for the purpose of the
assay? If not,
can a change in the procedure or one of its parameters improve the dynamic
range?
~ Does the procedure exhibit any clear "pathologies", i.e., does it give
ridiculous values
for the response if there are commonly occur-ing imperfections in the imaging
pro
cess? Can these pathologies be eliminated, controlled, or accounted for?
~ Can the procedure deal with the normal variation in the number andlor size
of cells in
an image?
In some cases the method may be obvious: in others, a number of possible
procedures may
suggest themselves. Even if one method appears clearly superior to others,
optimisation of
parameters may be required. The various procedures are applied to the data set
and the
criteria suggested above are determined, or the single procedure is applied
repeatedly with
adjustment of the parameter or parameters until the most satisfactory
combination of signal,
noise, range, etc. are arrived at. This is equivalent to the calibration of
any type of single-
channel sensor.
The number of ways of extracting a single value from an image is extremely
large, and
thus an intelligent approach must be taken to the initial step of reducing
this number to a
small, finite number of possible procedures. This is not to say that the
procedure arrived at is
CA 02450698 2003-12-23
19
necessarily the best procedure - but a global search for the best procedure is
simply out of
the question due to the sheer number of possibilities involved.
Image-based assays are no different than other assay techniques in that their
usefulness is
characterised by parameters such as the speaficity for the desired component
of the
sample, the dynamic range, the variance, the sensitivity, the concentration
range over which
the assay will work, and other such parameters. While it is not necessary to
characterise e-
ach and every one of these before using the assay, they represent the only way
to compare
one assay with another.
xample: Develog!n_~a Cuantita_tve ashy for GLUT4 Tran,~loca_ ion
GLUT4 is a member of the class of glucose transporter molecules which are
important in
cellular glucose uptake. It is known to translocate to the plasma membrane
under some
conditions of stimulation of glucose uptake. The ability to visualize the
glucose uptake re-
sponse noninvasively, without actually measuring glucose uptake, would be a
very useful
assay for anyone looking for, for example, treatments for type II diabetes.
A CHO cell line which stably expressed the human insulin receptor was used as
the basis for
a new cell line which stably expressed a fusion between GLUT4 and GFP. This
cell line was
expected to show translocation of GLUT4 to the plasma membrane as visualized
by the
movement of the GFP. The translocation could definitely be seen in the form of
the appea-
rance of local increases in the fluorescence in regions of the plasma membrane
which had a
characteristic shape or pattern. This is shown in Figure 12.
These objects became known as "snircles", and the phenomenon of their
appearance as
"snircling". In order to quantitate their appearance, a method had to be found
to isolate them
as objects in the image field, and then enumerate them, measure their area, or
determine
some parameter about them which correlated in a dose-dependent fashion with
the concen-
tration of insulin to which the cells had been exposed. In order to separate
the snircles, a bi-
narization procedure was applied in which one copy of the image smoothed with
a relatively
severe gaussian kernel (sigma = 2.5) was subtracted from another copy to which
only a re-
latively light gaussian smooth had been applied (sigma=0.5). The resultant
image was re-
scaled to its min/max range, and an automatic threshold was applied to divide
the image into
two levels. The thresholded image contains a background of one value all found
object with
another value. The found objects were first filtered through a filter to
remove objects far too
CA 02450698 2003-12-23
large and far too small to be snircles. The remaining objects, which represent
snirctes and
other artifacts from the image with approximately the same size and intensity
characteristics
as snircles, are passed into a classification procedure which has been
previously trained with
many images of snirdes to recognize snircles and exclude the other artifacts.
The result of
this procedure is a binary image which shows only the found snircfes to the
degree to which
the classification procedure can accurately identify them. The total area of
the snirdes is
then summed and this value is the quantitative measure of the degree of
snircling for that
image.
10 Definitions:
In the present specification and claims, the term "an influence" covers any
influence to which
the cellular response comprises a redistribution. Thus, e.g., heating,
cooling, high pressure,
low pressure, humidifying, or drying are influences on the cellular response
on which the re-
sulting redistribution can be quant~ed, but as mentioned above, perhaps the
most important
15 influences are the influences of contacting or incubating the cell or cells
with substances
which are known or suspected to exert and influence on the cellular response
involving a re-
distribution contribution. In another embodiment of the invention the
influence could be sub-
stances from a compound drug library.
2o In the present context, the term "green fluorescent protein" is intended to
indicate a protein
which, when expressed by a cell, emits fluorescence upon exposure to light of
the correct
excitation wavelength (cf. [(Chalfie ef a1.1994)]). In the following, GFP in
which one or more
amino acids have been substituted, inserted or deleted is most often termed
"modified GFP".
"GFP" as used herein includes wild-type GFP derived from the jelly fish
Aequorea victoria
and modifications of GFP, such as the blue fluorescent variant of GFP disdosed
by Heim et
al. (1994). Proc.NatLAcad.Sa. 91:12501, and other modifications that change
the spectral
properties of the GFP fluorescence, or modifications that exhibit increased
fluorescence
when expressed in cells at a temperature above about 30°C described in
PCTlDK96100051,
published as WO 97111094 on 27 March 1997, which comprises fluorescent protein
derived from Aequorea Green Fluorescent Protein (GFP) or any functional
analogue
thereof, wherein the amino acid in position 1 upstream from the chromophore
has been
mutated to provide an increase of fluorescence intensity when the
CA 02450698 2003-12-23
21
fluorescent protein of the invention is expressed in cells. Prefen~ed GFP
variants are F64L-
GFP, F64L-Y66H-GFP anri F64L-S65T-GFP. An especially preferred variant of GFP
for use
in all the aspects of this invention is EGFP (DNA encoding EGFP which is a
F64L-S65T va-
riant with codons optimized for expression in mammalian cells is available
from Clontech,
Palo Alto, plasmids containing the EGFP DNA sequence, cf. GenBank Acc. Nos.
055762,
055763).
The term "intracellular signalling pathway" and "signal transduction pathway"
are intended to
indicate the coordinated intracellular processes whereby a living cell
transduce an external
or internal signal into cellular responses. Said signal transduction will
involve an enzymatic
reaction said enzymes include but are not limited to protein kinases, GTPases,
ATPases,
protein phosphatases, phospholipases. The cellular responses include but are
not limited to
gene transcription, secretion, proliferation, mechanical activity, metabolic
activity, cell death.
The term "second messenger" is used to indicate a low molecular weight
component invol-
ved in the early events of intracellular signal transduction pathways.
The term "luminophore" is used to indicate a chemical substance which has the
property of
emitting light either inherently or upon stimulation with chemical or physical
means. This in-
cludes but is not limited to fluorescence, bioluminescence, phosphorescence,
chemilumine-
2o scence.
The term "mechanically intact living cell" is used to indicate a cell which is
considered living
according to standard criteria for that particular type of cell such as
maintenance of normal
membrane potential, energy metabolism, proliferative capability, and has not
experienced
any physically invasive treatment designed to introduce external substances
into the cell
such as microinjection.
The term "physiologically relevant" ,when applied to an experimentally
determined redistribu-
tion of an intracellular component, as measured by a change in the
luminescence properties
or distribution, is used to indicate that said redistribution can be explained
in terms of the un-
derlying biological phenomenon which gives rise to the redistribution.
CA 02450698 2003-12-23
22
The terms "image processing" and "image analysis" are used to describe a large
family of di-
gitat data analysis techniques or combination of such techniques which reduce
ordered ar-
rays of numbers (images) to quantitative information describing those ordered
arrays of
numbers. When said ordered arrays of numbers represent measured values from a
physical
process, the quantitative information derived is therefore a measure of the
physical process.
The term "fluorescent probe" is used to indicate a fluorescent fusion
polypeptide comprising
a GFP or any functional part thereof which is N- or C-terminally fused to a
biologically active
polypeptide as defined herein, optionally via a peptide linker consisting of
one or more amino
acid residues, where the size of the linker peptide in itself is not critical
as tong as the desi-
red functionality of the fluorescent probe is maintained. A fluorescent probe
according to the
invention is expressed in a cell and basically mimics the physiological
behaviour of the biolo-
gically active polypeptide moiety of the fusion polypeptide.
The term "mammalian cell" is intended to indicate any living cell of mammalian
origin. The
cell may be an established cell line, many of which are available from The
American Type
Culture Collection (ATCC, Virginia, USA) or a primary cell with a limited life
span derived
from a mammalian tissue, including tissues derived from a transgenic animal,
or a newly
established immortal cell line derived from a mammalian tissue including
transgenic tissues,
or a hybrid cell or cell line derived by fusing different celltypes of
mammalian origin e.g. hy-
bridoma cell lines. The cells may optionally express one or more non-native
gene products,
e.g. receptors, enzymes, enzyme substrates, prior to or in addition to the
fluorescent probe.
Preferred cell lines include but are not limited to those of fibrobiast
origin, e.g. BHK. CHO,
BALB, or of endothelial origin, e.g. HUVEC, l3AE (bovine artery endothelial),
CPAE (cow
pulmonary artery endothelial) or of pancreatic origin, e.g. RIN, INS-1, MINti,
bTC3, aTC6,
bTC6, HIT, or of hematopoietic origin, e.g. adipocyte origin, e.g. 3T3-L9,
neuro-
nallneuroendocrine origin, e.g. AtT20, PC12, GH3, muscle origin, e.g. SKMC,
A10, C2C12,
renal origin, e.g. HEK 293. LLC-PK1.
The term "hybrid polypeptide" is intended to indicate a polypeptide which is a
fusion of at 1e-
ast a portion of each of two proteins, in this case at least a portion of the
green fluorescent
protein, and at least a portion of a catalytic and/or regulatory domain of a
protein kinase.
Furthermore a hybrid polypeptide is intended to indicate a fusion polypeptide
comprising a
CA 02450698 2003-12-23
23
GFP or at least a portion of the green fluorescent protein that contains a
functional fluorop-
hore, and at least a portion of a biologically active polypeptide as defined
herein provided
that said fusion is not the PKCa-GFP, PKCy-GFP, and PKCs-GFP disclosed by
Schmidt et
al.and Sakai et al., respectively. Thus, GFP may be N- or C-terminally tagged
to a biologi-
cally active polypeptide, optionally via a linker portion or linker peptide
consisting of a sequ-
ence of one or more amino acids. The hybrid polypeptide or fusion poiypeptide
may act as a
fluorescent probe in intact living cells carrying a DNA sequence encoding the
hybrid poly-
peptide under conditions permitting expression of said hybrid polypeptide.
The term "kinase" is intended to indicate an enzyme that is capable of
phosphorylating a
cellular component.
The term "protein kinase" is intended to indicate an enzyme that is capable of
phosphoryla-
tang serine and/or threonine andlor tyrosine in peptides andlor proteins.
The term "phosphatase" is intended to indicate an enzyme that is capable of
dephosphoryla
ting phosphoserine and/or phosphothreonine and/or phosphotyrosine in peptides
and/or
proteins.
In the present context, the term "biologically active polypeptide" is intended
to indicate a po-
lypeptide affecting intracellular processes upon activation, such as an enzyme
which is acti-
ve in intracellular processes or a portion thereof comprising a desired amino
acid sequence
which has a biological function or exerts a biological effect in a cellular
system. !n the poly-
peptide one or several aminoacids may have been deleted, inserted or replaced
to alter its
biological function, e.g. by rendering a catalytic site inactive. Preferably,
the biologically acti-
ve polypeptide is selected from the group consisting of proteins taking part
in an intracellular
signalling pathway, such as enzymes involved in the intracellular
phosphorylation and dep-
hosphorylation processes including kinases, protein kinases and phosphorylases
as defined
herein, but also proteins making up the cytoskeleton play important roles in
intracellular sig-
nal transduction and are therefore included in the meaning of "biologically
active polypeptide"
3o herein. More preferably, the biologically active polypeptide is a protein
which according to its
state as activated or non-activated changes localisation within the cell,
preferably as an in-
CA 02450698 2003-12-23
24
termediary component in a signal transduction pathway. Included in this
preferred group of
biologically active polypeptides are CAMP dependent protein kinase A.
The term "a substance having biological activity" is intended to indicate any
sample which
has a biological function or exerts a biological effect in a cellular system.
The sample may be
a sample of a biological material such as a sample of a body fluid including
blood, plasma,
saliva, milk, urine, or a microbial or plant extract, an environmental sample
containing pollu-
tants including heavy metals or toxins, or it may be a sample containing a
compound or
mixture of compounds prepared by organic synthesis or genetic techniques.
The phrase "any change in fluorescence" means any change in absorption
properties, such
as wavelength and intensity, or any change in spectral properties of the
emitted light, such
as a change of wavelength, fluorescence lifetime, intensity or polarisation,
or any change in
the intracellular localisation of the fluorophore. it may thus be localised to
a specific cellular
component (e.g. organelle, membrane, cytoskeleton, molecular structure) or it
may be
evenly distributed throughout the cell or parts of the cell.
The term "organism" as used herein indicates any unicellular or multiceilular
organism prefe-
rably originating from the animal kingdom including protozoans, but also
organisms that are
2o members of the plant kingdoms, such as algae, fungi, bryophytes, and
vascular plants are
included in this definition.
The term "nucleic acid" is intended to indicate any type of poly- or
oligonucleic acid sequen-
ce, such as a DNA sequence, a cDNA sequence, or an RNA sequence.
The term "biologically equivalent" as it relates to proteins is intended to
mean that a first
protein is equivalent to a second protein if the cellular functions of the two
proteins may sub-
stitute for each other, e.g. if the two proteins are closely related isoforms
encoded by diffe-
rent genes, if they are splicing variants, or allelic variants derived from
the same gene, if
3t) they perform identical cellular functions in different cell types, or in
different species. The
term "biologically equivalent" as it relates to DNA is intended to mean that a
first DNA ssqu-
CA 02450698 2003-12-23
ence encoding a polypeptide is equivalent to a second DNA sequence encoding a
pofypepti-
de if the functional proteins encoded by the two genes are biologically
equivalent.
The phrase "back-tracking of a signal transduction pathway" is intended to
indicate a process
5 for defining more precisely at what level a signal transduction pathway is
affected, either by
the influence of chemical compounds or a disease state in an organism.
Consider a speck
signal transduction pathway represented by the bioactive polypeptides A - B -
C - D, with
signal transduction from A towards D. When investigating all components of
this signal
transduction pathway compounds or disease states that influence the activity
or redistribu-
10 tion of only D can be considered to act on C or downstream of C whereas
compounds or
disease states that influence the activity or redistribution of C and D, but
not of A and B can
be considered to act downstream of B.
The term "fixed cells" is used to mean cells treated with a cytological
fixative such as glu-
15 taraldehyde or formaldehyde, treatments which serve to chemically cross-
link and stabilize
soluble and insoluble proteins within the structure of the cell. Once in this
state, such pro-
teins cannot be lost from the structure of the now-dead cell.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1. CHO cells expressing the PIfAc-F64L-S65T-GFP hybrid protein have
been treated
in HAM's F12 medium with 50 mM forskolin at 37°C. The images of the GFP
fluorescence in
these cells have been taken at different time intervals after treatment, which
were: a) 40 se-
conds b) 60 seconds c) 70 seconds d) 80 seconds. The fluorescence changes from
a
punctate to a more even distribution within the (non-nuclear) cytoplasm.
CA 02450698 2003-12-23
26
Figure 2. Time-lapse analysis of forskolin induced PKAo-F64L-S65T-GFP
redistribution.
CHO cells, expressing the PKAc-F64L-S65T-GFP fusion protein were analysed by
time-
lapse fluorescence microscopy. Fluorescence micrographs were acquired at
regular intervals
from 2 min before to 8 min after the addition of agonist. The cells were
challenged with 1 mM
forskolin immediately after the upper left image was acquired (t=0). Frames
were collected at
the following times: i) 0, ii) 1, iii) 2, iv) 3, v) 4 and vi) 5 minutes. Scale
bar 10 mm.
Figure 3. Time-lapse analyses of PI(Ac-F64L-S65T-GFP redistribution in
response to various
70 agonists. The effects of 1 mM forskolin (A), 50 mM forskolin (B), 1mM
dbcAMP (C) and 100
mM IBMX (D) (additions indicated by open arrows) on the localisation of the
PKAc-F64L-
S65T-GFP fusion protein were analysed by time-lapse fluorescence microscopy of
CHOlPKAc-F64L-S65T-GFP cells. The effect of addition of 10 mM forskolin (open
arrow),
followed shortly by repeated washing with buffer (solid arrow), on the
localisation of the
PKAc-F64L-S65T-GFP fusion protein was analysed in the same cells (E). In a
parallel expe-
riment, the effect of adding 10 mM forskolin and 100 mM IBMX (open arrow)
followed by re-
peated washing with buffer containing 100 mM IBMX (solid arrow) was analysed
(F). Remo-
ving forskolin caused PKAc-F64L-S65T-GFP fusion protein to return to the
cytoplasmic ag-
gregates while this is prevented by the continued presence of IBMX (F). The
effect of 100
nM glucagon (Fig 3G, open arrow) on the localisation of the PKAc-F64L-S65T-GFP
fusion
protein is also shown for BHK/GR, PhCAc-F64L-S65T-GFP cells. The effect of 70
mM norepi-
nephrine (H), solid arrow, on the localisation of the PKAc-F64L-S65T-GFP
fusion protein
was analysed similarly, in transiently transfected CHO, PKAc-F64L-S65T-GFP
cells, pretre-
ated with 10 mM forskolin, open arrow, to increase [CAMP],. N.B. in Fig 3H the
x-axis counts
the image numbers, with 12 seconds between images. The raw data of each
experiment
consisted of 60 fluorescence micrographs acquired at regular intervals
including several
images acquired before the addition of buffer or agonist. The charts (A-G)
each show a
quantification of the response seen through all the 60 images, performed as
described in
analysis method 2. The change in total area of the highly fluorescent
aggregates, relative to
the initial area of fluorescent aggregates is plotted as the ordinate in all
graphs in Figure 3,
versus time for each experiment. Scale bar 10 mm.
CA 02450698 2003-12-23
27
Figure 4. Dose response curve (two experiments) for forskolin-induced
redistribution of the
PKAc-F64L-S65T-GFP fusion.
Figure 5. Time from initiation of a response to half maximal (t,n",~) and
maximal (t""x) PKAc-
F64L-S65T-GFP redistribution. The data was extracted from curves such as that
shown in
"Figure 2." All t"Z""" and t",m, values are given as meanfSD and are based on
a total of 26-30
cells from 2-3 independent experiments for each forskolin concentration. Since
the observed
redistribution is sustained over time, the t""~ values were taken as the
earliest time point at
which complete redistribution is reached. Note that the values do not relate
to the degree of
redistribution.
Figure 6. Parallel dose response analyses of forskolin induced CAMP elevation
and PKAc-
F64L-S65T-GFP redistribution. The effects of buffer or 5 increasing
concentrations of forsko-
lin on the localisation of the PKAc-F64L-S65T-GFP fusion protein in CHO/PKAc-
F64L-S65T-
GFP cells, grown in a 96 well plate, were analysed as described above.
Computing the ratio
of the SD's of fluorescence micrographs taken of the same field of cells,
prior to and 30 min
after the addition of forskofin, gave a reproducible measure of PKAc-F64L-S65T-
GFP redi-
stribution. The graph shows the individual 48 measurements and a trace of
their me-
ants.e.m at each forskolin concentration. For comparison, the effects of
buffer or 8 increa-
sing concentrations of forskolin on [cAMPJ were analysed by a scintillation
proximity assay of
cells grown under the same conditions. The graph shows a trace of the mean ~
s.e.m of 4
experiments expressed in arbitrary units.
Figure 7. t3HK cells stabfy transfected with the human muscarinic (hM1)
receptor and the
PKCa-F64L-S65T-GFP fusion. Carbachol (100 mM added at 1.0 second) induced a
transient
redistribution of PKCa-F64L-S65T-GFP from the cytoplasm to the plasma
membrane. Ima-
ges were taken at the following times: a) 1 second before carbachol addition,
b) 8.8 seconds
after addition and c) 52.8 seconds after addition.
CA 02450698 2003-12-23
28
Figure 8. BHK cells stably transfected with the hM1 receptor and PKCa-F64L-
S65T-GFP
fusion were treated with carbachol (1 mM, 10 mM, 100 mM). In single cells
intracellular
[Cap'] wa5 monitored simultaneously with the redistribution of PKCa-F64L-S65T-
GFP. Da-
shed line indicates the addition times of carbachol. The top panel shows
changes in the in-
tracellular Ca2' concentration of individual cells with time for each
treatment. The middle pa-
ne) shows changes in the average cytoplasmic GFP fluorescence for individual
cells against
time for each treatment. The bottom panel shows changes in the fluorescence of
the perip-
hery of single cells, within regions that specifically include the
circumferential edge of a cell
1o as seen in normal projection, the regions which offers best chance to
monitor changes in the
fluorescence intensity of the plasma membrane.
Figure 9. a) The hERK1-F64t_-S65T-GFP fusion expressed in HEK293 cells treated
with 100
mM of the MEK1 inhibitor PD98059 in HAM F-12 (without serum) for 30 minutes at
37 °C.
t5 The nuclei empty of fluorescence during this treatment.
b) The same cells as in (a) following treatment with 10 % foetal calf serum
for 15 minutes at
37 °C.
c) Time profiles for the redistribution of GFP fluorescence in HEK293 cells
following treat-
ment with various concentrations of EGF in Hepes buffer (HAM F-12 replaced
with Hepes
2o buffer directly before the experiment). Redistribution of fluorescence is
expressed as the
change in the ratio value between areas in nucleus and cytoplasm of single
cells. Each time
profile is the mean for the changes seen in six single cells.
d) Bar chart for the end-point measurements, 600 seconds after start of EGF
treatments, of
fluorescence change (nucleus:cytoplasm) following various concentrations of
EGF.
Figure 10.
a) The SMAD2-EGFP fusion expressed in HEK293 cells starved of serum overnight
in HAM
F-12. HAM F-12 was then replaced with Hepes buffer pH 7.2 immediately before
the expe-
riment. Scale bar is 10 mm.
3o b) HEK 293 cells expressing the SMAD2-EGFP fusion were treated with various
concentra-
tion of TGF-beta as indicated, and the redistribution of fluorescence
monitored against time.
CA 02450698 2003-12-23
29
The time profile plots represent increases in fluorescence within the nucleus,
normalised to
starting values in each cell measured. Each trace is the time profile for a
single cell nucleus.
c) A bar chart representing the end-point change in fluorescence within nuclei
(after 850 se-
conds of treatment) for different concentrations of TGF-beta. Each bar is the
value for a
single nucleus in each treatment.
Figure 11. The VASP-F64L-S65T-GFP fusion in CHO cells stably transfected with
the hu-
man insulin receptor. The cells were starved for two hours in HAM F-12 without
serum, then
treated with 10% foetal calf serum. The image shows the resulting
redistribution of fluore-
scence after 15 minutes of treatment. GFP fluorescence becomes localised in
structures
identified as focal adhesions along the length of actin stress fibres.
Figure 12. Time lapse recording GLUT4-GFP redistribution in CHO-HIR cells.
Time indicates
minutes after the addition of 100 nM insulin.
CA 02450698 2003-12-23
EXAMPLE 1
5 Construction, testing and implementation of an assay for cAMP based on PKA
activation in
real time within living cells.
Useful for monitoring the activity of signalling pathways which lead to
altered concentrations
of CAMP, e.g. activation of G-protein coupled receptors which couple to G-
proteins of the GS
or G, class.
~o
The catalytic subunit of the murine CAMP dependent protein kinase (PKAchnras
fused C-
terminally to a F64L-S65T derivative of GFP. The resulting fusion (PKAo-F64L-
S65T-GFP)
was used for monitoring in vivo the translocation and thereby the activation
of PKA.
Construction of the PKAc-F64L-S65T-GFP fusion:
15 Convenient restriction endonuclease sites were introduced into the cDNAs
encoding murine
PKAc (Gen Bank Accession number: M12303) and F64L-S65T-GFP (sequence disclosed
in
WO 97/11094) by polymerase chain reaction (PCR). The PCR reactions were
pertormed ac-
cording to standard protocols with the following primers:
5'PKAc: TTggACACAAgCTTTggACACCCTCAggATATgggCAACgCCgCCgCCgCCAAg
20 (SEQ 1D N0:3),
3'PKAc:gTCATCTTCTCgAgTCTTTCAggCgCgCCCAAACTCAgTAAACTCCTTgCCACAC
(SEQ ID N0:4) ,
5'GFP: TTggACACAAgCTT'fggACACggCgCgCCATgAgTAAAggAgAAgAACTTTTC (SE(Z ID
N0:1 ),
25 3'GFP: gTCATCTTCTCgAgTCTTACTCCTgAgg-fTTgTATAgTTCATCCATgCCATgT (SEQ ID
N0:2).
CA 02450698 2003-12-23
31
The PKAc amplification product was then digested with Hindlll+Ascl and the
F64L-S65T-
GFP product with Asct+Xhol. The two digested PCR products were subsequently
ligated
with a Hindlll+Xho1 digested plasmid (pZeoSV~ mammalian expression vector,
Invitrogen,
San Diego, CA, USA). The resulting fusion construct (SEGl ID N0:68 & 69) was
under con-
trot of the SV40 promoter.
Transfection and cell culture conditions.
Chinese hamster ovary cells (CHO), were transfected with the plasmid
containing the PKAc-
F64L-S65T-GFP fusion using the calcium phosphate precipitate method in HEPES-
buffered
saline (Sambrook et al., 1989). Stable transfectants were selected using 1000
mg Zeocinlml
(lnvitrogen) in the growth medium (DMEM with 1000 mg giucose/I, 10 % fetal
bovine serum
(FBS), 100 mg penicillin-streptomycin mixture ml-', 2 mM L-glutamine purchased
from Life
Technologies Inc., Gaithersburg, MD, USA). Untransfected CHO cells were used
as the
control. To assess the effect of glucagon on fusion protein translocation, the
PKAc-F64L-
S65T-GFP fusion was stably expressed in baby hamster kidney cells
overexpressing the
human glucagon receptor (BHKlGR cells) Untransfected BHK/GR cells were used as
the
control. Expression of GR was maintained with 500 mg G418/ml (Neo marker)
andPKAc-
F64L-S65T-GFP was maintained with 500 mg Zeocinlml (Sh ble marker). CHO cells
were
also simultaneously co-transfected with vectors containing the PKAc-F64L-S65T-
GFP fusion
and the human a2a adrenoceptor (hARa2a).
2o For fluorescence microscopy, cells were allowed to adhere to Lab-Tek
chambered cover-
glasses (Nalge Nunc Int., Naperville. IL, USA) for at least 24 hours and
cultured to about
80% confluence. Prior to experiments, the cells were cultured over night
without selection
pressure. in HAM F-12 medium with glutamax (Life Technologies), 100 mg
penicillin-
streptomycin mixture m1' and 0.3 % FBS. This medium has low autofluorescence
enabling
fluorescence microscopy of cells straight from the incubator.
Monitoring activity of PKA activity in real time;
Image acquisition of live cells was gathered using a Zeiss AxiovertT"' 135M
fluorescence mi-
croscope fitted with a Fluar 40X, NA: 1.3 oil immersion objective and coupled
to a Photomet-
rics CH250 charged coupled device (CCD) camera. The cells were illuminated
with a 100 W
HBO arc lamp. In the light path was a 470120 nm excitation filter, a 510 nm
dichroic mirror
CA 02450698 2003-12-23
32
and a 515115 nm emission filter for minimal image background. The cells were
kept and
monitored to be at 37°C with a custom built stage heater.
Images were processed and analyzed in the following manner:.
Method 1: Stepwise procedure for quantitation of translocation of PKA:
1. The image was corrected for dark current by performing a pixel-by-pixel
subtraction of a
dark image (an image taken under the same conditions as the actual image,
except the
camera shutter is not allowed to open).
2. The image was corrected for non-uniformity of the illumination by
performing a pixel-by-
pixel ratio with a flat field correction image (an image taken under the same
conditions as the
actual image of a uniformly fluorescent specimen).
3. The image histogram, i.e., the frequency of occurrence of each intensity
value in the im-
age, was calculated.
4. A smoothed, second derivative of the histogram was calculated and the
second zero is
determined. This zero corresponds to the inflection point of the histogram on
the high side of
~ 5 the main peak representing the bulk of the image pixel values.
5. The value determined in step 4 was subtracted from the image. All negative
values were
discarded.
6. The variance (square of the standard deviation) of the remaining pixel
values was deter
mined. This value represents the "response" for that image.
7. Scintillation proximity assay (SPA) for independent quantitation of CAMP:
CA 02450698 2003-12-23
33
Method 2: Alternative method for quantitation of PKA redistribution:
1. The fluorescent aggregates are segmented from each image using an
automatically
found threshold based on the maximisation of the information measure between
the object
and background. The a priori entropy of the image histogram is used as the
information me-
asure.
2. The area of each image occupied by the aggregates is calculated by counting
pixels in
the segmented areas.
3. The value obtained in step 2 for each image in a series, or treatment pair,
is normalised to
the value found for the first (unstimulated) image collected. A value of zero
(0) indicates no
redistribution of fluorescence from the starting condition. A value of one (1)
by this method
equals full redistribution.
Cells were cultured in HAM F-12 medium as described above, but in 96-well
plates. The me-
dium was exchanged with Cap'-HEPES buffer including 100 mM IBMX and the cells
were
stimulated with different concentrations of forskolin for 10 min. Reactions
were stopped with
addition of NaOH to 0.14 M and the amount of CAMP produced was measured with
the
CAMP-SPA kit, RPA538 (Amersham) as described by the manufacturer.
Manipulating intracellular levels of CAMP to test the PKAc-F64L-S65T-GFP
fusion.
The following compounds were used to vary CAMP levels: Forskolin, an activator
of adeny-
late cyclase; dbcAMP, a membrane permeable CAMP analog which is not degraded
by
phosphodiesterase; IBMX, an inhibitor of phosphodiesterase.
CHO cells stably expressing the PKAc-Ffi4L-S65T-GFP, showed a dramatic
translocation of
the fusion protein from a punctate distribution to an even distribution
throughout the cyto-
plasm following stimulation with 1 mM forskolin (n=3), 10 mM forskolin (n=4)
and 50 mM
forskolin (n=4) (Fig 1 ), or dbcAMP at 1 mM (n=6).
Fig. 2 shows the progression of response in time following treatment with 1 mM
forskoiin.
CA 02450698 2003-12-23
34
Fig. 3 gives a comparison of the average temporal profiles of fusion protein
redistribution
and a measure of the extent of each response to the three forskolin
concentrations (Fig. 3A,
E, B), and to 1 mM dbcAMP (fig 3C) which caused a similar but slower response,
and to ad-
dition of 100 mM IBMX (n=4, Fig. 3D) which also caused a slow response, even
in the ab-
sense of adenylate cyclase stimulation. Addition of buffer (n=2) had no effect
(data not
shown).
As a control far the behavior of the fusion protein, F64L-S65T-GFP alone was
expressed in
CHO cells and these were also given 50 mM forskolin (n=5); the uniform diffuse
distribution
characteristic of GFP in these cells was unaffected by such treatment (data
not shown).
1o The forskolin induced translocation of PKAo-F64L-S65T-GFP showed a dose-
response re-
lationship (Fig 4 and 6), see quantitative procedures above.
Reversibility of PKAc-F64L-S65T-GFP translocation.
The release of the PKAc probe from its cytoplasmic anchoring hotspots was
reversible.
Washing the cells repeatedly (5-8 times) with buffer after 10uM forskolin
treatment comple-
tely restored the punctate pattern within 2-5 min (n=2, Fig. 3E). In fact the
fusion protein re-
turned to a pattern of fluorescent cytoplasmic aggregates virtually
indistinguishable from that
observed before forskolin stimulation.
To test whether the return of fusion protein to the cytoplasmic aggregates
reflected a decre-
ased [cAMP],, cells were treated with a combination of 10 mM forskolin and 100
mM IBMX
(n=2) then washed repeatedly (5-8 times) with buffer containing 100 mM IBMX
(Fig. 3F). In
these experiments, the fusion protein did not return to its prestimulatory
localization after
removal of forskolin.
Testing the PKA-F64L-S65T-GFP probe with physiologically relevant agents.
To test the probe's response to receptor activation of adenylate cyciase, BHK
cells stably
transfected with the glucagon receptor and the PKA-F64L-S65T-GFP probe were
exposed to
glucagon stimulation. The giucagon receptor is coupled to a Gs protein which
activates
adenylate cyclase, thereby increasing the cAMP level. In these cells, addition
of 100 nM glu-
capon (n=2) caused the release of the PKA-F64L-S65T-GFP probe from the
cytoplasmic
aggregates and a resulting translocation of the fusion protein to a more even
cytoplasmic
CA 02450698 2003-12-23
distribution within 2-3 min (Fig. 3G). Similar but less pronounced effects
were seen at tower
glucagon concentrations (n=2, data not shown). Addition of buffer (n=2) had no
effect over
time (data not shown).
Transiently transfected CHO cells expressing hARa2a and the PKA-F64L-S65T-GFP
probe
5 were treated with 10 mM forskolin for 7.5 minutes, then, in the continued
presence of
forskolin, exposed to 10 mM norepinephrine to stimulate the exogenous
adrenoreceptors,
which couple to a G, protein, which inhibit adenyiate cydase. This treatment
led to reappear-
ance of fluorescence in the cytoplasmic aggregates indicative of a decease in
[CAMP], (Fig.
3H).
Fusion protein translocation correlated with [CAMP],
As described above, the time it took for a response to come to completion was
dependent on
the forskolin dose (Fig. 5) In addition the degree of responses was also dose
dependent. To
test the PKA-F64L-S65T-GFP fusion protein translocation in a semi high through-
put sy-
stem, CHO cells stably transfected with the PKA-F64L-S65T-GFP fusion was
stimulated
with buffer and 5 increasing doses of forskolin (n=8). Using the image
analysis algorithm de-
scribed above (Method 1 ), a dose response relationship was observed in the
range from
0.01-50 mM forskolin (Fig. 6). A half maximal stimulation was observed at
about 2 mM for-
skolin. In parallel, cells were stimulated with buffer and 8 increasing
concentrations of for-
skolin (n=4) in the range 0.01-50 mM. The amount of cAMP produced was measured
in an
SPA assay. A steep increase was observed between 1 and 5 mM forskolin
coincident with
the steepest part of the curve for fusion protein translocation (also Fig. 6)
EXAMPLE 2
4uantitation of redistribution in real-time within living cells.
Probe for detection of PKC activity in real time within living cells:
Construction of PKC-GFP fusion:
CA 02450698 2003-12-23
36
The probe was constructed by ligating iwo restriction enryme treated
polymerase chain re-
action (PCR) amplification products of the cDNA for murine PKCa (GenBank
Accession
number. M25811 ) and F64L-S65T-GFP (sequence disGosed in WO 97111094)
respectively.
Taq~ poiymerase and the following oligonucleotide primers were used for PCR;
5'mPKCa: TTggACACAAgCTTTggACACCCTCAggATATggCTgACgTTTACCCggCCAACg
(SEA ID N0:5),
3'mPKCa:gTCATCTTCTCgAgTCTTTCAggCgCgCCCTACTgCACTTTgCAAgATTgggTgC
(SEQ 1D N0:6),
5'F64L-S65T-GFP: TTggACACAAgCTTTggACACggCgCgCCATgAgTAAAggAgAAgAACTT-
TTC (SEQ ID N0:1 ),
3'F64L-S65T-GFP: gTCATCTTCTCgAgTCTTACTCCTgAggTTtgTATAgTTCATCCATgC-
CATgT (SEQ ID N0:2).
The hybrid DNA strand was inserted into the pZeoSV~ mammalian expression
vector as a
Hindlll-Xhol casette as described in example 1.
Cell Culture:
BHK cells expressing the human M1 receptor under the control of the inducible
metal-
lothionine promoter and maintained with the dihydrofolate reductase marker
were trans-
fected with the PKCa-F64L-S65T-GFP probe using the calcium phosphate
precipitate
method in HEPES buffered saline (HBS [pH 7.10J}. Stable transfectants were
selected using
1000 ug Zeocin~lml in the growth medium (DMEM with 1000 mg glucosell, 10 %
foetal bo-
vine serum (FBS), 100 mg penicillin-streptomycin mixture mi-1, 2 mM I-
glutamine}. The hM1
receptor and PKCa-F64L-S65T-GFP fusion protein were maintained with 500 nM
methotrexate and 500 pg Zeocin~lml respectively. 24 hours prior to any
experiment, the
cells were transferred to HAM F-12 medium with glutamax, 100 Ng penicillin-
streptomycin
mixture mf~' and 0.3 % FBS. This medium relieves selection pressure, gives a
low induction
of signal transduction pathways and has a low autofluorescence at the relevant
wavelength
enabling fluorescence microscopy of cells straight from the incubator.
Monitoring the PKC activity in real time:
Digital images of live cells were gathered using a Zeiss Axiovert 135M
fluorescence micro-
scope fitted with a 40X, NA: 1.3 oil immersion objective and coupled to a
Photometrics
CA 02450698 2003-12-23
37
CH250 charged coupled device (CCD) camera. The cells were illuminated with a
100 W arc
lamp. In the light path was a 470120 nm excitation filter, a 510 nm dichroic
mirror and a
515115 nm emission filter for minimal image background. The cells were kept
and monitored
to be at 37°C with a custom built stage heater.
Images were analyzed using the IPLab software package for Macintosh.
Upon stimulation of the M1-BHK cells, stably expressing the PKCa-F64L-S65T-GFP
fusion,
with carbachol we observed a dose-dependent transient translocation from the
cytoplasm to
the plasma membrane (Fig. 7a,b,c). Simultaneous measurement of the cytosolic
free cal-
cium concentration shows that the carbachol-induced calcium mobilisation
precedes the
1o translocation (Fig. 8).
Stepwise procedure for quantitation of translocation of PKC:
9. The image was corrected for dark current by performing a pixel-by-pixel
subtraction of a
dark image (an image taken under the same conditions as the actual image,
except the
camera shutter is not allowed to open).
2. The image was corrected for non-uniformity of the illumination by
performing a pixel-by-
pixel ratio with a flat field correction image (an image taken under the same
conditions as the
actual image of a uniformly fluorescent specimen).
3. A copy of the image was made in which the edges are identified. The edges
in the image
are found by a standard edge-detection procedure ! convolving the image with a
kernel
2o which removes any large-scale unchanging components (i.e., background) and
accentuates
any small-scale changes (i.e., sharp edges). This image was then converted to
a binary im-
age by threshhotding. Objects in the binary image which are too small to
represent the
edges of ceNs were discarded. A dilation of the binary image was performed to
Dose any
gaps in the image edges. Any edge objects in the image which were in contact
with the bor-
dens of the image are discarded. This binary image represents the edge mask.
4_ Another copy of image was made via the procedure in step 3. This copy was
further
processed to detect objects which enclose "holesu and setting all pixels
inside the holes to
the binary value of the edge, i.e., one. This image represents the whole cell
mask.
5. The original image was masked with the edge mask from step 3 and the sum
total of all
pixel values is determined.
CA 02450698 2003-12-23
38
6. The original image was masked with the whole cell mask from step 4 and the
sum tote!
of all pixel values was determined.
7. The value from step 5 was divided by the value from step 6 to give the
final result, the
fraction of fluorescence intensity in the cells which was localized in the
edges.
EXAMPLE 3
Probes for detection of mitogen activated protein kinase Erk1 redistribution.
Useful for monitoring signalNng pathways involving MAPK, e.g. to identify
compounds which
~o modulate the activity of the pathway in living cells.
Erk1, a serineJthreonine protein kinase, is a component of a signalling
pathway which is acti-
vated by e.g. many growth factors.
Probes for detection of ERK-1 activity in real time within living cells:
~5 The extracellular signal regulated kinase (ERK-1, a mitogen activated
protein kinase, MAPK)
is fused N- or C-terminally to a derivative of GFP. The resulting fusions
expressed in differ-
ent mammalian cells are used for monitoring in vivo the nuclear translocation,
and thereby
the activation, of ERK1 in response to stimuli that activate the MAPK pathway.
a) Construction of murine ERK1 - F64L-S65T-GFP fusion:
20 Convenient restriction endonuclease sites are introduced into the cDNAs
encoding murine
ERK1 (Geni3ank Accession number: 214249) and F64L-S65T-GFP (sequence disclosed
in
WO 97111094) by polymerase chain reaction (PCR). The PCR reactions are
performed ac-
cording to standard protocols with the following primers:
5'ERK1: TTggACACAAgCTTTggACACCCTCAggATATggCggCggCggCggCggCTCCggggg-
25 gCgggg (SEQ ID N0:7),
CA 02450698 2003-12-23
39
3'ERKI:gTCATCTTCTCgAgTCTTTCAggCgCgCCCggggCCCTCTggCgCCCCTggCTgg
(SEQ ID N0:8),
5'F64L-S65T-GFP: TTggACACAAgCTTTggACACggCgCgCCATgAgTAAAggAgAAgAACTT-
TTC (SEQ ID N0:1)
3'F64L-S65T-GFP: gTCATCTTCTCgAgTCTTACTCCTgAggTTTgTATAgTTCATCCATgC-
CATgT (SEQ ID N0:2)
To generate the mERK1-F64L-S65T-GFP (SEA ID N0:56 & 57) fusion the ERK1
amplifica-
tion product is digested with Hindlll+Ascl and the F64L-S65T-GFP product with
Ascl+Xhol.
To generate the F64L-S65T-GFP-mERK1 fusion the ERK1 amplification product is
then di-
1o Bested with Hindlll+Bsu361 and the F64L-S65T-GFP product with
Bsu361+Xhol.The two
pairs of digested PCR products are subsequently ligated with a Hindlll+Xhol
digested plas-
mid (pZeoSV~ mammalian expression vector, Invitrogen, San Diego, CA, USA). The
resul-
ting fusion constructs are under control of the SV40 promoter.
15 b) The human Erk1 gene (GenBank Accession number X60188) was amplified
using PCR
according to standard protocols with primers Erk1-top (SEQ ID N0:9) and Erk1-
bottoml+stop (SEiD ID N0:10) . The PCR product was digested with restriction
enzymes E-
coR1 and BamH1, and ligated into pEGFP-C1 (Cfontech, Palo Alto; GenBank
Accession
number U55763) digested with EcoR1 and BamHl. This produces an EGFP-Erk1
fusion
20 (SEQ ID N0:38 839) under the control of a CMV promoter.
The piasmid containing the EGFP-Erk1 fusion was transfected into HEK293 cells
employing
the FUGENE transfection reagent (Boehringer Mannheim). Prior to experiments
the cells
were grown to 80%-90% confluency 8 well chambers in DMEM with 10% FCS. The
cells we-
25 re washed in plain HAM F-12 medium (without FCS), and then incubated for 30-
60 minutes
in plain HAM F-12 (without FCS) with 100 micromolar PD98059, an inhibitor of
MEK1, a ki-
vase which activates Erid; this step effectively empties the nudeus of EGFP-
Erkl. Just be-
fore starting the experiment, the HAM F-12 was replaced with Hepes buffer
following a wash
with Hepes buffer. This removes the PD98059 inhibitor, if blocking of MEK1 is
still wanted
30 (e.g. in control experiments), the inhibitor is included in the Hepes
buffer.
The experimental setup of the microscope was as described in example 1.
CA 02450698 2003-12-23
60 images were collected with 10 seconds between each, and with the test
compound added
after image number 10.
Addition of EGF (1-100 nM) caused within minutes a redistribution of EGFP-Erk1
from the
5 cytoplasm into the nucleus (Fig. 9a,b).
The response was quantitated as described below and a dose-dependent
relationship bet
ween EGF concentration and nuclear translocation of EGFP-Erk1 was found (Fig.
9c,d). Re
ditribution of GFP fluorescence is expressed in this example as the change in
the ratio value
between areas in nuclear versus cytoplasmic compartments of the cell. Each
time profile is
1o the average of nuclear to cytoplasmic ratios from six cells in each
treatment.
EXAMPLE 4:
Probes for detection of Erk2 redistribution.
Useful for monitoring signalling pathways involving MAPK, e.g. to identify
compounds which
15 modulate the activity of the pathway in living cells.
Erk2, a serine/threonine protein kinase, is closely related to Erk1 but not
identical; it is a
component of a signalling pathway which is activated by e.g. many growth
factors.
a) The rat Erk2 gene (GenBank Accession number: M64300) was amplified using
PCR ac-
2o cording to standard protocols with primers Erk2-top (SEQ ID N0:11 ) and
Erlc2-bottom)+stop
(SEQ ID N0:13) The PCR product was digested with restriction enzymes Xho1 and
BamH1,
and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession number
U55763) dige-
sted with Xho1 and BamH1. This produces an EGFP-Erk2 fusion (SEQ ID N0:40 841)
under
the control of a CMV promoter.
25 b) The rat Erk2 gene (GenBank Accession number: M64300) was amplified using
PCR ac-
cording to standard protocols with primers (SEQ ID N0:11 ) Erk2-top and Erk2-
bottom!-stop
(SEA )D N0:12). The PCR product was digested with restriction enzymes Xho1 and
BamH1,
and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession number
U55762) dige-
sted with Xho1 and BamH1. This produces an Erk2-EGFP fusion (SEA )D N0:58 &59)
under
30 the control of a CMV promoter.
CA 02450698 2003-12-23
41
The resulting plasmids were transfected into CHO cells and BHK cells. The
cells were grown
under standard conditions. Prior to experiments, the cells were starved in
medium without
serum for 48-72 hours. This led to a predominantly cytoplasmic localization of
both probes,
especially in BHK cells. 10°l° fetal calf serum was added to the
cells and the fluorescence of
the cells was recorded as explained in example 3. Addition of serum caused the
probes to
redistribute into the nucleus within minutes of addition of serum.
EXAMPLE 5:
Probes for detection of Smad2 redistribution.
Useful for monitoring signalling pathways activated by some members of the
transforming
growth factor-beta family, e.g. to identify compounds which modulate the
activity of the pa-
thway in living cells.
Smad 2, a signal transducer, is a component of a signalling pathway which is
induced by
some members of the TGFbeta family of cytokines.
a) The human Smad2 gene (GenBank Accession number: AF027964) was amplified
using
PCR according to standard protocols with primers Smad2-top (SEQ ID N0:24) and
Smad2-
bottom/+stop {SEQ ID N0:26) . The PCR product was digested with restriction
enzymes E-
2o coR1 and Acc651, and ligated into pEGFP-C1 (Clontech; Paio Alto; GenBank
Accession
number 055763) digested with EcoR1 and Acc651. This produces an EGFP-Smad2
fusion
(SEQ ID N0:50&51) under the control of a CMV promoter.
b) The human Smad2 gene (GenBank Accession number: AF027964) was amplified
using
PCR according to standard protocols with primers Smad2-top (SEQ ID N0:24) and
Smad2
bottom/-stop (SEQ ID N0:25) . The PCR product was digested with restriction
enzymes E-
coR1 and Acc651, and ligated into pEGFP-N1 (Ctontech, Palo Alto; GenBank
Accession
number 055762) digested with EcoR1 and Acc651. This produces a Smad2-EGFP
fusion
(SEQ ID N0:74 875) under the control of a CMV promoter.
The plasmid containing the EGFP-Smad2 fusion was transfected into HEK293
cells, where it
showed a cytoplasmic distribution. Prior to experiments the cells were grown
in 8 well Nunc
CA 02450698 2003-12-23
42
chambers in DMEM with 10% FCS to 80% confluency and starved overnight in HAM F-
12
medium without FCS.
For experiments, the HAM F-12 medium was replaced with Hepes buffer pH 7.2.
The experimental setup of the microscope was as described in example 1.
90 images were collected with 10 seconds between each, and with the test
compound added
after image number 5.
After serum starvation of cells, each nucleus contains less GFP fluorescence
than the sur
rounding cytoplasm (Fig. 10a). Addition of TGFbeta caused within minutes a
redistribution of
1o EGFP-Smad2 from the cytoplasma into the nucleus (Fig. 10b).
The redistribution of fluorescence within the treated cells was quantified
simply as the fracti-
onal increase in nuclear fluorescence normalised to the starting value of GFP
fluorescence
in the nucleus of each unstimulated cell.
15 EXAMPLE 6:
Probe for detection of VASP redistribution.
Useful for monitoring signalling pathways involving rearrangement of
cytoskeletal elements,
e.g. to identify compounds which modulate the activity of the pathway in
living cells.
VASP, a phosphoprotein, is a component of cytoskeletal structures, which
redistributes in
2o response to signals which affect focal adhesions.
a) The human VASP gene (GenBank Accession number: 246389) was amplified using
PCR
according to standard protocols with primers VASP-top (SEA ID N0:94) and VASP-
bottom/+stop (SEQ ID N0:95). The PCR product was digested with restriction
enrymes
Hind3 and BamH1, and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank
Accession
25 number U55763) digested with Hind3and BamH1. This produces an EGFP-VASP
fusion
(SEQ ID N0:124 &125) under the control of a CMV promoter.
The resulting plasmid was transfected into CHO cells expressing the human
insulin receptor
using the calcium-phosphate transfection method. Prior to experiments, cells
were grown in
8 well Nunc chambers and starved overnight in medium without FCS.
CA 02450698 2003-12-23
43
Experiments are performed in a microscope setup as described in example 1.
10°!° FCS was added to the cells and images were collected. The
EGFP-VASP fusion was
redistributed from a somewhat even distribution near the periphery into more
localized
structures, identiFed as focal adhesion points (Fig. 11).
A large number of further GFP fusions have been made or are in the process of
being made,
as apparent from the following Examples 7-22 which also suggest suitable host
cells and
substances for activation of the cellular signalling pathways to be monitored
and analyzed.
'10
EXAMPLE 7:
Probe for detection of actin redistribution.
~5 Useful for monitoring signalling pathways involving rearrangement or
formation of actin fila-
ments, e.g. to identify compounds which modulate the activity of pathways
leading to cyto-
skeletal rearrangements in living cells.
Actin is a component of cytoskeletal structures, which redistributes in
response to very many
cellular signals.
2a
The actin binding domain of the human alpha-actinin gene (GenBank Accession
number:
X15804) was amplified using PCR according to standard protocols with primers
ABD-top
(SEQ ID N0:90) and ABD-bottom/-stop (SEQ ID N0:91 ). The PCR product was
digested
with restriction enzymes Hind3 and BamHl, and ligated into pEGFP-N1 (Clontech,
Palo Alto;
25 GenBank Accession number U55762) digested with Hind3 and BamH1. This
produced an
actin-binding-domain-EGFP fusion (SEQ ID N0:128 X129) under the control of a
CMV pro-
moter.
The resulting plasmid was transfected into CHO cells expressing the human
insulin receptor.
Cells were stimulated with insulin which caused the actin binding domain-EGFP
probe to be-
3o come redistributed into morphologically distinct membrane-associated
structures.
CA 02450698 2003-12-23
44
Example B:
Probes for detection of p38 redistribution.
Useful for monitoring signalling pathways responding to various cellular
stress situations,
e.g. to identify compounds which modulate the activity of the pathway in
living cells, or as a
counterscreen.
p38, a serinelthronine protein kinase, is a component of a stress-induced
signalling pathway
which is activated by many types of cellular stress, e.g. TNFalpha,
anisomycin, UV and mi-
1o tomycin C.
a) The human p38 gene (GenBank Accession number: L35253) was amplified using
PCR
according to standard protocols with primers p38-top (SEQ ID N0:14) and p38-
bottom/+stop (SEA ID NO: 16). The PCR product was digested with restriction
enzymes
Xho1 and BamH1, and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank
Accession
number U55763) digested with Xho1 and BamHl. This produced an EGFP-p38 fusion
(SEQ
ID N0:46 &47) under the control of a CMV promoter.
b) The human p38 gene (GenBank Accession number: L35253) was amplified using
PCR
according to standard protocols with primers p38-top (SEQ ID N0:13) and p38-
bottoml-stop
2o (SEO ID N0:15) . The PCR product was digested with restriction enzymes Xho1
and
BamH1, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession
number
U55762) digested with Xho1 and BamH1. This produced a p38-EGFP fusion (SEA ID
N0:64
&65) under the control of a CMV promoter.
The resulting plasmids are transfected into a suitable cell line, e.g. HEK293,
in which the
EGFP-p38 probe and/or the p38-EGFP probe should change its cellular
distribution from
predominantly cytoplasmic to nuclear within minutes in response to activation
of the signal-
ling pathway with e.g. anisomycin.
Example 9:
3o Probes for detection of Jnk1 redistribution.
CA 02450698 2003-12-23
Useful for monitoring signalling pathways responding to various cellular
stress situations,
e.g. to identify compounds which modulate the activity of the pathway in
living cells, or as a
counterscreen.
Jnk1, a serinelthreonine protein kinase, is a component of a stress-induced
signalling pa-
s thway different from the p38 described above, though it also is activated by
many types of
cellular stress, e.g. TNFalpha, anisomycin and UV.
a) The human Jnk1 gene (GenBank Accession number: L26318) was amplified using
PCR
according to standard protocols with primers Jnk-top (SEQ ID N0:17) and Jnk-
bottom/+stop
10 (SEQ ID N0:19) . The PCR product was digested with restriction enzymes Xho1
and
BamHl, and ligated into pEGFP-C1 (Cfontech, Paio Alto; Genl3ank Accession
number
055763) digested with Xho1 and BamH1. This produced an EGFP-Jnk1 fusion (SED
ID
N0:44 &45) under the control of a CMV promoter.
b) The human Jnk1 gene (GenBank Accession number. L26318) was amplified using
PCR
15 according to standard protocols with primers Jnk-top (SEQ ID N0:17) and Jnk-
bottoml-stop
(SEQ ID N0:18) . The PCR product was digested with restriction enzymes Xho1
and
BamH1, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession
number
055762) digested with Xho1 and BamH1. This produced a Jnk1-EGFP fusion (SEQ ID
N0:62 &63) under the control of a CMV promoter.
20 The resulting plasmids are transfected into a suitable cell line, e.g.
HEK293, in which the
EGFP-Jnk1 probe and/or the Jnk1-EGFP probe should change its cellular
distribution from
predominantly cytoplasmic to nuclear in response to activation of the
signalling pathway with
e.g. anisomycin.
Example 10:
Probes for detection of PKG redistribution.
Useful for monitoring signalling pathways involving changes in cydic GMP
levels, e.g. to
identify compounds which modulate the activity of the pathway in living cells.
3o PGK, a cGMP-dependent serinelthreonine protein kinase, mediates the
guanylyl-
cydaseIcGMP signal.
CA 02450698 2003-12-23
as
a) The human PKG gene (GenBank Accession number: Y07512) is amplified using
PCR ac-
cording to standard protocols with primers PKG-top (SEQ !D N0:81 ) and PKG-
bottom!+stop
(SEQ ID N0;83) . The PCR product is digested with restriction enzymes Xho1 and
BamH1,
and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession number
055763) dige-
sted with Xho1 and BamHl. This produces an EGFP-PKG fusion (SEQ ID N0:134
&135)
under the control of a CMV promoter.
b) The human PKG gene (GenBank Accession number. Y07512) is ampl~ed using PCR
ac-
cording to standard protocols w'tth primers PKG-top (SEQ ID N0:81 ) and PKG-
bottom/-stop
(SEQ ID NO: 82) . The PCR product is digested with restriction enzymes Xho1
and BamH1,
and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession number
055762) dige-
sted with Xho1 and BamH1. This produces a PKG-EGFP fusion (SEQ ID N0:136 8137)
un-
der the control of a CMV promoter.
The resulting plasmids are transfected into a suitable cell line, e.g. A10, in
which the EGFP-
PKG probe and/or the PKG-EGFP probe should change its cellular distribution
from cyto-
plasmic to one associated with cytoskeletal elements within minutes in
response to treatment
with agents which raise nitric oxide (NO) levels.
Example 11:
2o Probes for detection of IkappaB kinase redistribution.
Useful for monitoring signalling pathways leading to NFkappaB activation, e.g.
to identify
compounds which modulate the activity of the pathway in living cells.
IkappaB kinase, a serine/threonine kinase, is a component of a signalling
pathway which is
activated by a variety of inducers including cytokines, lymphokines, growth
factors and
stress.
a) The alpha subunit of the human IkappaB kinase gene (GenBank Accession
number:
AF009225) is amplified using PCR according to standard protocols with primers
lKK-top
(SEQ ID N0:96) and IKK-bottom/+stop (SEQ ID N0:98). The PCR product is
digested with
restriction enzymes EcoR1 and Acc651, and ligated into pEGFP-C1 (Clontech,
Palo Alto;
CA 02450698 2003-12-23
a~
GenBank Accession number 055763) digested with EcoRland Acc651. This produces
an
EGFP-IkappaB-kinase fusion (SEQ ID N0:120 &121 ) under the control of a CMV
promoter.
b) The alpha subunit of the human IkappaB kinase gene (GenBank Accession
number:
AF009225) is amplified using PCR according to standard protocols with primers
IKK-top
(SEQ ID N0:96) and IKK-bottom/-stop (SECa ID N0:97). The PCR product is
digested with
restriction enzymes EcoR1 and Acc651, and ligated into pEGFP-N1 (Clontech,
Palo Alto;
GenBank Accession number 055762) digested with EcoR1 and Acc651. This produces
an
IkappaB-kinase-EGFP fusion (SEQ ID N0:122 &123) under the control of a CMV
promoter.
The resulting plasmids are transfected into a suitable cell line, e.g. Jurkat,
in which the
1o EGFP-IkappaB-kinase probe and/or the lkappaB-kinase-EGFP probe should
achieve a more
cytoplasmic distribution within seconds following stimulation with e.g.
TNFalpha.
Example 12:
Probes for detection of CDK2 redistribution.
15 Useful for monitoring signalling pathways of the cell cycle, e.g. to
identity compounds which
modulate the activity of the pathway in living cells.
CDK2, a cyclin-dependent serine/threonine kinase, is a component of the
signalling system
which regulates the cell cycle.
2o a) The human CDK2 gene (GenBank Accession number: X61622) is ampl~ed using
PCR
according to standard protocols with primers CDK2-top (SEGO ID N0:102) and
CDK2-
bottoml+stop (SEQ 1D NO: 104). The PCR product is digested with restriction
enzymes Xho1
and BamH1, and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession
number
055763) digested with Xho1 and BamH1. This produces an EGFP-CDK2 fusion (SEQ
ID
25 N0:114 8115) under the control of a CMV promoter.
b) The human CDK2 gene (GenBank Accession number: X61622) is amplified using
PCR
according to standard protocols with primers CDK2-top (SE(a ID N0:102) and
CDK2-
bottom/-stop (SEQ ID N0:103). The PCR product is digested with restriction
enzymes Xho1
and BamH1, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession
number
30 055762) digested with Xho1 and BamH1. This produces a CDK2-EGFP fusion (SEQ
ID
N0:112 8113) under the control of a CMV promoter.
CA 02450698 2003-12-23
48
The resulting plasmids are transfected into a suitable cell tine, e.g. HE1C293
in which the
EGFP-CDK2 probe and/or the CDt(2-EGFP probe should change its cellular
distribution
from cytoplasmic in contact-inhibited cells, to nuclear location in response
to activation with a
number of growth factors, e.g. IGF.
Example 13:
Probes for detection of GrkS redistribution.
Useful for monitoring signalling pathways involving desensitization of G-
protein coupled re
ceptors, e.g. to identify compounds which modulate the activity of the pathway
in living cells.
1o Grk5, a G-protein coupled receptor kinase, is a component of signalling
pathways involving
membrane bound G-protein coupled receptors.
a) The human Grk5 gene (GenBank Accession number: L15388) is amplified using
PCR ao-
cording to standard protocols with primers GrkS-top (SEQ ID N0:27) and Grk5-
15 bottom/+stop (SEQ ID N0:29). The PCR product is digested with restriction
enzymes EcoR1
and BamHl, and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession
number
U55763) digested with EcoR1 and BamH1. This produces an EGFP-Grk5 fusion (SEQ
ID
N0:42 &43) under the control of a CMV promoter.
b) The human Grk5 gene (GenBank Accession number: L15388) is amplified using
PCR ac-
20 cording to standard protocols with primers GrkS-top (SEQ ID N0:27) and GrkS-
bottom/-stop
(SEQ ID N0:28). The PCR product is digested with restriction enzymes EcoR1 and
BamH1,
and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession number
U55762) dige-
sted with EcoR1 and BamH1. This produces a Grk5-EGFP fusion (SEA ID N0:60 &61)
un-
der the control of a CMV promoter.
25 The resulting plasmids are transfected into a suitable cell line, e.g.
HEK293 expressing a rat
dopamine D1A receptor, in which the EGFP-Grk5 probe and/or the Grk5-EGFP probe
should change its cellular distribution from predominantly cytoplasmic to
peripheral in re-
sponse to activation of the signalling pathway with e.g. dopamine.
30 Example 14:
CA 02450698 2003-12-23
49
Probes for detection of Zap70 redistribution.
Useful for monitoring signalling pathways involving the T cell receptor, e.g.
to identify com-
pounds which modulate the activity of the pathway in living cells.
Zap70, a tyrosine kinase, is a component of a signalling pathway which is
active in e.g. T-cell
differentiation.
a) The human Zap70 gene (GenBank Accession number: L05148) is ampiifted using
PCR
according to standard protocols with primers Zap70-top (SED ID N0:105) and
Zap70-
bottom/+stop (SEQ ID N0:107). The PCR product is digested with restriction
enzymes E-
coR1 and BamHl, and ligated into pEGFP-C1 (GenBank Accession number U55763)
dige-
sted with EcoR1 and BamHl. This produces an EGFP-Zap70 fusion (SEQ ID N0:108
&109)
under the control of a CMV promoter.
b) The human Zap70 gene (GenBank Accession number: L05148) is amplified using
PCR
according to standard protocols with primers Zap70-top (SEQ ID N0:105) and
Zap70-
bottom/-stop (SEQ ID N0:106). The PCR product is digested with restriction
enzymes E-
coR1 and BamHl, and ligated into pEGFP-N1 (Clontech, Pala Alto; GenBank
Accession
number U55762) digested with EcoR1 and BamH1. This produces a Zap70-EGFP
fusion
(SEQ ID N0:110 &111 ) under the control of a CMV promoter.
The resulting plasmids are transfected into a suixable cell line, e.g. Jurkat,
in which the
EGFP-Zap70 probe and/or the Zap70-EGFP probe should change its cellular
distribution
from cytoplasmic to membrane-associated within seconds in response to
activation of the T
cell receptor signalling pathway with e.g. antibodies to CD3epsilon.
Example 15:
Probes for detection of p85 redistribution.
Useful for monitoring signalling pathways involving PI-3 kinase, e.g. to
identify compounds
which modulate the activity of the pathway in living cells.
p85a1pha is the regulatory subunit of P13-kinase which is a component of many
pathways
involving membrane-bound tyrosine kinase receptors and G-protein-coupled
receptors.
CA 02450698 2003-12-23
a) The human p85alpha gene (GenBank Accession number: M61906) was amplified
using
PCR according to standard protocols with primers p85-top-C (SEQ ID N0:22) and
p85-
bottom/+stop (SEQ ID N0:23) . The PCR product was digested with restriction
enzymes
Bgl2 and BamHl, and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank
Accession
5 number 055763) digested with Bgl2 and BamH1. This produced an EGFP-p85aipha
fusion
(SEQ 1D N0:48 &49) under the control of a CMV promoter.
b) The human p85alpha gene (GenBank Accession number: M61906) was amplified
using
PCR according to standard protocols with primers p85-top-N (SEQ ID N0:20) and
p85-
bottoml-stop (SEQ ID N0:21 ) . The PCR product was digested with restriction
enzymes E-
coR1 and BamHl, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank
Accession
number 055762) digested with EcoR1 and BamH1. This produced a p85alpha-EGFP
fusion
(SEQ ID N0:66 867) under the control of a CMV promoter.
The resulting plasmids are transfected into a suitable cell line, e.g. CHO
expressing the hu-
man insulin receptor, in which the EGFP-p85 probe and/or the p85-EGFP probe
may change
15 its cellular distribution from cytoplasmic to membrane-associated within
minutes in response
to activation of the receptor with insulin.
Example 16:
Probes for detection of protein-tyrosine phosphatase redistribution.
20 Useful for monitoring signalling pathways involving tyrosine kinases, e.g.
to identify com-
pounds which modulate the activity of the pathway in living cells.
Protein-tyrosine phosphataselC, a tyrosine-specific phosphatase, is an
inhibitory compo-
nent in signalling pathways involving e.g. some growth factors.
25 a) The human protein-tyrosine phosphatase 1 C gene (GenBank Accession
number: X62055)
is amplified using PCR according to standard protocols with primers PTP-top
(SEQ ID
N0:99) and PTP-bottom/+stop (SEQ ID N0:101 ). The PCR product is digested with
restricti-
on enzymes Xho1 and EcoRl, and ligated into pEGFP-C1 (Clontech, Palo Alto;
GenBank
Accession number 055763) digested with Xho1 and EcoRl. This produces an EGFP-
PTP
3o fusion (SEQ ID N0:116 &117) under the control of a CMV promoter.
CA 02450698 2003-12-23
51
b) The human protein-tyrosine phosphatase 1 C gene (GenBank Accession number:
X62055)
is amplified using PCR according to standard protocols with primers PTP-top
(SEQ ID
N0:99) and PTP-bottom/-stop (SEQ ID N0:100). The PCR product is digested with
restricti-
on enzymes Xho1 and EcoRl, and ligated into pEGFP-N1 (Clontech, Palo Alto;
GenBank
Accession number 055762) digested with Xho1 and EcoRl. This produces a PTP-
EGFP
fusion (SEQ ID N0:118 8119) under the control of a CMV promoter.
The resulting plasmids are transfected into a suitable cell line, e.g. MCF-7
in which the
EGFP-PTP probe and/or the PTP-EGFP probe should change its cellular
distribution from
cytoplasm to the plasma menbrane within minutes in response to activation of
the growth
inhibitory signalling pathway with e.g. somatostatin.
Example 17:
Probes for detection of Smad4 redistribution.
Useful for monitoring signalling pathways involving most members of the
transforming
growth factor beta family, e.g. to identify compounds which modulate the
activity of the pa-
thway in living cells.
Smad4, a signal transducer, is a common component of signalling pathways
induced by va-
rious members of the TGFbeta family of cytokines.
a) The human Smad4 gene (Gent3ank Accession number. 044378) was amplified
using
PCR according to standard protocols with primers Smad4-top and Smad4-
bottom/+stop
(SEQ 1D N0:35) . The PCR product was digested with restriction enzymes EcoR1
and
BamH1, and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession
number
055763) digested with EcoR1 and BamH1. This produce an EGFP-Smad4 fusion (SEGI
ID
N0:52 853) under the control of a CMV promoter.
b) The human Smad4 gene (GenBank Accession number: 044378) was amplified using
PCR according to standard protocols with primers Smad4-top (SEQ ID N0:33) and
Smad4-
bottoml-stop (SEQ ID N0:34). The PCR product was digested with restriction
enzymes E-
coR1 and BamH1, and ligated into pEGFP-N1 (Clontech, Palo Alto; Genl3ank
Accession
number 055762) digested with EcoR1 and BamHl. This produced a Smad4-EGFP
fusion
(SEQ ID N0:76 877) under the control of a CMV promoter.
CA 02450698 2003-12-23
52
The resulting ptasmids are transfected into a cell line, e.g. HEK293 in which
the EGFP-
Smad4 ~ probe and/or the Smad4-EGFP probe should change its cellular
distribution within
minutes from cytoplasmic to nuGear in response to activation of the signalling
pathway with
e.g. TGFbeta.
Example 18:
Probes for detection of Stat5 redistribution.
Useful for monitoring signalling pathways involving the activation of tyrosine
kinases of the
Jak family, e.g. to identity compounds which modulate the activity of the
pathway in living
t0 cells.
StatS, signal transducer and activator of transcription, is a component of
signalling pathways
which are induced by e.g. many cytokines and growth factors.
a) The human StatS gene (GenBank Accession number: L41142) was amplified using
PCR
according to standard protocols with primers StatS-top (SEQ 10'.N0:30) and
StatS-
bottom!+stop (SEQ ID N0:32). The PCR product was digested with restriction
enzymes Bgl2
and Acc651, and ligated into pEGFP-C1 (Clontech; Palo Alto; GenBank Accession
number
U55763) digested with Bgl2 and Acc651. This produced an EGFP~StatS fusion (SEA
ID
N0:54 855) under the control of a CMV promoter.
b) The human Stat5 gene (GenBank Accession number: L41142) was amplified using
PCR
according to standard protocols with primers StatS-top (SECT ID N0:30) and
StatS-bottom/-
stop (SEQ ID N0:3). The PCR product as digested with restriction enzymes Bgl2
and
Ace65l, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession
number
U55762) digested with Bgl2 and Acc651. This produced a StatS-EGFP fusion (SEA
ID N0:78
879) under the control of a CMV promoter.
The resulting piasmids are transfected into a suitable cell line, e.g. MIN6 in
which the EGFP-
Stat5 probe and/or the StatS-EGFP probe should change its cellular
distribution from cyto-
plasmic !o nuGear within minutes in response to activation signalling pathway
with e.g. pro-
lactin.
CA 02450698 2003-12-23
53
Example 19:
Probes for detection of NFAT redistribution.
Useful for monitoring signalling pathways involving activation of NFAT, e.g.
to identify com-
pounds which modulate the activity of the pathway in living cells.
NFAT, an activator of transcription, is a component of signalling pathways
which is involved
in e.g. immune responses.
a) The human NFAT1 gene (GenBank Accession number: U43342) is amplified using
PCR
according to standard protocols with primers NFAT-top (SEQ ID N0:84) and NFAT-
i0 bottom/+stop (SEQ ID N0:86). The PCR product is digested with restriction
enzymes Xho1
and EcoR1, and tigated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession
number
U55763) digested with Xho1 and EcoR1. This produces an EGFP-NFAT fusion (SEQ
ID
N0:130 $131 ) under the control of a CMV promoter.
b) The human NEAT gene (GenBank Accession number: U43342) is amplified using
PCR
according to standard protocols with primers NFAT-top (SEQ ID N0:84) and NFAT-
bottoml-
stop (SEGl ID N0:85). The PCR product is digested with restriction enzymes
Xho1 and E-
coRl, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession number
U55762) digested with Xho1 and EcoRl. This produces an NFAT-EGFP fusion (SEQ
ID
N0:132 8133) under the control of a CMV promoter.
The resulting piasmids are transfected into a suitable cell line, e.g. Jurkat,
in which the
EGFP-NFAT probe andlor the NFAT-EGFP probe should change its cellular
distribution
from cytopiasmic to nuclear within minutes in response to activation of the
signalling pathway
with e.g. antibodies to CD3epsilon.
Example 20:
Probes for detection of NFkappaB redistribution.
Useful for monitoring signalling pathways leading to activation of NFkappa8,
e.g. to identify
compounds which modulate the activity of the pathway in living cells.
CA 02450698 2003-12-23
54
NFkappaB, an activator of transcription, is a component of signalling pathways
which are
responsive to a vanity of inducers including cytokines, fymphakines, some
immunosuppressi-
ve agents.
a) The human NFkappa8 p65 subunit gene (GenBank Accession number: M62399) is
am-
plified using PCR according to standard protocols with primers NFkappaB-top
{SEQ ID
N0:87) and NFkappaB-bottom!+stop (SEQ ID N0:89). The PCR product is digested
with
restriction enzymes Xho1 and BamHl, and iigated into pEGFP-C1 (Clontech, Palo
Alto;
GenBank Accession number 055763) digested with Xho1 and BamH1. This produces
an
1o EGFP-NFkappaB fusion (SEQ !D NO:142 & 143) under the control of a CMV
promoter.
b) The human NFkappaB p65 subunit gene (Genf3ank Accession number: M62399) is
am-
plified using PCR according to standard protocols with primers NFkappaB-top
(SEQ ID
N0:87) and NFkappaB-bottom/-stop (SEQ ID N0:88). The PCR product is digested
with re-
striction enzymes Xho1 and BamHl, and ligated into pEGFP-N1 (Clontech, Palo
Alto; Gen-
Bank Accession number 055762) digested with Xho1 and BamH1. This produces an
NFkappaB-EGFP fusion (SEQ ID N0:140 8 141 j under the control of a CMV
promoter.
The resulting plasmids are transfected into a suitable cell tine, e.g. Jurkat,
in which the
EGFP-NFkappaB probe andtor the NFkappaB-EGFP probe should change its cellular
distri-
bution from cytoplasmic to nuclear in response to activation of the signalling
pathway with
2o e.g. TNFalpha.
Example 21:
Probe for detection of RhoA redistribution.
Useful for monitoring signalling pathways involving RhoA, e.g. to identify
compounds which
modulate the activity of the pathway in living cells.
RhoA, a small GTPase, is a component of many signalling pathways, e.g. LPA
induced cyto-
skeletal rearrangements.
The human RhoA gene (GenBank Accession number: L25080) was amplified using PGR
according to standard protocols with primers RhoA-top (SEQ ID N0:92) and RhoA-
bottom/+stop (SEQ ID N0:93). The PCR product was digested with restriction
enzymes
CA 02450698 2003-12-23
Hind3 and BamHl, and ligated into pEGFP-C1 (Ciontech, Palo Alto; GenBank
Accession
number U55763) digested with Hind3and BamH1. This produced an EGFP-RhoA fusion
(SEQ ID N0:126 8127) under the control of a CMV promoter.
The resulting plasmid is transfected into a suitable cell line, e.g. Swiss3T3,
in which the
5 EGFP-RhoA probe should change its cellular distribution from a reasonably
homogenous to
a peripheral distribution within minutes of activation of the signalling
pathway with e.g. LPA.
Example 22:
Probes for detection of PKB redistribution.
Useful for monitoring signalling pathways involving PKB e.g. to identify
compounds which
10 modulate the activity of the pathway in living cells.
PKB, a serine/threonine kinase, is a component in various signalling pathways,
many of
which are activated by growth factors.
a) The human PKB gene (GenBank Accession number: M63167) is amplified using
PCR ac-
15 cording to standard protocols with primers PKB-top (SEQ ID N0:36) and PKB-
bottom/+stop
(SEQ ID N0:80) . The PCR product is digested with restriction enzymes Xho1 and
BamH1,
and ligated into pEGFP-C1 (Clontech, Palo Alto; GenBank Accession number
U55763) dige-
sted with Xho1 and BamHl. This produces an EGFP-PKB fusion (SEQ ID N0:13ii &
139)
under the control of a CMV promoter.
20 b) The human PKB gene (GenBank Accession number: M63167) was amplified
using PCR
according to standard protocols with primers PKB-top (SEQ ID N0:36) and PKB-
bottom/-
stop (SEQ ID N0:37) . The PCR product was digested with restriction enzymes
Xho1 and
BamH1, and ligated into pEGFP-N1 (Clontech, Palo Alto; GenBank Accession
number
U55762) digested with Xho1 and BamHl. This produced a PKB-EGFP fusion (SEQ ID
25 NO:70 871) under the control of a CMV promoter.
The resulting piasmids are transfected into a suitable cell tine, e.g. CHO
expressing the hu-
man insulin receptor, in which the EGFP-PKB probe and/or the PKB-EGFP probe
cycles
between cytoplasmic and membrane locations during the activation-deactivation
process
following addition of insulin. The transition should be apparent within
minutes.
CA 02450698 2003-12-23
56
REFERENCES:
Adams, S.R., Harootunian, A.T., Buechler, Y.J., Taylor, S.S. & Tsien, R.Y.
(1991) Nature
348, 694-697
Blobe, G.C., Stribling, D.S., Fabbro, D., Stabel, S & Hannun, Y.A. (1996) J.
Biol. Chem. 271,
15823-15830
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W. & Prasher, D.C. (1994) Science
263, 802-
805
Cossette, L,J., Hoglinger, O., Mou, L.J. 8 Shen. S.H. (1997) Exp. Celi Res.
223, 459-466
1o Del3emardi, M.A. 8 Brooker, G. (1996) Proc. Natl. Acad. 5ci. USA 93, 4577-
4582
Farese, R.V.. (1992) Biochem. J. 288, 319-323
Fulop Jr., T., Leblanc, C., Lacombe, G. 8~ Dupuis, G. (1995) FEES Lett. 375,
69-74
Godson, C., Masliah, E., Balboa, M.A., Ellisman, M.H. & Insel, P.A. (1996)
Biochem. Sio-
phys. Acta 1313, 63-71
Khalii, R.A., Lajoie, C., Resnidc, M.S. 8 Morgan, K.G. (1992) American
Physiol. Society c,
714-719
Sano, M., Kohno, M. & Iwanaga, M. (1995) Brain Res. 688, 213-218
Bastiaens, P.LH. & Jovin, T.M. (1996) Proc. Natl. Acad. Sci. USA 93, 8407-8412
Schmidt, D.J., Ikebe, M., Kitamura, K., & Fay, F.S. (1997) FASEB J. 11, 2924
(Abstract)
2o Sakai, N., Sasaki, K., Hasegawa, C., Ohkura, M., Suminka, K., Shiraf, Y. 8.
Saito, N. (1996)
Soc. Neuroscience 22, 69P (Abstract)
Sakai, N., Sakai, K. Hasegawa, C., Ohkura, M., Sumioka, ., Shirai, Y., &
Naoaki, S. (1997)
Japanese Journal of Pharmacology 73, 69P (Abstract of a meeting held 22-23
March)
CA 02450698 2003-12-23
57
SEQUENCE LISTING
(1) GENERAL INFORMATION
(i) APPLICANT: BioImage A/s
(ii) TITLE OF THE INVENTION: A METHOD FOR SCREENING SUBSTANCES FOR
EFFECT ON cAMP LEVELS BASED ON
INTRACELLULAR TRANSLOCATION OF PKA
(iii) NUMBER OF SEQUENCES: 143
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: BioImage A/S
(B) STREET: Mrzrkh0j Bygade 28
(C) CITY: Sraborg
(D) STATE: DK
(E) COUNTRY: DENMARK
(F) ZIP: 2860
(v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Diskette
(B) COMPUTER: IBM Compatible
(C) OPERATING SYSTEM: DOS
(D) SOFTWARE: FastSEQ for Windows Version 2.0
(vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER: 2,286,293
(B) FILING DATE: April 7, 1998
(vii) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER: DK 0392/97
(B) FILING DATE: April 7, 1997
(viii) PATENT AGENT INFORMATION:
(A) NAME: Patricia A. Rae (Dr.)
(B) REFERENCE NUMBER: 11467-11/PAR
(2) INFORMATION FOR SEQ ID NO:1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 53 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:
TTGGACACAA GCTTTGGACA CGGCGCGCCA TGAGTAAAGG AGAAGAACTT TTC 53
(2) INFORMATION FOR SEQ ID N0:2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 53 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
CA 02450698 2003-12-23
58
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:2:
GTCATCTTCT CGAGTCTTAC TCCTGAGGTT TGTATAGTTC ATCCATGCCA TGT 53
(2) INFORMATION FOR SEQ ID N0:3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 54 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:3:
TTGGACACAA GCTTTGGACA CCCTCAGGAT ATGGGCAACG CCGCCGCCGC CAAG 54
(2) INFORMATION FOR SEQ ID N0:4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 55 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:4:
GTCATCTTCT CGAGTCTTTC AGGCGCGCCC AAACTCAGTA AACTCCTTGC CACAC 55
(2) INFORMATION FOR SEQ ID N0:5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 55 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:5:
TTGGACACAA GCTTTGGACA CCCTCAGGAT ATGGCTGACG TTTACCCGGC CAACG 55
(2) INFORMATION FOR SEQ ID N0:6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 55 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:6:
GTCATCTTCT CGAGTCTTTC AGGCGCGCCC TACTGCACTT TGCAAGATTG GGTGC 55
(2) INFORMATION FOR SEQ ID N0:7:
CA 02450698 2003-12-23
59
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 64 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:7:
TTGGACACAA GCTTTGGACA CCCTCAGGAT ATGGCGGCGG CGGCGGCGGC TCCGGGGGGC 60
GGGG 64
(2) INFORMATION FOR SEQ ID N0:8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 55 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:8:
GTCATCTTCT CGAGTCTTTC AGGCGCGCCC GGGGCCCTCT GGCGCCCCTG GCTGG 55
(2) INFORMATTON FOR SEQ ID N0:9:
(i) SEQUENCE CHARACTERTSTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:9:
TAGAATTCAA CCATGGCGGC GGCGGCGGCG 30
(2) INFORMATION FOR SEQ ID NO:10:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRTPTION: SEQ ID NO:10:
TAGGATCCCT AGGGGGCCTC CAGCACTCC 29
(2) INFORMATION FOR SEQ ID NO:11:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
CA 02450698 2003-12-23
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:
TACTCGAGTA ACCATGGCGG CGGCGGCGGC G 31
(2) INFORMATION FOR SEQ ID N0:12:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 25 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:12:
TAGGATCCAT AGATCTGTAT CCTGG 25
(2) INFORMATION FOR SEQ ID N0:13:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 26 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:13:
TAGGATCCTT AAGATCTGTA TCCTGG 26
(2) INFORMATION FOR SEQ ID N0:14:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:14:
ATCTCGAGGG AAAATGTCTC AGGAGAGG 2g
(2) INFORMATION FOR SEQ ID N0:15:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:15:
ATGGATCCTC GGACTCCATC TCTTCTTG 2g
(2) INFORMATION FOR SEQ ID N0:16:
(i) SEQUENCE CHARACTERISTICS:
CA 02450698 2003-12-23
61
(A) LENGTH: 29 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:16:
ATGGATCCTC AGGACTCCAT CTCTTCTTG 2g
(2) INFORMATION FOR SEQ ID N0:17:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:17:
GTCTCGAGCC ATCATGAGCA GAAGCAAG 2g
(2) INFORMATION FOR SEQ ID N0:18:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:18:
GTGGATCCCA CTGCTGCACC TGTGCTA 27
(2) INFORMATION FOR SEQ ID N0:19:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:19:
GTGGATCCTC ACTGCTGCAC CTGTGCTA 2g
(2) INFORMATION FOR SEQ ID N0:20:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 40 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:20:
CA 02450698 2003-12-23
62
CGCGAATTCC GCCACCATGA GTGCTGAGGG GTACCAGTAC 40
(2) INFORMATION FOR SEQ ID N0:21:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:21:
CGCGGATCCT GTCGCCTCTG CTGTGCATAT AC 32
(2) INFORMATION FOR SEQ ID N0:22:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(vi) ORIGINAL SOURCE:
(A) ORGANISM: p85-top-C
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:22:
GGGAGATCTA TGAGTGCTGA GGGGTACCAG 30
(2) INFORMATION FOR SEQ ID N0:23:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:23:
GGGCGGATCC TCATCGCCTC TGCTGTGCAT ATAC 34
(2) INFORMATION FOR SEQ ID N0:24:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:24:
GTGAATTCGA CCATGTCGTC CATCTTGCCA TTC 33
(2) INFORMATION FOR SEQ ID N0:25:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
CA 02450698 2003-12-23
63
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:25:
GTGGTACCCA TGACATGCTT GAGCAACGCA C 31
(2) INFORMATION FOR SEQ ID N0:26:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:26:
GTGGTACCTT ATGACATGCT TGAGCAACGC AC 32
(2) INFORMATION FOR SEQ ID N0:27:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:27:
GTGAATTCGT CAATGGAGCT GGAAAACATC G 31
(2) INFORMATION FOR SEQ ID N0:28:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:28:
GTGGATCCCT GCTGCTTCCG GTGGAGTTCG 30
(2) INFORMATION FOR SEQ ID N0:29:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:29:
GTGGATCCCT AGCTGCTTCC GGTGGAGTTC G 31
CA 02450698 2003-12-23
64
(2) INFORMATION FOR SEQ ID N0:30:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:30:
GTAGATCTAC CATGGCGGGC TGGATCCAGG CC 32
(2) INFORMATION FOR SEQ ID N0:31:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:31:
GTGGTACCCA TGAGAGGGAG CCTCTGGCAG A 31
(2) INFORMATION FOR SEQ ID N0:32:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:32:
GTGGTACCTC ATGAGAGGGA GCCTCTGGCA G 31
(2) INFORMATION FOR SEQ ID N0:33:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:33:
GTGAATTCAA CCATGGACAA TATGTCTATT ACG 33
(2) INFORMATION FOR SEQ ID N0:34:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
CA 02450698 2003-12-23
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:34:
GTGGATCCCA GTCTAAAGGT TGTGGGTCTG C 31
(2) INFORMATION FOR SEQ ID N0:35:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY; linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:35:
GTGGATCCTC AGTCTAAAGG TTGTGGGTCT GC 32
(2) INFORMATION FOR SEQ ID N0:36:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0;36:
GTCTCGAGGC ACCATGAGCG ACGTGGC 27
(2) INFORMATION FOR SEQ ID N0:37:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:37:
TGGGATCCGA GGCCGTGCTG CTGGCCG 27
(2) INFORMATION FOR SEQ ID N0:38:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1896 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE;
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1891
(D) OTHER INFORMATION:
CA 02450698 2003-12-23
66
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:38:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
CA 02450698 2003-12-23
67
225 230 235 240
GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TCA ACC ATG GCG GCG GCG 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Thr Met Ala Ala Ala
245 250 255
GCG GCT CAG GGG GGC GGG GGC GGG GAG CCC CGT AGA ACC GAG GGG GTC 816
Ala Ala Gln Gly Gly Gly Gly Gly Glu Pro Arg Arg Thr Glu Gly Val
260 265 270
GGC CCG GGG GTC CCG GGG GAG GTG GAG ATG GTG AAG GGG CAG CCG TTC 864
Gly Pro Gly Val Pro Gly Glu Val Glu Met Val Lys Gly Gln Pro Phe
275 280 285
GAC GTG GGC CCG CGC TAC ACG CAG TTG CAG TAC ATC GGC GAG GGC GCG 912
Asp Val Gly Pro Arg Tyr Thr Gln Leu Gln Tyr Ile Gly Glu Gly Ala
290 295 300
TAC GGC ATG GTC AGC TCG GCC TAT GAC CAC GTG CGC AAG ACT CGC GTG 960
Tyr Gly Met Val Ser Ser Ala Tyr Asp His Val Arg Lys Thr Arg Val
305 310 315 320
GCC ATC AAG AAG ATC AGC CCC TTC GAA CAT CAG ACC TAC TGC CAG CGC 1008
Ala Ile Lys Lys Ile Ser Pro Phe Glu His Gln Thr Tyr Cys Gln Arg
325 330 335
ACG CTC CGG GAG ATC CAG ATC CTG CTG CGC TTC CGC CAT GAG AAT GTC 1056
Thr Leu Arg Glu Ile Gln Ile Leu Leu Arg Phe Arg His Glu Asn Val
340 345 350
ATC GGC ATC CGA GAC ATT CTG CGG GCG TCC ACC CTG GAA GCC ATG AGA 1104
Ile Gly Ile Arg Asp Ile Leu Arg Ala Ser Thr Leu Glu Ala Met Arg
355 360 365
GAT GTC TAC ATT GTG CAG GAC CTG ATG GAG ACT GAC CTG TAC AAG TTG 1152
Asp Val Tyr Ile Val Gln Asp Leu Met Glu Thr Asp Leu Tyr Lys Leu
370 375 380
CTG AAA AGC CAG CAG CTG AGC AAT GAC CAT ATC TGC TAC TTC CTC TAC 1200
Leu Lys Ser Gln Gln Leu Ser Asn Asp His Ile Cys Tyr Phe Leu Tyr
385 390 395 400
CAG ATC CTG CGG GGC CTC AAG TAC ATC CAC TCC GCC AAC GTG CTC CAC 1248
Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser Ala Asn Val Leu His
405 410 415
CGA GAT CTA AAG CCC TCC AAC CTG CTC AGC AAC ACC ACC TGC GAC CTT 1296
Arg Asp Leu Lys Pro Ser Asn Leu Leu Ser Asn Thr Thr Cys Asp Leu
420 425 430
AAG ATT TGT GAT TTC GGC CTG GCC CGG ATT GCC GAT CCT GAG CAT GAC 1344
Lys Ile Cys Asp Phe Gly Leu Ala Arg Ile Ala Asp Pro Glu His Asp
435 440 445
CAC ACC GGC TTC CTG ACG GAG TAT GTG GCT ACG CGC TGG TAC CGG GCC 1392
His Thr Gly Phe Leu Thr Glu Tyr Val Ala Thr Arg Trp Tyr Arg Ala
450 455 460
CCA GAG ATC ATG CTG AAC TCC AAG GGC TAT ACC AAG TCC ATC GAC ATC 1440
Pro Glu Ile Met Leu Asn Ser Lys Gly Tyr Thr Lys 5er Ile Asp Ile
CA 02450698 2003-12-23
68
465 470 475 480
TGG TCT GTG GGC TGC ATT CTG GCT GAG ATG CTC TCT AAC CGG CCC ATC 1488
Trp Ser Val Gly Cys Ile Leu Ala Glu Met Leu Ser Asn Arg Pro Ile
485 490 495
TTC CCT GGC AAG CAC TAC CTG GAT CAG CTC AAC CAC ATT CTG GGC ATC 1536
Phe Pro Gly Lys His Tyr Leu Asp Gln Leu Asn His Ile Leu Gly Ile
500 505 510
CTG GGC TCC CCA TCC CAG GAG GAC CTG AAT TGT ATC ATC AAC ATG AAG 1584
Leu Gly Ser Pro Ser Gln Glu Asp Leu Asn Cys Ile Ile Asn Met Lys
515 520 525
GCC CGA AAC TAC CTA CAG TCT CTG CCC TCC AAG ACC AAG GTG GCT TGG 1632
Ala Arg Asn Tyr Leu Gln Ser Leu Pro Ser Lys Thr Lys Val Ala Trp
530 535 540
GCC AAG CTT TTC CCC AAG TCA GAC TCC AAA GCC CTT GAC CTG CTG GAC 1680
Ala Lys Leu Phe Pro Lys Ser Asp Ser Lys Ala Leu Asp Leu Leu Asp
545 550 555 560
CGG ATG TTA ACC TTT AAC CCC AAT AAA CGG ATC ACA GTG GAG GAA GCG 1728
Arg Met Leu Thr Phe Asn Pro Asn Lys Arg Ile Thr Val Glu Glu Ala
565 570 575
CTG GCT CAC CCC TAC CTG GAG CAG TAC TAT GAC CCG ACG GAT GAG CCA 1776
Leu Ala His Pro Tyr Leu Glu Gln Tyr Tyr Asp Pro Thr Asp Glu Pro
580 585 590
GTG GCC GAG GAG CCC TTC ACC TTC GCC ATG GAG CTG GAT GAC CTA CCT 1824
Val Ala Glu Glu Pro Phe Thr Phe A1a Met Glu Leu Asp Asp Leu Pro
595 600 605
AAG GAG CGG CTG AAG GAG CTC ATC TTC CAG GAG ACA GCA CGC TTC CAG 1872
Lys Glu Arg Leu Lys Glu Leu Ile Phe Gln Glu Thr Ala Arg Phe Gln
610 615 620
CCC GGA GTG CTG GAG GCC C CCTAG 1896
Pro Gly Val Leu G1u Ala Pro
625 630
(2) INFORMATION FOR SEQ ID N0:39:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 631 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:39:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
CA 02450698 2003-12-23
69
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Tle Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Thr Met Ala Ala Ala
245 250 255
Ala Ala Gln Gly Gly Gly Gly Gly Glu Pro Arg Arg Thr Glu Gly Val
260 265 270
Gly Pro Gly Val Pro Gly Glu Val Glu Met Val Lys Gly Gln Pro Phe
275 280 285
Asp Val Gly Pro Arg Tyr Thr Gln Leu Gln Tyr Ile Gly Glu Gly Ala
290 295 300
Tyr Gly Met Val Ser Ser Ala Tyr Asp His Val Arg Lys Thr Arg Val
305 310 315 320
Ala Ile Lys Lys Ile Ser Pro Phe Glu His Gln Thr Tyr Cys Gln Arg
325 330 335
Thr Leu Arg Glu Ile Gln Ile Leu Leu Arg Phe Arg His Glu Asn Val
340 345 350
Ile Gly Ile Arg Asp Ile Leu Arg Ala Ser Thr Leu Glu Ala Met Arg
355 360 365
Asp Val Tyr Ile Val Gln Asp Leu Met Glu Thr Asp Leu Tyr Lys Leu
370 375 380
Leu Lys Ser Gln Gln Leu Ser Asn Asp His Ile Cys Tyr Phe Leu Tyr
385 390 395 400
Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser Ala Asn Val Leu His
405 410 415
Arg Asp Leu Lys Pro Ser Asn Leu Leu Ser Asn Thr Thr Cys Asp Leu
420 425 430
Lys Ile Cys Asp Phe Gly Leu Ala Arg Ile Ala Asp Pro Glu His Asp
435 440 445
His Thr Gly Phe Leu Thr Glu Tyr Val Ala Thr Arg Trp Tyr Arg Ala
450 455 460
Pro Glu Ile Met Leu Asn Ser Lys Gly Tyr Thr Lys Ser Ile Asp Ile
465 470 475 480
Trp Ser Val Gly Cys Ile Leu Ala Glu Met Leu Ser Asn Arg Pro Ile
485 490 495
Phe Pro Gly Lys His Tyr Leu Asp Gln Leu Asn His Ile Leu Gly Ile
500 505 510
CA 02450698 2003-12-23
Leu Gly Ser Pro Ser Gln Glu Asp Leu Asn Cys Ile Ile Asn Met Lys
515 520 525
Ala Arg Asn Tyr Leu Gln Ser Leu Pro Ser Lys Thr Lys Val Ala Trp
530 535 540
Ala Lys Leu Phe Pro Lys Ser Asp Ser Lys Ala Leu Asp Leu Leu Asp
545 550 555 560
Arg Met Leu Thr Phe Asn Pro Asn Lys Arg Ile Thr Val Glu Glu Ala
565 570 575
Leu Ala His Pro Tyr Leu Glu Gln Tyr Tyr Asp Pro Thr Asp G1u Pro
580 585 590
Val Ala Glu Glu Pro Phe Thr Phe Ala Met Glu Leu Asp Asp Leu Pro
595 600 605
Lys Glu Arg Leu Lys Glu Leu Ile Phe Gln Glu Thr Ala Arg Phe Gln
610 615 620
Pro Gly Val Leu Glu Ala Pro
625 630
(2) INFORMATION FOR SEQ ID N0:40:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1818 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAMEjKEY: Coding Sequence
(B) LOCATION: 1...1815
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:40:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
CA 02450698 2003-12-23
71
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GTA ACC ATG GCG GCG GCG GCG GCG GCG GGC CCG 768
Gly Leu Arg Ser Arg Val Thr Met Ala Ala Ala Ala Ala Ala Gly Pro
245 250 255
GAG ATG GTC CGC GGG CAG GTG TTC GAC GTG GGG CCG CGC TAC ACT AAT 816
Glu Met Val Arg Gly Gln Val Phe Asp Val Gly Pro Arg Tyr Thr Asn
260 265 270
CTC TCG TAC ATC GGA GAA GGC GCC TAC GGC ATG GTT TGT TCT GCT TAT 864
Leu Ser Tyr Ile Gly Glu Gly Ala Tyr Gly Met Val Cys Ser Ala Tyr
275 280 285
GAT AAT CTC AAC AAA GTT CGA GTT GCT ATC AAG AAA ATC AGT CCT TTT 912
Asp Asn Leu Asn Lys Val Arg Val Ala Ile Lys Lys Ile Ser Pro Phe
290 295 300
GAG CAC CAG ACC TAC TGT CAG AGA ACC CTG AGA GAG ATA AAA ATC CTA 960
Glu His Gln Thr Tyr Cys Gln Arg Thr Leu Arg Glu Ile Lys Ile Leu
305 310 315 320
CTG CGC TTC AGA CAT GAG AAC ATC ATC GGC ATC AAT GAC ATC ATC CGG 1008
Leu Arg Phe Arg His Glu Asn Ile Ile Gly Ile Asn Asp Ile Ile Arg
325 330 335
GCA CCA ACC ATT GAG CAG ATG AAA GAT GTA TAT ATA GTA CAG GAC CTC 1056
Ala Pro Thr Ile Glu Gln Met Lys Asp Val Tyr Ile Val Gln Asp Leu
CA 02450698 2003-12-23
72
340 345 350
ATG GAG ACA GAT CTT TAC AAG CTC TTG AAG ACA CAG CAC CTC AGC AAT 1104
Met Glu Thr Asp Leu Tyr Lys Leu Leu Lys Thr Gln His Leu Ser Asn
355 360 365
GAT CAT ATC TGC TAT TTT CTT TAT CAG ATC CTG AGA GGA TTA AAG TAT 1152
Asp His Ile Cys Tyr Phe Leu Tyr Gln Ile Leu Arg Gly Leu Lys Tyr
370 375 380
ATA CAT TCA GCT AAT GTT CTG CAC CGT GAC CTC AAG CCT TCC AAC CTC 1200
Ile His Ser Ala Asn Val Leu His Arg Asp Leu Lys Pro Ser Asn Leu
385 390 395 400
CTG CTG AAC ACC ACT TGT GAT CTC AAG ATC TGT GAC TTT GGC CTT GCC 1248
Leu Leu Asn Thr Thr Cys Asp Leu Lys Ile Cys Asp Phe Gly Leu Ala
405 410 415
CGT GTT GCA GAT CCA GAC CAT GAT CAT ACA GGG TTC TTG ACA GAG TAT 1296
Arg Val Ala Asp Pro Asp His Asp His Thr Gly Phe Leu Thr Glu Tyr
420 425 430
GTA GCC ACG CGT TGG TAC AGA GCT CCA GAA ATT ATG TTG AAT TCC AAG 1344
Val Ala Thr Arg Trp Tyr Arg Ala Pro Glu Ile Met Leu Asn Ser Lys
435 440 445
GGT TAT ACC AAG TCC ATT GAT ATT TGG TCT GTG GGC TGC ATC CTG GCA 1392
Gly Tyr Thr Lys Ser Ile Asp Ile Trp Ser Val Gly Cys Ile Leu Ala
450 455 460
GAG ATG CTA TCC AAC AGG CCT ATC TTC CCA GGA AAG CAT TAC CTT GAC 1440
Glu Met Leu Sex Asn Arg Pro Ile Phe Pro Gly Lys His Tyr Leu Asp
465 470 475 480
CAG CTG AAT CAC ATC CTG GGT ATT CTT GGA TCT CCA TCA CAG GAA GAT 1488
Gln Leu Asn His Ile Leu Gly Ile Leu Gly Ser Pro Ser Gln Glu Asp
485 490 495
CTG AAT TGT ATA ATA AAT TTA AAA GCT AGA AAC TAT TTG CTT TCT CTC 1536
Leu Asn Cys Ile Ile Asn Leu Lys Ala Arg Asn Tyr Leu Leu Ser Leu
500 505 510
CCG CAC AAA AAT AAG GTG CCG TGG AAC AGG TTG TTC CCA AAC GCT GAC 1584
Pro His Lys Asn Lys Val Pro Trp Asn Arg Leu Phe Pro Asn Ala Asp
515 520 525
TCC AAA GCT CTG GAT TTA CTG GAT AAA ATG TTG ACA TTT AAC CCT CAC 1632
Ser Lys Ala Leu Asp Leu Leu Asp Lys Met Leu Thr Phe Asn Pro His
530 535 540
AAG AGG ATT GAA GTT GAA CAG GCT CTG GCC CAC CCG TAC CTG GAG CAG 1680
Lys Arg Ile Glu Val Glu Gln Ala Leu Ala His Pro Tyr Leu Glu Gln
545 550 555 560
TAT TAT GAC CCA AGT GAT GAG CCC ATT GCT GAA GCA CCA TTC AAG TTT 1728
Tyr Tyr Asp Pro Ser Asp Glu Pro Ile Ala Glu Ala Pro Phe Lys Phe
565 570 575
GAC ATG GAG CTG GAC GAC TTA CCT AAG GAG AAG CTC AAA GAA CTC ATT 1776
Asp Met Glu Leu Asp Asp Leu Pro Lys Glu Lys Leu Lys Glu Leu Ile
CA 02450698 2003-12-23
73
580 585 590
TTT GAA GAG ACT GCT CGA TTC CAG CCA GGA TAC AGA TCT TAA 1818
Phe Glu Glu Thr Ala Arg Phe Gln Pro Gly Tyr Arg Ser
595 600 605
(2) INFORMATION FOR SEQ ID N0:41:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 605 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:41:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Va1 Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Tle Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Val Thr Met Ala Ala Ala Ala Ala Ala Gly Pro
245 250 255
Glu Met Val Arg Gly Gln Val Phe Asp Val Gly Pro Arg Tyr Thr Asn
260 265 270
Leu Ser Tyr Ile Gly Glu Gly Ala Tyr Gly Met Val Cys Ser Ala Tyr
275 280 285
Asp Asn Leu Asn Lys Val Arg Val Ala Ile Lys Lys Ile Ser Pro Phe
290 295 300
Glu His Gln Thr Tyr Cys Gln Arg Thr Leu Arg Glu Ile Lys Ile Leu
305 310 315 320
CA 02450698 2003-12-23
74
Leu Arg Phe Arg His Glu Asn Ile Ile Gly Ile Asn Asp Ile Ile Arg
325 330 335
Ala Pro Thr Ile Glu Gln Met Lys Asp Val Tyr Ile Val Gln Asp Leu
340 345 350
Met Glu Thr Asp Leu Tyr Lys Leu Leu Lys Thr Gln His Leu Ser Asn
355 360 365
Asp His Ile Cys Tyr Phe Leu Tyr Gln I1e Leu Arg Gly Leu Lys Tyr
370 375 380
Ile His Ser Ala Asn Val Leu His Arg Asp Leu Lys Pro Ser Asn Leu
385 390 395 400
Leu Leu Asn Thr Thr Cys Asp Leu Lys Ile Cys Asp Phe Gly Leu Ala
405 410 415
Arg Val Ala Asp Pro Asp His Asp His Thr Gly Phe Leu Thr Glu Tyr
420 425 430
Val Ala Thr Arg Trp Tyr Arg Ala Pro Glu Ile Met Leu Asn Ser Lys
435 440 445
Gly Tyr Thr Lys Ser Ile Asp Ile Trp Ser Va1 Gly Cys Ile Leu Ala
450 455 460
Glu Met Leu Ser Asn Arg Pro Ile Phe Pro Gly Lys His Tyr Leu Asp
465 470 475 480
Gln Leu Asn His Ile Leu Gly Ile Leu Gly Ser Pro Ser Gln Glu Asp
485 490 495
Leu Asn Cys Ile Ile Asn Leu Lys Ala Arg Asn Tyr Leu Leu Ser Leu
500 505 510
Pro His Lys Asn Lys Val Pro Trp Asn Arg Leu Phe Pro Asn Ala Asp
515 520 525
Ser Lys Ala Leu Asp Leu Leu Asp Lys Met Leu Thr Phe Asn Pro His
530 535 540
Lys Arg Ile Glu Val Glu Gln Ala Leu Ala His Pro Tyr Leu Glu Gln
545 550 555 560
Tyr Tyr Asp Pro Ser Asp Glu Pro Ile Ala Glu Ala Pro Phe Lys Phe
565 570 575
Asp Met Glu Leu Asp Asp Leu Pro Lys Glu Lys Leu Lys Glu Leu Ile
580 585 590
Phe Glu Glu Thr Ala Arg Phe Gln Pro Gly Tyr Arg Ser
595 600 605
(2) INFORMATION FOR SEQ ID N0:42:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2529 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2526
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:42:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
CA 02450698 2003-12-23
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TCG TCA ATG GAG CTG GAA 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Sex Ser Met Glu Leu Glu
245 250 255
AAC ATC GTG GCC AAC ACG GTC TTG CTG AAA GCC AGG GAA GGG GGC GGA 816
Asn Ile Val Ala Asn Thr Val Leu Leu Lys Ala Arg Glu Gly Gly Gly
CA 02450698 2003-12-23
76
260 265 270
GGA AAG CGC AAA GGG AAA AGC AAG AAG TGG AAA GAA ATC CTG AAG TTC 864
Gly Lys Arg Lys Gly Lys Ser Lys Lys Trp Lys Glu Ile Leu Lys Phe
275 280 285
CCT CAC ATT AGC CAG TGT GAA GAC CTC CGA AGG ACC ATA GAC AGA GAT 912
Pro His Ile Ser Gln Cys Glu Asp Leu Arg Arg Thr Ile Asp Arg Asp
290 295 300
TAC TGC AGT TTA TGT GAC AAG CAG CCA ATC GGG AGG CTG CTT TTC CGG 960
Tyr Cys Ser Leu Cys Asp Lys Gln Pro Ile Gly Arg Leu Leu Phe Arg
305 310 315 320
CAG TTT TGT GAA ACC AGG CCT GGG CTG GAG TGT TAC ATT CAG TTC CTG 1008
Gln Phe Cys Glu Thr Arg Pro Gly Leu Glu Cys Tyr Ile Gln Phe Leu
325 330 335
GAC TCC GTG GCA GAA TAT GAA GTT ACT CCA GAT GAA AAA CTG GGA GAG 1056
Asp Sex Val Ala Glu Tyr Glu Val Thr Pro Asp Glu Lys Leu Gly Glu
340 345 350
AAA GGG AAG GAA ATT ATG ACC AAG TAC CTC ACC CCA AAG TCC CCT GTT 1104
Lys Gly Lys Glu Ile Met Thr Lys Tyr Leu Thr Pro Lys Ser Pro Val
355 360 365
TTC ATA GCC CAA GTT GGC CAA GAC CTG GTC TCC CAG ACG GAG GAG AAG 1152
Phe Tle Ala Gln Val Gly Gln Asp Leu Val Ser Gln Thr Glu Glu Lys
370 375 380
CTC CTA CAG AAG CCG TGC AAA GAA CTC TTT TCT GCC TGT GCA CAG TCT 1200
Leu Leu Gln Lys Pro Cys Lys Glu Leu Phe Ser Ala Cys Ala Gln Ser
385 390 395 400
GTC CAC GAG TAC CTG AGG GGA GAA CCA TTC CAC GAA TAT CTG GAC AGC 1248
Val His Glu Tyr Leu Arg Gly Glu Pro Phe His G1u Tyr Leu Asp Ser
405 410 415
ATG TTT TTT GAC CGC TTT CTC CAG TGG AAG TGG TTG GAA AGG CAA CCG 1296
Met Phe Phe Asp Arg Phe Leu Gln Trp Lys Trp Leu Glu Arg Gln Pro
420 425 430
GTG ACC AAA AAC ACT TTC AGG CAG TAT CGA GTG CTA GGA AAA GGG GGC 1344
Val Thr Lys Asn Thr Phe Arg Gln Tyr Arg Val Leu Gly Lys Gly Gly
435 440 445
TTC GGG GAG GTC TGT GCC TGC CAG GTT CGG GCC ACG GGT AAA ATG TAT 1392
Phe Gly Glu Val Cys Ala Cys Gln Val Arg Ala Thr G1y Lys Met Tyr
450 455 460
GCC TGC AAG CGC TTG GAG AAG AAG AGG ATC AAA AAG AGG AAA GGG GAG 1440
Ala Cys Lys Arg Leu Glu Lys Lys Arg Ile Lys Lys Arg Lys Gly Glu
465 470 475 480
TCC ATG GCC CTC AAT GAG AAG CAG ATC CTC GAG AAG GTC AAC AGT CAG 1488
Ser Met Ala Leu Asn Glu Lys Gln Ile Leu Glu Lys Val Asn Ser Gln
485 490 495
TTT GTG GTC AAC CTG GCC TAT GCC TAC GAG ACC AAG GAT GCA CTG TGC 1536
Phe Val Val Asn Leu Ala Tyr Ala Tyr Glu Thr Lys Asp Ala Leu Cys
CA 02450698 2003-12-23
77
500 505 510
TTG GTC CTG ACC ATC ATG AAT GGG GGT GAC CTG AAG TTC CAC ATC TAC 1584
Leu Val Leu Thr Ile Met Asn Gly Gly Asp Leu Lys Phe His Ile Tyr
515 520 525
AAC ATG GGC AAC CCT GGC TTC GAG GAG GAG CGG GCC TTG TTT TAT GCG 1632
Asn Met Gly Asn Pro Gly Phe Glu Glu Glu Arg Ala Leu Phe Tyr Ala
530 535 540
GCA GAG ATC CTC TGC GGC TTA GAA GAC CTC CAC CGT GAG AAC ACC GTC 1680
Ala Glu Ile Leu Cys Gly Leu G1u Asp Leu His Arg Glu Asn Thr Val
545 550 555 560
TAC CGA GAT CTG AAA CCT GAA AAC ATC CTG TTA GAT GAT TAT GGC CAC 1728
Tyr Arg Asp Leu Lys Pro Glu Asn Ile Leu Leu Asp Asp Tyr Gly His
565 570 575
ATTAGG ATCTCAGAC CTGGGCTTG GCTGTGAAG ATCCCCGAG GGAGAC 1776
IleArg IleSerAsp LeuGlyLeu AlaValLys IleProGlu GlyAsp
580 585 590
CTGATC CGCGGCCGG GTGGGCACT GTTGGCTAC ATGGCCCCC GAAGTC 1824
LeuIle ArgGlyArg ValGlyThr Va1GlyTyr MetAlaPro GluVal
595 600 605
CTGAAC AACCAGAGG TACGGCCTG AGCCCCGAC TACTGGGGC CTTGGC 1872
LeuAsn AsnGlnArg TyrGlyLeu SerProAsp TyrTrpGly LeuGly
610 615 620
TGCCTC ATCTATGAG ATGATCGAG GGCCAGTCG CCGTTCCGC GGCCGT 1920
CysLeu IleTyrGlu MetIleGlu GlyGlnSer ProPheArg GlyArg
625 630 635 640
AAGGAG AAGGTGAAG CGGGAGGAG GTGGACCGC CGGGTCCTG GAGACG 1968
LysGlu LysValLys ArgGluGlu ValAspArg ArgValLeu GluThr
645 650 655
GAG GAG GTG TAC TCC CAC AAG TTC TCC GAG GAG GCC AAG TCC ATC TGC 2016
Glu Glu Val Tyr Ser His Lys Phe Ser Glu Glu Ala Lys Ser Ile Cys
660 665 670
AAG ATG CTG CTC ACG AAA GAT GCG AAG CAG AGG CTG GGC TGC CAG GAG 2064
Lys Met Leu Leu Thr Lys Asp Ala Lys Gln Arg Leu Gly Cys Gln Glu
675 680 685
GAG GGG GCT GCA GAG GTC AAG AGA CAC CCC TTC TTC AGG AAC ATG AAC 2112
Glu Gly Ala Ala Glu Val Lys Arg His Pro Phe Phe Arg Asn Met Asn
690 695 700
TTC AAG CGC TTA GAA GCC GGG ATG TTG GAC CCT CCC TTC GTT CCA GAC 2160
Phe Lys Arg Leu Glu Ala Gly Met Leu Asp Pro Pro Phe Val Pro Asp
705 710 715 720
CCC CGC GCT GTG TAC TGT AAG GAC GTG CTG GAC ATC GAG CAG TTC TCC 2208
Pro Arg Ala Val Tyr Cys Lys Asp Val Leu Asp Ile Glu Gln Phe Ser
725 730 735
ACT GTG AAG GGC GTC AAT CTG GAC CAC ACA GAC GAC GAC TTC TAC TCC 2256
Thr Val Lys Gly Val Asn Leu Asp His Thr Asp Asp Asp Phe Tyr Ser
CA 02450698 2003-12-23
78
740 745 750
AAG TTC TCC ACG GGC TCT GTG TCC ATC CCA TGG CAA AAC GAG ATG ATA 2304
Lys Phe Ser Thr Gly Ser Val Ser Ile Pro Trp Gln Asn Glu Met Ile
755 760 765
GAA ACA GAA TGC TTT AAG GAG CTG AAC GTG TTT GGA CCT AAT GGT ACC 2352
Glu Thr Glu Cys Phe Lys Glu Leu Asn Val Phe Gly Pro Asn Gly Thr
770 775 780
CTC CCG CCA GAT CTG AAC AGA AAC CAC CCT CCG GAA CCG CCC AAG AAA 2400
Leu Pro Pro Asp Leu Asn Arg Asn His Pro Pro Glu Pro Pro Lys Lys
785 790 795 800
GGG CTG CTC CAG AGA CTC TTC AAG CGG CAG CAT CAG AAC AAT TCC AAG 2448
Gly Leu Leu Gln Arg Leu Phe Lys Arg Gln His Gln Asn Asn Ser Lys
805 810 815
AGT TCG CCC AGC TCC AAG ACC AGT TTT AAC CAC CAC ATA AAC TCA AAC 2496
Ser Ser Pro Ser Ser Lys Thr Ser Phe Asn His His Ile Asn Ser Asn
820 825 830
CAT GTC AGC TCG AAC TCC ACC GGA AGC AGC TAG 2529
His Val Ser Ser Asn Ser Thr Gly Ser Ser
835 840
(2) INFORMATION FOR SEQ ID N0:43:
(i1 SEQUENCE CHARACTERISTICS:
(A) LENGTH: 842 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:43:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
CA 02450698 2003-12-23
79
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Ser Met Glu Leu Glu
245 250 255
Asn Ile Val Ala Asn Thr Val Leu Leu Lys Ala Arg Glu Gly Gly Gly
260 265 270
Gly Lys Arg Lys Gly Lys Ser Lys Lys Trp Lys Glu Ile Leu Lys Phe
275 280 285
Pro His Ile Ser Gln Cys Glu Asp Leu Arg Arg Thr Ile Asp Arg Asp
290 295 300
Tyr Cys Ser Leu Cys Asp Lys Gln Pro Ile Gly Arg Leu Leu Phe Arg
305 310 315 320
Gln Phe Cys Glu Thr Arg Pro Gly Leu Glu Cys Tyr Ile Gln Phe Leu
325 330 335
Asp Ser Val Ala Glu Tyr Glu Val Thr Pro Asp Glu Lys Leu Gly Glu
340 345 350
Lys Gly Lys Glu Ile Met Thr Lys Tyr Leu Thr Pro Lys Ser Pro Val
355 360 365
Phe Ile Ala Gln Val Gly Gln Asp Leu Val Ser Gln Thr Glu Glu Lys
370 375 380
Leu Leu Gln Lys Pro Cys Lys Glu Leu Phe Ser Ala Cys Ala Gln Ser
385 390 395 400
Val His Glu Tyr Leu Arg Gly Glu Pro Phe His Glu Tyr Leu Asp Ser
405 410 415
Met Phe Phe Asp Arg Phe Leu Gln Trp Lys Trp Leu Glu Arg Gln Pro
420 425 430
Val Thr Lys Asn Thr Phe Arg Gln Tyr Arg Val Leu Gly Lys Gly Gly
435 440 445
Phe Gly Glu Val Cys Ala Cys Gln Val Arg Ala Thr Gly Lys Met Tyr
450 455 460
Ala Cys Lys Arg Leu Glu Lys Lys Arg Ile Lys Lys Arg Lys Gly Glu
465 470 475 480
Ser Met Ala Leu Asn Glu Lys Gln Ile Leu Glu Lys Val Asn Ser Gln
485 490 495
Phe Val Val Asn Leu Ala Tyr Ala Tyr Glu Thr Lys Asp Ala Leu Cys
500 505 510
Leu Val Leu Thr Ile Met Asn Gly Gly Asp Leu Lys Phe His Ile Tyr
515 520 525
Asn Met Gly Asn Pro Gly Phe Glu Glu Glu Arg Ala Leu Phe Tyr Ala
530 535 540
Ala Glu Ile Leu Cys Gly Leu Glu Asp Leu His Arg Glu Asn Thr Val
545 550 555 560
Tyr Arg Asp Leu Lys Pro Glu Asn Ile Leu Leu Asp Asp Tyr Gly His
565 570 575
Ile Arg Ile Ser Asp Leu Gly Leu Ala Val Lys Ile Pro Glu Gly Asp
580 585 590
Leu Ile Arg Gly Arg Va1 Gly Thr Val Gly Tyr Met Ala Pro Glu Val
595 600 605
Leu Asn Asn Gln Arg Tyr Gly Leu Ser Pro Asp Tyr Trp Gly Leu Gly
610 615 620
Cys Leu Ile Tyr Glu Met Ile Glu Gly Gln Ser Pro Phe Arg Gly Arg
625 630 635 640
CA 02450698 2003-12-23
Lys Glu Lys Val Lys Arg Glu Glu Val Asp Arg Arg Val Leu Glu Thr
645 650 655
Glu Glu Val Tyr Ser His Lys Phe Ser Glu Glu Ala Lys Ser Ile Cys
660 665 670
Lys Met Leu Leu Thr Lys Asp Ala Lys Gln Arg Leu Gly Cys Gln Glu
675 680 685
Glu Gly Ala Ala Glu Val Lys Arg His Pro Phe Phe Arg Asn Met Asn
690 695 700
Phe Lys Arg Leu Glu Ala Gly Met Leu Asp Pro Pro Phe Val Pro Asp
705 710 715 720
Pro Arg Ala Val Tyr Cys Lys Asp Val Leu Asp Ile Glu Gln Phe Ser
725 730 735
Thr Val Lys Gly Val Asn Leu Asp His Thr Asp Asp Asp Phe Tyr Ser
740 745 750
Lys Phe Ser Thr Gly Ser Val Ser Ile Pro Trp Gln Asn Glu Met Ile
755 760 765
Glu Thr Glu Cys Phe Lys Glu Leu Asn Val Phe Gly Pro Asn Gly Thr
770 775 780
Leu Pro Pro Asp Leu Asn Arg Asn His Pro Pro Glu Pro Pro Lys Lys
785 790 795 800
Gly Leu Leu Gln Arg Leu Phe Lys Arg Gln His Gln Asn Asn Ser Lys
805 810 815
Ser Ser Pro Ser Ser Lys Thr Ser Phe Asn His His Ile Asn Ser Asn
820 825 830
His Val Ser Ser Asn Ser Thr Gly Ser Ser
835 840
(2) INFORMATION FOR SEQ ID N0:44:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1902 base pairs
(B) TYPE. nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1899
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:44:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CA 02450698 2003-12-23
81
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTGAAG TTCGAGGGC GACACCCTG GTGAACCGC ATCGAGCTG AAGGGC 384
ValLys PheGluG1y AspThrLeu ValAsnArg IleGluLeu LysGly
115 120 125
ATCGAC TTCAAGGAG GACGGCAAC ATCCTGGGG CACAAGCTG GAGTAC 432
IleAsp PheLysGlu AspGlyAsn IleLeuGly HisLysLeu GluTyr
130 135 140
AACTAC AACAGCCAC AACGTCTAT ATCATGGCC GACAAGCAG AAGAAC 480
AsnTyr AsnSerHis AsnValTyr IleMetAla AspLysGln LysAsn
145 150 155 160
GGCATC AAGGTGAAC TTCAAGATC CGCCACAAC ATCGAGGAC GGCAGC 528
GlyIle LysValAsn PheLysIle ArgHisAsn IleGluAsp GlySer
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Sex
225 230 235 240
GGA CTC AGA TCT CGA GCT CGA GCC ATC ATG AGC AGA AGC AAG CGT GAC 768
Gly Leu Arg Ser Arg Ala Arg Ala Ile Met Ser Arg Ser Lys Arg Asp
245 250 255
AAC AAT TTT TAT AGT GTA GAG ATT GGA GAT TCT ACA TTC ACA GTC CTG 816
Asn Asn Phe Tyr Ser Val Glu Ile Gly Asp Ser Thr Phe Thr Val Leu
260 265 270
AAA CGA TAT CAG AAT TTA AAA CCT ATA GGC TCA GGA GCT CAA GGA ATA 864
Lys Arg Tyr Gln Asn Leu Lys Pro Ile Gly Ser Gly Ala Gln Gly Ile
275 280 285
GTA TGC GCA GCT TAT GAT GCC ATT CTT GAA AGA AAT GTT GCA ATC AAG 912
Val Cys Ala Ala Tyr Asp Ala Ile Leu Glu Arg Asn Val Ala Ile Lys
290 295 300
CA 02450698 2003-12-23
82
AAG CTA AGC CGA CCA TTT CAG AAT CAG ACT CAT GCC AAG CGG GCC TAC 960
Lys Leu Ser Arg Pro Phe Gln Asn Gln Thr His Ala Lys Arg Ala Tyr
305 310 315 320
AGA GAG CTA GTT CTT ATG AAA TGT GTT AAT CAC AAA AAT ATA ATT GGC 1008
Arg Glu Leu Val Leu Met Lys Cys Val Asn His Lys Asn Ile Ile Gly
325 330 335
CTT TTG AAT GTT TTC ACA CCA CAG AAA TCC CTA GAA GAA TTT CAA GAT 1056
Leu Leu Asn Val Phe Thr Pro Gln Lys Ser Leu Glu Glu Phe Gln Asp
340 345 350
GTT TAC ATA GTC ATG GAG CTC ATG GAT GCA AAT CTT TGC CAA GTG ATT 1104
Val Tyr Ile Va1 Met Glu Leu Met Asp Ala Asn Leu Cys Gln Val Ile
355 360 365
CAG ATG GAG CTA GAT CAT GAA AGA ATG TCC TAC CTT CTC TAT CAG ATG 1152
Gln Met Glu Leu Asp His Glu Arg Met Ser Tyr Leu Leu Tyr Gln Met
370 375 380
CTG TGT GGA ATC AAG CAC CTT CAT TCT GCT GGA ATT ATT CAT CGG GAC 1200
Leu Cys Gly Ile Lys His Leu His Ser Ala Gly Ile Ile His Arg Asp
385 390 395 400
TTA AAG CCC AGT AAT ATA GTA GTA AAA TCT GAT TGC ACT TTG AAG ATT 1248
Leu Lys Pro Ser Asn Ile Val Val Lys Ser Asp Cys Thr Leu Lys Ile
405 410 415
CTT GAC TTC GGT CTG GCC AGG ACT GCA GGA ACG AGT TTT ATG ATG ACG 1296
Leu Asp Phe Gly Leu Ala Arg Thr Ala Gly Thr Ser Phe Met Met Thr
420 425 430
CCT TAT GTA GTG ACT CGC TAC TAC AGA GCA CCC GAG GTC ATC CTT GGC 1344
Pro Tyr Val Val Thr Arg Tyr Tyr Arg Ala Pro Glu Val Ile Leu Gly
435 440 445
ATG GGC TAC AAG GAA AAC GTG GAT TTA TGG TCT GTG GGG TGC ATT ATG 1392
Met Gly Tyr Lys Glu Asn Val Asp Leu Trp Ser Val Gly Cys Ile Met
450 455 460
GGA GAA ATG GTT TGC CAC AAA ATC CTC TTT CCA GGA AGG GAC TAT ATT 1440
Gly Glu Met Val Cys His Lys Ile Leu Phe Pro Gly Arg Asp Tyr Ile
465 470 475 480
GAT CAG TGG AAT AAA GTT ATT GAA CAG CTT GGA ACA CCA TGT CCT GAA 1488
Asp Gln Trp Asn Lys Val Ile G1u Gln Leu Gly Thr Pro Cys Pro Glu
485 490 495
TTC ATG AAG AAA CTG CAA CCA ACA GTA AGG ACT TAC GTT GAA AAC AGA 1536
Phe Met Lys Lys Leu Gln Pro Thr Val Arg Thr Tyr Val Glu Asn Arg
500 505 510
CCT AAA TAT GCT GGA TAT AGC TTT GAG AAA CTC TTC CCT GAT GTC CTT 1584
Pro Lys Tyr Ala Gly Tyr Ser Phe Glu Lys Leu Phe Pro Asp Val Leu
515 520 525
TTC CCA GCT GAC TCA GAA CAC AAC AAA CTT AAA GCC AGT CAG GCA AGG 1632
Phe Pro Ala Asp Ser Glu His Asn Lys Leu Lys Ala Ser Gln Ala Arg
530 535 540
CA 02450698 2003-12-23
83
GAT TTG TTA TCC AAA ATG CTG GTA ATA GAT GCA TCT AAA AGG ATC TCT 1680
Asp Leu Leu Ser Lys Met Leu Val Ile Asp Ala Ser Lys Arg Ile Ser
545 550 555 560
GTA GAT GAA GCT CTC CAA CAC CCG TAC ATC AAT GTC TGG TAT GAT CCT 1728
Val Asp Glu Ala Leu Gln His Pro Tyr Ile Asn Val Trp Tyr Asp Pro
565 570 575
TCT GAA GCA GAA GCT CCA CCA CCA AAG ATC CCT GAC AAG CAG TTA GAT 1776
Ser Glu Ala Glu Ala Pro Pro Pro Lys Ile Pro Asp Lys Gln Leu Asp
580 585 590
GAA AGG GAA CAC ACA ATA GAA GAG TGG AAA GAA TTG ATA TAT AAG GAA 1824
Glu Arg Glu His Thr Ile Glu Glu Trp Lys Glu Leu Ile Tyr Lys Glu
595 600 605
GTT ATG GAC TTG GAG GAG AGA ACC AAG AAT GGA GTT ATA CGG GGG CAG 1872
Val Met Asp Leu Glu Glu Arg Thr Lys Asn Gly Val I1e Arg Gly Gln
610 615 620
CCC TCT CCT TTA GCA CAG GTG CAG CAG TGA 1902
Pro Ser Pro Leu Ala Gln Val Gln Gln
625 630
(2) INFORMATION FOR SEQ ID N0:45:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 633 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:45:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
CA 02450698 2003-12-23
84
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Arg Ala Ile Met Ser Arg Ser Lys Arg Asp
245 250 255
Asn Asn Phe Tyr Ser Val Glu Ile Gly Asp Ser Thr Phe Thr Val Leu
260 265 270
Lys Arg Tyr Gln Asn Leu Lys Pro Ile Gly Ser Gly Ala Gln Gly Ile
275 280 285
Val Cys Ala Ala Tyr Asp Ala Ile Leu Glu Arg Asn Val Ala Ile Lys
290 295 300
Lys Leu Ser Arg Pro Phe Gln Asn Gln Thr His Ala Lys Arg Ala Tyr
305 310 315 320
Arg Glu Leu Val Leu Met Lys Cys Val Asn His Lys Asn Ile Ile Gly
325 330 335
Leu Leu Asn Val Phe Thr Pro Gln Lys Ser Leu Glu Glu Phe Gln Asp
340 345 350
Val Tyr Ile Val Met Glu Leu Met Asp Ala Asn Leu Cys Gln Val Ile
355 360 365
Gln Met Glu Leu Asp His Glu Arg Met Ser Tyr Leu Leu Tyr Gln Met
370 375 380
Leu Cys Gly Ile Lys His Leu His Ser Ala Gly Ile Ile His Arg Asp
385 390 395 400
Leu Lys Pro Ser Asn Ile Val Val Lys Ser Asp Cys Thr Leu Lys Ile
405 410 415
Leu Asp Phe Gly Leu Ala Arg Thr Ala Gly Thr Ser Phe Met Met Thr
420 425 430
Pro Tyr Val Val Thr Arg Tyr Tyr Arg Ala Pro Glu Val Ile Leu Gly
435 440 445
Met Gly Tyr Lys Glu Asn Val Asp Leu Trp Ser Val Gly Cys Ile Met
450 455 460
Gly Glu Met Val Cys His Lys Ile Leu Phe Pro Gly Arg Asp Tyr Ile
465 470 475 480
Asp Gln Trp Asn Lys Val Ile Glu Gln Leu Gly Thr Pro Cys Pro Glu
485 490 495
Phe Met Lys Lys Leu Gln Pro Thr Val Arg Thr Tyr Val Glu Asn Arg
500 505 510
Pro Lys Tyr Ala Gly Tyr Ser Phe Glu Lys Leu Phe Pro Asp Val Leu
515 520 525
Phe Pro Ala Asp Ser Glu His Asn Lys Leu Lys Ala Ser Gln Ala Arg
530 535 540
Asp Leu Leu Ser Lys Met Leu Val Ile Asp Ala Ser Lys Arg Ile Ser
545 550 555 560
Val Asp Glu Ala Leu Gln His Pro Tyr Ile Asn Val Trp Tyr Asp Pro
565 570 575
Ser Glu Ala Glu Ala Pro Pro Pro Lys Ile Pro Asp Lys Gln Leu Asp
580 585 590
Glu Arg Glu His Thr Ile Glu Glu Trp Lys Glu Leu Ile Tyr Lys Glu
595 600 605
Val Met Asp Leu Glu Glu Arg Thr Lys Asn Gly Val Ile Arg Gly Gln
610 615 620
Pro Ser Pro Leu Ala Gln Val Gln Gln
625 630
(2) INFORMATION FOR SEQ ID N0:46:
CA 02450698 2003-12-23
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1824 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1821
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:46:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Fhe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
CA 02450698 2003-12-23
86
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GGG AAA ATG TCT CAG GAG AGG CCC ACG TTC TAC 768
Gly Leu Arg Ser Arg Gly Lys Met Ser Gln Glu Arg Pro Thr Phe Tyr
245 250 255
CGG CAG GAG CTG AAC AAG ACA ATC TGG GAG GTG CCC GAG CGT TAC CAG 816
Arg Gln Glu Leu Asn Lys Thr Ile Trp Glu Val Pro Glu Arg Tyr Gln
260 265 270
AAC CTG TCT CCA GTG GGC TCT GGC GCC TAT GGC TCT GTG TGT GCT GCT 864
Asn Leu Ser Pro Val Gly Ser Gly Ala Tyr Gly Ser Val Cys Ala Ala
275 280 285
TTT GAC ACA AAA ACG GGG TTA CGT GTG GCA GTG AAG AAG CTC TCC AGA 912
Phe Asp Thr Lys Thr Gly Leu Arg Val Ala Val Lys Lys Leu Ser Arg
290 295 300
CCA TTT CAG TCC ATC ATT CAT GCG AAA AGA ACC TAC AGA GAA CTG CGG 960
Pro Phe Gln Ser Ile Ile His Ala Lys Arg Thr Tyr Arg Glu Leu Arg
305 310 315 320
TTA CTT AAA CAT ATG AAA CAT GAA AAT GTG ATT GGT CTG TTG GAC GTT 1008
Leu Leu Lys His Met Lys His Glu Asn Va1 Ile Gly Leu Leu Asp Val
325 330 335
TTT ACA CCT GCA AGG TCT CTG GAG GAA TTC AAT GAT GTG TAT CTG GTG 1056
Phe Thr Pro Ala Arg Ser Leu Glu Glu Phe Asn Asp Val Tyr Leu Val
340 345 350
ACC CAT CTC ATG GGG GCA GAT CTG AAC AAC ATT GTG AAA TGT CAG AAG 1104
Thr His Leu Met Gly Ala Asp Leu Asn Asn Ile Val Lys Cys Gln Lys
355 360 365
CTT ACA GAT GAC CAT GTT CAG TTC CTT ATC TAC CAA ATT CTC CGA GGT 1152
Leu Thr Asp Asp His Val Gln Phe Leu Ile Tyr Gln Ile Leu Arg Gly
370 375 380
CTA AAG TAT ATA CAT TCA GCT GAC ATA ATT CAC AGG GAC CTA AAA CCT 1200
Leu Lys Tyr Ile His Ser Ala Asp Ile Ile His Arg Asp Leu Lys Pro
385 390 395 400
AGT AAT CTA GCT GTG AAT GAA GAC TGT GAG CTG AAG ATT CTG GAT TTT 1248
Ser Asn Leu Ala Val Asn Glu Asp Cys Glu Leu Lys Ile Leu Asp Phe
405 410 415
CA 02450698 2003-12-23
87
GGA CTG GCT CGG CAC ACA GAT GAT GAA ATG ACA GGC TAC GTG GCC ACT 1296
Gly Leu Ala Arg His Thr Asp Asp Glu Met Thr Gly Tyr Val Ala Thr
420 425 430
AGG TGG TAC AGG GCT CCT GAG ATC ATG CTG AAC TGG ATG CAT TAC AAC 1344
Arg Trp Tyr Arg Ala Pro Glu Ile Met Leu Asn Trp Met His Tyr Asn
435 440 445
CAG ACA GTT GAT ATT TGG TCA GTG GGA TGC ATA ATG GCC GAG CTG TTG 1392
Gln Thr Val Asp Ile Trp Ser Val Gly Cys Ile Met Ala Glu Leu Leu
450 455 460
ACT GGA AGA ACA TTG TTT CCT GGT ACA GAC CAT ATT GAT CAG TTG AAG 1440
Thr Gly Arg Thr Leu Phe Pro Gly Thr Asp His Ile Asp Gln Leu Lys
465 470 475 480
CTC ATT TTA AGA CTC GTT GGA ACC CCA GGG GCT GAG CTT TTG AAG AAA 1488
Leu Ile Leu Arg Leu Val Gly Thr Pro Gly Ala Glu Leu Leu Lys Lys
485 490 495
ATC TCC TCA GAG TCT GCA AGA AAC TAT ATT CAG TCT TTG ACT CAG ATG 1536
Ile Ser Ser Glu Ser Ala Arg Asn Tyr Ile Gln Ser Leu Thr Gln Met
500 505 510
CCG AAG ATG AAC TTT GCG AAT GTA TTT ATT GGT GCC AAT CCC CTG GCT 1584
Pro Lys Met Asn Phe Ala Asn Val Phe Ile Gly Ala Asn Pro Leu Ala
515 520 525
GTC GAC TTG CTG GAG AAG ATG CTT GTA TTG GAC TCA GAT AAG AGA ATT 1632
Val Asp Leu Leu Glu Lys Met Leu Val Leu Asp Ser Asp Lys Arg Ile
530 535 540
ACA GCG GCC CAA GCC CTT GCA CAT GCC TAC TTT GCT CAG TAC CAC GAT 1680
Thr Ala Ala Gln Ala Leu Ala His Ala Tyr Phe Ala Gln Tyr His Asp
545 550 555 560
CCT GAT GAT GAA CCA GTG GCC GAT CCT TAT GAT CAG TCC TTT GAA AGC 1728
Pro Asp Asp Glu Pro Val Ala Asp Pro Tyr Asp Gln Ser Phe Glu Ser
565 570 575
AGG GAC CTC CTT ATA GAT GAG TGG AAA AGC CTG ACC TAT GAT GAA GTC 1776
Arg Asp Leu Leu Ile Asp Glu Trp Lys Ser Leu Thr Tyr Asp Glu Val
580 585 590
ATC AGC TTT GTG CCA CCA CCC CTT GAC CAA GAA GAG ATG GAG TCC TGA 1824
Ile Ser Phe Val Pro Pro Pro Leu Asp Gln Glu Glu Met Glu Ser
595 600 605
(2) INFORMATION FOR SEQ ID N0:47:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 607 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
CA 02450698 2003-12-23
88
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:47:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Va1 Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Gly Lys Met Ser Gln Glu Arg Pro Thr Phe Tyr
245 250 255
Arg Gln Glu Leu Asn Lys Thr Ile Trp Glu Val Pro Glu Arg Tyr Gln
260 265 270
Asn Leu Ser Pro Val Gly Ser Gly Ala Tyr Gly Ser Val Cys Ala Ala
275 280 285
Phe Asp Thr Lys Thr Gly Leu Arg Val Ala Val Lys Lys Leu Ser Arg
290 295 300
Pro Phe Gln Ser Ile Ile His Ala Lys Arg Thr Tyr Arg Glu Leu Arg
305 310 315 320
Leu Leu Lys His Met Lys His Glu Asn Val Ile Gly Leu Leu Asp Val
325 330 335
Phe Thr Pro Ala Arg Ser Leu Glu Glu Phe Asn Asp Val Tyr Leu Val
340 345 350
Thr His Leu Met Gly Ala Asp Leu Asn Asn Ile Val Lys Cys Gln Lys
355 360 365
Leu Thr Asp Asp His Val Gln Phe Leu Ile Tyr Gln Ile Leu Arg Gly
370 375 380
Leu Lys Tyr Ile His Ser Ala Asp Ile Ile His Arg Asp Leu Lys Pro
385 390 395 400
Ser Asn Leu Ala Val Asn Glu Asp Cys Glu Leu Lys Ile Leu Asp Phe
405 410 415
Gly Leu Ala Arg His Thr Asp Asp Glu Met Thr Gly Tyr Val Ala Thr
420 425 430
Arg Trp Tyr Arg Ala Pro Glu Ile Met Leu Asn Trp Met His Tyr Asn
435 440 445
Gln Thr Val Asp Ile Trp Ser Val Gly Cys Ile Met Ala Glu Leu Leu
450 455 460
CA 02450698 2003-12-23
89
Thr Gly Arg Thr Leu Phe Pro Gly Thr Asp His Ile Asp Gln Leu Lys
465 470 475 480
Leu Ile Leu Arg Leu Val Gly Thr Pro Gly Ala Glu Leu Leu Lys Lys
485 490 495
Ile Ser Ser Glu Ser Ala Arg Asn Tyr Ile Gln Ser Leu Thr Gln Met
500 505 510
Pro Lys Met Asn Phe Ala Asn Val Phe Ile Gly Ala Asn Pro Leu Ala
515 520 525
Val Asp Leu Leu Glu Lys Met Leu Val Leu Asp Ser Asp Lys Arg Ile
530 535 540
Thr Ala Ala Gln Ala Leu Ala His Ala Tyr Phe Ala Gln Tyr His Asp
545 550 555 560
Pro Asp Asp Glu Pro Val Ala Asp Pro Tyr Asp Gln Ser Phe Glu Ser
565 570 575
Arg Asp Leu Leu I1e Asp Glu Trp Lys Ser Leu Thr Tyr Asp Glu Val
580 585 590
Ile Ser Phe Val Pro Pro Pro Leu Asp Gln Glu Glu Met Glu Ser
595 600 605
(2) INFORMATION FOR SEQ ID N0:48:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2907 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2904
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:48:
ATGGTGAGC AAGGGCGAG GAGCTGTTC ACCGGGGTG GTGCCCATC CTG 48
MetValSer LysGlyGlu GluLeuPhe ThrGlyVal ValProIle Leu
1 5 10 15
GTCGAGCTG GACGGCGAC GTAAACGGC CACAAGTTC AGCGTGTCC GGC 96
ValGluLeu AspGlyAsp ValAsnGly HisLysPhe SerValSer Gly
20 25 30
GAGGGCGAG GGCGATGCC ACCTACGGC AAGCTGACC CTGAAGTTC ATC 144
GluGlyGlu GlyAspAla ThrTyrGly LysLeuThr LeuLysPhe Ile
35 40 45
TGCACCACC GGCAAGCTG CCCGTGCCC TGGCCCACC CTCGTGACC ACC 192
CysThrThr GlyLysLeu ProValPro TrpProThr LeuValThr Thr
50 55 60
CTGACCTAC GGCGTGCAG TGCTTCAGC CGCTACCCC GACCACATG AAG 240
LeuThrTyr GlyValGln CysPheSer ArgTyrPro AspHisMet Lys
65 70 75 80
CAGCACGAC TTCTTCAAG TCCGCCATG CCCGAAGGC TACGTCCAG GAG 288
GlnHisAsp PhePheLys SerAlaMet ProGluGly TyrValGln Glu
85 90 95
CA 02450698 2003-12-23
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGACTC AGATCT AGTGCTGAGGGG TACCAGTAC AGA CTG TAT 768
ATG GCG
GlyLeu ArgSexMet SerAlaGluGly TyrGlnTyr ArgAla Leu Tyr
245 250 255
GATTAT AAAAAGGAA AGAGAAGAAGAT ATTGACTTG CACTTG GGT GAC 816
AspTyr LysLysGlu ArgGluGluAsp IleAspLeu HisLeu Gly Asp
260 265 270
ATATTG ACTGTGAAT AAAGGGTCCTTA GTAGCTCTT GGATTC AGT GAT 864
IleLeu ThrValAsn LysGlySerLeu ValAlaLeu GlyPhe Ser Asp
275 280 285
GGACAG GAAGCCAGG CCTGAAGAAATT GGCTGGTTA AATGGC TAT AAT 912
GlyGln GluAlaArg ProGluGluIle GlyTrpLeu AsnGly Tyr Asn
290 295 300
GAA ACC ACA GGG GAA AGG GGG GAC TTT CCG GGA ACT TAC GTA GAA TAT 960
Glu Thr Thr Gly Glu Arg Gly Asp Phe Pro Gly Thr Tyr Val Glu Tyr
305 310 315 320
ATT GGA AGG AAA AAA ATC TCG CCT CCC ACA CCA AAG CCC CGG CCA CCT 1008
Ile Gly Arg Lys Lys Ile Ser Pro Pro Thr Pro Lys Pro Arg Pro Pro
325 330 335
CA 02450698 2003-12-23
91
CGG CCT CTT CCT GTT GCA CCA GGT TCT TCG AAA ACT GAA GCA GAT GTT 1056
Arg Pro Leu Pro Val Ala Pro Gly Ser Ser Lys Thr Glu Ala Asp Val
340 345 350
GAA CAA CAA GCT TTG ACT CTC CCG GAT CTT GCA GAG CAG TTT GCC CCT 1104
Glu Gln Gln Ala Leu Thr Leu Pro Asp Leu Ala Glu Gln Phe Ala Pro
355 360 365
CCT GAC ATT GCC CCG CCT CTT CTT ATC AAG CTC GTG GAA GCC ATT GAA 1152
Pro Asp Ile Ala Pro Pro Leu Leu Ile Lys Leu Val Glu Ala Ile Glu
370 375 380
AAG AAA GGT CTG GAA TGT TCA ACT CTA TAC AGA ACA CAG AGC TCC AGC 1200
Lys Lys Gly Leu Glu Cys Ser Thr Leu Tyr Arg Thr Gln Ser Ser Ser
385 390 395 400
AAC CTG GCA GAA TTA CGA CAG CTT CTT GAT TGT GAT ACA CCC TCC GTG 1248
Asn Leu Ala Glu Leu Arg Gln Leu Leu Asp Cys Asp Thr Pro Ser Val
405 410 415
GACTTGGAA ATCGAT GTGCACGTT TTGGCTGAC GCTTTCAAA 1296
ATG CGC
AspLeuGlu MetIleAsp ValHisVal LeuAlaAsp AlaPheLys Arg
420 425 430
TATCTCCTG GACTTACCA AATCCTGTC ATTCCAGCA GCCGTTTAC AGT 1344
TyrLeuLeu AspLeuPro AsnProVal IleProAla AlaValTyr Ser
435 440 445
GAAATGATT TCTTTAGCT CCAGAAGTA CAAAGCTCC GAAGAATAT ATT 1392
GluMetIle SerLeuAla ProGluVal GlnSerSer GluGluTyr Ile
450 455 460
CAGCTATTG AAGAAGCTT ATTAGGTCG CCTAGCATA CCTCATCAG TAT 1440
GlnLeuLeu LysLysLeu IleArgSer ProSerIle ProHisGln Tyr
465 470 475 480
TGGCTTACG CTTCAGTAT TTGTTAAAA CATTTCTTC AAGCTCTCT CAA 1488
TrpLeuThr LeuGlnTyr LeuLeuLys HisPhePhe LysLeuSex Gln
485 490 495
ACC TCC AGC AAA AAT CTG TTG AAT GCA AGA GTA CTC TCT GAA ATT TTC 1536
Thr Ser Ser Lys Asn Leu Leu Asn Ala Arg Va1 Leu Ser Glu Ile Phe
500 505 510
AGC CCT ATG CTT TTC AGA TTC TCA GCA GCC AGC TCT GAT AAT ACT GAA 1584
Ser Pro Met Leu Phe Arg Phe Ser Ala Ala Ser Ser Asp Asn Thr Glu
515 520 525
AAC CTC ATA AAA GTT ATA GAA ATT TTA ATC TCA ACT GAA TGG AAT GAA 1632
Asn Leu Ile Lys Val Ile Glu Ile Leu Ile Ser Thr Glu Trp Asn Glu
530 535 540
CGA CAG CCT GCA CCA GCA CTG CCT CCT AAA CCA CCA AAA CCT ACT ACT 1680
Arg Gln Pro Ala Pro Ala Leu Pro Pro Lys Pro Pro Lys Pro Thr Thr
545 550 555 560
GTA GCC AAC AAC GGT ATG AAT AAC AAT ATG TCC TTA CAA AAT GCT GAA 1728
Val Ala Asn Asn Gly Met Asn Asn Asn Met Ser Leu Gln Asn Ala Glu
565 570 575
CA 02450698 2003-12-23
92
TGG TAC TGG GGA GAT ATC TCG AGG GAA GAA GTG AAT GAA AAA CTT CGA 1776
Trp Tyr Trp Gly Asp Ile Ser Arg Glu Glu Val Asn Glu Lys Leu Arg
580 585 590
GAT ACA GCA GAC GGG ACC TTT TTG GTA CGA GAT GCG TCT ACT AAA ATG 1824
Asp Thr Ala Asp Gly Thr Phe Leu Val Arg Asp Ala Ser Thr Lys Met
595 600 605
CAT GGT GAT TAT ACT CTT ACA CTA AGG AAA GGG GGA AAT AAC AAA TTA 1872
His Gly Asp Tyr Thr Leu Thr Leu Arg Lys Gly Gly Asn Asn Lys Leu
610 615 620
ATC AAA ATA TTT CAT CGA GAT GGG AAA TAT GGC TTC TCT GAC CCA TTA 1920
Ile Lys Ile Phe His Arg Asp Gly Lys Tyr Gly Phe Ser Asp Pro Leu
625 630 635 640
ACC TTC AGT TCT GTG GTT GAA TTA ATA AAC CAC TAC CGG AAT GAA TCT 1968
Thr Phe Ser Ser Val Val Glu Leu Ile Asn His Tyr Arg Asn Glu Ser
645 650 655
CTA GCT CAG TAT AAT CCC AAA TTG GAT GTG AAA TTA CTT TAT CCA GTA 2016
Leu Ala Gln Tyr Asn Pro Lys Leu Asp Val Lys Leu Leu Tyr Pro Val
660 665 670
TCC AAA TAC CAA CAG GAT CAA GTT GTC AAA GAA GAT AAT ATT GAA GCT 2064
Ser Lys Tyr Gln Gln Asp Gln Val Val Lys Glu Asp Asn Ile Glu Ala
675 680 685
GTA GGG AAA AAA TTA CAT GAA TAT AAC ACT CAG TTT CAA GAA AAA AGT 2112
Val Gly Lys Lys Leu His Glu Tyr Asn Thr Gln Phe Gln Glu Lys Ser
690 695 700
CGA GAA TAT GAT AGA TTA TAT GAA GAA TAT ACC CGC ACA TCC CAG GAA 2160
Arg Glu Tyr Asp Arg Leu Tyr Glu Glu Tyr Thr Arg Thr Ser Gln Glu
705 710 715 720
ATC CAA ATG AAA AGG ACA GCT ATT GAA GCA TTT AAT GAA ACC ATA AAA 2208
Ile Gln Met Lys Arg Thr Ala Ile Glu Ala Phe Asn Glu Thr Ile Lys
725 730 735
ATA TTT GAA GAA CAG TGC CAG ACC CAA GAG CGG TAC AGC AAA GAA TAC 2256
Ile Phe Glu Glu Gln Cys Gln Thr Gln Glu Arg Tyr Ser Lys Glu Tyr
740 745 750
ATA GAA AAG TTT AAA CGT GAA GGC AAT GAG AAA GAA ATA CAA AGG ATT 2304
Tle Glu Lys Phe Lys Arg Glu Gly Asn Glu Lys Glu Ile Gln Arg Ile
755 760 765
ATG CAT AAT TAT GAT AAG TTG AAG TCT CGA ATC AGT GAA ATT ATT GAC 2352
Met His Asn Tyr Asp Lys Leu Lys Ser Arg Ile Ser Glu I1e Ile Asp
770 775 780
AGT AGA AGA AGA TTG GAA GAA GAC TTG AAG AAG CAG GCA GCT GAG TAT 2400
Ser Arg Arg Arg Leu Glu Glu Asp Leu Lys Lys Gln Ala Ala Glu Tyr
785 790 795 800
CGA GAA ATT GAC AAA CGT ATG AAC AGC ATT AAA CCA GAC CTT ATC CAG 2448
Arg Glu Ile Asp Lys Arg Met Asn Ser Ile Lys Pro Asp Leu Ile Gln
805 810 815
CA 02450698 2003-12-23
93
CTG AGA AAG ACG AGA GAC CAA TAC TTG ATG TGG TTG ACT CAA AAA GGT 2496
Leu Arg Lys Thr Arg Asp Gln Tyr Leu Met Trp Leu Thr Gln Lys Gly
820 825 830
GTT CGG CAA AAG AAG TTG AAC GAG TGG TTG GGC AAT GAA AAC ACT GAA 2544
Val Arg Gln Lys Lys Leu Asn Glu Trp Leu Gly Asn Glu Asn Thr Glu
835 840 845
GAC CAA TAT TCA CTG GTG GAA GAT GAT GAA GAT TTG CCC CAT CAT GAT 2592
Asp Gln Tyr Ser Leu Val Glu Asp Asp Glu Asp Leu Pro His His Asp
850 855 860
GAG AAG ACA TGG AAT GTT GGA AGC AGC AAC CGA AAC AAA GCT GAA AAC 2640
Glu Lys Thr Trp Asn Val Gly Ser Ser Asn Arg Asn Lys Ala Glu Asn
865 870 875 880
CTG TTG CGA GGG AAG CGA GAT GGC ACT TTT CTT GTC CGG GAG AGC AGT 2688
Leu Leu Arg Gly Lys Arg Asp Gly Thr Phe Leu Val Arg Glu Ser Ser
885 890 895
AAA CAG GGC TGC TAT GCC TGC TCT GTA GTG GTG GAC GGC GAA GTA AAG 2736
Lys Gln Gly Cys Tyr Ala Cys Ser Val Val Val Asp Gly Glu Val Lys
900 905 910
CAT TGT GTC ATA AAC AAA ACA GCA ACT GGC TAT GGC TTT GCC GAG CCC 2784
His Cys Val Ile Asn Lys Thr Ala Thr Gly Tyr Gly Phe Ala Glu Pro
915 920 925
TAT AAC TTG TAC AGC TCT CTG AAA GAA CTG GTG CTA CAT TAC CAA CAC 2832
Tyr Asn Leu Tyr Ser Ser Leu Lys Glu Leu Val Leu His Tyr Gln His
930 935 940
ACC TCC CTT GTG CAG CAC AAC GAC TCC CTC AAT GTC ACA CTA GCC TAC 2880
Thr Ser Leu Val G1n His Asn Asp Ser Leu Asn Val Thr Leu Ala Tyr
945 950 955 960
CCA GTA TAT GCA CAG CAG AGG CGA TGA 2907
Pro Val Tyr Ala Gln Gln Arg Arg
965
(2) INFORMATION FOR SEQ ID N0:49:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 968 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:49:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
CA 02450698 2003-12-23
94
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Met Ser Ala Glu Gly Tyr Gln Tyr Arg Ala Leu Tyr
245 250 255
Asp Tyr Lys Lys Glu Arg Glu Glu Asp Ile Asp Leu His Leu Gly Asp
260 265 270
Ile Leu Thr Val Asn Lys Gly Ser Leu Val Ala Leu Gly Phe Ser Asp
275 280 285
Gly Gln Glu Ala Arg Pro Glu Glu I1e Gly Trp Leu Asn Gly Tyr Asn
290 295 300
Glu Thr Thr Gly Glu Arg Gly Asp Phe Pro Gly Thr Tyr Val Glu Tyr
305 310 315 320
Ile Gly Arg Lys Lys Ile Ser Pro Pro Thr Pro Lys Pro Arg Pro Pro
325 330 335
Arg Pro Leu Pro Val Ala Pro Gly Ser Ser Lys Thr Glu Ala Asp Val
340 345 350
Glu Gln Gln Ala Leu Thr Leu Pro Asp Leu Ala Glu Gln Phe Ala Pro
355 360 365
Pro Asp Ile Ala Pro Pro Leu Leu Ile Lys Leu Val Glu Ala Ile Glu
370 375 380
Lys Lys Gly Leu Glu Cys Ser Thr Leu Tyr Arg Thr Gln Ser Ser Ser
385 390 395 400
Asn Leu Ala Glu Leu Arg Gln Leu Leu Asp Cys Asp Thr Pro Ser Val
405 410 415
Asp Leu Glu Met Ile Asp Val His Val Leu Ala Asp Ala Phe Lys Arg
420 425 430
Tyr Leu Leu Asp Leu Pro Asn Pro Val Ile Pro Ala Ala Val Tyr Ser
435 440 445
Glu Met Ile Ser Leu Ala Pro Glu Val Gln Ser Ser Glu Glu Tyr Ile
450 455 460
Gln Leu Leu Lys Lys Leu Ile Arg Ser Pro Ser Ile Pro His Gln Tyr
465 470 475 480
Trp Leu Thr Leu Gln Tyr Leu Leu Lys His Phe Phe Lys Leu Ser Gln
485 490 495
Thr Ser Ser Lys Asn Leu Leu Asn Ala Arg Val Leu Ser Glu Ile Phe
500 505 510
Ser Pro Met Leu Phe Arg Phe Ser Ala Ala Ser Ser Asp Asn Thr Glu
515 520 525
CA 02450698 2003-12-23
Asn Leu Ile Lys Val Ile Glu Ile Leu Ile Ser Thr Glu Trp Asn Glu
530 535 540
Arg Gln Pro Ala Pro Ala Leu Pro Pro Lys Pro Pro Lys Pro Thr Thr
545 550 555 560
Val Ala Asn Asn Gly Met Asn Asn Asn Met Ser Leu Gln Asn Ala Glu
565 570 575
Trp Tyr Trp Gly Asp Ile Ser Arg Glu Glu Val Asn Glu Lys Leu Arg
580 585 590
Asp Thr Ala Asp Gly Thr Phe Leu Val Arg Asp Ala Ser Thr Lys Met
595 600 605
His Gly Asp Tyr Thr Leu Thr Leu Arg Lys Gly Gly Asn Asn Lys Leu
610 615 620
Ile Lys Ile Phe His Arg Asp Gly Lys Tyr Gly Phe Ser Asp Pro Leu
625 630 635 640
Thr Phe Ser Ser Val Val Glu Leu Ile Asn His Tyr Arg Asn Glu Ser
645 650 655
Leu Ala Gln Tyr Asn Pro Lys Leu Asp Val Lys Leu Leu Tyr Pro Val
660 665 670
Ser Lys Tyr Gln Gln Asp Gln Val Val Lys Glu Asp Asn Ile Glu Ala
675 680 685
Val Gly Lys Lys Leu His Glu Tyr Asn Thr Gln Phe Gln Glu Lys Ser
690 695 700
Arg Glu Tyr Asp Arg Leu Tyr Glu Glu Tyr Thr Arg Thr Ser Gln Glu
705 710 715 720
Ile Gln Met Lys Arg Thr Ala Ile Glu Ala Phe Asn Glu Thr Ile Lys
725 730 735
Ile Phe Glu Glu Gln Cys Gln Thr Gln Glu Arg Tyr Ser Lys Glu Tyr
740 745 750
Ile Glu Lys Phe Lys Arg Glu Gly Asn Glu Lys Glu Ile Gln Arg Ile
755 760 765
Met His Asn Tyr Asp Lys Leu Lys Ser Arg Ile Ser Glu Ile Ile Asp
770 775 780
Ser Arg Arg Arg Leu Glu Glu Asp Leu Lys Lys Gln Ala Ala Glu Tyr
785 790 795 800
Arg Glu Ile Asp Lys Arg Met Asn Ser Ile Lys Pro Asp Leu Ile Gln
805 810 815
Leu Arg Lys Thr Arg Asp Gln Tyr Leu Met Trp Leu Thr Gln Lys Gly
820 825 830
Val Arg Gln Lys Lys Leu Asn Glu Trp Leu Gly Asn Glu Asn Thr Glu
835 840 845
Asp Gln Tyr Ser Leu Val Glu Asp Asp Glu Asp Leu Pro His His Asp
850 855 860
G1u Lys Thr Trp Asn Val Gly Ser Ser Asn Arg Asn Lys Ala Glu Asn
865 870 875 880
Leu Leu Arg Gly Lys Arg Asp Gly Thr Phe Leu Val Arg Glu Ser Ser
885 890 895
Lys Gln Gly Cys Tyr Ala Cys Ser Val Val Val Asp Gly Glu Val Lys
900 905 910
His Cys Val Ile Asn Lys Thr Ala Thr Gly Tyr Gly Phe Ala Glu Pro
915 920 925
Tyr Asn Leu Tyr Ser Ser Leu Lys Glu Leu Val Leu His Tyr Gln His
930 935 940
Thr Sex Leu Val Gln His Asn Asp Ser Leu Asn Val Thr Leu Ala Tyr
945 950 955 960
Pro Val Tyr Ala Gln Gln Arg Arg
965
(2) INFORMATION FOR SEQ ID N0:50:
(i) SEQUENCE CHARACTERISTICS:
CA 02450698 2003-12-23
96
(A) LENGTH: 2160 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAMEfKEY: Coding Sequence
(B) LOCATION: 1...2157
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:50:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
CA 02450698 2003-12-23
97
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TCG ACC ATG TCG TCC ATC 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Thr Met Ser Ser Ile
245 250 255
TTG CCA TTC ACG CCG CCA GTT GTG AAG AGA CTG CTG GGA TGG AAG AAG 816
Leu Pro Phe Thr Pro Pro Val Val Lys Arg Leu Leu Gly Trp Lys Lys
260 265 270
TCAGCTGGT GGGTCTGGAGGA GCAGGC GGAGGAGAG CAGAATGGG CAG 864
SerAlaGly GlySerGlyGly AlaGly GlyGlyGlu GlnAsnGly Gln
275 280 285
GAAGAAAAG TGGTGTGAGAAA GCAGTG AAAAGTCTG GTGAAGAAG CTA 912
GluGluLys TrpCysGluLys AlaVal LysSerLeu ValLysLys Leu
290 295 300
AAGAAAACA GGACGATTAGAT GAGCTT GAGAAAGCC ATCACCACT CAA 960
LysLysThr GlyArgLeuAsp GluLeu GluLysAla IleThrThr Gln
305 310 315 320
AACTGTAAT ACTAAATGTGTT ACCATA CCAAGCACT TGCTCTGAA ATT 1008
AsnCysAsn ThrLysCysVal ThrIle ProSerThr CysSerGlu Ile
325 330 335
TGG GGA CTG AGT ACA CCA AAT ACG ATA GAT CAG TGG GAT ACA ACA GGC 1056
Trp Gly Leu Ser Thr Pro Asn Thr Ile Asp Gln Trp Asp Thr Thr Gly
340 345 350
CTT TAC AGC TTC TCT GAA CAA ACC AGG TCT CTT GAT GGT CGT CTC CAG 1104
Leu Tyr Ser Phe Ser Glu Gln Thr Arg Ser Leu Asp Gly Arg Leu Gln
355 360 365
GTA TCC CAT CGA AAA GGA TTG CCA CAT GTT ATA TAT TGC CGA TTA TGG 1152
Val Ser His Arg Lys Gly Leu Pro His Val Ile Tyr Cys Arg Leu Trp
370 375 380
CGC TGG CCT GAT CTT CAC AGT CAT CAT GAA CTC AAG GCA ATT GAA AAC 1200
Arg Trp Pro Asp Leu His Ser His His Glu Leu Lys Ala Ile Glu Asn
385 390 395 400
TGC GAA TAT GCT TTT AAT CTT AAA AAG GAT GAA GTA TGT GTA AAC CCT 1248
Cys Glu Tyr Ala Phe Asn Leu Lys Lys Asp Glu Val Cys Val Asn Pro
405 410 415
TAC CAC TAT CAG AGA GTT GAG ACA CCA GTT TTG CCT CCA GTA TTA GTG 1296
Tyr His Tyr Gln Arg Val Glu Thr Pro Val Leu Pro Pro Val Leu Val
CA 02450698 2003-12-23
98
420 425 430
CCC CGA CAC ACC GAG ATC CTA ACA GAA CTT CCG CCT CTG GAT GAC TAT 1344
Pro Arg His Thr Glu Ile Leu Thr Glu Leu Pro Pro Leu Asp Asp Tyr
435 440 445
ACT CAC TCC ATT CCA GAA AAC ACT AAC TTC CCA GCA GGA ATT GAG CCA 1392
Thr His Ser Ile Pro Glu Asn Thr Asn Phe Pro Ala Gly Tle Glu Pro
450 455 460
CAG AGT AAT TAT ATT CCA GAA ACG CCA CCT CCT GGA TAT ATC AGT GAA 1440
Gln Ser Asn Tyr Ile Pro Glu Thr Pro Pro Pro Gly Tyr Ile Ser Glu
465 470 475 480
GATGGAGAA AGTGAC CAACAGTTG AATCAA ATGGACACA GGC 1488
ACA AGT
AspGlyGlu ThrSerAsp GlnGlnLeu AsnGlnSer MetAspThr Gly
485 490 495
TCTCCAGCA GAACTATCT CCTACTACT CTTTCCCCT GTTAATCAT AGC 1536
SerProAla GluLeuSer ProThrThr LeuSerPro ValAsnHis Ser
500 505 510
TTGGATTTA CAGCCAGTT ACTTACTCA GAACCTGCA TTTTGGTGT TCA 1584
LeuAspLeu GlnProVal ThrTyrSer GluProAla PheTrpCys Ser
515 520 525
ATAGCATAT TATGAATTA AATCAGAGG GTTGGAGAA ACCTTCCAT GCA 1632
IleAlaTyr TyrGluLeu AsnGlnArg ValGlyGlu ThrPheHis Ala
530 535 540
TCACAGCCC TCACTCACT GTAGATGGC TTTACAGAC CCATCAAAT TCA 1680
SerGlnPro SerLeuThr ValAspGly PheThrAsp ProSerAsn Ser
545 550 555 560
GAGAGGTTC TGCTTAGGT TTACTCTCC AATGTTAAC CGAAATGCC ACG 1728
GluArgPhe CysLeuGly LeuLeuSer AsnValAsn ArgAsnAla Thr
565 570 575
GTAGAAATG ACAAGAAGG CATATAGGA AGAGGAGTG CGCTTATAC TAC 1776
ValGluMet ThrArgArg HisIleGly ArgGlyVal ArgLeuTyr Tyr
580 585 590
ATAGGTGGG GAAGTTTTT GCTGAGTGC CTAAGTGAT AGTGCAATC TTT 1824
IleGlyGly GluValPhe AlaGluCys LeuSerAsp SerAlaIle Phe
595 600 605
GTGCAGAGC CCCAATTGT AATCAGAGA TATGGCTGG CACCCTGCA ACA 1872
ValGlnSer ProAsnCys AsnGlnArg TyrGlyTrp HisProAla Thr
610 615 620
GTGTGTAAA ATTCCACCA GGCTGTAAT CTGAAGATC TTCAACAAC CAG 1920
ValCysLys IleProPro GlyCysAsn LeuLysIle PheAsnAsn Gln
625 630 635 640
GAATTTGCT GCTCTTCTG GCTCAGTCT GTTAATCAG GGTTTTGAA GCC 1968
GluPheAla AlaLeuLeu AlaGlnSer ValAsnGln GlyPheGlu Ala
645 650 655
GTCTATCAG CTAACTAGA ATGTGCACC ATAAGAATG AGTTTTGTG AAA 2016
ValTyrGln LeuThrArg MetCysThr IleArgMet SerPheVal Lys
CA 02450698 2003-12-23
99
660 665 670
GGG TGG GGA GCA GAA TAC CGA AGG CAG ACG GTA ACA AGT ACT CCT TGC 2064
Gly Trp Gly Ala Glu Tyr Arg Arg Gln Thr Val Thr Ser Thr Pro Cys
675 680 685
TGG ATT GAA CTT CAT CTG AAT GGA CCT CTA CAG TGG TTG GAC AAA GTA 2112
Trp Ile Glu Leu His Leu Asn Gly Pro Leu Gln Trp Leu Asp Lys Val
690 695 700
TTA ACT CAG ATG GGA TCC CCT TCA GTG CGT TGC TCA AGC ATG TCA TAA 2160
Leu Thr Gln Met Gly Ser Pro Ser Val Arg Cys Ser Ser Met Ser
705 710 715
(2) INFORMATION FOR SEQ ID N0:51:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 719 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:51:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Thr Met Ser Ser Ile
245 250 255
CA 02450698 2003-12-23
100
Leu Pro Phe Thr Pro Pro Val Val Lys Arg Leu Leu Gly Trp Lys Lys
260 265 270
Ser Ala Gly Gly Ser Gly Gly Ala Gly Gly Gly Glu Gln Asn Gly Gln
275 280 285
Glu Glu Lys Trp Cys Glu Lys Ala Val Lys Ser Leu Val Lys Lys Leu
290 295 300
Lys Lys Thr Gly Arg Leu Asp Glu Leu Glu Lys Ala Ile Thr Thr Gln
305 310 315 320
Asn Cys Asn Thr Lys Cys Val Thr Ile Pro Ser Thr Cys Ser Glu Ile
325 330 335
Trp Gly Leu Ser Thr Pro Asn Thr Ile Asp Gln Trp Asp Thr Thr Gly
340 345 350
Leu Tyr Ser Phe Ser Glu Gln Thr Arg Ser Leu Asp Gly Arg Leu Gln
355 360 365
Val Ser His Arg Lys Gly Leu Pro His Val Ile Tyr Cys Arg Leu Trp
370 375 380
Arg Trp Pro Asp Leu His Ser His His Glu Leu Lys Ala Ile Glu Asn
385 390 395 400
Cys Glu Tyr Ala Phe Asn Leu Lys Lys Asp Glu Val Cys Val Asn Pro
405 410 415
Tyr His Tyr Gln Arg Val Glu Thr Pro Val Leu Pro Pro Val Leu Val
420 425 430
Pro Arg His Thr G1u Ile Leu Thr Glu Leu Pro Pro Leu Asp Asp Tyr
435 440 445
Thr His Ser Ile Pro Glu Asn Thr Asn Phe Pro Ala Gly Ile Glu Pro
450 455 460
Gln Ser Asn Tyr Ile Pro Glu Thr Pro Pro Pro Gly Tyr Ile Ser Glu
465 470 475 480
Asp Gly Glu Thr Ser Asp Gln Gln Leu Asn Gln Ser Met Asp Thr Gly
485 490 495
Ser Pro Ala Glu Leu Ser Pro Thr Thr Leu Ser Pro Val Asn His Ser
500 505 510
Leu Asp Leu Gln Pro Val Thr Tyr Ser Glu Pro Ala Phe Trp Cys Ser
515 520 525
Ile Ala Tyr Tyr Glu Leu Asn Gln Arg Val Gly Glu Thr Phe His Ala
530 535 540
Ser Gln Pro Ser Leu Thr Val Asp Gly Phe Thr Asp Pro Ser Asn Sex
545 550 555 560
Glu Arg Phe Cys Leu Gly Leu Leu Ser Asn Val Asn Arg Asn Ala Thr
565 570 575
Val Glu Met Thr Arg Arg His Ile Gly Arg Gly Val Arg Leu Tyr Tyr
580 585 590
Ile Gly Gly Glu Val Phe Ala Glu Cys Leu Ser Asp Ser Ala Ile Phe
595 600 605
Val Gln Ser Pro Asn Cys Asn Gln Arg Tyr Gly Trp His Pro Ala Thr
610 615 620
Val Cys Lys Ile Pro Pro Gly Cys Asn Leu Lys Ile Phe Asn Asn Gln
625 630 635 640
Glu Phe Ala Ala Leu Leu Ala Gln Ser Val Asn Gln Gly Phe Glu Ala
645 650 655
Val Tyr Gln Leu Thr Arg Met Cys Thr Ile Arg Met Ser Phe Val Lys
660 665 670
Gly Trp Gly Ala Glu Tyr Arg Arg Gln Thr Val Thr Ser Thr Pro Cys
675 680 685
Trp Ile Glu Leu His Leu Asn Gly Pro Leu Gln Trp Leu Asp Lys Val
690 695 700
Leu Thr Gln Met Gly Ser Pro Ser Val Arg Cys Ser Ser Met Ser
705 710 715
(2) INFORMATION FOR SEQ ID N0:52:
CA 02450698 2003-12-23
101
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2421 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2418
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:52:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys G1y
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
CA 02450698 2003-12-23
102
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TCG AAT TCA ACC ATG GAC 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Asn Ser Thr Met Asp
245 250 255
AAT ATG TCT ATT ACG AAT ACA CCA ACA AGT AAT GAT GCC TGT CTG AGC 816
Asn Met Ser Ile Thr Asn Thr Pro Thr Ser Asn Asp Ala Cys Leu Ser
260 265 270
ATT GTG CAT AGT TTG ATG TGC CAT AGA CAA GGT GGA GAG AGT GAA ACA 864
Ile Val His Ser Leu Met Cys His Arg Gln Gly Gly Glu Ser Glu Thr
275 280 285
TTT GCA AAA AGA GCA ATT GAA AGT TTG GTA AAG AAG CTG AAG GAG AAA 912
Phe Ala Lys Arg Ala Ile Glu Ser Leu Val Lys Lys Leu Lys Glu Lys
290 295 300
AAA GAT GAA TTG GAT TCT TTA ATA ACA GCT ATA ACT ACA AAT GGA GCT 960
Lys Asp Glu Leu Asp Ser Leu Ile Thr Ala I1e Thr Thr Asn Gly Ala
305 310 315 320
CAT CCT AGT AAA TGT GTT ACC ATA CAG AGA ACA TTG GAT GGG AGG CTT 1008
His Pro Ser Lys Cys Val Thr Ile Gln Arg Thr Leu Asp Gly Arg Leu
325 330 335
CAG GTG GCT GGT CGG AAA GGA TTT CCT CAT GTG ATC TAT GCC CGT CTC 1056
Gln Val Ala Gly Arg Lys Gly Phe Pro His Val Ile Tyr Ala Arg Leu
340 345 350
TGG AGG TGG CCT GAT CTT CAC AAA AAT GAA CTA AAA CAT GTT AAA TAT 1104
Trp Arg Trp Pro Asp Leu His Lys Asn Glu Leu Lys His Val Lys Tyr
355 360 365
TGT CAG TAT GCG TTT GAC TTA AAA TGT GAT AGT GTC TGT GTG AAT CCA 1152
Cys Gln Tyr Ala Phe Asp Leu Lys Cys Asp Ser Val Cys Val Asn Pro
370 375 380
TAT CAC TAC GAA CGA GTT GTA TCA CCT GGA ATT GAT CTC TCA GGA TTA 1200
Tyr His Tyr Glu Arg Val Val Ser Pro Gly Ile Asp Leu Ser Gly Leu
385 390 395 400
ACA CTG CAG AGT AAT GCT CCA TCA AGT ATG ATG GTG AAG GAT GAA TAT 1248
Thr Leu Gln Ser Asn Ala Pro Ser Ser Met Met Val Lys Asp Glu Tyr
405 410 415
CA 02450698 2003-12-23
103
GTG CAT GAC TTT GAG GGA CAG CCA TCG TTG TCC ACT GAA GGA CAT TCA 1296
Val His Asp Phe Glu Gly Gln Pro Ser Leu Ser Thr Glu Gly His Ser
420 425 430
ATT CAA ACC ATC CAG CAT CCA CCA AGT AAT CGT GCA TCG ACA GAG ACA 1344
Ile Gln Thr Ile Gln His Pro Pro Ser Asn Arg Ala Ser Thr Glu Thr
435 440 445
TAC AGC ACC CCA GCT CTG TTA GCC CCA TCT GAG TCT AAT GCT ACC AGC 1392
Tyr Sex Thr Pro Ala Leu Leu Ala Pro Ser Glu Ser Asn Ala Thr Ser
450 455 460
ACT GCC AAC TTT CCC AAC ATT CCT GTG GCT TCC ACA AGT CAG CCT GCC 1440
Thr Ala Asn Phe Pro Asn Ile Pro Val Ala Ser Thr Ser Gln Pro Ala
465 470 475 480
AGT ATA CTG GGG GGC AGC CAT AGT GAA GGA CTG TTG CAG ATA GCA TCA 1488
Ser Ile Leu Gly Gly Ser His Ser Glu Gly Leu Leu Gln Ile Ala Ser
485 490 495
GGG CCT CAG CCA GGA CAG CAG CAG AAT GGA TTT ACT GGT CAG CCA GCT 1536
Gly Pro Gln Pro Gly Gln Gln Gln Asn Gly Phe Thr Gly Gln Pro Ala
500 505 510
ACT TAC CAT CAT AAC AGC ACT ACC ACC TGG ACT GGA AGT AGG ACT GCA 1584
Thr Tyr His His Asn Ser Thr Thr Thr Trp Thr Gly Ser Arg Thr Ala
515 520 525
CCA TAC ACA CCT AAT TTG CCT CAC CAC CAA AAC GGC CAT CTT CAG CAC 1632
Pro Tyr Thr Pro Asn Leu Pro His His Gln Asn Gly His Leu Gln His
530 535 540
CAC CCG CCT ATG CCG CCC CAT CCC GGA CAT TAC TGG CCT GTT CAC AAT 1680
His Pro Pro Met Pro Pro His Pro Gly His Tyr Trp Pro Val His Asn
545 550 555 560
GAG CTT GCA TTC CAG CCT CCC ATT TCC AAT CAT CCT GCT CCT GAG TAT 1728
Glu Leu Ala Phe Gln Pro Pro Ile Ser Asn His Pro Ala Pro Glu Tyr
565 570 575
TGG TGT TCC ATT GCT TAC TTT GAA ATG GAT GTT CAG GTA GGA GAG ACA 1776
Trp Cys Ser Ile Ala Tyr Phe Glu Met Asp Val Gln Val Gly Glu Thr
580 585 590
TTT AAG GTT CCT TCA AGC TGC CCT ATT GTT ACT GTT GAT GGA TAC GTG 1824
Phe Lys Val Pro Ser Ser Cys Pro Ile Val Thr Val Asp Gly Tyr Val
595 600 605
GAC CCT TCT GGA GGA GAT CGC TTT TGT TTG GGT CAA CTC TCC AAT GTC 1872
Asp Pro Ser Gly Gly Asp Arg Phe Cys Leu Gly Gln Leu Ser Asn Val
610 615 620
CAC AGG ACA GAA GCC ATT GAG AGA GCA AGG TTG CAC ATA GGC AAA GGT 1920
His Arg Thr Glu Ala Ile Glu Arg Ala Arg Leu His Ile Gly Lys Gly
625 630 635 640
GTG CAG TTG GAA TGT AAA GGT GAA GGT GAT GTT TGG GTC AGG TGC CTT 1968
Val Gln Leu Glu Cys Lys Gly Glu Gly Asp Val Trp Val Arg Cys Leu
645 650 655
CA 02450698 2003-12-23
104
AGT GAC CAC GCG GTC TTT GTA CAG AGT TAC TAC TTA GAC AGA GAA GCT 2016
Ser Asp His Ala Val Phe Val Gln Ser Tyr Tyr Leu Asp Arg Glu Ala
660 665 670
GGG CGT GCA CCT GGA GAT GCT GTT CAT AAG ATC TAC CCA AGT GCA TAT 2064
Gly Arg Ala Pro Gly Asp Ala Val His Lys Ile Tyr Pro Ser Ala Tyr
675 680 685
ATA AAG GTC TTT GAT TTG CGT CAG TGT CAT CGA CAG ATG CAG CAG CAG 2112
Ile Lys Val Phe Asp Leu Arg Gln Cys His Arg Gln Met Gln Gln Gln
690 695 700
GCG GCT ACT GCA CAA GCT GCA GCA GCT GCC CAG GCA GCA GCC GTG GCA 2160
Ala Ala Thr Ala Gln Ala Ala Ala Ala Ala Gln Ala Ala Ala Val Ala
705 710 715 720
GGA AAC ATC CCT GGC CCA GGA TCA GTA GGT GGA ATA GCT CCA GCT ATC 2208
Gly Asn Ile Pro Gly Pro Gly Ser Val Gly Gly Ile Ala Pro Ala Ile
725 730 735
AGT CTG TCA GCT GCT GCT GGA ATT GGT GTT GAT GAC CTT CGT CGC TTA 2256
Ser Leu Ser Ala Ala Ala Gly Ile Gly Val Asp Asp Leu Arg Arg Leu
740 745 750
TGC ATA CTC AGG ATG AGT TTT GTG AAA GGC TGG GGA CCG GAT TAC CCA 2304
Cys Ile Leu Arg Met Ser Phe Val Lys Gly Trp Gly Pro Asp Tyr Pro
755 760 765
AGA CAG AGC ATC AAA GAA ACA CCT TGC TGG ATT GAA ATT CAC TTA CAC 2352
Arg Gln Ser Ile Lys Glu Thr Pro Cys Trp Ile Glu Ile His Leu His
770 775 780
CGG GCC CTC CAG CTC CTA GAC GAA GTA CTT CAT ACC ATG CCG ATT GCA 2400
Arg Ala Leu Gln Leu Leu Asp Glu Val Leu His Thr Met Pro Ile Ala
785 790 795 800
GAC CCA CAA CCT TTA GAC TGA 2421
Asp Pro Gln Pro Leu Asp
805
(2) INFORMATION FOR SEQ ID N0:53:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 806 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:53:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
CA 02450698 2003-12-23
105
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Asn Ser Thr Met Asp
245 250 255
Asn Met Ser Ile Thr Asn Thr Pro Thr Ser Asn Asp Ala Cys Leu Ser
260 265 270
Ile Val His Ser Leu Met Cys His Arg Gln Gly Gly Glu Ser Glu Thr
275 280 285
Phe Ala Lys Arg Ala I1e Glu Ser Leu Val Lys Lys Leu Lys Glu Lys
290 295 300
Lys Asp Glu Leu Asp Ser Leu Ile Thr Ala Ile Thr Thr Asn Gly Ala
305 310 315 320
His Pro Ser Lys Cys Val Thr Ile Gln Arg Thr Leu Asp Gly Arg Leu
325 330 335
Gln Val Ala Gly Arg Lys Gly Phe Pro His Val Ile Tyr Ala Arg Leu
340 345 350
Trp Arg Trp Pro Asp Leu His Lys Asn Glu Leu Lys His Val Lys Tyr
355 360 365
Cys Gln Tyr Ala Phe Asp Leu Lys Cys Asp Ser Val Cys Val Asn Pro
370 375 380
Tyr His Tyr Glu Arg Val Val Ser Pro Gly Ile Asp Leu Sex Gly Leu
385 390 395 400
Thr Leu Gln Ser Asn Ala Pro Ser Ser Met Met Val Lys Asp Glu Tyr
405 410 415
Val His Asp Phe Glu Gly Gln Pro Ser Leu Ser Thr Glu Gly His Ser
420 425 430
Ile Gln Thr Ile Gln His Pro Pro Ser Asn Arg Ala Ser Thr Glu Thr
435 440 445
Tyr Ser Thr Pro Ala Leu Leu Ala Pro Ser Glu Ser Asn Ala Thr Ser
450 455 460
Thr Ala Asn Phe Pro Asn Ile Pro Val Ala Ser Thr Ser Gln Pro Ala
465 470 475 480
Ser Ile Leu Gly Gly Ser His Ser Glu Gly Leu Leu Gln Ile Ala Ser
485 490 495
Gly Pro Gln Pro Gly Gln Gln Gln Asn Gly Phe Thr Gly Gln Pro Ala
500 505 510
Thr Tyr His His Asn Ser Thr Thr Thr Trp Thr Gly Ser Arg Thr Ala
515 520 525
CA 02450698 2003-12-23
106
Pro Tyr Thr Pro Asn Leu Pro His His Gln Asn Gly His Leu Gln His
530 535 540
His Pro Pro Met Pro Pro His Pro Gly His Tyr Trp Pro Val His Asn
545 550 555 560
Glu Leu Ala Phe Gln Pro Pro Ile Ser Asn His Pro Ala Pro Glu Tyr
565 570 575
Trp Cys Ser Ile Ala Tyr Phe Glu Met Asp Val Gln Val Gly Glu Thr
580 585 590
Phe Lys Val Pro Ser Ser Cys Pro Ile Val Thr Val Asp Gly Tyr Val
595 600 605
Asp Pro Ser Gly Gly Asp Arg Phe Cys Leu Gly Gln Leu Ser Asn Val
610 615 620
His Arg Thr Glu Ala Ile Glu Arg Ala Arg Leu His Ile Gly Lys Gly
625 630 635 640
Val Gln Leu Glu Cys Lys Gly Glu Gly Asp Val Trp Val Arg Cys Leu
645 650 655
Ser Asp His Ala Val Phe Val Gln Ser Tyr Tyr Leu Asp Arg Glu Ala
660 665 670
Gly Arg Ala Pro Gly Asp Ala Val His Lys Ile Tyr Pro Ser Ala Tyr
675 680 685
Ile Lys Val Phe Asp Leu Arg Gln Cys His Arg Gln Met Gln Gln Gln
690 695 700
Ala Ala Thr Ala Gln Ala Ala Ala Ala Ala Gln Ala Ala Ala Val Ala
705 710 715 720
Gly Asn Ile Pro Gly Fro Gly Ser Val Gly Gly Ile Ala Pro Ala Ile
725 730 735
Ser Leu Ser Ala Ala Ala Gly Ile Gly Val Asp Asp Leu Arg Arg Leu
740 745 750
Cys Ile Leu Arg Met Ser Phe Val Lys Gly Trp Gly Pro Asp Tyr Pro
755 760 765
Arg Gln Ser Ile Lys Glu Thr Pro Cys Trp Tle Glu Ile His Leu His
770 775 780
Arg Ala Leu Gln Leu Leu Asp Glu Val Leu His Thr Met Pro Ile Ala
785 790 795 800
Asp Pro Gln Pro Leu Asp
805
(2) INFORMATION FOR SEQ ID N0:54:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 3120 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...3117
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:54:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
CA 02450698 2003-12-23
107
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Tzp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Va1 Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT ACC ATG GCG GGC TGG ATC CAG GCC CAG CAG CTG CAG 768
Gly Leu Arg Ser Thr Met Ala Gly Trp Ile Gln Ala Gln Gln Leu Gln
245 250 255
GGA GAC GCG CTG CGC CAG ATG CAG GTG CTG TAC GGC CAG CAC TTC CCC 816
Gly Asp Ala Leu Arg Gln Met Gln Val Leu Tyr Gly Gln His Phe Pro
CA 02450698 2003-12-23
108
260 265 270
ATC GAG GTC CGG CAC TAC TTG GCC CAG TGG ATT GAG AGC CAG CCA TGG 864
Ile Glu Val Arg His Tyr Leu Ala Gln Trp Ile Glu Ser Gln Pro Trp
275 280 285
GAT GCC ATT GAC TTG GAC AAT CCC CAG GAC AGA GCC CAA GCC ACC CAG 912
Asp Ala Ile Asp Leu Asp Asn Pro Gln Asp Arg Ala Gln Ala Thr Gln
290 295 300
CTC CTG GAG GGC CTG GTG CAG GAG CTG CAG AAG AAG GCG GAG CAC CAG 960
Leu Leu Glu Gly Leu Val Gln Glu Leu Gln Lys Lys Ala Glu His Gln
305 310 315 320
GTG GGG GAA GAT GGG TTT TTA CTG AAG ATC AAG CTG GGG CAC TAC GCC 1008
Val Gly Glu Asp Gly Phe Leu Leu Lys Ile Lys Leu Gly His Tyr Ala
325 330 335
ACG CAG CTC CAG AAA ACA TAT GAC CGC TGC CCC CTG GAG CTG GTC CGC 1056
Thr Gln Leu Gln Lys Thr Tyr Asp Arg Cys Pro Leu Glu Leu Val Arg
340 345 350
TGC ATC CGG CAC ATT CTG TAC AAT GAA CAG AGG CTG GTC CGA GAA GCC 1104
Cys Ile Arg His Ile Leu Tyr Asn Glu Gln Arg Leu Val Arg Glu Ala
355 360 365
AAC AAT TGC AGC TCT CCG GCT GGG ATC CTG GTT GAC GCC ATG TCC CAG 1152
Asn Asn Cys Ser Ser Pro Ala Gly Ile Leu Val Asp Ala Met Ser Gln
370 375 380
AAG CAC CTT CAG ATC AAC CAG ACA TTT GAG GAG CTG CGA CTG GTC ACG 1200
Lys His Leu Gln Ile Asn Gln Thr Phe Glu Glu Leu Arg Leu Val Thr
385 390 395 400
CAG GAC ACA GAG AAT GAG CTG AAG AAA CTG CAG CAG ACT CAG GAG TAC 1248
Gln Asp Thr Glu Asn Glu Leu Lys Lys Leu Gln Gln Thr Gln Glu Tyr
405 410 415
TTC ATC ATC CAG TAC CAG GAG AGC CTG AGG ATC CAA GCT CAG TTT GCC 1296
Phe Ile Ile Gln Tyr Gln Glu Ser Leu Arg Ile Gln Ala Gln Phe Ala
420 425 430
CAG CTG GCC CAG CTG AGC CCC CAG GAG CGT CTG AGC CGG GAG ACG GCC 1344
Gln Leu Ala Gln Leu Ser Pro Gln Glu Arg Leu Ser Arg Glu Thr Ala
435 440 445
CTC CAG CAG AAG CAG GTG TCT CTG GAG GCC TGG TTG CAG CGT GAG GCA 1392
Leu Gln Gln Lys Gln Val Ser Leu Glu Ala Trp Leu Gln Arg Glu Ala
450 455 460
CAG ACA CTG CAG CAG TAC CGC GTG GAG CTG GCC GAG AAG CAC CAG AAG 1440
Gln Thr Leu Gln Gln Tyr Arg Val Glu Leu Ala Glu Lys His Gln Lys
465 470 475 480
ACC CTG CAG CTG CTG CGG AAG CAG CAG ACC ATC ATC CTG GAT GAC GAG 1488
Thr Leu Gln Leu Leu Arg Lys Gln Gln Thr Ile Ile Leu Asp Asp Glu
485 490 495
CTG ATC CAG TGG AAG CGG CGG CAG CAG CTG GCC GGG AAC GGC GGG CCC 1536
Leu Ile Gln Trp Lys Arg Arg Gln Gln Leu Ala Gly Asn Gly Gly Pro
CA 02450698 2003-12-23
109
500 505 510
CCC GAG GGC AGC CTG GAC GTG CTA CAG TCC TGG TGT GAG AAG TTG GCC 1584
Pro Glu Gly Ser Leu Asp Val Leu Gln Ser Trp Cys G1u Lys Leu Ala
515 520 525
GAG ATC ATC TGG CAG AAC CGG CAG CAG ATC CGC AGG GCT GAG CAC CTC 1632
Glu Ile Ile Trp Gln Asn Arg Gln Gln Ile Arg Arg Ala Glu His Leu
530 535 540
TGC CAG CAG CTG CCC ATC CCC GGC CCA GTG GAG GAG ATG CTG GCC GAG 1680
Cys Gln Gln Leu Pro Ile Pro Gly Pro Val Glu Glu Met Leu Ala Glu
545 550 555 560
GTC AAC GCC ACC ATC ACG GAC ATT ATC TCA GCC CTG GTG ACC AGC ACA 1728
Val Asn Ala Thr Ile Thr Asp Ile Ile Ser Ala Leu Val Thr Ser Thr
565 570 575
TTC ATC ATT GAG AAG CAG CCT CCT CAG GTC CTG AAG ACC CAG ACC AAG 1776
Phe Ile Ile Glu Lys Gln Pro Pro Gln Val Leu Lys Thr Gln Thr Lys
580 585 590
TTT GCA GCC ACC GTA CGC CTG CTG GTG GGC GGG AAG CTG AAC GTG CAC 1824
Phe Ala Ala Thr Val Arg Leu Leu Val Gly Gly Lys Leu Asn Val His
595 600 605
ATG AAT CCC CCC CAG GTG AAG GCC ACC ATC ATC AGT GAG CAG CAG GCC 1872
Met Asn Pro Pro Gln Val Lys Ala Thr Ile Ile Ser Glu Gln Gln Ala
610 615 620
AAG TCT CTG CTT AAA AAT GAG AAC ACC CGC AAC GAG TGC AGT GGT GAG 1920
Lys Ser Leu Leu Lys Asn Glu Asn Thr Arg Asn Glu Cys Ser Gly Glu
625 630 635 640
ATC CTG AAC AAC TGC TGC GTG ATG GAG TAC CAC CAA GCC ACG GGC ACC 1968
Ile Leu Asn Asn Cys Cys Val Met Glu Tyr His Gln Ala Thr Gly Thr
645 650 655
CTC AGT GCC CAC TTC AGG AAC ATG TCA CTG AAG AGG ATC AAG CGT GCT 2016
Leu Ser Ala His Phe Arg Asn Met Ser Leu Lys Arg Ile Lys Arg Ala
660 665 670
GAC CGG CGG GGT GCA GAG TCC GTG ACA GAG GAG AAG TTC ACA GTC CTG 2064
Asp Arg Arg Gly Ala Glu Ser Val Thr Glu Glu Lys Phe Thr Val Leu
675 680 685
TTTGAG TCTCAGTTCAGT GTTGGCAGC AATGAGCTT GTGTTC CAGGTG 2112
PheGlu SerGlnPheSer ValGlySer AsnGluLeu ValPhe GlnVal
690 695 700
AAGACT CTGTCCCTACCT GTGGTTGTC ATCGTCCAC GGCAGC CAGGAC 2160
LysThr LeuSerLeuPro ValValVal IleValHis GlySer GlnAsp
705 710 715 720
CACAAT GCCACGGCTACT GTGCTGTGG GACAATGCC TTTGCT GAGCCG 2208
HisAsn AlaThrAlaThr ValLeuTrp AspAsnAla PheAla GluPro
725 730 735
GGCAGG GTGCCATTTGCC GTGCCTGAC AAAGTGCTG TGGCCG CAGCTG 2256
GlyArg ValProPheAla ValProAsp LysValLeu TrpPro GlnLeu
CA 02450698 2003-12-23
110
740 745 750
TGT GAG GCG CTC AAC ATG AAA TTC AAG GCC GAA GTG CAG AGC AAC CGG 2304
Cys Glu Ala Leu Asn Met Lys Phe Lys Ala Glu Val Gln Ser Asn Arg
755 760 765
GGC CTG ACC AAG GAG AAC CTC GTG TTC CTG GCG CAG AAA CTG TTC AAC 2352
Gly Leu Thr Lys Glu Asn Leu Val Phe Leu A1a Gln Lys Leu Phe Asn
770 775 780
AAC AGC AGC AGC CAC CTG GAG GAC TAC AGT GGC CTG TCC GTG TCC TGG 2400
Asn Ser Ser Ser His Leu Glu Asp Tyr Ser Gly Leu Ser Val Ser Trp
785 790 795 800
TCC CAG TTC AAC AGG GAG AAC TTG CCG GGC TGG AAC TAC ACC TTC TGG 2448
Ser Gln Phe Asn Arg Glu Asn Leu Pro Gly Trp Asn Tyr Thr Phe Trp
805 810 815
CAG TGG TTT GAC GGG GTG ATG GAG GTG TTG AAG AAG CAC CAC AAG CCC 2496
Gln Trp Phe Asp Gly Val Met Glu Val Leu Lys Lys His His Lys Pro
820 825 830
CAC TGG AAT GAT GGG GCC ATC CTA GGT TTT GTG AAT AAG CAA CAG GCC 2544
His Trp Asn Asp Gly Ala Ile Leu G1y Phe Val Asn Lys Gln Gln Ala
835 840 845
CAC GAC CTG CTC ATC AAC AAG CCC GAC GGG ACC TTC TTG TTG CGC TTT 2592
His Asp Leu Leu Ile Asn Lys Pro Asp Gly Thr Phe Leu Leu Arg Phe
850 855 860
AGT GAC TCA GAA ATC GGG GGC ATC ACC ATC GCC TGG AAG TTT GAC TCC 2640
Ser Asp Ser Glu Ile Gly Gly Ile Thr Ile Ala Trp Lys Phe Asp Ser
865 870 875 880
CCG GAA CGC AAC CTG TGG AAC CTG AAA CCA TTC ACC ACG CGG GAT TTC 2688
Pro Glu Arg Asn Leu Trp Asn Leu Lys Pro Phe Thr Thr Arg Asp Phe
885 890 895
TCC ATC AGG TCC CTG GCT GAC CGG CTG GGG GAC CTG AGC TAT CTC ATC 2736
Ser Ile Arg Ser Leu Ala Asp Arg Leu Gly Asp Leu Ser Tyr Leu Ile
900 905 910
TAT GTG TTT CCT GAC CGC CCC AAG GAT GAG GTC TTC TCC AAG TAC TAC 2784
Tyr Val Phe Pro Asp Arg Pro Lys Asp Glu Val Phe Ser Lys Tyr Tyr
915 920 925
ACT CCT GTG CTG GCT AAA GCT GTT GAT GGA TAT GTG AAA CCA CAG ATC 2832
Thr Pro Val Leu Ala Lys Ala Val Asp Gly Tyr Val Lys Pro Gln Ile
930 935 940
AAG CAA GTG GTC CCT GAG TTT GTG AAT GCA TCT GCA GAT GCT GGG GGC 2880
Lys Gln Val Val Pro Glu Phe Val Asn Ala Ser Ala Asp Ala Gly Gly
945 950 955 960
AGC AGC GCC ACG TAC ATG GAC CAG GCC CCC TCC CCA GCT GTG TGC CCC 2928
Ser Ser Ala Thr Tyr Met Asp Gln Ala Pro Ser Pro Ala Val Cys Pro
965 970 975
CAG GCT CCC TAT AAC ATG TAC CCA CAG AAC CCT GAC CAT GTA CTC GAT 2976
Gln Ala Pro Tyr Asn Met Tyr Pro Gln Asn Pro Asp His Val Leu Asp
CA 02450698 2003-12-23
111
980 985 990
CAG GAT GGA GAA TTC GAC CTG GAT GAG ACC ATG GAT GTG GCC AGG CAC 3024
Gln Asp Gly Glu Phe Asp Leu Asp Glu Thr Met Asp Val Ala Arg His
995 1000 1005
GTG GAG GAA CTC TTA CGC CGA CCA ATG GAC AGT CTT GAC TCC CGC CTC 3072
Val Glu Glu Leu Leu Arg Arg Pro Met Asp Ser Leu Asp Ser Arg Leu
1010 1015 1020
TCG CCC CCT GCC GGT CTT TTC ACC TCT GCC AGA GGC TCC CTC TCA TGA 3120
Ser Pro Pro Ala Gly Leu Phe Thr Ser Ala Arg Gly Ser Leu Ser
1025 1030 1035 1
(2) INFORMATION FOR SEQ ID N0:55:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1039 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:55:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 S 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Thr Met Ala Gly Trp Ile Gln Ala Gln Gln Leu Gln
245 250 255
CA 02450698 2003-12-23
112
Gly Asp Ala Leu Arg Gln Met Gln Val Leu Tyr Gly Gln His Phe Pro
260 265 270
Ile Glu Val Arg His Tyr Leu Ala Gln Trp Ile Glu Ser Gln Pro Trp
275 280 285
Asp Ala Ile Asp Leu Asp Asn Pro Gln Asp Arg Ala Gln Ala Thr Gln
290 295 300
Leu Leu Glu Gly Leu Val Gln Glu Leu Gln Lys Lys Ala G1u His Gln
305 310 315 320
Val Gly Glu Asp Gly Phe Leu Leu Lys Ile Lys Leu Gly His Tyr Ala
325 330 335
Thr Gln Leu Gln Lys Thr Tyr Asp Arg Cys Pro Leu Glu Leu Val Arg
340 345 350
Cys Ile Arg His Ile Leu Tyr Asn Glu Gln Arg Leu Val Arg Glu Ala
355 360 365
Asn Asn Cys Ser Ser Pro Ala Gly Ile Leu Val Asp Ala Met Ser Gln
370 375 380
Lys His Leu Gln Ile Asn Gln Thr Phe Glu Glu Leu Arg Leu Val Thr
385 390 395 400
Gln Asp Thr Glu Asn Glu Leu Lys Lys Leu Gln Gln Thr Gln Glu Tyr
405 410 415
Phe Ile Ile Gln Tyr Gln Glu Ser Leu Arg Ile Gln Ala Gln Phe Ala
420 425 430
Gln Leu Ala Gln Leu Ser Pro Gln Glu Arg Leu Ser Arg Glu Thr Ala
435 440 445
Leu Gln Gln Lys Gln Val Ser Leu Glu Ala Trp Leu Gln Arg Glu Ala
450 455 460
Gln Thr Leu Gln Gln Tyr Arg Val Glu Leu Ala Glu Lys His Gln Lys
465 470 475 480
Thr Leu Gln Leu Leu Arg Lys Gln Gln Thr Ile Ile Leu Asp Asp Glu
485 490 495
Leu Ile Gln Trp Lys Arg Arg Gln Gln Leu Ala Gly Asn Gly Gly Pro
500 505 510
Pro Glu Gly Ser Leu Asp Val Leu Gln Ser Trp Cys Glu Lys Leu Ala
515 520 525
Glu Ile Ile Trp Gln Asn Arg Gln Gln Ile Arg Arg Ala Glu His Leu
530 535 540
Cys Gln Gln Leu Pro Ile Pro Gly Pro Val Glu Glu Met Leu Ala Glu
545 550 555 560
Val Asn Ala Thr Ile Thr Asp Ile Ile Ser Ala Leu Val Thr Ser Thr
565 570 575
Phe Ile Ile Glu Lys Gln Pro Pro Gln Val Leu Lys Thr Gln Thr Lys
580 585 590
Phe Ala Ala Thr Val Arg Leu Leu Val Gly Gly Lys Leu Asn Val His
595 600 605
Met Asn Pro Pro Gln Val Lys Ala Thr Ile Ile Ser Glu Gln Gln Ala
610 615 620
Lys Ser Leu Leu Lys Asn Glu Asn Thr Arg Asn Glu Cys Ser Gly Glu
625 630 635 640
Ile Leu Asn Asn Cys Cys Val Met Glu Tyr His Gln Ala Thr Gly Thr
645 650 655
Leu Ser Ala His Phe Arg Asn Met Ser Leu Lys Arg Ile Lys Arg Ala
660 665 670
Asp Arg Arg Gly Ala Glu Ser Val Thr Glu Glu Lys Phe Thr Val Leu
675 680 685
Phe Glu Ser Gln Phe Ser Val Gly Ser Asn Glu Leu Val Phe Gln Val
690 695 700
Lys Thr Leu Ser Leu Pro Val Val Val Ile Val His Gly Ser Gln Asp
705 710 715 720
His Asn Ala Thr Ala Thr Val Leu Trp Asp Asn Ala Phe Ala Glu Pro
725 730 735
CA 02450698 2003-12-23
113
Gly Arg Val Pro Phe Ala Val Pro Asp Lys Val Leu Trp Pro Gln Leu
740 745 750
Cys G1u Ala Leu Asn Met Lys Phe Lys Ala Glu Val Gln Ser Asn Arg
755 760 765
Gly Leu Thr Lys Glu Asn Leu Val Phe Leu Ala Gln Lys Leu Phe Asn
770 775 780
Asn Ser Ser Ser His Leu Glu Asp Tyr Ser Gly Leu Ser Val Ser Trp
785 790 795 800
Ser Gln Phe Asn Arg Glu Asn Leu Pro Gly Trp Asn Tyr Thr Phe Trp
805 810 815
Gln Trp Phe Asp Gly Val Met Glu Val Leu Lys Lys His His Lys Pro
820 825 830
His Trp Asn Asp Gly Ala Ile Leu Gly Phe Val Asn Lys Gln Gln Ala
835 840 845
His Asp Leu Leu Ile Asn Lys Pro Asp Gly Thr Phe Leu Leu Arg Phe
850 855 860
Ser Asp Ser Glu Ile Gly Gly Ile Thr Ile Ala Trp Lys Phe Asp Ser
865 870 875 880
Pro Glu Arg Asn Leu Trp Asn Leu Lys Pro Phe Thr Thr Arg Asp Phe
885 890 895
Ser Ile Arg Ser Leu Ala Asp Arg Leu Gly Asp Leu Ser Tyr Leu Ile
900 905 910
Tyr Val Phe Pro Asp Arg Pro Lys Asp Glu Val Phe Ser Lys Tyr Tyr
915 920 925
Thr Pro Val Leu Ala Lys Ala Val Asp Gly Tyr Val Lys Pro Gln Ile
930 935 940
Lys Gln Val Val Pro Glu Phe Val Asn Ala Ser Ala Asp Ala Gly Gly
945 950 955 960
Ser Ser Ala Thr Tyr Met Asp Gln Ala Pro Ser Pro Ala Val Cys Pro
965 970 975
Gln Ala Pro Tyr Asn Met Tyr Pro Gln Asn Pro Asp His Val Leu Asp
980 985 990
Gln Asp Gly Glu Phe Asp Leu Asp Glu Thr Met Asp Val Ala Arg His
995 1000 1005
Val Glu Glu Leu Leu Arg Arg Pro Met Asp Ser Leu Asp Ser Arg Leu
1010 1015 1020
Ser Pro Pro Ala Gly Leu Phe Thr Ser Ala Arg Gly Ser Leu Ser
025 1030 1035 1
(2) INFORMATION FOR SEQ ID N0:56:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1875 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1872
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:56:
ATG GCG GCG GCG GCG GCG GCT CCG GGG GGC GGG GGC GGG GAG CCC AGG 48
Met Ala Ala Ala Ala Ala Ala Pro Gly Gly Gly Gly Gly Glu Pro Arg
1 5 10 15
CA 02450698 2003-12-23
114
GGA ACT GCT GGG GTC GTC CCG GTG GTC CCC GGG GAG GTG GAG GTG GTG 96
Gly Thr Ala Gly Val Val Pro Val Val Pro Gly Glu Val Glu Val Val
20 25 30
AAG GGG CAG CCA TTC GAT GTG GGC CCA CGC TAC ACG CAG CTG CAG TAC 144
Lys Gly Gln Pro Phe Asp Val Gly Pro Arg Tyr Thr Gln Leu Gln Tyr
35 40 45
ATC GGC GAG GGC GCG TAC GGC ATG GTC AGC TCA GCT TAT GAC CAC GTG 192
Ile Gly Glu Gly Ala Tyr Gly Met Val Ser Ser Ala Tyr Asp His Val
50 55 60
CGC AAG ACC AGA GTG GCC ATC AAG AAG ATC AGC CCC TTT GAG CAT CAA 240
Arg Lys Thr Arg Val Ala Ile Lys Lys Ile Ser Pro Phe Glu His Gln
65 70 75 80
ACC TAC TGT CAG CGC ACG CTG AGG GAG ATC CAG ATC TTG CTG CGA TTC 288
Thr Tyr Cys Gln Arg Thr Leu Arg Glu Ile Gln Ile Leu Leu Arg Phe
85 90 95
CGC CAT GAG AAT GTT ATA GGC ATC CGA GAC ATC CTC AGA GCG CCC ACC 336
Arg His Glu Asn Val Ile Gly Ile Arg Asp Ile Leu Arg Ala Pro Thr
100 105 110
CTG GAA GCC ATG AGA GAT GTT TAC ATT GTT CAG GAC CTC ATG GAG ACA 384
Leu Glu Ala Met Arg Asp Val Tyr Ile Val Gln Asp Leu Met Glu Thr
115 120 125
GAC CTG TAC AAG CTG CTT AAA AGC CAG CAG CTG AGC AAT GAC CAC ATC 432
Asp Leu Tyr Lys Leu Leu Lys Ser Gln Gln Leu Ser Asn Asp His Ile
130 135 140
TGC TAC TTC CTC TAC CAG ATC CTC CGG GGC CTC AAG TAT ATA CAC TCA 480
Cys Tyr Phe Leu Tyr Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser
145 150 155 160
GCC AAT GTG CTG CAC CGG GAC CTG AAG CCT TCC AAT CTG CTT ATC AAC 528
Ala Asn Val Leu His Arg Asp Leu Lys Pro Ser Asn Leu Leu Ile Asn
165 170 175
ACC ACC TGC GAC CTT AAG ATC TGT GAT TTT GGC CTG GCC CGG ATT GCT 576
Thr Thr Cys Asp Leu Lys Ile Cys Asp Phe Gly Leu Ala Arg Ile Ala
180 185 190
GAC CCT GAG CAC GAC CAC ACT GGC TTT CTG ACG GAG TAT GTG GCC ACA 624
Asp Pro Glu His Asp His Thr G1y Phe Leu Thr Glu Tyr Val Ala Thr
195 200 205
CGC TGG TAC CGA GCC CCA GAG ATC ATG CTT AAT TCC AAG GGC TAC ACC 672
Arg Trp Tyr Arg Ala Pro Glu Ile Met Leu Asn Ser Lys Gly Tyr Thr
210 215 220
AAA TCC ATC GAC ATC TGG TCT GTG GGC TGC ATT CTG GCT GAG ATG CTC 720
Lys Ser Ile Asp Ile Trp Ser Val Gly Cys Ile Leu Ala Glu Met Leu
225 230 235 240
TCC AAC CGG CCC ATC TTC CCC GGC AAG CAC TAC CTG GAC CAG CTC AAC 768
Ser Asn Arg Pro Ile Phe Pro Gly Lys His Tyr Leu Asp Gln Leu Asn
245 250 255
CA 02450698 2003-12-23
115
CAC ATT CTA GGT ATC TTG GGT TCC CCA TCC CAG GAG GAC CTT AAT TGC 816
His Ile Leu Gly Ile Leu Gly Ser Pro Ser Gln Glu Asp Leu Asn Cys
260 265 270
ATC ATT AAC ATG AAG GCC CGA AAC TAC CTG CAG TCT CTG CCC TCG AAA 864
Ile Ile Asn Met Lys-Ala Arg Asn Tyr Leu Gln Ser Leu Pro Ser Lys
275 280 285
ACC AAG GTG GCT TGG GCC AAG CTC TTT CCT AAA TCT GAC TCC AAA GCT 912
Thr Lys Val Ala Trp Ala Lys Leu Phe Pro Lys Ser Asp Ser Lys Ala
290 295 300
CTT GAC CTG CTG GAC CGG ATG TTA ACC TTC AAC CCA AAC AAG CGC ATC 960
Leu Asp Leu Leu Asp Arg Met Leu Thr Phe Asn Pro Asn Lys Arg Ile
305 310 315 320
ACA GTA GAG GAA GCG CTG GCT CAC CCT TAC CTG GAA CAG TAC TAC GAT 1008
Thr Val Glu Glu Ala Leu Ala His Pro Tyr Leu Glu Gln Tyr Tyr Asp
325 330 335
CCG ACA GAT GAG CCA GTG GCC GAG GAG CCA TTC ACC TTC GAC ATG GAG 1056
Pro Thr Asp Glu Pro Val Ala Glu Glu Pro Phe Thr Phe Asp Met Glu
340 345 350
CTG GAT GAC CTC CCC AAG GAG CGG CTG AAG GAG TTG ATC TTC CAG GAG 1104
Leu Asp Asp Leu Pro Lys Glu Arg Leu Lys Glu Leu Ile Phe Gln Glu
355 360 365
ACA GCC CGC TTC CAG CCA GGG GCG CCA GAG GGC CCC GGG CGC GCC ATG 1152
Thr Ala Arg Phe Gln Pro Gly Ala Pro Glu Gly Pro Gly Arg Ala Met
370 375 380
AGT AAA GGA GAA GAA CTT TTC ACT GGA GTT GTC CCA ATT CTT GTT GAA 1200
Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu
385 390 395 400
TTA GAT GGC GAT GTT AAT GGG CAA AAA TTC TCT GTT AGT GGA GAG GGT 1248
Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val Ser Gly Glu Gly
405 410 415
GAA GGT GAT GCA ACA TAC GGA AAA CTT ACC CTT AAA TTT ATT TGC ACT 1296
Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr
420 425 430
ACT GGG AAG CTA CCT GTT CCA TGG CCA ACG CTT GTC ACT ACT CTC ACT 1344
Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr
435 440 445
TAT GGT GTT CAA TGC TTT TCT AGA TAC CCA GAT CAT ATG AAA CAG CAT 1392
Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His
450 455 460
GAC TTT TTC AAG AGT GCC ATG CCC GAA GGT TAT GTA CAG GAA AGA ACT 1440
Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr
465 470 475 480
ATA TTT TAC AAA GAT GAC GGG AAC TAC AAG ACA CGT GCT GAA GTC AAG 1488
Ile Phe Tyr Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys
485 490 495
CA 02450698 2003-12-23
116
TTT GAA GGT GAT ACC CTT GTT AAT AGA ATC GAG TTA AAA GGT ATT GAT 1536
Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp
500 505 510
TTT AAA GAA GAT GGA AAC ATT CTT GGA CAC AAA ATG GAA TAC AAT TAT 1584
Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Met Glu Tyr Asn Tyr
515 520 525
AAC TCA CAT AAT GTA TAC ATC ATG GCA GAC AAA CCA AAG AAT GGC ATC 1632
Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Pro Lys Asn Gly Ile
530 535 540
AAA GTT AAC TTC AAA ATT AGA CAC AAC ATT AAA GAT GGA AGC GTT CAA 1680
Lys Val Asn Phe Lys Ile Arg His Asn Ile Lys Asp Gly Ser Val Gln
545 550 555 560
TTA GCA GAC CAT TAT CAA CAA AAT ACT CCA ATT GGC GAT GGC CCT GTC 1728
Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val
565 570 575
CTT TTA CCA GAC AAC CAT TAC CTG TCC ACG CAA TCT GCC CTT TCC AAA 1776
Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys
580 585 590
GAT CCC AAC GAA AAG AGA GAT CAC ATG ATC CTT CTT GAG TTT GTA ACA 1824
Asp Pro Asn Glu Lys Arg Asp His Met Ile Leu Leu Glu Phe Val Thr
595 600 605
GCT GCT GGG ATT ACA CAT GGC ATG GAT GAA CTA TAC AAA CCT CAG GAG T 1873
Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys Pro Gln Glu
610 615 620
AA 1875
(2) INFORMATION FOR SEQ ID N0:57:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 624 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:57:
Met Ala Ala Ala Ala Ala Ala Pro Gly Gly Gly Gly Gly Glu Pro Arg
1 5 10 15
Gly Thr Ala Gly Val Val Pro Val Val Pro Gly Glu Val Glu Val Val
20 25 30
Lys Gly Gln Pro Phe Asp Val Gly Pro Arg Tyr Thr Gln Leu Gln Tyr
35 40 45
Ile Gly Glu Gly Ala Tyr Gly Met Val Ser Ser Ala Tyr Asp His Val
50 55 60
Arg Lys Thr Arg Val Ala Ile Lys Lys Ile Ser Pro Phe Glu His Gln
65 70 75 80
Thr Tyr Cys Gln Arg Thr Leu Arg Glu Ile Gln Ile Leu Leu Arg Phe
85 90 95
Arg His Glu Asn Val Ile Gly Ile Arg Asp Ile Leu Arg Ala Pro Thr
CA 02450698 2003-12-23
117
100 105 110
Leu Glu Ala Met Arg Asp Val Tyr Ile Val Gln Asp Leu Met Glu Thr
115 120 125
Asp Leu Tyr Lys Leu Leu Lys Ser Gln Gln Leu Ser Asn Asp His Ile
130 135 140
Cys Tyr Phe Leu Tyr Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser
145 150 155 160
Ala Asn Val Leu His Arg Asp Leu Lys Pro Ser Asn Leu Leu Ile Asn
165 170 175
Thr Thr Cys Asp Leu Lys Ile Cys Asp Phe Gly Leu Ala Arg Ile Ala
180 185 190
Asp Pro,Glu His Asp His Thr Gly Phe Leu Thr Glu Tyr Val Ala Thr
195 200 205
Arg Trp Tyr Arg Ala Pro Glu Ile Met Leu Asn Ser Lys Gly Tyr Thr
210 215 220
Lys Ser Ile Asp Ile Trp Ser Val Gly Cys Ile Leu Ala Glu Met Leu
225 230 235 240
Ser Asn Arg Pro Ile Phe Pro Gly Lys His Tyr Leu Asp Gln Leu Asn
245 250 255
His Ile Leu Gly Ile Leu Gly Ser Pro Ser Gln Glu Asp Leu Asn Cys
260 265 270
Ile Ile Asn Met Lys Ala Arg Asn Tyr Leu Gln Ser Leu Pro Ser Lys
275 280 285
Thr Lys Val Ala Trp Ala Lys Leu Phe Pro Lys Ser Asp Ser Lys Ala
290 295 300
Leu Asp Leu Leu Asp Arg Met Leu Thr Phe Asn Pro Asn Lys Arg Ile
305 310 315 320
Thr Val Glu Glu Ala Leu Ala His Pro Tyr Leu Glu Gln Tyr Tyr Asp
325 330 335
Pro Thr Asp Glu Pro Val Ala Glu Glu Pro Phe Thr Phe Asp Met Glu
340 345 350
Leu Asp Asp Leu Pro Lys Glu Arg Leu Lys Glu Leu Ile Phe Gln Glu
355 360 365
Thr Ala Arg Phe Gln Pro Gly Ala Pro Glu Gly Pro Gly Arg Ala Met
370 375 380
Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu
385 390 395 400
Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val Ser Gly Glu Gly
405 410 415
Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr
420 425 430
Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr
435 440 445
Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His
450 455 460
Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr
465 470 475 480
Ile Phe Tyr Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys
485 490 495
Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp
500 505 510
Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Met Glu Tyr Asn Tyr
515 520 525
Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Pro Lys Asn Gly Ile
530 535 540
Lys Val Asn Phe Lys Ile Arg His Asn Ile Lys Asp Gly Ser Val Gln
545 550 555 560
Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val
565 570 575
Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys
CA 02450698 2003-12-23
118
580 585 590
Asp Pro Asn Glu Lys Arg Asp His Met Ile Leu Leu Glu Phe Val Thr
595 600 605
Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys Pro Gln Glu
610 615 620
(2) INFORMATION FOR SEQ ID N0:58:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1815 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAMEjKEY: Coding Sequence
(B) LOCATION: 1...1811
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:58:
ATG GCG GCG GCG GCG GCG GCG GGC CCG GAG ATG GTC CGC GGG CAG GTG 48
Met Ala Ala Ala Ala Ala Ala Gly Pro Glu Met Val Arg Gly Gln Val
1 5 10 15
TTC GAC GTG GGG CCG CGC TAC ACT AAT CTC TCG TAC ATC GGA GAA GGC 96
Phe Asp Val Gly Pro Arg Tyr Thr Asn Leu Ser Tyr Ile Gly Glu Gly
20 25 30
GCC TAC GGC ATG GTT TGT TCT GCT TAT GAT AAT CTC AAC AAA GTT CGA 144
Ala Tyr Gly Met Val Cys Ser A1a Tyr Asp Asn Leu Asn Lys Val Arg
35 40 45
GTT GCT ATC AAG AAA ATC AGT CCT TTT GAG CAC CAG ACC TAC TGT CAG 192
Val Ala Ile Lys Lys Ile Ser Pro Phe Glu His Gln Thr Tyr Cys Gln
50 55 60
AGA ACC CTG AGA GAG ATA AAA ATC CTA CTG CGC TTC AGA CAT GAG AAC 240
Arg Thr Leu Arg Glu Ile Lys Ile Leu Leu Arg Phe Arg His Glu Asn
65 70 75 80
ATC ATC GGC ATC AAT GAC ATC ATC CGG GCA CCA ACC ATT GAG CAG ATG 288
Ile Ile Gly Ile Asn Asp I1e Ile Arg A1a Pro Thr Ile Glu Gln Met
85 90 95
AAA GAT GTA TAT ATA GTA CAG GAC CTC ATG GAG ACA GAT CTT TAC AAG 336
Lys Asp Val Tyr Ile Val Gln Asp Leu Met Glu Thr Asp Leu Tyr Lys
100 105 110
CTC TTG AAG ACA CAG CAC CTC AGC AAT GAT CAT ATC TGC TAT TTT CTT 384
Leu Leu Lys Thr Gln His Leu Ser Asn Asp His Ile Cys Tyr Phe Leu
115 120 125
TAT CAG ATC CTG AGA GGA TTA AAG TAT ATA CAT TCA GCT AAT GTT CTG 432
Tyr Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser Ala Asn Val Leu
130 135 140
CAC CGT GAC CTC AAG CCT TCC AAC CTC CTG CTG AAC ACC ACT TGT GAT 480
CA 02450698 2003-12-23
119
His Arg Asp Leu Lys Pro Ser Asn Leu Leu Leu Asn Thr Thr Cys Asp
145 150 155 160
CTC AAG ATC TGT GAC TTT GGC CTT GCC CGT GTT GCA GAT CCA GAC CAT 528
Leu Lys Ile Cys Asp Phe Gly Leu Ala Arg Val Ala Asp Pro Asp His
165 170 175
GAT CAT ACA GGG TTC TTG ACA GAG TAT GTA GCC ACG CGT TGG TAC AGA 576
Asp His Thr Gly Phe Leu Thr Glu Tyr Val Ala Thr Arg Trp Tyr Arg
180 185 190
GCT CCA GAA ATT ATG TTG AAT TCC AAG GGT TAT ACC AAG TCC ATT GAT 624
Ala Pro Glu Ile Met Leu Asn Ser Lys Gly Tyr Thr Lys Ser Ile Asp
195 200 205
ATT TGG TCT GTG GGC TGC ATC CTG GCA GAG ATG CTA TCC AAC AGG CCT 672
Ile Trp Ser Val Gly Cys Ile Leu Ala Glu Met Leu Ser Asn Arg Pro
210 215 220
ATC TTC CCA GGA AAG CAT TAC CTT GAC CAG CTG AAT CAC ATC CTG GGT 720
Ile Phe Pro Gly Lys His Tyr Leu Asp Gln Leu Asn His Ile Leu Gly
225 230 235 240
ATT CTT GGA TCT CCA TCA CAG GAA GAT CTG AAT TGT ATA ATA AAT TTA 768
Ile Leu Gly Ser Pro Ser Gln Glu Asp Leu Asn Cys Tle Ile Asn Leu
245 250 255
AAA AGA TATTTG CTTTCTCTC CCGCACAAA AAG GTGCCG 816
GCT AAC AAT
LysAlaArg AsnTyrLeu LeuSerLeu ProHisLys AsnLys ValPro
260 265 270
TGGAACAGG TTGTTCCCA AACGCTGAC TCCAAAGCT CTGGAT TTACTG 864
TrpAsnArg LeuPhePro AsnAlaAsp SerLysAla LeuAsp LeuLeu
275 280 285
GATAAAATG TTGACATTT AACCCTCAC AAGAGGATT GAAGTT GAACAG 912
AspLysMet LeuThrPhe AsnProHis LysArgIle GluVal GluGln
290 295 300
GCTCTGGCC CACCCGTAC CTGGAGCAG TATTATGAC CCAAGT GATGAG 960
AlaLeuAla HisProTyr LeuGluGln TyrTyrAsp ProSer AspGlu
305 310 315 320
CCC ATT GCT GAA GCA CCA TTC AAG TTT GAC ATG GAG CTG GAC GAC TTA 1008
Pro Ile Ala Glu Ala Pro Phe Lys Phe Asp Met Glu Leu Asp Asp Leu
325 330 335
CCT AAG GAG AAG CTC AAA GAA CTC ATT TTT GAA GAG ACT GCT CGA TTC 1056
Pro Lys Glu Lys Leu Lys Glu Leu Ile Phe Glu Glu Thr Ala Arg Phe
340 345 350
CAG CCA GGA TAC AGA TCT ATG GAT CCA CCG GTC GCC ACC ATG GTG AGC 1104
Gln Pro Gly Tyr Arg Ser Met Asp Pro Pro Val Ala Thr Met Val Ser
355 360 365
AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG GTC GAG CTG 1152
Lys Gly Glu Glu Leu Phe Thr G1y Val Val Pro Ile Leu Val Glu Leu
370 375 380
GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC GAG GGC GAG 1200
CA 02450698 2003-12-23
120
Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu
385 390 395 400
GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC TGC ACC ACC 1248
Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr
405 410 415
GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC CTG ACC TAC 1296
Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr
420 425 430
GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG CAG CAC GAC 1344
Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp
435 440 445
TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG CGC ACC ATC 1392
Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile
450 455 460
TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG GTG AAG TTC 1440
Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe
465 470 475 480
GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC ATC GAC TTC 1488
Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe
485 490 495
AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC AAC TAC AAC 1536
Lys Glu Asp G1y Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn
500 505 510
AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC GGC ATC AAG 1584
Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys
515 520 525
GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC GTG CAG CTC 1632
Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu
530 535 540
GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC CCC GTG CTG 1680
Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu
545 550 555 560
CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG AGC AAA GAC 1728
Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp
565 570 575
CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC GTG ACC GCC 1776
Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala
580 585 590
GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AA GTAA 1815
Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
595 600
(2) INFORMATION FOR SEQ ID N0:59:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 604 amino acids
CA 02450698 2003-12-23
121
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:59:
Met Ala Ala Ala Ala Ala Ala Gly Pro Glu Met Val Arg Gly Gln Val
1 5 10 15
Phe Asp Val Gly Pro Arg Tyr Thr Asn Leu Ser Tyr Ile Gly Glu Gly
20 25 30
Ala Tyr Gly Met Val Cys Ser Ala Tyr Asp Asn Leu Asn Lys Val Arg
35 40 45
Val Ala Ile Lys Lys Ile Ser Pro Phe Glu His G1n Thr Tyr Cys Gln
50 55 60
Arg Thr Leu Arg Glu I1e Lys Ile Leu Leu Arg Phe Arg His Glu Asn
65 70 75 80
Ile Ile Gly Ile Asn Asp Ile Ile Arg Ala Pro Thr Ile Glu Gln Met
85 90 95
Lys Asp Val Tyr Ile Val Gln Asp Leu Met Glu Thr Asp Leu Tyr Lys
100 105 110
Leu Leu Lys Thr Gln His Leu Ser Asn Asp His Ile Cys Tyr Phe Leu
115 120 125
Tyr Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser Ala Asn Val Leu
130 135 140
His Arg Asp Leu Lys Pro Ser Asn Leu Leu Leu Asn Thr Thr Cys Asp
145 150 155 160
Leu Lys Ile Cys Asp Phe G1y Leu Ala Arg Val Ala Asp Pro Asp His
165 170 175
Asp His Thr Gly Phe Leu Thr Glu Tyr Val Ala Thr Arg Trp Tyr Arg
180 185 190
Ala Pro Glu Ile Met Leu Asn Ser Lys Gly Tyr Thr Lys Ser Ile Asp
195 200 205
Ile Trp Ser Val Gly Cys Ile Leu Ala Glu Met Leu Ser Asn Arg Pro
210 215 220
Ile Phe Pro Gly Lys His Tyr Leu Asp G1n Leu Asn His Ile Leu Gly
225 230 235 240
Ile Leu Gly Ser Pro Ser Gln Glu Asp Leu Asn Cys I1e Ile Asn Leu
245 250 255
Lys Ala Arg Asn Tyr Leu Leu Ser Leu Pro His Lys Asn Lys Val Pro
260 265 270
Trp Asn Arg Leu Phe Pro Asn Ala Asp Ser Lys Ala Leu Asp Leu Leu
275 280 285
Asp Lys Met Leu Thr Phe Asn Pro His Lys Arg Ile Glu Val Glu Gln
290 295 300
Ala Leu Ala His Pro Tyr Leu Glu Gln Tyr Tyr Asp Pro Ser Asp Glu
305 310 315 320
Pro Ile Ala Glu Ala Pro Phe Lys Phe Asp Met Glu Leu Asp Asp Leu
325 330 335
Pro Lys Glu Lys Leu Lys Glu Leu Ile Phe Glu Glu Thr Ala Arg Phe
340 345 350
Gln Pro Gly Tyr Arg Ser Met Asp Pro Pro Val Ala Thr Met Val Ser
355 360 365
Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu
370 375 380
Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu
385 390 395 400
Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr
CA 02450698 2003-12-23
122
405 410 415
Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr
420 425 430
Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp
435 440 445
Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile
450 455 460
Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe
465 470 475 480
Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe
485 490 495
Lys Glu Asp G1y Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn
500 505 510
Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys
515 520 525
Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu
530 535 540
Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu
545 550 555 560
Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp
565 570 575
Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala
580 585 590
Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
595 600
(2) INFORMATION FOR SEQ ID N0:60:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2511 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2508
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:60:
ATG GAG CTG GAA AAC ATC GTG GCC AAC ACG GTC TTG CTG AAA GCC AGG 48
Met Glu Leu Glu Asn Ile Val Ala Asn Thr Val Leu Leu Lys Ala Arg
1 5 10 15
GAA GGG GGC GGA GGA AAG CGC AAA GGG AAA AGC AAG AAG TGG AAA GAA 96
Glu Gly Gly Gly Gly Lys Arg Lys Gly Lys Ser Lys Lys Trp Lys Glu
20 25 30
ATC CTG AAG TTC CCT CAC ATT AGC CAG TGT GAA GAC CTC CGA AGG ACC 144
Ile Leu Lys Phe Pro His Ile Ser Gln Cys Glu Asp Leu Arg Arg Thr
35 40 45
ATA GAC AGA GAT TAC TGC AGT TTA TGT GAC AAG CAG CCA ATC GGG AGG 192
Ile Asp Arg Asp Tyr Cys Ser Leu Cys Asp Lys Gln Pro Ile Gly Arg
50 55 60
CTG CTT TTC CGG CAG TTT TGT GAA ACC AGG CCT GGG CTG GAG TGT TAC 240
CA 02450698 2003-12-23
123
Leu Leu Phe Arg Gln Phe Cys Glu Thr Arg Pro Gly Leu Glu Cys Tyr
65 70 75 80
ATT CAG TTC CTG GAC TCC GTG GCA GAA TAT GAA GTT ACT CCA GAT GAA 288
Ile Gln Phe Leu Asp Ser Val Ala Glu Tyr Glu Val Thr Pro Asp Glu
85 90 95
AAA CTG GGA GAG AAA GGG AAG GAA ATT ATG ACC AAG TAC CTC ACC CCA 336
Lys Leu Gly Glu Lys Gly Lys Glu Ile Met Thr Lys Tyr Leu Thr Pro
100 105 110
AAG TCC CCT GTT TTC ATA GCC CAA GTT GGC CAA GAC CTG GTC TCC CAG 384
Lys Ser Pro Val Phe Ile Ala Gln Val Gly Gln Asp Leu Val Ser Gln
115 120 125
ACG GAG GAG AAG CTC CTA CAG AAG CCG TGC AAA GAA CTC TTT TCT GCC 432
Thr Glu Glu Lys Leu Leu Gln Lys Pro Cys Lys Glu Leu Phe Ser Ala
130 135 140
TGT GCA CAG TCT GTC CAC GAG TAC CTG AGG GGA GAA CCA TTC CAC GAA 480
Cys Ala Gln Ser Val His Glu Tyr Leu Arg Gly Glu Pro Phe His Glu
145 150 155 160
TAT CTG GAC AGC ATG TTT TTT GAC CGC TTT CTC CAG TGG AAG TGG TTG 528
Tyr Leu Asp Ser Met Phe Phe Asp Arg Phe Leu Gln Trp Lys Trp Leu
165 170 175
GAA AGG CAA CCG GTG ACC AAA AAC ACT TTC AGG CAG TAT CGA GTG CTA 576
Glu Arg Gln Pro Val Thr Lys Asn Thr Phe Arg Gln Tyr Arg Val Leu
180 185 190
GGA AAA GGG GGC TTC GGG GAG GTC TGT GCC TGC CAG GTT CGG GCC ACG 624
Gly Lys Gly Gly Phe Gly Glu Val Cys Ala Cys Gln Val Arg Ala Thr
195 200 205
GGT AAA ATG TAT GCC TGC AAG CGC TTG GAG AAG AAG AGG ATC AAA AAG 672
Gly Lys Met Tyr Ala Cys Lys Arg Leu Glu Lys Lys Arg Ile Lys Lys
210 215 220
AGG AAA GGG GAG TCC ATG GCC CTC AAT GAG AAG CAG ATC CTC GAG AAG 720
Arg Lys Gly Glu Ser Met Ala Leu Asn Glu Lys Gln Ile Leu Glu Lys
225 230 235 240
GTC AAC AGT CAG TTT GTG GTC AAC CTG GCC TAT GCC TAC GAG ACC AAG 768
Val Asn Ser Gln Phe Val Val Asn Leu Ala Tyr Ala Tyr G1u Thr Lys
245 250 255
GAT GCA CTG TGC TTG GTC CTG ACC ATC ATG AAT GGG GGT GAC CTG AAG 816
Asp Ala Leu Cys Leu Val Leu Thr Ile Met Asn Gly Gly Asp Leu Lys
260 265 270
TTC CAC ATC TAC AAC ATG GGC AAC CCT GGC TTC GAG GAG GAG CGG GCC 864
Phe His Ile Tyr Asn Met Gly Asn Pro Gly Phe Glu Glu Glu Arg Ala
275 280 285
TTG TTT TAT GCG GCA GAG ATC CTC TGC GGC TTA GAA GAC CTC CAC CGT 912
Leu Phe Tyr Ala Ala Glu Ile Leu Cys Gly Leu Glu Asp Leu His Arg
290 295 300
GAG AAC ACC GTC TAC CGA GAT CTG AAA CCT GAA AAC ATC CTG TTA GAT 960
CA 02450698 2003-12-23
124
Glu Asn Thr Val Tyr Arg Asp Leu Lys Pro Glu Asn Ile Leu Leu Asp
305 310 315 320
GAT TAT GGC CAC ATT AGG ATC TCA GAC CTG GGC TTG GCT GTG AAG ATC 1008
Asp Tyr Gly His Ile Arg Ile Ser Asp Leu Gly Leu Ala Val Lys Ile
325 330 335
CCC GAG GGA GAC CTG ATC CGC GGC CGG GTG GGC ACT GTT GGC TAC ATG 1056
Pro Glu G1y Asp Leu Ile Arg Gly Arg Val Gly Thr Val Gly Tyr Met
340 345 350
GCC CCC GAA GTC CTG AAC AAC CAG AGG TAC GGC CTG AGC CCC GAC TAC ll04
Ala Pro Glu Val Leu Asn Asn Gln Arg Tyr Gly Leu Ser Pro Asp Tyr
355 360 365
TGG GGC CTT GGC TGC CTC ATC TAT GAG ATG ATC GAG GGC CAG TCG CCG 1152
Trp Gly Leu Gly Cys Leu Ile Tyr Glu Met Ile Glu Gly Gln Ser Pro
370 375 380
TTC CGC GGC CGT AAG GAG AAG GTG AAG CGG GAG GAG GTG GAC CGC CGG 1200
Phe Arg Gly Arg Lys Glu Lys Val Lys Arg Glu Glu Val Asp Arg Arg
385 390 395 400
GTC CTG GAG ACG GAG GAG GTG TAC TCC CAC AAG TTC TCC GAG GAG GCC 1248
Val Leu Glu Thr Glu Glu Val Tyr Ser His Lys Phe Ser Glu Glu Ala
405 410 415
AAG TCC ATC TGC AAG ATG CTG CTC ACG AAA GAT GCG AAG CAG AGG CTG 1296
Lys Ser Ile Cys Lys Met Leu Leu Thr Lys Asp Ala Lys Gln Arg Leu
420 425 430
GGC TGC CAG GAG GAG GGG GCT GCA GAG GTC AAG AGA CAC CCC TTC TTC 1344
Gly Cys Gln Glu Glu Gly Ala Ala Glu Val Lys Arg His Pro Phe Phe
435 440 445
AGG AAC ATG AAC TTC AAG CGC TTA GAA GCC GGG ATG TTG GAC CCT CCC 1392
Arg Asn Met Asn Phe Lys Arg Leu Glu Ala Gly Met Leu Asp Pro Pro
450 455 460
TTC GTT CCA GAC CCC CGC GCT GTG TAC TGT AAG GAC GTG CTG GAC ATC 1440
Phe Val Pro Asp Pro Arg Ala Val Tyr Cys Lys Asp Val Leu Asp Ile
465 470 475 480
GAG CAG TTC TCC ACT GTG AAG GGC GTC AAT CTG GAC CAC ACA GAC GAC 1488
Glu Gln Phe Ser Thr Val Lys Gly Val Asn Leu Asp His Thr Asp Asp
485 490 495
GAC TTC TAC TCC AAG TTC TCC ACG GGC TCT GTG TCC ATC CCA TGG CAA 1536
Asp Phe Tyr Ser Lys Phe Ser Thr Gly Ser Val Ser Ile Pro Trp Gln
500 505 510
AAC GAG ATG ATA GAA ACA GAA TGC TTT AAG GAG CTG AAC GTG TTT GGA 1584
Asn Glu Met Ile Glu Thr Glu Cys Phe Lys Glu Leu Asn Val Phe Gly
515 520 525
CCT AAT GGT ACC CTC CCG CCA GAT CTG AAC AGA AAC CAC CCT CCG GAA 1632
Pro Asn Gly Thr Leu Pro Pro Asp Leu Asn Arg Asn His Pro Pro Glu
530 535 540
CCG CCC AAG AAA GGG CTG CTC CAG AGA CTC TTC AAG CGG CAG CAT CAG 1680
CA 02450698 2003-12-23
125
Pro Pro Lys Lys Gly Leu Leu Gln Arg Leu Phe Lys Arg Gln His Gln
545 550 555 560
AAC AAT TCC AAG AGT TCG CCC AGC TCC AAG ACC AGT TTT AAC CAC CAC 1728
Asn Asn Ser Lys Ser Ser Pro Ser Ser Lys Thr Ser Phe Asn His His
565 570 575
ATA AAC TCA AAC CAT GTC AGC TCG AAC TCC ACC GGA AGC AGC AGG GAT 1776
Ile Asn Ser Asn His Val Ser Ser Asn Ser Thr Gly Ser Ser Arg Asp
580 585 590
CCA CCG GTC GCC ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG 1824
Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly
595 600 605
GTG GTG CCC ATC CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG 1872
Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys
610 615 620
TTC AGC GTG TCC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG 1920
Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu
625 630 635 640
ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC 1968
Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro
645 650 655
ACC CTC GTG ACC ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC 2016
Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr
660 665 670
CCC GAC CAC ATG AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA 2064
Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu
675 680 685
GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC 2112
Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr
690 695 700
AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC 2160
Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg
705 710 715 720
ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG 2208
Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly
725 730 735
CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC 2256
His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala
740 745 750
GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC 2304
Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn
755 760 765
ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC 2352
Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr
770 775 780
CCC ATC GGC GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC 2400
CA 02450698 2003-12-23
126
Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser
785 790 795 800
ACC CAG TCC GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG 2448
Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met
805 810 815
GTC CTG CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC 2496
Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp
820 825 830
GAG CTG TAC AAG TAA 2511
Glu Leu Tyr Lys
835
(2) INFORMATION FOR SEQ ID N0:61:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 836 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:61:
Met Glu Leu Glu Asn Ile Val Ala Asn Thr Val Leu Leu Lys Ala Arg
1 5 10 15
Glu Gly Gly Gly Gly Lys Arg Lys Gly Lys Ser Lys Lys Trp Lys Glu
20 25 30
Ile Leu Lys Phe Pro His Ile Ser Gln Cys Glu Asp Leu Arg Arg Thr
35 40 45
Ile Asp Arg Asp Tyr Cys Ser Leu Cys Asp Lys Gln Pro Ile Gly Arg
50 55 60
Leu Leu Phe Arg Gln Phe Cys Glu Thr Arg Pro Gly Leu Glu Cys Tyr
65 70 75 80
Ile Gln Phe Leu Asp Ser Val Ala Glu Tyr Glu Val Thr Pro Asp Glu
85 90 95
Lys Leu Gly Glu Lys Gly Lys Glu Ile Met Thr Lys Tyr Leu Thr Pro
100 105 110
Lys Ser Pro Val Phe Ile Ala Gln Val Gly Gln Asp Leu Val Ser Gln
115 120 125
Thr Glu Glu Lys Leu Leu Gln Lys Pro Cys Lys Glu Leu Phe Ser Ala
130 135 140
Cys Ala Gln Ser Val His Glu Tyr Leu Arg Gly Glu Pro Phe His Glu
145 150 155 160
Tyr Leu Asp Ser Met Phe Phe Asp Arg Phe Leu Gln Trp Lys Trp Leu
165 170 175
Glu Arg Gln Pro Val Thr Lys Asn Thr Phe Arg Gln Tyr Arg Val Leu
180 185 190
Gly Lys Gly Gly Phe Gly Glu Val Cys Ala Cys Gln Val Arg Ala Thr
195 200 205
Gly Lys Met Tyr Ala Cys Lys Arg Leu Glu Lys Lys Arg Ile Lys Lys
210 215 220
Arg Lys Gly Glu Ser Met Ala Leu Asn Glu Lys Gln Ile Leu Glu Lys
225 230 235 240
Val Asn Ser Gln Phe Val Val Asn Leu Ala Tyr Ala Tyr Glu Thr Lys
CA 02450698 2003-12-23
127
245 250 255
Asp Ala Leu Cys Leu Val Leu Thr Ile Met Asn Gly Gly Asp Leu Lys
260 265 270
Phe His Ile Tyr Asn Met Gly Asn Pro Gly Phe Glu Glu Glu Arg Ala
275 280 285
Leu Phe Tyr Ala Ala Glu Ile Leu Cys Gly Leu Glu Asp Leu His Arg
290 295 300
Glu Asn Thr Val Tyr Arg Asp Leu Lys Pro Glu Asn Ile Leu Leu Asp
305 310 315 320
Asp Tyr Gly His Ile Arg Ile Ser Asp Leu Gly Leu Ala Val Lys Ile
325 330 335
Pro Glu Gly Asp Leu Ile Arg Gly Arg Val Gly Thr Val Gly Tyr Met
340 345 350
Ala Pro Glu Val Leu Asn Asn Gln Arg Tyr Gly Leu Ser Pro Asp Tyr
355 360 365
Trp Gly Leu Gly Cys Leu Ile Tyr Glu Met Ile Glu Gly Gln Ser Pro
370 375 380
Phe Arg Gly Arg Lys Glu Lys Val Lys Arg Glu Glu Val Asp Arg Arg
385 390 395 400
Val Leu Glu Thr Glu G1u Val Tyr Ser His Lys Phe Ser Glu Glu Ala
405 410 415
Lys Ser Ile Cys Lys Met Leu Leu Thr Lys Asp Ala Lys Gln Arg Leu
420 425 430
Gly Cys Gln Glu Glu Gly Ala Ala Glu Val Lys Arg His Pro Phe Phe ,
435 440 445
Arg Asn Met Asn Phe Lys Arg Leu Glu Ala Gly Met Leu Asp Pro Pro
450 455 460
Phe Val Pro Asp Pro Arg Ala Val Tyr Cys Lys Asp Val Leu Asp Ile
465 470 475 480
Glu Gln Phe Ser Thr Val Lys Gly Val Asn Leu Asp His Thr Asp Asp
485 490 495
Asp Phe Tyr Ser Lys Phe Ser Thr Gly Ser Val Ser Ile Pro Trp Gln
500 505 510
Asn Glu Met Ile Glu Thr Glu Cys Phe Lys Glu Leu Asn Val Phe Gly
515 520 525
Pro Asn Gly Thr Leu Pro Pro Asp Leu Asn Arg Asn His Pro Pro Glu
530 535 540
Pro Pro Lys Lys Gly Leu Leu Gln Arg Leu Phe Lys Arg Gln His Gln
545 550 555 560
Asn Asn Ser Lys Ser Ser Pro Ser Ser Lys Thr Ser Phe Asn His His
565 570 575
Ile Asn Ser Asn His Val Ser Ser Asn Ser Thr Gly Ser Ser Arg Asp
580 585 590
Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly
595 600 605
Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys
610 615 620
Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu
625 630 635 640
Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro
645 650 655
Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr
660 665 670
Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu
675 680 685
Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr
690 695 700
Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg
705 710 715 720
Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly
CA 02450698 2003-12-23
128
725 730 735
His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala
740 745 750
Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn
755 760 765
Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr
770 775 780
Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser
785 790 795 800
Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met
805 810 815
Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp
820 825 830
Glu Leu Tyr Lys
835
(2) INFORMATION FOR SEQ ID N0:62:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1893 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNES5: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1890
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:62:
ATG AGC AGA AGC AAG CGT GAC AAC AAT TTT TAT AGT GTA GAG ATT GGA 48
Met Ser Arg Ser Lys Arg Asp Asn Asn Phe Tyr Ser Val Glu Ile Gly
1 5 10 15
GAT TCT ACA TTC ACA GTC CTG AAA CGA TAT CAG AAT TTA AAA CCT ATA 96
Asp Ser Thr Phe Thr Val Leu Lys Arg Tyr Gln Asn Leu Lys Pro Ile
20 25 30
GGC TCA GGA GCT CAA GGA ATA GTA TGC GCA GCT TAT GAT GCC ATT CTT 144
Gly Ser Gly Ala Gln Gly Ile Val Cys Ala Ala Tyr Asp Ala Ile Leu
35 40 45
GAAAGA GTT GCA AAG AAGCTA CGACCA CAGAATCAG 192
AAT ATC AGC TTT
GluArg Val AlaIleLys LysLeuSer ArgProPhe GlnAsnGln
Asn
50 55 60
ACTCAT AAG CGGGCCTAC AGAGAGCTA GTTCTTATG AAATGTGTT 240
GCC
ThrHis Lys ArgAlaTyr ArgGluLeu ValLeuMet LysCysVal
Ala
65 70 75 80
AATCAC AAT ATAATTGGC CTTTTGAAT GTTTTCACA CCACAGAAA 288
AAA
AsnHis Asn IleIleGly LeuLeuAsn ValPheThr ProGlnLys
Lys
85 90 95
TCCCTA GAA TTTCAAGAT GTTTACATA GTCATGGAG CTCATGGAT 336
GAA
SerLeu Glu PheGlnAsp ValTyrIle ValMetGlu LeuMetAsp
Glu
100 105 110
CA 02450698 2003-12-23
129
GCA AAT CTT TGC CAA GTG ATT CAG ATG GAG CTA GAT CAT GAA AGA ATG 384
Ala Asn Leu Cys Gln Val Ile Gln Met Glu Leu Asp His Glu Arg Met
115 120 125
TCC TAC CTT CTC TAT CAG ATG CTG TGT GGA ATC AAG CAC CTT CAT TCT 432
Ser Tyr Leu Leu Tyr Gln Met Leu Cys Gly Tle Lys His Leu His Ser
130 135 140
GCT GGA ATT ATT CAT CGG GAC TTA AAG CCC AGT AAT ATA GTA GTA AAA 480
Ala Gly Ile Ile His Arg Asp Leu Lys Pro Ser Asn Ile Val Val Lys
145 150 155 160
TCT GAT TGC ACT TTG AAG ATT CTT GAC TTC GGT CTG GCC AGG ACT GCA 528
Ser Asp Cys Thr Leu Lys Ile Leu Asp Phe Gly Leu Ala Arg Thr Ala
165 170 175
GGA ACG AGT TTT ATG ATG ACG CCT TAT GTA GTG ACT CGC TAC TAC AGA 576
Gly Thr Ser Phe Met Met Thr Pro Tyr Val Val Thr Arg Tyr Tyr Arg
180 185 190
GCA CCC GAG GTC ATC CTT GGC ATG GGC TAC AAG GAA AAC GTG GAT TTA 624
Ala Pro Glu Val Ile Leu Gly Met Gly Tyr Lys Glu Asn Val Asp Leu
195 200 205
TGG TCT GTG GGG TGC ATT ATG GGA GAA ATG GTT TGC CAC AAA ATC CTC 672
Trp Ser Val Gly Cys Ile Met Gly Glu Met Val Cys His Lys Ile Leu
210 215 220
TTT CCA GGA AGG GAC TAT ATT GAT CAG TGG AAT AAA GTT ATT GAA CAG 720
Phe Pro Gly Arg Asp Tyr Ile Asp Gln Trp Asn Lys Val Ile Glu Gln
225 230 235 240
CTT GGA ACA CCA TGT CCT GAA TTC ATG AAG AAA CTG CAA CCA ACA GTA 768
Leu Gly Thr Pro Cys Pro Glu Phe Met Lys Lys Leu Gln Pro Thr Val
245 250 255
AGG ACT TAC GTT GAA AAC AGA CCT AAA TAT GCT GGA TAT AGC TTT GAG 816
Arg Thr Tyr Val Glu Asn Arg Pro Lys Tyr Ala Gly Tyr Ser Phe Glu
260 265 270
AAA CTC TTC CCT GAT GTC CTT TTC CCA GCT GAC TCA GAA CAC AAC AAA 864
Lys Leu Phe Pro Asp Val Leu Phe Pro Ala Asp Ser Glu His Asn Lys
275 280 285
CTT AAA GCC AGT CAG GCA AGG GAT TTG TTA TCC AAA ATG CTG GTA ATA 912
Leu Lys Ala Ser Gln Ala Arg Asp Leu Leu Ser Lys Met Leu Val Ile
290 295 300
GAT GCA TCT AAA AGG ATC TCT. GTA GAT GAA GCT CTC CAA CAC CCG TAC 960
Asp Ala Ser Lys Arg Ile Ser Val Asp Glu Ala Leu Gln His Pro Tyr
305 310 315 320
ATC AAT GTC TGG TAT GAT CCT TCT GAA GCA GAA GCT CCA CCA CCA AAG 1008
Ile Asn Val Trp Tyr Asp Pro Ser Glu Ala Glu Ala Pro Pro Pro Lys
325 330 335
ATC CCT GAC AAG CAG TTA GAT GAA AGG GAA CAC ACA ATA GAA GAG TGG 1056
Ile Pro Asp Lys Gln Leu Asp Glu Arg Glu His Thr Ile Glu Glu Trp
340 345 350
CA 02450698 2003-12-23
130
AAA GAA TTG ATA TAT AAG GAA GTT ATG GAC TTG GAG GAG AGA ACC AAG 1104
Lys Glu Leu Ile Tyr Lys Glu Val Met Asp Leu Glu Glu Arg Thr Lys
355 360 365
AAT GGA GTT ATA CGG GGG CAG CCC TCT CCT TTA GCA CAG GTG CAG CAG 1152
Asn Gly Val Ile Arg Gly Gln Pro Ser Pro Leu Ala Gln Val Gln Gln
370 375 380
TGG GAT CCA CCG GTC GCC ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC 1200
Trp Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe
385 390 395 400
ACC GGG GTG GTG CCC ATC CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC 1248
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
405 410 415
CAC AAG TTC AGC GTG TCC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC 1296
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
420 425 430
AAG CTG ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC 1344
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
435 440 445
TGG CCC ACC CTC GTG ACC ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC 1392
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
450 455 460
CGC TAC CCC GAC CAC ATG AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG 1440
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
465 470 475 480
CCC GAA GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC 1488
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
485 490 495
AAC TAC AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG 1536
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
500 505 510
AAC CGC ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC 1584
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
515 520 525
CTG GGG CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC 1632
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
530 535 540
ATG GCC GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC 1680
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
545 550 555 560
CAC AAC ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG 1728
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
565 570 575
AAC ACC CCC ATC GGC GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC 1776
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
580 585 590
CA 02450698 2003-12-23
131
CTG AGC ACC CAG TCC GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT 1824
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
595 600 605
CAC ATG GTC CTG CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC 1872
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
610 615 620
ATG GAC GAG CTG TAC AAG TAA 1893
Met Asp Glu Leu Tyr Lys
625 630
(2) INFORMATION FOR SEQ ID N0:63:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 630 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY. linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:63:
Met Ser Arg 5er Lys Arg Asp Asn Asn Phe Tyr Ser Val Glu Ile Gly
1 5 10 15
Asp Ser Thr Phe Thr Val Leu Lys Arg Tyr Gln Asn Leu Lys Pro Ile
20 25 30
Gly Ser Gly Ala Gln Gly Ile Val Cys Ala Ala Tyr Asp Ala Ile Leu
35 40 45
Glu Arg Asn Val Ala Ile Lys Lys Leu Ser Arg Pro Phe Gln Asn Gln
50 55 60
Thr His Ala Lys Arg Ala Tyr Arg Glu Leu Val Leu Met Lys Cys Val
65 70 75 80
Asn His Lys Asn Ile Ile Gly Leu Leu Asn Val Phe Thr Pro Gln Lys
85 90 95
Ser Leu Glu Glu Phe Gln Asp Val Tyr Ile Val Met Glu Leu Met Asp
100 105 110
Ala Asn Leu Cys Gln Val Ile Gln Met Glu Leu Asp His Glu Arg Met
115 120 125
Ser Tyr Leu Leu Tyr Gln Met Leu Cys Gly Ile Lys His Leu His Ser
130 135 140
Ala G1y Ile Ile His Arg Asp Leu Lys Pro Ser Asn Ile Val Val Lys
145 150 155 160
Ser Asp Cys Thr Leu Lys Ile Leu Asp Phe Gly Leu Ala Arg Thr Ala
165 170 175
Gly Thr Ser Phe Met Met Thr Pro Tyr Val Val Thr Arg Tyr Tyr Arg
180 185 190
Ala Pro Glu Val Ile Leu Gly Met Gly Tyr Lys Glu Asn Val Asp Leu
195 200 205
Trp Ser Val Gly Cys Ile Met Gly Glu Met Val Cys His Lys Ile Leu
210 215 220
Phe Pro Gly Arg Asp Tyr Ile Asp Gln Trp Asn Lys Val Ile Glu Gln
225 230 235 240
Leu Gly Thr Pro Cys Pro Glu Phe Met Lys Lys Leu Gln Pro Thr Val
245 250 255
Arg Thr Tyr Val Glu Asn Arg Pro Lys Tyr Ala Gly Tyr Ser Phe Glu
CA 02450698 2003-12-23
132
260 265 270
Lys Leu Phe Pro Asp Val Leu Phe Pro Ala Asp Ser Glu His Asn Lys
275 280 285
Leu Lys Ala Ser Gln Ala Arg Asp Leu Leu Ser Lys Met Leu Val Ile
290 295 300
Asp Ala Ser Lys Arg Ile Ser Val Asp Glu Ala Leu Gln His Pro Tyr
305 310 315 320
Ile Asn Val Trp Tyr Asp Pro Ser Glu Ala Glu Ala Pro Pro Pro Lys
325 330 335
Ile Pro Asp Lys Gln Leu Asp Glu Arg Glu His Thr Ile Glu Glu Trp
340 345 350
Lys Glu Leu Ile Tyr Lys Glu Val Met Asp Leu Glu Glu Arg Thr Lys
355 360 365
Asn Gly Val Ile Arg Gly Gln Pro Ser Pro Leu Ala Gln Val Gln Gln
370 375 380
Trp Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe
385 390 395 400
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
405 410 415
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
420 425 430
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
435 440 445
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
450 455 460
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
465 470 475 480
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
485 490 495
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
500 505 510
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
515 520 525
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
530 535 540
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
545 550 555 560
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
565 570 575
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
580 585 590
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
595 600 605
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
610 615 620
Met Asp Glu Leu Tyr Lys
625 630
(2) INFORMATION FOR SEQ ID N0:64:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1821 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
CA 02450698 2003-12-23
133
(B) LOCATION: 1...1818
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:64:
ATG TCT CAG GAG AGG CCC ACG TTC TAC CGG CAG GAG CTG AAC AAG ACA 48
Met Ser Gln Glu Arg Pro Thr Phe Tyr Arg Gln Glu Leu Asn Lys Thr
1 5 10 15
ATC TGG GAG GTG CCC GAG CGT TAC CAG AAC CTG TCT CCA GTG GGC TCT 96
Ile Trp Glu Val Pro Glu Arg Tyr Gln Asn Leu Ser Pro Val Gly Ser
20 25 30
GGC GCC TAT GGC TCT GTG TGT GCT GCT TTT GAC ACA AAA ACG GGG TTA 144
Gly Ala Tyr Gly Ser Val Cys Ala Ala Phe Asp Thr Lys Thr Gly Leu
35 40 45
CGT GTG GCA GTG AAG AAG CTC TCC AGA CCA TTT CAG TCC ATC ATT CAT 192
Arg Val Ala Val Lys Lys Leu Ser Arg Pro Phe Gln Ser Ile Ile His
50 55 60
GCG AAA AGA ACC TAC AGA GAA CTG CGG TTA CTT AAA CAT ATG AAA CAT 240
Ala Lys Arg Thr Tyr Arg Glu Leu Arg Leu Leu Lys His Met Lys His
65 70 75 80
GAA AAT GTG ATT GGT CTG TTG GAC GTT TTT ACA CCT GCA AGG TCT CTG 288
Glu Asn Val Ile Gly Leu Leu Asp Val Phe Thr Pro Ala Arg Ser Leu
85 90 95
GAG GAA TTC AAT GAT GTG TAT CTG GTG ACC CAT CTC ATG GGG GCA GAT 336
Glu Glu Phe Asn Asp Val Tyr Leu Val Thr His Leu Met Gly Ala Asp
100 105 110
CTG AAC AAC ATT GTG AAA TGT CAG AAG CTT ACA GAT GAC CAT GTT CAG 384
Leu Asn Asn Ile Val Lys Cys Gln Lys Leu Thr Asp Asp His Val Gln
115 120 125
TTC CTT ATC TAC CAA ATT CTC CGA GGT CTA AAG TAT ATA CAT TCA GCT ~ 432
Phe Leu Ile Tyr Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser Ala
130 135 140
GAC ATA ATT CAC AGG GAC CTA AAA CCT AGT AAT CTA GCT GTG AAT GAA 480
Asp Ile Ile His Arg Asp Leu Lys Pro Ser Asn Leu Ala Val Asn Glu
145 150 155 160
GAC TGT GAG CTG AAG ATT CTG GAT TTT GGA CTG GCT CGG CAC ACA GAT 528
Asp Cys Glu Leu Lys Ile Leu Asp Phe Gly Leu Ala Arg His Thr Asp
165 170 175
GAT GAA ATG ACA GGC TAC GTG GCC ACT AGG TGG TAC AGG GCT CCT GAG 576
Asp Glu Met Thr Gly Tyr Val Ala Thr Arg Trp Tyr Arg Ala Pro Glu
180 185 190
ATC ATG CTG AAC TGG ATG CAT TAC AAC CAG ACA GTT GAT ATT TGG TCA 624
Ile Met Leu Asn Trp Met His Tyr Asn Gln Thr Val Asp Ile Trp Ser
195 200 205
GTG GGA TGC ATA ATG GCC GAG CTG TTG ACT GGA AGA ACA TTG TTT CCT 672
Val Gly Cys Ile Met Ala Glu Leu Leu Thr Gly Arg Thr Leu Phe Pro
210 215 220
CA 02450698 2003-12-23
134
GGT ACA GAC CAT ATT GAT CAG TTG AAG CTC ATT TTA AGA CTC GTT GGA 720
Gly Thr Asp His Ile Asp Gln Leu Lys Leu Ile Leu Arg Leu Val Gly
225 230 235 240
ACC CCA GGG GCT GAG CTT TTG AAG AAA ATC TCC TCA GAG TCT GCA AGA 768
Thr Pro Gly Ala Glu Leu Leu Lys Lys Ile Ser Ser Glu Ser Ala Arg
245 250 255
AAC TAT ATT CAG TCT TTG ACT CAG ATG CCG AAG ATG AAC TTT GCG AAT 816
Asn Tyr Ile Gln Ser Leu Thr Gln Met Pro Lys Met Asn Phe Ala Asn
260 265 270
GTA TTT ATT GGT GCC AAT CCC CTG GCT GTC GAC TTG CTG GAG AAG ATG 864
Val Phe Ile Gly Ala Asn Pro Leu Ala Val Asp Leu Leu Glu Lys Met
275 280 285
CTT GTA TTG GAC TCA GAT AAG AGA ATT ACA GCG GCC CAA GCC CTT GCA 912
Leu Val Leu Asp Ser Asp Lys Arg Ile Thr Ala Ala Gln Ala Leu Ala
290 295 300
CAT GCC TAC TTT GCT CAG TAC CAC GAT CCT GAT GAT GAA CCA GTG GCC 960
His Ala Tyr Phe Ala Gln Tyr His Asp Fro Asp Asp Glu Pro Val Ala
305 310 315 320
GAT CCT TAT GAT CAG TCC TTT GAA AGC AGG GAC CTC CTT ATA GAT GAG 1008
Asp Pro Tyr Asp Gln Ser Phe Glu Ser Arg Asp Leu Leu Ile Asp Glu
325 330 335
TGG AAA AGC CTG ACC TAT GAT GAA GTC ATC AGC TTT GTG CCA CCA CCC 1056
Trp Lys Ser Leu Thr Tyr Asp Glu Val Ile Ser Phe Val Pro Pro Pro
340 345 350
CTT GAC CAA GAA GAG ATG GAG TCC GAG GAT CCA CCG GTC GCC ACC ATG 1104
Leu Asp Gln Glu Glu Met Glu Ser Glu Asp Pro Pro Val Ala Thr Met
355 360 365
GTGAGCAAG GGCGAGGAG CTGTTCACC GGGGTGGTG CCCATCCTG GTC 1152
ValSerLys GlyGluGlu LeuPheThr GlyValVal ProIleLeu Val
370 375 380
GAGCTGGAC GGCGACGTA AACGGCCAC AAGTTCAGC GTGTCCGGC GAG 1200
GluLeuAsp GlyAspVal AsnGlyHis LysPheSer ValSerGly Glu
385 390 395 400
GGCGAGGGC GATGCCACC TACGGCAAG CTGACCCTG AAGTTCATC TGC 1248
GlyGluGly AspAlaThr TyrGlyLys LeuThrLeu LysPheIle Cys
405 410 415
ACCACCGGC AAGCTGCCC GTGCCCTGG CCCACCCTC GTGACCACC CTG 1296
ThrThrGly LysLeuPro ValProTrp ProThrLeu ValThrThr Leu
420 425 430
ACCTACGGC GTGCAGTGC TTCAGCCGC TACCCCGAC CACATGAAG CAG 1344
ThrTyrGly ValGlnCys PheSerArg TyrProAsp HisMetLys Gln
435 440 445
CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG CGC 1392
His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
450 455 460
CA 02450698 2003-12-23
135
ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG GTG 1440
Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
465 470 475 480
AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC ATC 1488
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
485 490 495
GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC AAC 1536
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
500 505 510
TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC GGC 1584
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
515 520 525
ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC GTG 1632
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
530 535 540
CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC CCC 1680
Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro
545 550 555 560
GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG AGC 1728
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
565 570 575
AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC GTG 1776
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val
580 585 590
ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TAA 1821
Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
595 600 605
(2) INFORMATION FOR SEQ ID N0:65:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 606 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:65:
Met Ser Gln Glu Arg Pro Thr Phe Tyr Arg Gln Glu Leu Asn Lys Thr
1 5 10 15
Ile Trp Glu Val Pro Glu Arg Tyr Gln Asn Leu Ser Pro Val Gly Ser
20 25 30
Gly Ala Tyr Gly Ser Val Cys Ala Ala Phe Asp Thr Lys Thr Gly Leu
35 40 45
Arg Val Ala Val Lys Lys Leu Ser Arg Pro Phe Gln Ser Ile Ile His
50 55 60
Ala Lys Arg Thr Tyr Arg Glu Leu Arg Leu Leu Lys His Met Lys His
CA 02450698 2003-12-23
136
65 70 75 80
Glu Asn Val Ile Gly Leu Leu Asp Val Phe Thr Pro Ala Arg Ser Leu
85 90 95
Glu Glu Phe Asn Asp Val Tyr Leu Val Thr His Leu Met Gly Ala Asp
100 105 110
Leu Asn Asn Ile Val Lys Cys Gln Lys Leu Thr Asp Asp His Val Gln
115 120 125
Phe Leu Ile Tyr Gln Ile Leu Arg Gly Leu Lys Tyr Ile His Ser Ala
130 135 140
Asp Ile Ile His Arg Asp Leu Lys Pro Ser Asn Leu Ala Val Asn Glu
145 150 155 160
Asp Cys Glu Leu Lys Ile Leu Asp Phe Gly Leu Ala Arg His Thr Asp
165 170 175
Asp Glu Met Thr Gly Tyr Val Ala Thr Arg Trp Tyr Arg Ala Pro Glu
180 185 190
Ile Met Leu Asn Trp Met His Tyr Asn Gln Thr Val Asp Ile Trp Ser
195 200 205
Val Gly Cys Ile Met Ala Glu Leu Leu Thr Gly Arg Thr Leu Phe Pro
210 215 220
Gly Thr Asp His Ile Asp Gln Leu Lys Leu Ile Leu Arg Leu Val Gly
225 230 235 240
Thr Pro Gly Ala Glu Leu Leu Lys Lys Ile Ser Ser Glu Ser Ala Arg
245 250 255
Asn Tyr Ile Gln Ser Leu Thr Gln Met Pro Lys Met Asn Phe Ala Asn
260 265 270
Val Phe Ile Gly Ala Asn Pro Leu Ala Val Asp Leu Leu Glu Lys Met
275 280 285
Leu Val Leu Asp Ser Asp Lys Arg Ile Thr Ala Ala Gln Ala Leu Ala
290 295 300
His Ala Tyr Phe Ala Gln Tyr His Asp Pro Asp Asp Glu Pro Val Ala
305 310 315 320
Asp Pro Tyr Asp Gln Ser Phe Glu Ser Arg Asp Leu Leu Ile Asp Glu
325 330 335
Trp Lys Ser Leu Thr Tyr Asp G1u Val Ile Ser Phe Val Pro Pro Pro
340 345 350
Leu Asp Gln Glu Glu Met Glu Ser Glu Asp Pro Pro Val Ala Thr Met
355 360 365
Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
370 375 380
Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu
385 390 395 400
Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys
405 410 415
Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
420 425 430
Thr Tyr Gly Va1 Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln
435 440 445
His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
450 455 460
Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
465 470 475 480
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
485 490 495
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
500 505 510
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
515 520 525
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
530 535 540
Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro
CA 02450698 2003-12-23
137
545 550 555 560
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
565 570 575
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val
580 585 590
Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
595 600 605
(2) INFORMATION FOR SEQ ID N0:66:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2913 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/REY: Coding Sequence
(B) LOCATION: 1,..2910
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:66:
ATG AGT GCT GAG GGG TAC CAG TAC AGA GCG CTG TAT GAT TAT AAA AAG 48
Met Ser Ala Glu Gly Tyr Gln Tyr Arg Ala Leu Tyr Asp Tyr Lys Lys
1 5 10 15
GAA AGA GAA GAA GAT ATT GAC TTG CAC TTG GGT GAC ATA TTG ACT GTG 96
Glu Arg Glu Glu Asp Ile Asp Leu His Leu Gly Asp Ile Leu Thr Val
20 25 30
AAT AAA GGG TCC TTA GTA GCT CTT GGA TTC AGT GAT GGA CAG GAA GCC 144
Asn Lys Gly Ser Leu Val Ala Leu Gly Phe Ser Asp Gly Gln Glu Ala
35 40 45
AGG CCT GAA GAA ATT GGC TGG TTA AAT GGC TAT AAT GAA ACC ACA GGG 192
Arg Pro Glu Glu Ile Gly Trp Leu Asn Gly Tyr Asn Glu Thr Thr Gly
50 55 60
GAA AGG GGG GAC TTT CCG GGA ACT TAC GTA GAA TAT ATT GGA AGG AAA 240
Glu Arg Gly Asp Phe Pro Gly Thr Tyr Val Glu Tyr Ile Gly Arg Lys
65 70 75 80
AAA ATC TCG CCT CCC ACA CCA AAG CCC CGG CCA CCT CGG CCT CTT CCT 288
Lys Ile Ser Pro Pro Thr Pro Lys Pro Arg Pro Pro Arg Pro Leu Pro
85 90 95
GTT GCA CCA GGT TCT TCG AAA ACT GAA GCA GAT GTT GAA CAA CAA GCT 336
Val Ala Pro Gly Ser Ser Lys Thr Glu Ala Asp Val Glu Gln Gln Ala
100 105 110
TTG ACT CTC CCG GAT CTT GCA GAG CAG TTT GCC CCT CCT GAC ATT GCC 384
Leu Thr Leu Pro Asp Leu Ala Glu Gln Phe Ala Pro Pro Asp Ile Ala
115 120 125
CCG CCT CTT CTT ATC AAG CTC GTG GAA GCC ATT GAA AAG AAA GGT CTG 432
Pro Pro Leu Leu Ile Lys Leu Val Glu Ala Ile Glu Lys Lys Gly Leu
130 135 140
CA 02450698 2003-12-23
138
GAA TGT TCA ACT CTA TAC AGA ACA CAG AGC TCC AGC AAC CTG GCA GAA 480
Glu Cys Ser Thr Leu Tyr Arg Thr Gln Ser Ser Ser Asn Leu Ala Glu
145 150 155 160
TTA CGA CAG CTT CTT GAT TGT GAT ACA CCC TCC GTG GAC TTG GAA ATG 528
Leu Arg Gln Leu Leu Asp Cys Asp Thr Pro Ser Val Asp Leu Glu Met
165 170 175
ATC GAT GTG CAC GTT TTG GCT GAC GCT TTC AAA CGC TAT CTC CTG GAC 576
Ile Asp Val His Val Leu Ala Asp Ala Phe Lys Arg Tyr Leu Leu Asp
180 185 190
TTA CCA AAT CCT GTC ATT CCA GCA GCC GTT TAC AGT GAA ATG ATT TCT 624
Leu Pro Asn Pro Val Ile Pro Ala Ala Val Tyr Ser Glu Met Ile Ser
195 200 205
TTA GCT CCA GAA GTA CAA AGC TCC GAA GAA TAT ATT CAG CTA TTG AAG 672
Leu Ala Pro Glu Val Gln Ser Ser Glu Glu Tyr Ile Gln Leu Leu Lys
210 215 220
AAG CTT ATT AGG TCG CCT AGC ATA CCT CAT CAG TAT TGG CTT ACG CTT 720
Lys Leu Ile Arg Ser Pro Ser Ile Pro His Gln Tyr Trp Leu Thr Leu
225 230 235 240
CAG TAT TTG TTA AAA CAT TTC TTC AAG CTC TCT CAA ACC TCC AGC AAA 768
Gln Tyr Leu Leu Lys His Phe Phe Lys Leu Ser Gln Thr Ser Ser Lys
245 250 255
AAT CTG TTG AAT GCA AGA GTA CTC TCT GAA ATT TTC AGC CCT ATG CTT 816
Asn Leu Leu Asn Ala Arg Val Leu Ser Glu Ile Phe Ser Pro Met Leu
260 265 270
TTC AGA TTC TCA GCA GCC AGC TCT GAT AAT ACT GAA AAC CTC ATA AAA 864
Phe Arg Phe Ser Ala Ala Ser Ser Asp Asn Thr Glu Asn Leu Ile Lys
275 280 285
GTT ATA GAA ATT TTA ATC TCA ACT GAA TGG AAT GAA CGA CAG CCT GCA 912
Val Ile Glu Ile Leu Ile Ser Thr Glu Trp Asn Glu Arg Gln Pro Ala
290 295 300
CCA GCA CTG CCT CCT AAA CCA CCA AAA CCT ACT ACT GTA GCC AAC AAC 960
Pro Ala Leu Pro Pro Lys Pro Pro Lys Pro Thr Thr Val Ala Asn Asn
305 310 315 320
GGT ATG AAT AAC AAT ATG TCC TTA CAA AAT GCT GAA TGG TAC TGG GGA 1008
Gly Met Asn Asn Asn Met Ser Leu Gln Asn Ala Glu Trp Tyr Trp Gly
325 330 335
GAT ATC TCG AGG GAA GAA GTG AAT GAA AAA CTT CGA GAT ACA GCA GAC 1056
Asp Ile Ser Arg Glu Glu Val Asn Glu Lys Leu Arg Asp Thr Ala Asp
340 345 350
GGG ACC TTT TTG GTA CGA GAT GCG TCT ACT AAA ATG CAT GGT GAT TAT 1104
Gly Thr Phe Leu Val Arg Asp Ala Ser Thr Lys Met His Gly Asp Tyr
355 360 365
ACT CTT ACA CTA AGG AAA GGG GGA AAT AAC AAA TTA ATC AAA ATA TTT 1152
Thr Leu Thr Leu Arg Lys Gly Gly Asn Asn Lys Leu Ile Lys Ile Phe
370 375 380
CA 02450698 2003-12-23
139
CAT CGA GAT GGG AAA TAT GGC TTC TCT GAC CCA TTA ACC TTC AGT TCT 1200
His Arg Asp Gly Lys Tyr Gly Phe Ser Asp Pro Leu Thr Phe Ser Ser
385 390 395 400
GTG GTT GAA TTA ATA AAC CAC TAC CGG AAT GAA TCT CTA GCT CAG TAT 1248
Val Val Glu Leu Ile Asn His Tyr Arg Asn Glu Ser Leu Ala Gln Tyr
405 410 415
AAT CCC AAA TTG GAT GTG AAA TTA CTT TAT CCA GTA TCC AAA TAC CAA 1296
Asn Pro Lys Leu Asp Val Lys Leu Leu Tyr Pro Val Ser Lys Tyr Gln
420 425 430
CAG GAT CAA GTT GTC AAA GAA GAT AAT ATT GAA GCT GTA GGG AAA AAA 1344
Gln Asp Gln Val Val Lys Glu Asp Asn Ile Glu Ala Val Gly Lys Lys
435 440 445
TTA CAT GAA TAT AAC ACT CAG TTT CAA GAA AAA AGT CGA GAA TAT GAT 1392
Leu His Glu Tyr Asn Thr Gln Phe Gln Glu Lys Ser Arg Glu Tyr Asp
450 455 460
AGA TTA TAT GAA GAA TAT ACC CGC ACA TCC CAG GAA ATC CAA ATG AAA 1440
Arg Leu Tyr Glu Glu Tyr Thr Arg Thr Ser Gln Glu Ile Gln Met Lys
465 470 475 480
AGG ACA GCT ATT GAA GCA TTT AAT GAA ACC ATA AAA ATA TTT GAA GAA 1488
Arg Thr Ala Ile Glu Ala Phe Asn Glu Thr Ile Lys Ile Phe Glu Glu
485 490 495
CAG TGC CAG ACC CAA GAG CGG TAC AGC AAA GAA TAC ATA GAA AAG TTT 1536
Gln Cys Gln Thr Gln Glu Arg Tyr Ser Lys Glu Tyr Ile Glu Lys Phe
500 505 510
AAA CGT GAA GGC AAT GAG AAA GAA ATA CAA AGG ATT ATG CAT AAT TAT 1584
Lys Arg Glu Gly Asn Glu Lys Glu Ile Gln Arg Ile Met His Asn Tyr
515 520 525
GAT AAG TTG AAG TCT CGA ATC AGT GAA ATT ATT GAC AGT AGA AGA AGA 1632
Asp Lys Leu Lys Ser Arg Ile Ser Glu Ile Ile Asp Ser Arg Arg Arg
530 535 540
TTG GAA GAA GAC TTG AAG AAG CAG GCA GCT GAG TAT CGA GAA ATT GAC 1680
Leu G1u Glu Asp Leu Lys Lys Gln Ala Ala Glu Tyr Arg Glu Ile Asp
545 550 555 560
AAA CGT ATG AAC AGC ATT AAA CCA GAC CTT ATC CAG CTG AGA AAG ACG 1728
Lys Arg Met Asn Ser Ile Lys Pro Asp Leu Ile Gln Leu Arg Lys Thr
565 570 575
AGA GAC CAA TAC TTG ATG TGG TTG ACT CAA AAA GGT GTT CGG CAA AAG 1776
Arg Asp Gln Tyr Leu Met Trp Leu Thr Gln Lys Gly Val Arg Gln Lys
580 585 590
AAG TTG AAC GAG TGG TTG GGC AAT GAA AAC ACT GAA GAC CAA TAT TCA 1824
Lys Leu Asn Glu Trp Leu Gly Asn Glu Asn Thr Glu Asp Gln Tyr Ser
595 600 605
CTG GTG GAA GAT GAT GAA GAT TTG CCC CAT CAT GAT GAG AAG ACA TGG 1872
Leu Val Glu Asp Asp Glu Asp Leu Pro His His Asp Glu Lys Thr Trp
610 615 620
CA 02450698 2003-12-23
140
AAT GTT GGA AGC AGC AAC CGA AAC AAA GCT GAA AAC CTG TTG CGA GGG 1920
Asn Val Gly Ser Ser Asn Arg Asn Lys Ala Glu Asn Leu Leu Arg Gly
625 630 635 640
AAG CGA GAT GGC ACT TTT CTT GTC CGG GAG AGC AGT AAA CAG GGC TGC 1968
Lys Arg Asp Gly Thr Phe Leu Val Arg Glu Ser Ser Lys Gln Gly Cys
645 650 655
TAT GCC TGC TCT GTA GTG GTG GAC GGC GAA GTA AAG CAT TGT GTC ATA 2016
Tyr Ala Cys Ser Val Val Val Asp Gly Glu Val Lys His Cys Val Ile
660 665 670
AAC AAA ACA GCA ACT GGC TAT GGC TTT GCC GAG CCC TAT AAC TTG TAC 2064
Asn Lys Thr Ala Thr Gly Tyr Gly Phe Ala Glu Pro Tyr Asn Leu Tyr
675 680 685
AGC TCT CTG AAA GAA CTG GTG CTA CAT TAC CAA CAC ACC TCC CTT GTG 2112
Ser Ser Leu Lys Glu Leu Val Leu His Tyr Gln His Thr Ser Leu Val
690 695 700
CAG CAC AAC GAC TCC CTC AAT GTC ACA CTA GCC TAC CCA GTA TAT GCA 2160
Gln His Asn Asp Ser Leu Asn Val Thr Leu Ala Tyr Pro Val Tyr Ala
705 710 715 720
CAG CAG AGG CGA CAG GAT CCA CCG GTC GCC ACC ATG GTG AGC AAG GGC 2208
Gln Gln Arg Arg Gln Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly
725 730 735
GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG GTC GAG CTG GAC GGC 2256
Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly
740 745 750
GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC GAG GGC GAG GGC GAT 2304
Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp
755 760 765
GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG 2352
Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys
770 775 780
CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC CTG ACC TAC GGC GTG 2400
Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val
785 790 795 800
CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG CAG CAC GAC TTC TTC 2448
Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe
805 810 815
AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC 2496
Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe
820 825 830
AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC 2544
Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly
835 840 845
GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG 2592
Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu
850 855 860
CA 02450698 2003-12-23
141
GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC 2640
Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His
865 870 875 880
AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC 2688
Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn
885 890 895
TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC 2736
Phe Lys Ile Arg His Asn Ile Glu Asp Gly Sex Val Gln Leu Ala Asp
900 905 910
CACTAC CAGCAGAAC ACCCCCATCGGC GACGGC CCCGTGCTG CTGCCC 2784
HisTyr GlnGlnAsn ThrProIleGly AspGly ProValLeu LeuPro
915 920 925
GACAAC CACTACCTG AGCACCCAGTCC GCCCTG AGCAAAGAC CCCAAC 2832
AspAsn HisTyrLeu SerThrGlnSer AlaLeu SerLysAsp ProAsn
930 935 940
GAGAAG CGCGATCAC ATGGTCCTGCTG GAGTTC GTGACCGCC GCCGGG 2880
GluLys ArgAspHis MetValLeuLeu GluPhe ValThrAla AlaGly
945 950 955 960
ATCACT CTCGGCATG GACGAGCTGTAC AAGTAA 2913
IleThr LeuGlyMet AspGluLeuTyr Lys
965 970
(2) INFORMATION FOR SEQ ID N0:67:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 970 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:67:
Met Ser Ala Glu Gly Tyr Gln Tyr Arg Ala Leu Tyr Asp Tyr Lys Lys
1 5 10 15
Glu Arg Glu Glu Asp Ile Asp Leu His Leu Gly Asp Ile Leu Thr Val
20 25 30
Asn Lys Gly Ser Leu Val Ala Leu Gly Phe Ser Asp Gly Gln Glu Ala
35 40 45
Arg Pro Glu Glu Ile Gly Trp Leu Asn Gly Tyr Asn Glu Thr Thr G1y
50 55 60
Glu Arg Gly Asp Phe Pro Gly Thr Tyr Val Glu Tyr Ile Gly Arg Lys
65 70 75 80
Lys Ile Ser Pro Pro Thr Pro Lys Pro Arg Pro Pro Arg Pro Leu Pro
85 90 95
Val Ala Pro Gly Ser Ser Lys Thr Glu Ala Asp Val Glu Gln Gln Ala
100 105 110
Leu Thr Leu Pro Asp Leu Ala Glu Gln Phe Ala Pro Pro Asp Ile Ala
115 120 125
Pro Pro Leu Leu Ile Lys Leu Val Glu Ala Ile Glu Lys Lys Gly Leu
CA 02450698 2003-12-23
142
130 135 140
Glu Cys Ser Thr Leu Tyr Arg Thr Gln Ser Ser Ser Asn Leu Ala Glu
145 150 155 160
Leu Arg Gln Leu Leu Asp Cys Asp Thr Pro Ser Val Asp Leu Glu Met
165 170 175
Ile Asp Val His Val Leu Ala Asp Ala Phe Lys Arg Tyr Leu Leu Asp
180 185 190
Leu Pro Asn Pro Val Ile Pro A1a Ala Val Tyr Ser Glu Met Ile Ser
195 200 205
Leu Ala Pro Glu Val Gln Ser Ser Glu Glu Tyr Ile Gln Leu Leu Lys
210 215 220
Lys Leu Ile Arg Ser Pro Ser Ile Pro His Gln Tyr Trp Leu Thr Leu
225 230 235 240
Gln Tyr Leu Leu Lys His Phe Phe Lys Leu Ser Gln Thr Ser Ser Lys
245 250 255
Asn Leu Leu Asn Ala Arg Val Leu Ser Glu Ile Phe Ser Pro Met Leu
260 265 270
Phe Arg Phe Ser Ala Ala Ser Ser Asp Asn Thr Glu Asn Leu Ile Lys
275 280 285
Val Ile Glu Ile Leu I1e Ser Thr Glu Trp Asn Glu Arg Gln Pro Ala
290 295 300
Pro Ala Leu Pro Pro Lys Pro Pro Lys Pro Thr Thr Val Ala Asn Asn
305 310 315 320
Gly Met Asn Asn Asn Met Ser Leu Gln Asn Ala Glu Trp Tyr Trp Gly
325 330 335
Asp Ile Ser Arg Glu Glu Val Asn Glu Lys Leu Arg Asp Thr Ala Asp
340 345 350
Gly Thr Phe Leu Val Arg Asp Ala Ser Thr Lys Met His Gly Asp Tyr
355 360 365
Thr Leu Thr Leu Arg Lys Gly Gly Asn Asn Lys Leu Ile Lys Ile Phe
370 375 380
His Arg Asp Gly Lys Tyr Gly Phe Ser Asp Pro Leu Thr Phe Sex Ser
385 390 395 400
Val Val Glu Leu Ile Asn His Tyr Arg Asn Glu Ser Leu Ala Gln Tyr
405 410 415
Asn Pro Lys Leu Asp Val Lys Leu Leu Tyr Pro Val Ser Lys Tyr Gln
420 425 430
Gln Asp Gln Val Val Lys Glu Asp Asn Ile Glu Ala Val Gly Lys Lys
435 440 445
Leu His Glu Tyr Asn Thr Gln Phe Gln Glu Lys Ser Arg Glu Tyr Asp
450 455 460
Arg Leu Tyr Glu Glu Tyr Thr Arg Thr Ser Gln Glu Ile Gln Met Lys
465 470 475 480
Arg Thr Ala Ile Glu Ala Phe Asn Glu Thr Ile Lys Ile Phe Glu Glu
485 490 495
Gln Cys Gln Thr Gln Glu Arg Tyr Ser Lys Glu Tyr Ile Glu Lys Phe
500 505 510
Lys Arg Glu Gly Asn Glu Lys G1u Ile Gln Arg Ile Met His Asn Tyr
515 520 525
Asp Lys Leu Lys Ser Arg Ile Ser Glu Ile Ile Asp Ser Arg Arg Arg
530 535 540
Leu Glu Glu Asp Leu Lys Lys Gln Ala Ala Glu Tyr Arg Glu Ile Asp
545 550 555 560
Lys Arg Met Asn Ser Ile Lys Pro Asp Leu Ile Gln Leu Arg Lys Thr
565 570 575
Arg Asp Gln Tyr Leu Met Trp Leu Thr Gln Lys Gly Val Arg Gln Lys
580 585 590
Lys Leu Asn Glu Trp Leu Gly Asn Glu Asn Thr Glu Asp Gln Tyr Ser
595 600 605
Leu Val Glu Asp Asp Glu Asp Leu Pro His His Asp Glu Lys Thr Trp
CA 02450698 2003-12-23
143
610 615 620
Asn Val Gly Ser Ser Asn Arg Asn Lys Ala Glu Asn Leu Leu Arg Gly
625 630 635 640
Lys Arg Asp Gly Thr Phe Leu Val Arg Glu Ser Ser Lys Gln Gly Cys
645 650 655
Tyr Ala Cys Ser Val Val Val Asp Gly Glu Val Lys His Cys Val Ile
660 665 670
Asn Lys Thr Ala Thr Gly Tyr Gly Phe Ala Glu Pro Tyr Asn Leu Tyr
675 680 685
Ser Ser Leu Lys Glu Leu Val Leu His Tyr Gln His Thr Ser Leu Val
690 695 700
Gln His Asn Asp Ser Leu Asn Val Thr Leu Ala Tyr Pro Val Tyr Ala
705 710 715 720
Gln Gln Arg Arg Gln Asp Pro Pro Va1 Ala Thr Met Val Ser Lys Gly
725 730 735
G1u Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly
740 745 750
Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp
755 760 765
Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys
770 775 780
Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val
785 790 795 800
Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe
805 810 815
Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe
820 825 830
Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly
835 840 845
Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu
850 855 860
Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His
865 870 875 880
Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn
885 890 895
Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp
900 905 910
His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro
915 920 925
Asp Asn His Tyr Leu Sex Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn
930 935 940
Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly
945 950 955 960
Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
965 970
(2) INFORMATION FOR SEQ ID N0:68:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1788 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1785
(D) OTHER INFORMATION:
CA 02450698 2003-12-23
144
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:68:
ATG GGC AAC GCC GCC GCC GCC AAG AAG GGC AGC GAG CAG GAG AGC GTG 48
Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val
1 5 10 15
AAA GAG TTC CTA GCC AAA GCC AAG GAA GAT TTC CTG AAA AAA TGG GAA 96
Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu
20 25 30
GAC CCC TCT CAG AAT ACA GCC CAG TTG GAT CAG TTT GAT AGA ATC AAG 144
Asp Pro Ser Gln Asn Thr Ala Gln Leu Asp Gln Phe Asp Arg Ile Lys
35 40 45
ACC CTT GGC ACC GGC TCC TTT GGG CGA GTG ATG CTG GTG AAG CAC AAG 192
Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Lys
50 55 60
GAG AGT GGG AAC CAC TAC GCC ATG AAG ATC TTA GAC AAG CAG AAG GTG 240
Glu Ser Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val
65 70 75 80
GTG AAG CTA AAG CAG ATC GAG CAC ACT CTG AAT GAG AAG CGC ATC CTG 288
Val Lys Leu Lys Gln Ile Glu His Thr Leu Asn Glu Lys Arg Ile Leu
85 90 95
CAG GCC GTC AAC TTC CCG TTC CTG GTC AAA CTT GAA TTC TCC TTC AAG 336
Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys
100 105 110
GAC AAC TCA AAC CTG TAC ATG GTC ATG GAG TAT GTA GCT GGT GGC GAG 384
Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Ala Gly Gly Glu
115 120 125
ATG TTC TCC CAC CTA CGG CGG ATT GGA AGG TTC AGC GAG CCC CAT GCC 432
Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala
130 135 140
CGT TTC TAC GCG GCG CAG ATC GTC CTG ACC TTT GAG TAT CTG CAC TCC 480
Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser
145 150 155 160
CTG GAC CTC ATC TAC CGG GAC CTG AAG CCC GAG AAT CTT CTC ATC GAC 528
Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp
165 170 175
CAG CAG GGC TAT ATT CAG GTG ACA GAC TTC GGT TTT GCC AAG CGT GTG 576
Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val
180 185 190
AAA GGC CGT ACT TGG ACC TTG TGT GGG ACC CCT GAG TAC TTG GCC CCC 624
Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro
195 200 205
GAG ATT ATC CTG AGC AAA GGC TAC AAC AAG GCT GTG GAC TGG TGG GCT 672
Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala
210 215 220
CTC GGA GTC CTC ATC TAC GAG ATG GCT GCT GGT TAC CCA CCC TTC TTC 720
CA 02450698 2003-12-23
145
Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe
225 230 235 240
GCT GAC CAG CCT ATC CAG ATC TAT GAG AAA ATC GTC TCT GGG AAG GTG 768
Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val
245 250 255
CGG TTC CCA TCC CAC TTC AGC TCT GAC TTG AAG GAC CTG CTG CGG AAC 816
Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn
260 265 270
CTT CTG CAA GTG GAT CTA ACC AAG CGC TTT GGA AAC CTC AAG GAC GGG 864
Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asp Gly
275 280 285
GTCAAT GACATCAAG AACCACAAGTGG TTTGCC ACGACTGAC TGGATT 912
ValAsn AspIleLys AsnHisLysTrp PheAla ThrThrAsp TrpIle
290 295 300
GCCATC TATCAGAGA AAGGTGGAAGCT CCCTTC ATACCAAAG TTTAAA 960
AlaIle TyrGlnArg LysValGluAla ProPhe IleProLys PheLys
305 310 315 320
GGCCCT GGGGACACG AGTAACTTTGAC GACTAT GAGGAGGAA GAGATC 1008
GlyPro GlyAspThr SerAsnPheAsp AspTyr GluGluGlu GluIle
325 330 335
CGGGTC TCCATCAAT GAGAAGTGTGGC AAGGAG TTTACTGAG TTTGGG 1056
ArgVal SerIleAsn GluLysCysGly LysGlu PheThrGlu PheGly
340 345 350
CGCGCC ATGAGTAAA GGAGAAGAACTT TTCACT GGAGTTGTC CCAATT 1104
ArgAla MetSerLys GlyGluGluLeu PheThr GlyValVal ProIle
355 360 365
CTTGTT GAATTAGAT GGCGATGTTAAT GGGCAA AAATTCTCT GTTAGT 1152
LeuVal GluLeuAsp GlyAspValAsn GlyG1n LysPheSer ValSer
370 375 380
GGAGAG GGTGAAGGT GATGCAACATAC GGAAAA CTTACCCTT AAATTT 1200
GlyGlu GlyGluGly AspAlaThrTyr GlyLys LeuThrLeu LysPhe
385 390 395 400
ATTTGC ACTACTGGG AAGCTACCTGTT CCATGG CCAACGCTT GTCACT 1248
IleCys ThrThrGly LysLeuProVal ProTrp ProThrLeu ValThr
405 410 415
ACTCTC ACTTATGGT GTTCAATGCTTT TCTAGA TACCCAGAT CATATG 1296
ThrLeu ThrTyrGly ValGlnCysPhe SerArg TyrProAsp HisMet
420 425 430
AAACAG CATGACTTT TTCAAGAGTGCC ATGCCC GAAGGTTAT GTACAG 1344
LysGln HisAspPhe PheLysSerAla MetPro GluGlyTyr ValGln
435 440 445
GAAAGA ACTATATTT TACAAAGATGAC GGGAAC TACAAGACA CGTGCT 1392
GluArg ThrIlePhe TyrLysAspAsp GlyAsn TyrLysThr ArgAla
450 455 460
GAA GTC AAG TTT GAA GGT GAT ACC CTT GTT AAT AGA ATC GAG TTA AAA 1440
CA 02450698 2003-12-23
146
Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys
465 470 475 480
GGT ATT GAT TTT AAA GAA GAT GGA AAC ATT CTT GGA CAC AAA ATG GAA 1488
Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Met Glu
485 490 495
TAC AAT TAT AAC TCA CAT AAT GTA TAC ATC ATG GCA GAC AAA CCA AAG 1536
Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Pro Lys
500 505 510
AAT GGC ATC AAA GTT AAC TTC AAA ATT AGA CAC AAC ATT AAA GAT GGA 1584
Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Lys Asp Gly
515 520 525
AGCGTT CAATTAGCA GACCATTAT CAACAAAAT ACTCCAATT GGCGAT 1632
SerVal GlnLeuAla AspHisTyr GlnGlnAsn ThrProIle GlyAsp
530 535 540
GGCCCT GTCCTTTTA CCAGACAAC CATTACCTG TCCACGCAA TCTGCC 1680
GlyPro ValLeuLeu ProAspAsn HisTyrLeu SerThrG1n SerAla
545 550 555 560
CTTTCC AAAGATCCC AACGAAAAG AGAGATCAC ATGATCCTT CTTGAG 1728
LeuSer LysAspPro AsnGluLys ArgAspHis MetIleLeu LeuGlu
565 570 575
TTTGTA ACAGCTGCT GGGATTACA CATGGCATG GATGAACTA TACAAA 1776
PheVal ThrAlaAla GlyI1eThr HisGlyMet AspGluLeu TyrLys
580 585 590
CCTCAG GAGTAA 1788
ProGln Glu
595
(2) INFORMATION FOR SEQ ID N0:69:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 595 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:69:
Met Gly Asn Ala Ala Ala Ala Lys Lys Gly Ser Glu Gln Glu Ser Val
1 5 10 15
Lys Glu Phe Leu Ala Lys Ala Lys Glu Asp Phe Leu Lys Lys Trp Glu
20 25 30
Asp Pro Ser Gln Asn Thr Ala Gln Leu Asp Gln Phe Asp Arg Ile Lys
35 40 45
Thr Leu Gly Thr Gly Ser Phe Gly Arg Val Met Leu Val Lys His Lys
50 55 60
Glu Ser Gly Asn His Tyr Ala Met Lys Ile Leu Asp Lys Gln Lys Val
65 70 75 80
Val Lys Leu Lys Gln Ile G1u His Thr Leu Asn Glu Lys Arg Ile Leu
CA 02450698 2003-12-23
147
85 90 95
Gln Ala Val Asn Phe Pro Phe Leu Val Lys Leu Glu Phe Ser Phe Lys
100 105 110
Asp Asn Ser Asn Leu Tyr Met Val Met Glu Tyr Val Ala Gly Gly Glu
115 120 125
Met Phe Ser His Leu Arg Arg Ile Gly Arg Phe Ser Glu Pro His Ala
130 135 140
Arg Phe Tyr Ala Ala Gln Ile Val Leu Thr Phe Glu Tyr Leu His Ser
145 150 155 160
Leu Asp Leu Ile Tyr Arg Asp Leu Lys Pro Glu Asn Leu Leu Ile Asp
165 170 175
Gln Gln Gly Tyr Ile Gln Val Thr Asp Phe Gly Phe Ala Lys Arg Val
180 185 190
Lys Gly Arg Thr Trp Thr Leu Cys Gly Thr Pro Glu Tyr Leu Ala Pro
195 200 205
Glu Ile Ile Leu Ser Lys Gly Tyr Asn Lys Ala Val Asp Trp Trp Ala
210 215 220
Leu Gly Val Leu Ile Tyr Glu Met Ala Ala Gly Tyr Pro Pro Phe Phe
225 230 235 240
Ala Asp Gln Pro Ile Gln Ile Tyr Glu Lys Ile Val Ser Gly Lys Val
245 250 255
Arg Phe Pro Ser His Phe Ser Ser Asp Leu Lys Asp Leu Leu Arg Asn
260 265 270
Leu Leu Gln Val Asp Leu Thr Lys Arg Phe Gly Asn Leu Lys Asp Gly
275 280 285
Val Asn Asp Ile Lys Asn His Lys Trp Phe Ala Thr Thr Asp Trp Ile
290 295 300
Ala Ile Tyr Gln Arg Lys Val Glu Ala Pro Phe Ile Pro Lys Phe Lys
305 310 315 320
Gly Pro Gly Asp Thr Ser Asn Phe Asp Asp Tyr Glu Glu Glu Glu Ile
325 330 335
Arg Val Ser Ile Asn Glu Lys Cys Gly Lys Glu Phe Thr Glu Phe Gly
340 345 350
Arg Ala Met Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile
355 360 365
Leu Val Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val Ser
370 375 380
Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe
385 390 395 400
Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr
405 410 415
Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met
420 425 430
Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln
435 440 445
Glu Arg Thr Ile Phe Tyr Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala
450 455 460
Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys
465 470 475 480
Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Met Glu
485 490 495
Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Pro Lys
500 505 510
Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Lys Asp Gly
515 S20 525
Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp
530 535 540
G1y Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala
545 550 555 560
Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Ile Leu Leu Glu
CA 02450698 2003-12-23
148
565 570 575
Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr Lys
580 585 590
Pro Gln Glu
595
(2)INFORMATION ID N0:70:
FOR
SEQ
(i) QUENCE CS:
SE CHARACTERISTI
(A)LENGTH:2181 base irs
pa
(B)TYPE:
nucleic
acid
(C)STRANDEDNESS:
single
(D)TOPOLOGY:
linear
(i i) TYPE: cDNA
MOLECULE
(ix)
FEATURE:
(A)NAME/KEY: quence
Coding
Se
(B)LOCATION:
1...2178
(D)OTHER
INFORMATION:
(xi) DESCRIPTION:SEQ N0:70:
SEQUENCE ID
ATGAGC GACGTG ATT GTG GAGGGTTGG CTGCACAAA CGAGGG 48
GCT AAG
MetSer AspVal Ile Val GluGlyTrp LeuHisLys ArgGly
Ala Lys
1 5 10 15
GAGTAC ATCAAG TGG CGG CGCTACTTC CTCCTCAAG AATGAT 96
ACC CCA
GluTyr IleLys Trp Arg ArgTyrPhe LeuLeuLys AsnAsp
Thr Pro
20 25 30
GGCACC TTCATT TAC AAG CGGCCGCAG GATGTGGAC CAACGT 144
GGC GAG
G1yThr PheIle Tyr Lys ArgProGln AspValAsp GlnArg
Gly Glu
35 40 45
GAGGCT CCCCTC AAC TTC GTGGCGCAG TGCCAGCTG ATGAAG 192
AAC TCT
GluAla ProLeu Asn Phe ValAlaGln CysGlnLeu MetLys
Asn Ser
50 55 60
ACGGAG CGGCCC CCC AAC TTCATCATC CGCTGCCTG CAGTGG 240
CGG ACC
ThrGlu ArgPro Pro Asn PheIleIle ArgCysLeu GlnTrp
Arg Thr
65 70 75 80
ACCACT GTCATC CGC ACC CATGTGGAG ACTCCTGAG GAGCGG 288
GAA TTC
ThrThr ValIle Arg Thr HisValGlu ThrProGlu GluArg
Glu Phe
85 90 95
GAGGAG TGGACA GCC ATC ACTGTGGCT GACGGCCTC AAGAAG 336
ACC CAG
GluGlu TrpThr Ala Ile ThrValAla AspGlyLeu LysLys
Thr Gln
100 105 110
CAGGAG GAGGAG ATG GAC CGGTCGGGC TCACCCAGT GACAAC 384
GAG TTC
GlnGlu GluGlu Met Asp ArgSerGly SerProSer AspAsn
Glu Phe
115 120 125
TCAGGG GCTGAA ATG GAG TCCCTGGCC AAGCCCAAG CACCGC 432
GAG GTG
SerGly AlaGlu Met Glu SerLeuAla LysProLys HisArg
Glu Val
130 135 140
GTG ACC ATG AAC GAG TTT GAG TAC CTG AAG CTG CTG GGC AAG GGC ACT 480
CA 02450698 2003-12-23
149
Val Thr Met Asn Glu Phe Glu Tyr Leu Lys Leu Leu Gly Lys Gly Thr
145 150 155 160
TTC GGC AAG GTG ATC CTG GTG AAG GAG AAG GCC ACA GGC CGC TAC TAC 528
Phe Gly Lys Val Ile Leu Val Lys Glu Lys Ala Thr Gly Arg Tyr Tyr
165 170 175
GCC ATG AAG ATC CTC AAG AAG GAA GTC ATC GTG GCC AAG GAC GAG GTG 576
Ala Met Lys Ile Leu Lys Lys Glu Val Ile Val Ala Lys Asp Glu Val
180 185 190
GCC CAC ACA CTC ACC GAG AAC CGC GTC CTG CAG AAC TCC AGG CAC CCC 624
Ala His Thr Leu Thr Glu Asn Arg Val Leu Gln Asn Ser Arg His Pro
195 200 205
TTC CTC ACA GCC CTG AAG TAC TCT TTC CAG ACC CAC GAC CGC CTC TGC 672
Phe Leu Thr Ala Leu Lys Tyr Ser Phe Gln Thr His Asp Arg Leu Cys
210 215 220
TTT GTC ATG GAG TAC GCC AAC GGG GGC GAG CTG TTC TTC CAC CTG TCC 720
Phe Val Met Glu Tyr Ala Asn Gly Gly Glu Leu Phe Phe His Leu Sex
225 230 235 240
CGG GAA CGT GTG TTC TCC GAG GAC CGG GCC CGC TTC TAT GGC GCT GAG 768
Arg Glu Arg Val Phe Ser Glu Asp Arg Ala Arg Phe Tyr Gly Ala Glu
245 250 255
ATT GTG TCA GCC CTG GAC TAC CTG CAC TCG GAG AAG AAC GTG GTG TAC 816
Ile Val Ser Ala Leu Asp Tyr Leu His Ser Glu Lys Asn Val Val Tyr
260 265 270
CGG GAC CTC AAG CTG GAG AAC CTC ATG CTG GAC AAG GAC GGG CAC ATT 864
Arg Asp Leu Lys Leu Glu Asn Leu Met Leu Asp Lys Asp Gly His Ile
275 280 285
AAG ATC ACA GAC TTC GGG CTG TGC AAG GAG GGG ATC AAG GAC GGT GCC 912
Lys Ile Thr Asp Phe Gly Leu Cys Lys Glu Gly Ile Lys Asp Gly Ala
290 295 300
ACC ATG AAG ACC TTT TGC GGC ACA CCT GAG TAC CTG GCC CCC GAG GTG 960
Thr Met Lys Thr Phe Cys Gly Thr Pro G1u Tyr Leu Ala Pro Glu Val
305 310 315 320
CTG GAG GAC AAT GAC TAC GGC CGT GCA GTG GAC TGG TGG GGG CTG GGC 1008
Leu Glu Asp Asn Asp Tyr Gly Arg Ala Val Asp Trp Trp Gly Leu Gly
325 330 335
GTG GTC ATG TAC GAG ATG ATG TGC GGT CGC CTG CCC TTC TAC AAC CAG 1056
Val Val Met Tyr Glu Met Met Cys Gly Arg Leu Pro Phe Tyr Asn Gln
340 345 350
GAC CAT GAG AAG CTT TTT GAG CTC ATC CTC ATG GAG GAG ATC CGC TTC 1104
Asp His Glu Lys Leu Phe Glu Leu Ile Leu Met Glu Glu Ile Arg Phe
355 360 365
CCG CGC ACG CTT GGT CCC GAG GCC AAG TCC TTG CTT TCA GGG CTG CTC 1152
Pro Arg Thr Leu Gly Pro Glu Ala Lys Ser Leu Leu Ser Gly Leu Leu
370 375 380
AAG AAG GAC CCC AAG CAG AGG CTT GGC GGG GGC TCC GAG GAC GCC AAG 1200
CA 02450698 2003-12-23
150
Lys Lys Asp Pro Lys Gln Arg Leu Gly Gly Gly Ser Glu Asp Ala Lys
385 390 395 400
GAG ATC ATG CAG CAT CGC TTC TTT GCC GGT ATC GTG TGG CAG CAC GTG 1248
Glu Ile Met Gln His Arg Phe Phe Ala Gly Ile Val Trp Gln His Val
405 410 415
TAC GAG AAG AAG CTC AGC CCA CCC TTC AAG CCC CAG GTC ACG TCG GAG 1296
Tyr Glu Lys Lys Leu Ser Pro Pro Phe Lys Pro Gln Val Thr Ser Glu
420 425 430
ACT GAC ACC AGG TAT TTT GAT GAG GAG TTC ACG GCC CAG ATG ATC ACC 1344
Thr Asp Thr Arg Tyr Phe Asp Glu Glu Phe Thr Ala Gln Met Ile Thr
435 440 445
ATC ACA CCA CCT GAC CAA GAT GAC AGC ATG GAG TGT GTG GAC AGC GAG 1392
Ile Thr Pro Pro Asp Gln Asp Asp Ser Met Glu Cys Val Asp Ser Glu
450 455 460
CGC AGG CCC CAC TTC CCC CAG TTC TCC TAC TCG GCC AGC AGC ACG GCC 1440
Arg Arg Pro His Phe Pro Gln Phe Ser Tyr Ser Ala Ser Ser Thr Ala
465 470 475 480
TCG GAT CCA CCG GTC GCC ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC 1488
Ser Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe
485 490 495
ACCGGG GTGGTGCCCATC CTGGTCGAG CTGGACGGC GACGTA GGC 1536
AAC
ThrGly ValValProIle LeuValGlu LeuAspGly AspVal AsnGly
500 505 510
CACAAG TTCAGCGTGTCC GGCGAGGGC GAGGGCGAT GCCACC TACGGC 1584
HisLys PheSerValSer GlyGluGly GluGlyAsp AlaThr TyrGly
515 520 525
AAGCTG ACCCTGAAGTTC ATCTGCACC ACCGGCAAG CTGCCC GTGCCC 1632
LysLeu ThrLeuLysPhe IleCysThr ThrGlyLys LeuPro ValPro
530 535 540
TGGCCC ACCCTCGTGACC ACCCTGACC TACGGCGTG CAGTGC TTCAGC 1680
TrpPro ThrLeuValThr ThrLeuThr TyrGlyVal GlnCys PheSer
545 550 555 560
CGCTAC CCCGACCACATG AAGCAGCAC GACTTCTTC AAGTCC GCCATG 1728
ArgTyr ProAspHisMet LysGlnHis AspPhePhe LysSer AlaMet
565 570 575
CCC GAA GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC 1776
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
580 585 590
AAC TAC AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG 1824
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
595 600 605
AAC CGC ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC 1872
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
610 615 620
CTG GGG CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC 1920
CA 02450698 2003-12-23
151
Leu Gly His Lys Leu Glu Tyx Asn Tyr Asn Ser His Asn Val Tyr Ile
625 630 635 640
ATG GCC GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC 1968
Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg
645 650 655
CAC AAC ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG 2016
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
660 665 670
AAC ACC CCC ATC GGC GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC 2064
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
675 680 685
CTG AGC ACC CAG TCC GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT 2112
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
690 695 700
CAC ATG GTC CTG CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC 2160
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
705 710 715 720
ATG GAC GAG CTG TAC AAG TAA 2181
Met Asp Glu Leu Tyr Lys
725
(2) INFORMATION FOR SEQ ID N0:71:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 726 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:71:
Met Ser Asp Val Ala Ile Val Lys Glu Gly Trp Leu His Lys Arg Gly
1 5 10 15
Glu Tyr Ile Lys Thr Trp Arg Pro Arg Tyr Phe Leu Leu Lys Asn Asp
20 25 30
Gly Thr Phe Ile Gly Tyr Lys Glu Arg Pro Gln Asp Val Asp Gln Arg
35 40 45
Glu Ala Pro Leu Asn Asn Phe Ser Val Ala Gln Cys Gln Leu Met Lys
50 55 60
Thr G1u Arg Pro Arg Pro Asn Thr Phe Ile Ile Arg Cys Leu Gln Trp
65 70 75 80
Thr Thr Val Ile Glu Arg Thr Phe His Val Glu Thr Pro Glu Glu Arg
85 90 95
Glu Glu Trp Thr Thr Ala Ile Gln Thr Val Ala Asp Gly Leu Lys Lys
100 105 110
Gln Glu Glu Glu Glu Met Asp Phe Arg Ser Gly Ser Pro Ser Asp Asn
115 120 125
Ser Gly Ala Glu Glu Met Glu Val Ser Leu Ala Lys Pro Lys His Arg
130 135 140
Val Thr Met Asn Glu Phe Glu Tyr Leu Lys Leu Leu Gly Lys Gly Thr
CA 02450698 2003-12-23
152
145 150 155 160
Phe Gly Lys Val Ile Leu Val Lys Glu Lys Ala Thr Gly Arg Tyr Tyr
165 170 175
Ala Met Lys Ile Leu Lys Lys Glu Val Ile Val Ala Lys Asp Glu Val
180 185 190
Ala His Thr Leu Thr Glu Asn Arg Val Leu Gln Asn Ser Arg His Pro
195 200 205
Phe Leu Thr Ala Leu Lys Tyr Ser Phe Gln Thr His Asp Arg Leu Cys
210 215 220
Phe Val Met Glu Tyr Ala Asn Gly Gly Glu Leu Phe Phe His Leu Ser
225 230 235 240
Arg Glu Arg Val Phe Ser Glu Asp Arg Ala Arg Phe Tyr Gly Ala Glu
245 250 255
Ile Val Ser Ala Leu Asp Tyr Leu His Ser Glu Lys Asn Val Val Tyr
260 265 270
Arg Asp Leu Lys Leu Glu Asn Leu Met Leu Asp Lys Asp Gly His Ile
275 280 285
Lys Ile Thr Asp Phe Gly Leu Cys Lys Glu Gly Ile Lys Asp Gly Ala
290 295 300
Thr Met Lys Thr Phe Cys Gly Thr Pro Glu Tyr Leu Ala Pro Glu Val
305 310 315 320
Leu Glu Asp Asn Asp Tyr Gly Arg Ala Val Asp Trp Trp Gly Leu Gly
325 330 335
Val Val Met Tyr Glu Met Met Cys Gly Arg Leu Pro Phe Tyr Asn Gln
340 345 350
Asp His Glu Lys Leu Phe Glu Leu Ile Leu Met Glu Glu Ile Arg Phe
355 360 365
Pro Arg Thr Leu Gly Pro Glu Ala Lys Ser Leu Leu Ser Gly Leu Leu
370 375 380
Lys Lys Asp Pro Lys Gln Arg Leu Gly Gly Gly Ser Glu Asp Ala Lys
385 390 395 400
Glu Ile Met Gln His Arg Phe Phe Ala Gly Ile Val Trp G1n His Val
405 410 415
Tyr Glu Lys Lys Leu Ser Pro Pro Phe Lys Pro Gln Val Thr Ser Glu
420 425 430
Thr Asp Thr Arg Tyr Phe Asp Glu Glu Phe Thr Ala Gln Met Ile Thr
435 440 445
Ile Thr Pro Pro Asp Gln Asp Asp Ser Met Glu Cys Val Asp Ser Glu
450 455 460
Arg Arg Pro His Phe Pro Gln Phe Ser Tyr Ser Ala Ser Ser Thr Ala
465 470 475 480
Ser Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe
485 490 495
Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly
500 505 510
His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly
515 520 525
Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro
530 535 540
Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser
545 550 555 560
Arg Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met
565 570 575
Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly
580 585 590
Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val
595 600 605
Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile
610 615 620
Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile
CA 02450698 2003-12-23
153
625 630 635 640
Met Ala Asp Lys Gln Lys Asn Gly I1e Lys Val Asn Phe Lys Ile Arg
645 650 655
His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln
660 665 670
Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr
675 680 685
Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp
690 695 700
His Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly
705 710 715 720
Met Asp Glu Leu Tyr Lys
725
(2) INFORMATION FOR SEQ ID N0:72:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2751 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2748
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:72:
ATG GCT GAC GTT TAC CCG GCC AAC GAC TCC ACG GCG TCT CAG GAC GTG 48
Met Ala Asp Val Tyr Pro Ala Asn Asp Ser Thr Ala Ser Gln Asp Val
1 5 10 15
GCC AAC CGC TTC GCC CGC AAA GGG GCG CTG AGG CAG AAG AAC GTG CAT 96
Ala Asn Arg Phe Ala Arg Lys Gly Ala Leu Arg Gln Lys Asn Val His
20 25 30
GAG GTG AAA GAC CAC AAA TTC ATC GCC CGC TTC TTC AAG CAA CCC ACC 144
Glu Val Lys Asp His Lys Phe Ile Ala Arg Phe Phe Lys Gln Pro Thr
35 40 45
TTC TGC AGC CAC TGC ACC GAC TTC ATC TGG GGG TTT GGG AAA CAA GGC 192
Phe Cys Ser His Cys Thr Asp Phe Ile Trp Gly Phe Gly Lys Gln Gly
50 55 60
TTC CAG TGC CAA GTT TGC TGT TTT GTG GTT CAT AAG AGG TGC CAT GAG 240
Phe Gln Cys Gln Val Cys Cys Phe Val Val His Lys Arg Cys His Glu
65 70 75 80
TTC GTT ACG TTC TCT TGT CCG GGT GCG GAT AAG GGA CCT GAC ACT GAC 288
Phe Val Thr Phe Ser Cys Pro Gly Ala Asp Lys Gly Pro Asp Thr Asp
85 90 95
GAC CCC AGG AGC AAG CAC AAG TTC AAA ATC CAC ACA TAC GGA AGC CCT 336
Asp Pro Arg Ser Lys His Lys Phe Lys Ile His Thr Tyr Gly Ser Pro
100 105 110
ACC TTC TGT GAT CAC TGT GGG TCC CTG CTC TAT GGA CTT ATC CAC CAA 384
CA 02450698 2003-12-23
154
Thr Phe Cys Asp His Cys Gly Sex Leu Leu Tyr Gly Leu Ile His Gln
115 120 125
GGG ATG AAA TGT GAC ACC TGC GAC ATG AAT GTT CAC AAC CAG TGT GTG 432
Gly Met Lys Cys Asp Thr Cys Asp Met Asn Val His Asn Gln Cys Val
130 135 140
ATC AAT GAC CCT AGC CTC TGC GGA ATG GAT CAC ACA GAG AAG AGG GGG 480
Ile Asn Asp Pro Ser Leu Cys Gly Met Asp His Thr Glu Lys Arg Gly
145 150 155 160
CGG ATT TAT CTG AAG GCT GAG GTC ACT GAT GAA AAG CTC CAC GTC ACG 528
Arg Ile Tyr Leu Lys Ala Glu Val Thr Asp Glu Lys Leu His Val Thr
165 170 175
GTA CGA GAT GCA AAA AAT CTA ATC CCT ATG GAT CCA AAT GGG CTT TCG 576
Val Arg Asp Ala Lys Asn Leu Ile Pro Met Asp Pro Asn Gly Leu Ser
180 185 190
GAT CCT TAT GTG AAG CTG AAA CTA ATC CCT GAC CCC AAG AAT GAG AGC 624
Asp Pro Tyr Val Lys Leu Lys Leu Ile Pro Asp Pro Lys Asn Glu Ser
195 200 205
AAA CAG AAA ACC AAA ACC ATC CGC TCC AAC CTG AAT CCT CAG TGG AAT 672
Lys Gln Lys Thr Lys Thr Ile Arg Ser Asn Leu Asn Pro Gln Trp Asn
210 215 220
GAG TCC TTC ACG TTC AAA TTA AAA CCT TCA GAC AAA GAC CGG CGA CTG 720
Glu Ser Phe Thr Phe Lys Leu Lys Pro Ser Asp Lys Asp Arg Arg Leu
225 230 235 240
TCT GTA GAA ATC TGG GAC TGG GAT CGG ACG ACT CGG AAT GAC TTC ATG 768
Ser Val Glu Ile Trp Asp Trp Asp Arg Thr Thr Arg Asn Asp Phe Met
245 250 255
GGA TCC CTT TCC TTT GGT GTC TCA GAG CTA ATG AAG ATG CCG GCC AGT 816
Gly Ser Leu Ser Phe Gly Val Ser Glu Leu Met Lys Met Pro Ala Ser
260 265 270
GGA TGG TAT AAA GCT CAC AAC CAA GAA GAG GGC GAA TAT TAC AAC GTG 864
Gly Trp Tyr Lys Ala His Asn Gln Glu Glu Gly Glu Tyr Tyr Asn Val
275 280 285
CCC ATT CCA GAA GGA GAT GAA GAA GGC AAC ATG GAA CTC AGG CAG AAG 912
Pro Ile Pro Glu Gly Asp Glu Glu Gly Asn Met Glu Leu Arg Gln Lys
290 295 300
TTT GAG AAA GCC AAG CTA GGT CCT GTT GGT AAC AAA GTC ATC AGC CCT 960
Phe Glu Lys Ala Lys Leu Gly Pro Val Gly Asn Lys Val Ile Ser Pro
305 310 315 320
TCA GAA GAC AGA AAG CAA CCA TCC AAC AAC CTG GAC AGA GTG AAA CTC 1008
Ser Glu Asp Arg Lys Gln Pro Ser Asn Asn Leu Asp Arg Val Lys Leu
325 330 335
ACA GAC TTC AAC TTC CTC ATG GTG CTG GGG AAG GGG AGT TTT GGG AAG 1056
Thr Asp Phe Asn Phe Leu Met Val Leu Gly Lys Gly Ser Phe Gly Lys
340 345 350
GTG ATG CTT GCT GAC AGG AAG GGA ACG GAG GAA CTG TAC GCC ATC AAG 1104
CA 02450698 2003-12-23
155
Val Met Leu Ala Asp Arg Lys Gly Thr Glu Glu Leu Tyr Ala Ile Lys
355 360 365
ATC CTG AAG AAG GAC GTG GTG ATC CAG GAC GAC GAC GTG GAG TGC ACC 1152
Ile Leu Lys Lys Asp Val Val Ile Gln Asp Asp Asp Val Glu Cys Thr
370 375 380
ATG GTG GAG AAG CGC GTG CTG GCC CTG CTG GAC AAG CCG CCA TTT CTG 1200
Met Val Glu Lys Arg Val Leu Ala Leu Leu Asp Lys Pro Pro Phe Leu
385 390 395 400
ACA CAG CTG CAC TCC TGC TTC CAG ACA GTG GAC CGG CTG TAC TTC GTC 1248
Thr Gln Leu His Ser Cys Phe Gln Thr Val Asp Arg Leu Tyr Phe Val
405 410 415
ATG GAA TAC GTC AAC GGC GGG GAT CTT ATG TAC CAC ATT CAG CAA GTC 1296
Met Glu Tyr Val Asn Gly Gly Asp Leu Met Tyr His Ile Gln Gln Val
420 425 430
GGG AAA TTT AAG GAG CCA CAA GCA GTA TTC TAC GCA GCC GAG ATC TCC 1344
Gly Lys Phe Lys Glu Pro Gln Ala Val Phe Tyr Ala Ala Glu Ile Ser
435 440 445
ATC GGA CTG TTC TTC CTT CAT AAA AGA GGG ATC ATT TAC AGG GAT CTG 1392
Ile Gly Leu Phe Phe Leu His Lys Arg Gly Ile Ile Tyr Arg Asp Leu
450 455 460
AAG CTG AAC AAT GTC ATG CTG AAC TCA GAA GGG CAC ATC AAA ATC GCC 1440
Lys Leu Asn Asn Val Met Leu Asn Ser Glu Gly His Ile Lys Ile Ala
465 470 475 480
GAC TTC GGG ATG TGC AAG GAA CAC ATG ATG GAT GGA GTC ACG ACC AGG 1488
Asp Phe G1y Met Cys Lys Glu His Met Met Asp Gly Val Thr Thr Arg
485 490 495
ACC TTC TGC GGA ACT CCG GAC TAC ATT GCC CCA GAG ATA ATC GCT TAC 1536
Thr Phe Cys Gly Thr Pro Asp Tyr Ile Ala Pro Glu Ile Ile Ala Tyr
500 505 510
CAG CCG TAC GGG AAG TCT GTA GAT TGG TGG GCG TAC GGT GTG CTG CTG 1584
Gln Pro Tyr Gly Lys Ser Val Asp Trp Trp Ala Tyr Gly Val Leu Leu
515 520 525
TAC GAG ATG CTA GCC GGG CAG CCT CCG TTT GAT GGT GAA GAT GAA GAT 1632
Tyr Glu Met Leu Ala Gly Gln Pro Pro Phe Asp Gly Glu Asp Glu Asp
530 535 540
GAA CTG TTT CAG TCT ATA ATG GAG CAC AAC GTG TCC TAC CCC AAA TCC 1680
Glu Leu Phe Gln Ser Ile Met G1u His Asn Val Ser Tyr Pro Lys Ser
545 550 555 560
TTG TCC AAG GAA GCC GTC TCC ATC TGC AAA GGA CTT ATG ACC AAA CAG 1728
Leu Ser Lys Glu Ala Val Ser Ile Cys Lys Gly Leu Met Thr Lys Gln
565 570 575
CCT GCC AAG CGA CTG GGC TGC GGG CCC GAG GGA GAG AGG GAT GTC AGA 1776
Pro Ala Lys Arg Leu Gly Cys Gly Pro Glu Gly Glu Arg Asp Val Arg
580 585 590
GAG CAT GCC TTC TTC AGG AGG ATC GAC TGG GAG AAA CTG GAG AAC AGG 1824
CA 02450698 2003-12-23
156
Glu His Ala Phe Phe Arg Arg Ile Asp Trp Glu Lys Leu Glu Asn Arg
595 600 605
GAG ATC CAA CCA CCA TTC AAG CCC AAA GTG TGT GGC AAA GGA GCA GAA 1872
Glu Ile Gln Pro Pro Phe Lys Pro Lys Val Cys Gly Lys Gly Ala Glu
610 615 620
AAC TTT GAC AAG TTC TTC ACG CGA GGA CAG CCT GTC TTA ACA CCA CCA 1920
Asn Phe Asp Lys Phe Phe Thr Arg Gly Gln Pro Val Leu Thr Pro Pro
625 630 635 640
GAT CAG CTG GTC ATT GCT AAC ATA GAC CAA TCT GAT TTT GAA GGG TTC 1968
Asp Gln Leu Val Ile Ala Asn Ile Asp Gln Ser Asp Phe Glu Gly Phe
645 650 655
TCG TAT GTC AAC CCC CAG TTT GTG CAC CCA ATC TTG CAA AGT GCA GTA 2016
Ser Tyr Val Asn Pro Gln Phe Val His Pro Ile Leu Gln Ser Ala Val
660 665 670
GGG CGC GCC ATG AGT AAA GGA GAA GAA CTT TTC ACT GGA GTT GTC CCA 2064
Gly Arg Ala Met Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro
675 680 685
ATT CTT GTT GAA TTA GAT GGC GAT GTT AAT GGG CAA AAA TTC TCT GTT 2112
Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val
690 695 700
AGT GGA GAG GGT GAA GGT GAT GCA ACA TAC GGA AAA CTT ACC CTT AAA 2160
Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys
705 710 715 720
TTT ATT TGC ACT ACT GGG AAG CTA CCT GTT CCA TGG CCA ACG CTT GTC 2208
Phe I1e Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val
725 730 735
ACT ACT CTC ACT TAT GGT GTT CAA TGC TTT TCT AGA TAC CCA GAT CAT 2256
Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His
740 745 750
ATG AAA CAG CAT GAC TTT TTC AAG AGT GCC ATG CCC GAA GGT TAT GTA 2304
Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val
755 760 765
CAG GAA AGA ACT ATA TTT TAC AAA GAT GAC GGG AAC TAC AAG ACA CGT 2352
Gln Glu Arg Thr Ile Phe Tyr Lys Asp Asp Gly Asn Tyr Lys Thr Arg
770 775 780
GCT GAA GTC AAG TTT GAA GGT GAT ACC CTT GTT AAT AGA ATC GAG TTA 2400
Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu
785 790 795 800
AAA GGT ATT GAT TTT AAA GAA GAT GGA AAC ATT CTT GGA CAC AAA ATG 2448
Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Met
805 810 815
GAA TAC AAT TAT AAC TCA CAT AAT GTA TAC ATC ATG GCA GAC AAA CCA 2496
Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Pro
820 825 830
AAG AAT GGC ATC AAA GTT AAC TTC AAA ATT AGA CAC AAC ATT AAA GAT 2544
CA 02450698 2003-12-23
157
Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Lys Asp
835 840 845
GGA AGC GTT CAA TTA GCA GAC CAT TAT CAA CAA AAT ACT CCA ATT GGC 2592
Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly
850 855 860
GAT GGC CCT GTC CTT TTA CCA GAC AAC CAT TAC CTG TCC ACG CAA TCT 2640
Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser
865 870 875 880
GCC CTT TCC AAA GAT CCC AAC GAA AAG AGA GAT CAC ATG ATC CTT CTT 2688
Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Ile Leu Leu
885 890 895
GAG TTT GTA ACA GCT GCT GGG ATT ACA CAT GGC ATG GAT GAA CTA TAC 2736
Glu Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr
900 905 910
AAA CCT CAG GAG TAA 2751
Lys Pro Gln Glu
915
(2) INFORMATION FOR SEQ ID N0:73:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 916 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:73:
Met Ala Asp Val Tyr Pro Ala Asn Asp Ser Thr Ala Ser Gln Asp Val
1 5 10 15
Ala Asn Arg Phe Ala Arg Lys Gly Ala Leu Arg Gln Lys Asn Val His
20 25 30
Glu Val Lys Asp His Lys Phe Ile Ala Arg Phe Phe Lys Gln Pro Thr
35 40 45
Phe Cys Ser His Cys Thr Asp Phe Ile Trp Gly Phe Gly Lys Gln Gly
50 55 60
Phe Gln Cys Gln Val Cys Cys Phe Val Val His Lys Arg Cys His Glu
65 70 75 80
Phe Val Thr Phe Ser Cys Pro Gly Ala Asp Lys Gly Pro Asp Thr Asp
85 90 95
Asp Pro Arg Ser Lys His Lys Phe Lys Ile His Thr Tyr Gly Ser Pro
100 105 110
Thr Phe Cys Asp His Cys Gly Ser Leu Leu Tyr Gly Leu Ile His Gln
115 120 125
Gly Met Lys Cys Asp Thr Cys Asp Met Asn Val His Asn Gln Cys Val
130 135 140
Ile Asn Asp Pro Ser Leu Cys Gly Met Asp His Thr Glu Lys Arg Gly
145 150 155 160
Arg Ile Tyr Leu Lys Ala Glu Val Thr Asp Glu Lys Leu His Val Thr
165 170 175
Val Arg Asp Ala Lys Asn Leu Ile Pro Met Asp Pro Asn Gly Leu Ser
CA 02450698 2003-12-23
158
180 185 190
Asp Pro Tyr Val Lys Leu Lys Leu Ile Pro Asp Pro Lys Asn Glu Ser
195 200 205
Lys Gln Lys Thr Lys Thr Ile Arg Ser Asn Leu Asn Pro Gln Trp Asn
210 215 220
Glu Ser Phe Thr Phe Lys Leu Lys Pro Ser Asp Lys Asp Arg Arg Leu
225 230 235 240
Sex Val Glu Ile Trp Asp Trp Asp Arg Thr Thr Arg Asn Asp Phe Met
245 250 255
Gly Ser Leu Ser Phe Gly Val Ser Glu Leu Met Lys Met Pro Ala Ser
260 265 270
Gly Trp Tyr Lys Ala His Asn Gln Glu Glu Gly Glu Tyr Tyr Asn Val
275 280 285
Pro Ile Pro Glu Gly Asp Glu Glu Gly Asn Met Glu Leu Arg Gln Lys
290 295 300
Phe Glu Lys Ala Lys Leu Gly Pro Val Gly Asn Lys Val Ile Ser Pro
305 310 315 320
Ser Glu Asp Arg Lys Gln Pro Ser Asn Asn Leu Asp Arg Val Lys Leu
325 330 335
Thr Asp Phe Asn Phe Leu Met Val Leu Gly Lys Gly Ser Phe Gly Lys
340 345 350
Val Met Leu Ala Asp Arg Lys Gly Thr Glu Glu Leu Tyr Ala Ile Lys
355 360 365
Ile Leu Lys Lys Asp Val Val Ile Gln Asp Asp Asp Val Glu Cys Thr
370 375 380
Met Val Glu Lys Arg Val Leu Ala Leu Leu Asp Lys Pro Pro Phe Leu
385 390 395 400
Thr Gln Leu His Ser Cys Phe Gln Thr Val Asp Arg Leu Tyr Phe Val
405 410 415
Met Glu Tyr Val Asn Gly Gly Asp Leu Met Tyr His Ile Gln Gln Val
420 425 430
Gly Lys Phe Lys Glu Pro Gln Ala Val Phe Tyr Ala Ala Glu Ile Ser
435 440 445
Ile Gly Leu Phe Phe Leu His Lys Arg Gly Ile Ile Tyr Arg Asp Leu
450 455 460
Lys Leu Asn Asn Val Met Leu Asn Ser Glu Gly His Ile Lys Ile Ala
465 470 475 480
Asp Phe Gly Met Cys Lys Glu His Met Met Asp Gly Val Thr Thr Arg
485 490 495
Thr Phe Cys Gly Thr Pro Asp Tyr Tle Ala Pro Glu Ile Ile Ala Tyr
500 505 510
Gln Pro Tyr Gly Lys Ser Val Asp Trp Trp Ala Tyr Gly Val Leu Leu
515 520 525
Tyr Glu Met Leu Ala Gly Gln Pro Pro Phe Asp Gly Glu Asp Glu Asp
530 535 540
Glu Leu Phe Gln Ser Ile Met Glu His Asn Val Ser Tyr Pro Lys Ser
545 550 555 560
Leu Ser Lys Glu Ala Val Ser Ile Cys Lys Gly Leu Met Thr Lys G1n
565 570 575
Pro Ala Lys Arg Leu Gly Cys Gly Pro Glu Gly Glu Arg Asp Val Arg
580 585 590
Glu His Ala Phe Phe Arg Arg Ile Asp Trp Glu Lys Leu Glu Asn Arg
595 600 605
Glu Ile Gln Pro Pro Phe Lys Pro Lys Val Cys Gly Lys Gly Ala Glu
610 615 620
Asn Phe Asp Lys Phe Phe Thr Arg Gly Gln Pro Val Leu Thr Pro Pro
625 630 635 640
Asp Gln Leu Val Ile Ala Asn Ile Asp Gln Ser Asp Phe Glu Gly Phe
645 650 655
Ser Tyr Val Asn Pro Gln Phe Val His Pro Ile Leu Gln Ser Ala Val
CA 02450698 2003-12-23
159
660 665 670
Gly Arg Ala Met Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro
675 680 685
Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly Gln Lys Phe Ser Val
690 695 700
Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys
705 710 715 720
Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val
725 730 735
Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His
740 745 750
Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val
755 760 765
Gln Glu Arg Thr Ile Phe Tyr Lys Asp Asp Gly Asn Tyr Lys Thr Arg
770 775 780
Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu
785 790 795 800
Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Met
805 810 815
Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Pro
820 825 830
Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Lys Asp
835 840 845
G1y Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly
850 855 860
Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser
865 870 875 880
Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Ile Leu Leu
885 890 895
Glu Phe Val Thr Ala Ala Gly Ile Thr His Gly Met Asp Glu Leu Tyr
900 905 910
Lys Pro Gln Glu
915
(2) INFORMATION FOR SEQ ID N0:74:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2157 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2154
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:74:
ATG TCG TCC ATC TTG CCA TTC ACG CCG CCA GTT GTG AAG AGA CTG CTG 48
Met Ser Ser Ile Leu Pro Phe Thr Pro Pro Val Val Lys Arg Leu Leu
1 5 10 15
GGA TGG AAG AAG TCA GCT GGT GGG TCT GGA GGA GCA GGC GGA GGA GAG 96
Gly Trp Lys Lys Ser Ala Gly Gly Ser Gly Gly Ala Gly Gly Gly Glu
20 25 30
CAG AAT GGG CAG GAA GAA AAG TGG TGT GAG AAA GCA GTG AAA AGT CTG 144
CA 02450698 2003-12-23
160
Gln Asn Gly Gln Glu Glu Lys Trp Cys Glu Lys Ala Val Lys Ser Leu
35 40 45
GTG AAG AAG CTA AAG AAA ACA GGA CGA TTA GAT GAG CTT GAG AAA GCC 192
Val Lys Lys Leu Lys Lys Thr Gly Arg Leu Asp Glu Leu Glu Lys Ala
50 55 60
ATC ACC ACT CAA AAC TGT AAT ACT AAA TGT GTT ACC ATA CCA AGC ACT 240
Ile Thr Thr Gln Asn Cys Asn Thr Lys Cys Val Thr Ile Pro Ser Thr
65 70 75 80
TGC TCT GAA ATT TGG GGA CTG AGT ACA CCA AAT ACG ATA GAT CAG TGG 288
Cys Ser Glu Ile Trp Gly Leu Ser Thr Pro Asn Thr Ile Asp Gln Trp
85 90 95
GAT ACA ACA GGC CTT TAC AGC TTC TCT GAA CAA ACC AGG TCT CTT GAT 336
Asp Thr Thr Gly Leu Tyr Ser Phe Ser Glu Gln Thr Arg Ser Leu Asp
100 105 110
GGT CGT CTC CAG GTA TCC CAT CGA AAA GGA TTG CCA CAT GTT ATA TAT 384
Gly Arg Leu Gln Val Ser His Arg Lys Gly Leu Pro His Val Ile Tyr
115 120 125
TGC CGA TTA TGG CGC TGG CCT GAT CTT CAC AGT CAT CAT GAA CTC AAG 432
Cys Arg Leu Trp Arg Trp Pro Asp Leu His Ser His His Glu Leu Lys
130 135 140
GCA ATT GAA AAC TGC GAA TAT GCT TTT AAT CTT AAA AAG GAT GAA GTA 480
Ala Ile Glu Asn Cys Glu Tyr Ala Phe Asn Leu Lys Lys Asp Glu Val
145 150 155 160
TGT GTA AAC CCT TAC CAC TAT CAG AGA GTT GAG ACA CCA GTT TTG CCT 528
Cys Val Asn Pro Tyr His Tyr Gln Arg Val Glu Thr Pro Val Leu Pro
165 170 175
CCA GTA TTA GTG CCC CGA CAC ACC GAG ATC CTA ACA GAA CTT CCG CCT 576
Pro Val Leu Val Pro Arg His Thr Glu Ile Leu Thr Glu Leu Pro Pro
180 185 190
CTG GAT GAC TAT ACT CAC TCC ATT CCA GAA AAC ACT AAC TTC CCA GCA 624
Leu Asp Asp Tyr Thr His Ser Ile Pro Glu Asn Thr Asn Phe Pro Ala
195 200 205
GGA ATT GAG CCA CAG AGT AAT TAT ATT CCA GAA ACG CCA CCT CCT GGA 672
Gly Ile Glu Pro Gln Ser Asn Tyr Ile Pro Glu Thr Pro Pro Pro Gly
210 215 220
TAT ATC AGT GAA GAT GGA GAA ACA AGT GAC CAA CAG TTG AAT CAA AGT 720
Tyr Ile Ser Glu Asp Gly Glu Thr Ser Asp Gln Gln Leu Asn Gln Ser
225 230 235 240
ATG GAC ACA GGC TCT CCA GCA GAA CTA TCT CCT ACT ACT CTT TCC CCT 768
Met Asp Thr Gly Ser Pro Ala Glu Leu Ser Pro Thr Thr Leu Ser Pro
245 250 255
GTT AAT CAT AGC TTG GAT TTA CAG CCA GTT ACT TAC TCA GAA CCT GCA 816
Val Asn His Ser Leu Asp Leu Gln Pro Val Thr Tyr Ser Glu Pro Ala
260 265 270
TTT TGG TGT TCA ATA GCA TAT TAT GAA TTA AAT CAG AGG GTT GGA GAA 864
CA 02450698 2003-12-23
161
Phe Trp Cys Ser Ile Ala Tyr Tyr Glu Leu Asn Gln Arg Val Gly Glu
275 280 285
ACC TTC CAT GCA TCA CAG CCC TCA CTC ACT GTA GAT GGC TTT ACA GAC 912
Thr Phe His Ala Ser Gln Pro Ser Leu Thr Val Asp Gly Phe Thr Asp
290 295 300
CCA TCA AAT TCA GAG AGG TTC TGC TTA GGT TTA CTC TCC AAT GTT AAC 960
Pro Ser Asn Ser Glu Arg Phe Cys Leu Gly Leu Leu Ser Asn Val Asn
305 310 315 320
CGA AAT GCC ACG GTA GAA ATG ACA AGA AGG CAT ATA GGA AGA GGA GTG 1008
Arg Asn Ala Thr Val Glu Met Thr Arg Arg His Ile Gly Arg Gly Val
325 330 335
CGC TTA TAC TAC ATA GGT GGG GAA GTT TTT GCT GAG TGC CTA AGT GAT 1056
Arg Leu Tyr Tyr Ile Gly Gly Glu Val Phe Ala Glu Cys Leu Ser Asp
340 345 350
AGT GCA ATC TTT GTG CAG AGC CCC AAT TGT AAT CAG AGA TAT GGC TGG 1104
Ser Ala Ile Phe Val Gln Ser Pro Asn Cys Asn Gln Arg Tyr Gly Trp
355 360 365
CAC CCT GCA ACA GTG TGT AAA ATT CCA CCA GGC TGT AAT CTG AAG ATC 1152
His Pro Ala Thr Val Cys Lys Ile Pro Pro Gly Cys Asn Leu Lys Ile
370 375 380
TTC AAC AAC CAG GAA TTT GCT GCT CTT CTG GCT CAG TCT GTT AAT CAG 1200
Phe Asn Asn Gln Glu Phe Ala Ala Leu Leu Ala Gln Ser Val Asn Gln
385 390 395 400
GGT TTT GAA GCC GTC TAT CAG CTA ACT AGA ATG TGC ACC ATA AGA ATG 1248
Gly Phe Glu Ala Val Tyr Gln Leu Thr Arg Met Cys Thr Ile Arg Met
405 410 415
AGT TTT GTG AAA GGG TGG GGA GCA GAA TAC CGA AGG CAG ACG GTA ACA 1296
Ser Phe Val Lys Gly Trp Gly Ala Glu Tyr Arg Arg Gln Thr Val Thr
420 425 430
AGT ACT CCT TGC TGG ATT GAA CTT CAT CTG AAT GGA CCT CTA CAG TGG 1344
Ser Thr Pro Cys Trp Ile Glu Leu His Leu Asn Gly Pro Leu Gln Trp
435 440 445
TTG GAC AAA GTA TTA ACT CAG ATG GGA TCC CCT TCA GTG CGT TGC TCA 1392
Leu Asp Lys Val Leu Thr Gln Met Gly Ser Pro Ser Val Arg Cys Ser
450 455 460
AGC ATG TCA TGG GTA CCG CGG GCC CGG GAT CCA CCG GTC GCC ACC ATG 1440
Ser Met Ser Trp Val Pro Arg Ala Arg Asp Pro Pro Val Ala Thr Met
465 470 475 480
GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG GTC 1488
Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
485 490 495
GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC GAG 1536
Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu
500 505 510
GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC TGC 1584
CA 02450698 2003-12-23
162
Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys
515 520 525
ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC CTG 1632
Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
530 535 540
ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG CAG 1680
Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln
545 550 555 560
CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG CGC 1728
His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
565 570 575
ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG GTG 1776
Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
580 585 590
AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC ATC 1824
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
595 600 605
GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC AAC 1872
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
610 615 620
TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC GGC 1920
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
625 630 635 640
ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC GTG 1968
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
645 650 655
CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC CCC 2016
Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro
660 665 670
GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG AGC 2064
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
675 680 685
AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC GTG 2112
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu G1u Phe Val
690 695 700
ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TAA 2157
Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
705 710 715
(2) INFORMATION FOR SEQ ID N0:75:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 718 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
CA 02450698 2003-12-23
163
{ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE; internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:75:
Met Ser Ser Ile Leu Pro Phe Thr Pro Pro Val Val Lys Arg Leu Leu
1 5 10 15
Gly Trp Lys Lys Ser Ala Gly Gly Ser Gly Gly Ala G1y Gly Gly Glu
20 25 30
Gln Asn Gly Gln Glu Glu Lys Trp Cys Glu Lys Ala Val Lys Ser Leu
35 40 45
Val Lys Lys Leu Lys Lys Thr Gly Arg Leu Asp Glu Leu Glu Lys Ala
50 55 60
Ile Thr Thr Gln Asn Cys Asn Thr Lys Cys Val Thr Ile Pro Ser Thr
65 70 75 80
Cys Ser Glu Ile Trp Gly Leu Ser Thr Pro Asn Thr Ile Asp Gln Trp
85 90 95
Asp Thr Thr Gly Leu Tyr Ser Phe Ser Glu Gln Thr Arg Ser Leu Asp
100 105 110
Gly Arg Leu Gln Val Ser His Arg Lys Gly Leu Pro His Val Ile Tyr
115 120 125
Cys Arg Leu Trp Arg Trp Pro Asp Leu His Ser His His Glu Leu Lys
130 135 140
Ala Ile Glu Asn Cys Glu Tyr Ala Phe Asn Leu Lys Lys Asp Glu Val
145 150 155 160
Cys Val Asn Pro Tyr His Tyr Gln Arg Val Glu Thr Pro Val Leu Pro
165 170 175
Pro Val Leu Val Pro Arg His Thr Glu Ile Leu Thr Glu Leu Pro Pro
180 185 190
Leu Asp Asp Tyr Thr His Ser Ile Pro Glu Asn Thr Asn Phe Pro Ala
195 200 205
Gly I1e Glu Pro Gln Ser Asn Tyr Ile Pro Glu Thr Pro Pro Pro Gly
210 215 220
Tyr Ile Ser Glu Asp Gly Glu Thr Ser Asp Gln Gln Leu Asn Gln Ser
225 230 235 240
Met Asp Thr Gly Ser Pro Ala Glu Leu Ser Pro Thr Thr Leu Ser Pro
245 250 255
Val Asn His Ser Leu Asp Leu Gln Pro Val Thr Tyr Ser Glu Pro Ala
260 265 270
Phe Trp Cys Ser Ile Ala Tyr Tyr Glu Leu Asn Gln Arg Val Gly Glu
275 280 285
Thr Phe His Ala Ser Gln Pro Ser Leu Thr Val Asp Gly Phe Thr Asp
290 295 300
Pro Ser Asn Ser Glu Arg Phe Cys Leu Gly Leu Leu Ser Asn Val Asn
305 310 315 320
Arg Asn Ala Thr Val Glu Met Thr Arg Arg His Ile Gly Arg Gly Val
325 330 335
Arg Leu Tyr Tyr Ile Gly Gly Glu Val Phe Ala Glu Cys Leu Ser Asp
340 345 350
Ser Ala Ile Phe Val Gln Ser Pro Asn Cys Asn Gln Arg Tyr Gly Trp
355 360 365
His Pro Ala Thr Val Cys Lys Ile Pro Pro Gly Cys Asn Leu Lys Ile
370 375 380
Phe Asn Asn Gln Glu Phe Ala Ala Leu Leu Ala Gln Ser Val Asn Gln
385 390 395 400
Gly Phe Glu Ala Val Tyr Gln Leu Thr Arg Met Cys Thr Ile Arg Met
405 410 415
Ser Phe Val Lys Gly Trp Gly Ala Glu Tyr Arg Arg Gln Thr Val Thr
420 425 430
Ser Thr Pro Cys Trp Ile Glu Leu His Leu Asn Gly Pro Leu Gln Trp
CA 02450698 2003-12-23
164
435 440 445
Leu Asp Lys Val Leu Thr Gln Met Gly Ser Pro Ser Val Arg Cys Ser
450 455 460
Ser Met Ser Trp Val Pro Arg Ala Arg Asp Pro Pro Val Ala Thr Met
465 470 475 480
Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
485 490 495
Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Sex Gly Glu
500 505 510
Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys
515 520 525
Thr Thr G1y Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
530 535 540
Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln
545 550 555 560
His Asp Phe Phe Lys Sex Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
565 570 575
Thr I1e Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
580 585 590
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
595 600 605
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
610 615 620
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
625 630 635 640
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
645 650 655
Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro
660 665 670
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
675 680 685
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val
690 695 700
Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
705 710 715
(2) INFORMATION FOR SEQ ID N0:76:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2397 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2394
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:76:
ATG GAC AAT ATG TCT ATT ACG AAT ACA CCA ACA AGT AAT GAT GCC TGT 48
Met Asp Asn Met Ser Ile Thr Asn Thr Pro Thr Ser Asn Asp Ala Cys
1 5 10 15
CTG AGC ATT GTG CAT AGT TTG ATG TGC CAT AGA CAA GGT GGA GAG AGT 96
Leu Ser Ile Val His Ser Leu Met Cys His Arg Gln Gly Gly Glu Ser
20 25 30
CA 02450698 2003-12-23
165
GAA ACA TTT GCA AAA AGA GCA ATT GAA AGT TTG GTA AAG AAG CTG AAG 144
Glu Thr Phe Ala Lys Arg Ala Ile Glu Ser Leu Val Lys Lys Leu Lys
35 40 45
GAG AAA AAA GAT GAA TTG GAT TCT TTA ATA ACA GCT ATA ACT ACA AAT 192
Glu Lys Lys Asp Glu Leu Asp Ser Leu Ile Thr Ala Ile Thr Thr Asn
50 55 60
GGA GCT CAT CCT AGT AAA TGT GTT ACC ATA CAG AGA ACA TTG GAT GGG 240
Gly Ala His Pro Ser Lys Cys Val Thr Ile Gln Arg Thr Leu Asp Gly
65 70 75 80
AGG CTT CAG GTG GCT GGT CGG AAA GGA TTT CCT CAT GTG ATC TAT GCC 288
Arg Leu Gln Val Ala Gly Arg Lys Gly Phe Pro His Val Ile Tyr Ala
85 90 95
CGT CTC TGG AGG TGG CCT GAT CTT CAC AAA AAT GAA CTA AAA CAT GTT 336
Arg Leu Trp Arg Trp Pro Asp Leu His Lys Asn Glu Leu Lys His Val
100 105 110
AAA TAT TGT CAG TAT GCG TTT GAC TTA AAA TGT GAT AGT GTC TGT GTG 384
Lys Tyr Cys Gln Tyr Ala Phe Asp Leu Lys Cys Asp Ser Val Cys Val
115 120 125
AAT CCA TAT CAC TAC GAA CGA GTT GTA TCA CCT GGA ATT GAT CTC TCA 432
Asn Pro Tyr His Tyr Glu Arg Val Val Ser Pro Gly Ile Asp Leu Ser
130 135 140
GGA TTA ACA CTG CAG AGT AAT GCT CCA TCA AGT ATG ATG GTG AAG GAT 480
Gly Leu Thr Leu Gln Ser Asn Ala Pro Ser Ser Met Met Val Lys Asp
145 150 155 160
GAA TAT GTG CAT GAC TTT GAG GGA CAG CCA TCG TTG TCC ACT GAA GGA 528
Glu Tyr Val His Asp Phe Glu Gly Gln Pro Ser Leu Ser Thr Glu Gly
165 170 175
CAT TCA ATT CAA ACC ATC CAG CAT CCA CCA AGT AAT CGT GCA TCG ACA 576
His Ser Ile Gln Thr Ile Gln His Pro Pro Ser Asn Arg Ala Ser Thr
180 185 190
GAG ACA TAC AGC ACC CCA GCT CTG TTA GCC CCA TCT GAG TCT AAT GCT 624
Glu Thr Tyr Ser Thr Pro Ala Leu Leu Ala Pro Ser Glu Ser Asn Ala
195 200 205
ACC AGC ACT GCC AAC TTT CCC AAC ATT CCT GTG GCT TCC ACA AGT CAG 672
Thr Ser Thr Ala Asn Phe Pro Asn Ile Pro Val Ala Ser Thr Ser Gln
210 215 220
CCT GCC AGT ATA CTG GGG GGC AGC CAT AGT GAA GGA CTG TTG CAG ATA 720
Pro Ala Ser Ile Leu Gly Gly Ser His Ser Glu Gly Leu Leu Gln Ile
225 230 235 240
GCA TCA GGG CCT CAG CCA GGA CAG CAG CAG AAT GGA TTT ACT GGT CAG 768
Ala Ser Gly Pro Gln Pro Gly Gln Gln Gln Asn Gly Phe Thr Gly Gln
245 250 255
CCA GCT ACT TAC CAT CAT AAC AGC ACT ACC ACC TGG ACT GGA AGT AGG 816
Pro Ala Thr Tyr His His Asn Sex Thr Thr Thr Trp Thr Gly Ser Arg
260 265 270
CA 02450698 2003-12-23
166
ACT GCA CCA TAC ACA CCT AAT TTG CCT CAC CAC CAA AAC GGC CAT CTT 864
Thr Ala Pro Tyr Thr Pro Asn Leu Pro His His Gln Asn Gly His Leu
275 280 285
CAG CAC CAC CCG CCT ATG CCG CCC CAT CCC GGA CAT TAC TGG CCT GTT 912
Gln His His Pro Pro Met Pro Pro His Pro Gly His Tyr Trp Pro Val
290 295 300
CAC AAT GAG CTT GCA TTC CAG CCT CCC ATT TCC AAT CAT CCT GCT CCT 960
His Asn Glu Leu Ala Phe Gln Pro Pro Ile Ser Asn His Pro Ala Pro
305 310 315 320
GAG TAT TGG TGT TCC ATT GCT TAC TTT GAA ATG GAT GTT CAG GTA GGA 1008
Glu Tyr Trp Cys Ser Ile Ala Tyr Phe Glu Met Asp Val Gln Val Gly
325 330 335
GAG ACA TTT AAG GTT CCT TCA AGC TGC CCT ATT GTT ACT GTT GAT GGA 1056
Glu Thr Phe Lys Val Pro Ser Ser Cys Pro I1e Val Thr Val Asp Gly
340 345 350
TAC GTG GAC CCT TCT GGA GGA GAT CGC TTT TGT TTG GGT CAA CTC TCC 1104
Tyr Val Asp Pro Ser Gly Gly Asp Arg Phe Cys Leu Gly Gln Leu Ser
355 360 365
AAT GTC CAC AGG ACA GAA GCC ATT GAG AGA GCA AGG TTG CAC ATA GGC 1152
Asn Val His Arg Thr Glu Ala Ile Glu Arg Ala Arg Leu His Ile Gly
370 375 380
AAA GGT GTG CAG TTG GAA TGT AAA GGT GAA GGT GAT GTT TGG GTC AGG 1200
Lys Gly Val Gln Leu Glu Cys Lys Gly Glu Gly Asp Val Trp Val Arg
385 390 395 400
TGC CTT AGT GAC CAC GCG GTC TTT GTA CAG AGT TAC TAC TTA GAC AGA 1248
Cys Leu Ser Asp His Ala Val Phe Val Gln Ser Tyr Tyr Leu Asp Arg
405 410 415
GAA GCT GGG CGT GCA CCT GGA GAT GCT GTT CAT AAG ATC TAC CCA AGT 1296
Glu Ala Gly Arg A1a Pro Gly Asp Ala Val His Lys Ile Tyr Pro Ser
420 425 430
GCA TAT ATA AAG GTC TTT GAT TTG CGT CAG TGT CAT CGA CAG ATG CAG 1344
Ala Tyr Ile Lys Val Phe Asp Leu Arg Gln Cys His Arg Gln Met Gln
435 440 445
CAG CAG GCG GCT ACT GCA CAA GCT GCA GCA GCT GCC CAG GCA GCA GCC 1392
Gln Gln Ala Ala Thr Ala Gln Ala Ala Ala Ala Ala Gln Ala Ala Ala
450 455 460
GTG GCA GGA AAC ATC CCT GGC CCA GGA TCA GTA GGT GGA ATA GCT CCA 1440
Val Ala Gly Asn Ile Pro Gly Pro Gly Ser Val G1y Gly Ile Ala Pro
465 470 475 480
GCT ATC AGT CTG TCA GCT GCT GCT GGA ATT GGT GTT GAT GAC CTT CGT 1488
Ala Ile Ser Leu Ser Ala Ala Ala Gly Ile Gly Val Asp Asp Leu Arg
485 490 495
CGC TTA TGC ATA CTC AGG ATG AGT TTT GTG AAA GGC TGG GGA CCG GAT 1536
Arg Leu Cys Ile Leu Arg Met Ser Phe Val Lys Gly Trp Gly Pro Asp
500 505 510
CA 02450698 2003-12-23
167
TAC CCA AGA CAG AGC ATC AAA GAA ACA CCT TGC TGG ATT GAA ATT CAC 1584
Tyr Pro Arg Gln Ser Ile Lys Glu Thr Pro Cys Trp Ile Glu Ile His
515 520 525
TTA CAC CGG GCC CTC CAG CTC CTA GAC GAA GTA CTT CAT ACC ATG CCG 1632
Leu His Arg Ala Leu Gln Leu Leu Asp Glu Val Leu His Thr Met Pro
530 535 540
ATT GCA GAC CCA CAA CCT TTA GAC TGG GAT CCA CCG GTC GCC ACC ATG 1680
Ile Ala Asp Pro Gln Pro Leu Asp Trp Asp Pro Pro Val Ala Thr Met
545 550 555 560
GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG GTC 1728
Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
565 570 575
GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC GAG 1776
Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu
580 585 590
GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC TGC 1824
Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys
595 600 605
ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC CTG 1872
Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
610 615 620
ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG CAG 1920
Thr Tyr Gly Val G1n Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln
625 630 635 640
CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG CGC 1968
His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
645 650 655
ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG GTG 2016
Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
660 665 670
AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC ATC 2064
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
675 680 685
GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC AAC 2112
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
690 695 700
TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC GGC 2160
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
705 710 715 720
ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC GTG 2208
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
725 730 735
CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC CCC 2256
Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro
740 745 750
CA 02450698 2003-12-23
168
GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG AGC 2304
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
755 760 765
AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC GTG 2352
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val
770 775 780
ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TAA 2397
Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
785 790 795
(2) INFORMATION FOR SEQ ID N0:77:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 798 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:77:
Met Asp Asn Met Ser Ile Thr Asn Thr Pro Thr Ser Asn Asp Ala Cys
1 5 10 15
Leu Ser Ile Val His Ser Leu Met Cys His Arg Gln Gly Gly Glu Sex
20 25 30
Glu Thr Phe Ala Lys Arg Ala Ile Glu Ser Leu Val Lys Lys Leu Lys
35 40 45
Glu Lys Lys Asp Glu Leu Asp Ser Leu Ile Thr Ala Ile Thr Thr Asn
50 55 60
Gly Ala His Pro Ser Lys Cys Val Thr Ile Gln Arg Thr Leu Asp Gly
65 70 75 80
Arg Leu Gln Val Ala Gly Arg Lys Gly Phe Pro His Val Ile Tyr Ala
85 90 95
Arg Leu Trp Arg Trp Pro Asp Leu His Lys Asn Glu Leu Lys His Val
100 105 110
Lys Tyr Cys G1n Tyr Ala Phe Asp Leu Lys Cys Asp Ser Val Cys Val
115 120 125
Asn Pro Tyr His Tyr Glu Arg Val Val Ser Pro Gly Ile Asp Leu Ser
130 135 140
Gly Leu Thr Leu Gln Ser Asn Ala Pro Ser Ser Met Met Val Lys Asp
145 150 155 160
Glu Tyr Val His Asp Phe Glu Gly Gln Pro Ser Leu Ser Thr Glu Gly
165 170 175
His Ser Ile Gln Thr Ile Gln His Pro Pro Ser Asn Arg Ala Ser Thr
180 185 190
Glu Thr Tyr Ser Thr Pro Ala Leu Leu Ala Pro Ser Glu Ser Asn Ala
195 200 205
Thr Ser Thr Ala Asn Phe Pro Asn Ile Pro Val Ala Ser Thr Ser Gln
210 215 220
Pro Ala Ser Ile Leu Gly Gly Ser His Ser Glu Gly Leu Leu Gln Ile
225 230 235 240
Ala Ser Gly Pro Gln Pro Gly Gln Gln Gln Asn Gly Phe Thr Gly Gln
245 250 255
Pro Ala Thr Tyr His His Asn Ser Thr Thr Thr Trp Thr Gly Ser Arg
CA 02450698 2003-12-23
169
260 265 270
Thr Ala Pro Tyr Thr Pro Asn Leu Pro His His Gln Asn Gly His Leu
275 280 285
Gln His His Pro Pro Met Pro Pro His Pro Gly His Tyr Trp Pro Val
290 295 300
His Asn Glu Leu Ala Phe Gln Pro Pro Ile Ser Asn His Pro Ala Pro
305 310 315 320
Glu Tyr Trp Cys Ser Ile Ala Tyr Phe Glu Met Asp Val Gln Va1 Gly
325 330 335
Glu Thr Phe Lys Val Pro Ser Ser Cys Pro Ile Val Thr Val Asp Gly
340 345 350
Tyr Val Asp Pro Ser Gly Gly Asp Arg Phe Cys Leu Gly Gln Leu Ser
355 360 365
Asn Val His Arg Thr Glu Ala Ile Glu Arg Ala Arg Leu His Ile Gly
370 375 380
Lys Gly Val Gln Leu Glu Cys Lys Gly Glu Gly Asp Val Trp Val Arg
385 390 395 400
Cys Leu Ser Asp His Ala Val Phe Val Gln Ser Tyr Tyr Leu Asp Arg
405 410 415
Glu Ala Gly Arg Ala Pro Gly Asp Ala Val His Lys Ile Tyr Pro Ser
420 425 430
Ala Tyr Ile Lys Val Phe Asp Leu Arg Gln Cys His Arg Gln Met Gln
435 440 445
Gln Gln Ala Ala Thr Ala Gln Ala Ala Ala Ala Ala Gln Ala Ala Ala
450 455 460
Val Ala Gly Asn Ile Pro Gly Pro Gly Ser Val Gly Gly Ile Ala Pro
465 470 475 480
Ala Ile Ser Leu Ser Ala Ala Ala Gly Ile Gly Val Asp Asp Leu Arg
485 490 495
Arg Leu Cys Ile Leu Arg Met Ser Phe Val Lys Gly Trp Gly Pro Asp
500 505 510
Tyr Pro Arg Gln Ser Ile Lys Glu Thr Pro Cys Trp Ile Glu Ile His
515 520 525
Leu His Arg Ala Leu Gln Leu Leu Asp Glu Val Leu His Thr Met Pro
530 535 540
Ile Ala Asp Pro Gln Pro Leu Asp Trp Asp Pro Pro Val Ala Thr Met
545 550 555 560
Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val
565 570 575
Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu
580 585 590
Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys
595 600 605
Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu
610 615 620
Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln
625 630 635 640
His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg
645 650 655
Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val
660 665 670
Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile
675 680 685
Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn
690 695 700
Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly
705 710 715 720
Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val
725 730 735
Gln Leu Ala Asp His Tyr G1n Gln Asn Thr Pro Ile Gly Asp Gly Pro
CA 02450698 2003-12-23
170
740 745 750
Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser
755 760 765
Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val
770 775 780
Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
785 790 795
(2) INFORMATION FOR SEQ ID N0:78:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 3138 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...3135
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:78:
ATG GCG GGC TGG ATC CAG GCC CAG CAG CTG CAG GGA GAC GCG CTG CGC 48
Met Ala Gly Trp Ile Gln Ala Gln Gln Leu Gln Gly Asp Ala Leu Arg
1 5 10 15
CAG ATG CAG GTG CTG TAC GGC CAG CAC TTC CCC ATC GAG GTC CGG CAC 96
Gln Met Gln Val Leu Tyr Gly Gln His Phe Pro Ile Glu Val Arg His
20 25 30
TAC TTG GCC CAG TGG ATT GAG AGC CAG CCA TGG GAT GCC ATT GAC TTG 144
Tyr Leu Ala Gln Trp Ile Glu Ser Gln Pro Trp Asp Ala Ile Asp Leu
35 40 45
GAC AAT CCC CAG GAC AGA GCC CAA GCC ACC CAG CTC CTG GAG GGC CTG 192
Asp Asn Pro Gln Asp Arg Ala Gln Ala Thr Gln Leu Leu Glu Gly Leu
50 55 60
GTG CAG GAG CTG CAG AAG AAG GCG GAG CAC CAG GTG GGG GAA GAT GGG 240
Val Gln Glu Leu Gln Lys Lys Ala Glu His Gln Val Gly Glu Asp Gly
65 70 75 80
TTT TTA CTG AAG ATC AAG CTG GGG CAC TAC GCC ACG CAG CTC CAG AAA 288
Phe Leu Leu Lys Ile Lys Leu Gly His Tyr Ala Thr Gln Leu Gln Lys
85 90 95
ACA TAT GAC CGC TGC CCC CTG GAG CTG GTC CGC TGC ATC CGG CAC ATT 336
Thr Tyr Asp Arg Cys Pro Leu Glu Leu Val Arg Cys Ile Arg His Ile
100 105 110
CTG TAC AAT GAA CAG AGG CTG GTC CGA GAA GCC AAC AAT TGC AGC TCT 384
Leu Tyr Asn Glu Gln Arg Leu Val Arg Glu Ala Asn Asn Cys Ser Ser
115 120 125
CCG GCT GGG ATC CTG GTT GAC GCC ATG TCC CAG AAG CAC CTT CAG ATC 432
Pro Ala Gly Ile Leu Val Asp Ala Met Ser Gln Lys His Leu Gln Ile
130 135 140
CA 02450698 2003-12-23
171
AAC CAG ACA TTT GAG GAG CTG CGA CTG GTC ACG CAG GAC ACA GAG AAT 480
Asn Gln Thr Phe Glu Glu Leu Arg Leu Val Thr Gln Asp Thr Glu Asn
145 150 155 160
GAG CTG AAG AAA CTG CAG CAG ACT CAG GAG TAC TTC ATC ATC CAG TAC 528
Glu Leu Lys Lys Leu Gln Gln Thr Gln Glu Tyr Phe Ile Ile Gln Tyr
165 170 175
CAG GAG AGC CTG AGG ATC CAA GCT CAG TTT GCC CAG CTG GCC CAG CTG 576
Gln Glu Ser Leu Arg Ile Gln Ala Gln Phe Ala Gln Leu Ala Gln Leu
180 185 190
AGC CCC CAG GAG CGT CTG AGC CGG GAG ACG GCC CTC CAG CAG AAG CAG 624
Ser Pro Gln G1u Arg Leu Ser Arg Glu Thr Ala Leu Gln Gln Lys Gln
195 200 205
GTG TCT CTG GAG GCC TGG TTG CAG CGT GAG GCA CAG ACA CTG CAG CAG 672
Val Ser Leu Glu Ala Trp Leu Gln Arg Glu Ala Gln Thr Leu Gln Gln
210 215 220
TAC CGC GTG GAG CTG GCC GAG AAG CAC CAG AAG ACC CTG CAG CTG CTG 720
Tyr Arg Val Glu Leu Ala Glu Lys His Gln Lys Thr Leu Gln Leu Leu
225 230 235 240
CGG AAG CAG CAG ACC ATC ATC CTG GAT GAC GAG CTG ATC CAG TGG AAG 768
Arg Lys Gln Gln Thr Ile Ile Leu Asp Asp Glu Leu Ile Gln Trp Lys
245 250 255
CGG CGG CAG CAG CTG GCC GGG AAC GGC GGG CCC CCC GAG GGC AGC CTG 816
Arg Arg Gln Gln Leu Ala Gly Asn Gly Gly Pro Pro Glu Gly Ser Leu
260 265 270
GAC GTG CTA CAG TCC TGG TGT GAG AAG TTG GCC GAG ATC ATC TGG CAG 864
Asp Val Leu Gln Ser Trp Cys Glu Lys Leu Ala Glu Ile Ile Trp Gln
275 280 285
AACCGGCAGCAG ATCCGCAGG GCTGAGCAC CTCTGCCAG CAGCTGCCC 912
AsnArgGlnGln IleArgArg AlaGluHis LeuCysGln GlnLeuPro
290 295 300
ATCCCCGGCCCA GTGGAGGAG ATGCTGGCC GAGGTCAAC GCCACCATC 960
IleProGlyPro ValGluGlu MetLeuA1a GluValAsn AlaThrIle
305 310 315 320
ACGGACATTATC TCAGCCCTG GTGACCAGC ACATTCATC ATTGAGAAG 1008
ThrAspIleIle SerAlaLeu ValThrSer ThrPheIle IleGluLys
325 330 335
CAGCCTCCTCAG GTCCTGAAG ACCCAGACC AAGTTTGCA GCCACCGTA 1056
GlnProProGln ValLeuLys ThrGlnThr LysPheAla AlaThrVal
340 345 350
CGCCTGCTGGTG GGCGGGAAG CTGAACGTG CACATGAAT CCCCCCCAG 1104
ArgLeuLeuVal GlyGlyLys LeuAsnVal HisMetAsn ProProGln
355 360 365
GTG AAG GCC ACC ATC ATC AGT GAG CAG CAG GCC AAG TCT CTG CTT AAA 1152
Val Lys Ala Thr Ile Ile Ser Glu Gln Gln Ala Lys Ser Leu Leu Lys
370 375 380
CA 02450698 2003-12-23
172
AAT GAG AAC ACC CGC AAC GAG TGC AGT GGT GAG ATC CTG AAC AAC TGC 1200
Asn Glu Asn Thr Arg Asn Glu Cys Ser Gly Glu Ile Leu Asn Asn Cys
385 390 395 400
TGC GTG ATG GAG TAC CAC CAA GCC ACG GGC ACC CTC AGT GCC CAC TTC 1248
Cys Val Met Glu Tyr His Gln Ala Thr Gly Thr Leu Ser Ala His Phe
405 410 415
AGG AAC ATG TCA CTG AAG AGG ATC AAG CGT GCT GAC CGG CGG GGT GCA 1296
Arg Asn Met Ser Leu Lys Arg Ile Lys Arg Ala Asp Arg Arg Gly Ala
420 425 430
GAG TCC GTG ACA GAG GAG AAG TTC ACA GTC CTG TTT GAG TCT CAG TTC 1344
Glu Ser Val Thr Glu Glu Lys Phe Thr Val Leu Phe Glu Ser Gln Phe
435 440 445
AGT GTT GGC AGC AAT GAG CTT GTG TTC CAG GTG AAG ACT CTG TCC CTA 1392
Ser Val Gly Ser Asn Glu Leu Val Phe Gln Val Lys Thr Leu Ser Leu
450 455 460
CCT GTG GTT GTC ATC GTC CAC GGC AGC CAG GAC CAC AAT GCC ACG GCT 1440
Pro Val Val Val Ile Val His Gly Ser Gln Asp His Asn Ala Thr Ala
465 470 475 480
ACT GTG CTG TGG GAC AAT GCC TTT GCT GAG CCG GGC AGG GTG CCA TTT 1488
Thr Val Leu Trp Asp Asn Ala Phe Ala Glu Pro Gly Arg Val Pro Phe
485 490 495
GCC GTG CCT GAC AAA GTG CTG TGG CCG CAG CTG TGT GAG GCG CTC AAC 1536
Ala Val Pro Asp Lys Val Leu Trp Pro Gln Leu Cys Glu Ala Leu Asn
500 505 510
ATG AAA TTC AAG GCC GAA GTG CAG AGC AAC CGG GGC CTG ACC AAG GAG 1584
Met Lys Phe Lys Ala Glu Val Gln Sex Asn Arg Gly Leu Thr Lys Glu
515 520 525
AAC CTC GTG TTC CTG GCG CAG AAA CTG TTC AAC AAC AGC AGC AGC CAC 1632
Asn Leu Val Phe Leu Ala Gln Lys Leu Phe Asn Asn Ser Ser Ser His
530 535 540
CTG GAG GAC TAC AGT GGC CTG TCC GTG TCC TGG TCC CAG TTC AAC AGG 1680
Leu Glu Asp Tyr Ser Gly Leu Ser Val Ser Trp Ser Gln Phe Asn Arg
545 550 555 560
GAG AAC TTG CCG GGC TGG AAC TAC ACC TTC TGG CAG TGG TTT GAC GGG 1728
Glu Asn Leu Pro Gly Trp Asn Tyr Thr Phe Trp Gln Trp Phe Asp Gly
565 570 575
GTG ATG GAG GTG TTG AAG AAG CAC CAC AAG CCC CAC TGG AAT GAT GGG 1776
Val Met Glu Val Leu Lys Lys His His Lys Pro His Trp Asn Asp Gly
580 585 590
GCC ATC CTA GGT TTT GTG AAT AAG CAA CAG GCC CAC GAC CTG CTC ATC 1824
Ala Ile Leu Gly Phe Val Asn Lys Gln Gln Ala His Asp Leu Leu Ile
595 600 605
AAC AAG CCC GAC GGG ACC TTC TTG TTG CGC TTT AGT GAC TCA GAA ATC 1872
Asn Lys Pro Asp Gly Thr Phe Leu Leu Arg Phe Ser Asp Ser Glu Ile
610 615 620
CA 02450698 2003-12-23
173
GGG GGC ATC ACC ATC GCC TGG AAG TTT GAC TCC CCG GAA CGC AAC CTG 1920
Gly Gly Ile Thr Ile Ala Trp Lys Phe Asp Ser Pro Glu Arg Asn Leu
625 630 635 640
TGG AAC CTG AAA CCA TTC ACC ACG CGG GAT TTC TCC ATC AGG TCC CTG 1968
Trp Asn Leu Lys Pro Phe Thr Thr Arg Asp Phe Ser Ile Arg Ser Leu
645 650 655
GCT GAC CGG CTG GGG GAC CTG AGC TAT CTC ATC TAT GTG TTT CCT GAC 2016
Ala Asp Arg Leu Gly Asp Leu Ser Tyr Leu Ile Tyr Val Phe Pro Asp
660 665 670
CGC CCC AAG GAT GAG GTC TTC TCC AAG TAC TAC ACT CCT GTG CTG GCT 2064
Arg Pro Lys Asp Glu Val Phe Ser Lys Tyr Tyr Thr Pro Val Leu Ala
675 680 685
AAA GCT GTT GAT GGA TAT GTG AAA CCA CAG ATC AAG CAA GTG GTC CCT 2112
Lys Ala Val Asp Gly Tyr Val Lys Pro Gln Ile Lys Gln Val Val Pro
690 695 700
GAG TTT GTG AAT GCA TCT GCA GAT GCT GGG GGC AGC AGC GCC ACG TAC 2160
Glu Phe Val Asn Ala Ser Ala Asp Ala Gly Gly Ser Ser Ala Thr Tyr
705 710 715 720
ATG GAC CAG GCC CCC TCC CCA GCT GTG TGC CCC CAG GCT CCC TAT AAC 2208
Met Asp Gln Ala Pro Ser Pro Ala Val Cys Pro Gln Ala Pro Tyr Asn
725 730 735
ATG TAC CCA CAG AAC CCT GAC CAT GTA CTC GAT CAG GAT GGA GAA TTC 2256
Met Tyr Pro Gln Asn Pro Asp His Val Leu Asp Gln Asp Gly Glu Phe
740 745 750
GAC CTG GAT GAG ACC ATG GAT GTG GCC AGG CAC GTG GAG GAA CTC TTA 2304
Asp Leu Asp Glu Thr Met Asp Val Ala Arg His Val Glu Glu Leu Leu
755 760 765
CGC CGA CCA ATG GAC AGT CTT GAC TCC CGC CTC TCG CCC CCT GCC GGT 2352
Arg Arg Pro Met Asp Ser Leu Asp Ser Arg Leu Ser Pro Pro Ala Gly
770 775 780
CTT TTC ACC TCT GCC AGA GGC TCC CTC TCA TGG GTA CCG CGG GCC CGG 2400
Leu Phe Thr Ser Ala Arg Gly Ser Leu Ser Trp Val Pro Arg Ala Arg
785 790 795 800
GAT CCA CCG GTC GCC ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC 2448
Asp Pro Pro Val Ala Thr Met Val Sex Lys Gly Glu Glu Leu Phe Thr
805 810 815
GGG GTG GTG CCC ATC CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC 2496
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
820 825 830
AAG TTC AGC GTG TCC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG 2544
Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys
835 840 845
CTG ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG 2592
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
850 855 860
CA 02450698 2003-12-23
174
CCC ACC CTC GTG ACC ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC 2640
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg
865 870 875 880
TAC CCC GAC CAC ATG AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC 2688
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
885 890 895
GAA GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC 2736
Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
900 905 910
TAC AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC 2784
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
915 920 925
CGC ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG 2832
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
930 935 940
GGG CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG 2880
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met
945 950 955 960
GCC GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC 2928
Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His
965 970 975
AAC ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC 2976
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
980 985 990
ACC CCC ATC GGC GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG 3024
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
995 1000 1005
AGC ACC CAG TCC GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC 3072
Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
1010 1015 1020
ATG GTC CTG CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG 3120
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met
1025 1030 1035 1040
GAC GAG CTG TAC AAG TAA 3138
Asp Glu Leu Tyr Lys
1045
(2) INFORMATION FOR SEQ ID N0:79:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1045 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
CA 02450698 2003-12-23
175
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:79:
Met Ala Gly Trp Ile Gln Ala Gln Gln Leu Gln Gly Asp Ala Leu Arg
1 5 10 15
Gln Met Gln Val Leu Tyr Gly Gln His Phe Pro Ile Glu Val Arg His
20 25 30
Tyr Leu Ala Gln Trp Ile Glu Ser Gln Pro Trp Asp Ala Ile Asp Leu
35 40 45
Asp Asn Pro Gln Asp Arg Ala Gln Ala Thr Gln Leu Leu Glu Gly Leu
50 55 60
Val Gln Glu Leu Gln Lys Lys Ala Glu His Gln Val Gly Glu Asp Gly
65 70 75 80
Phe Leu Leu Lys Ile Lys Leu Gly His Tyr Ala Thr Gln Leu Gln Lys
85 90 95
Thr Tyr Asp Arg Cys Pro Leu Glu Leu Val Arg Cys Ile Arg His Ile
100 105 110
Leu Tyr Asn Glu Gln Arg Leu Val Arg Glu Ala Asn Asn Cys Ser Ser
115 120 125
Pro Ala Gly Ile Leu Val Asp Ala Met Ser Gln Lys His Leu Gln Ile
130 135 140
Asn Gln Thr Phe Glu Glu Leu Arg Leu Val Thr Gln Asp Thr Glu Asn
145 150 155 160
Glu Leu Lys Lys Leu Gln Gln Thr Gln Glu Tyr Phe Ile Ile Gln Tyr
165 170 175
Gln Glu Ser Leu Arg Ile Gln Ala Gln Phe Ala Gln Leu Ala Gln Leu
180 185 190
Ser Pro Gln Glu Arg Leu Ser Arg Glu Thr Ala Leu Gln Gln Lys Gln
195 200 205
Val Ser Leu Glu Ala Trp Leu Gln Arg Glu Ala Gln Thr Leu Gln Gln
210 215 220
Tyr Arg Val Glu Leu Ala Glu Lys His Gln Lys Thr Leu Gln Leu Leu
225 230 235 240
Arg Lys Gln Gln Thr Ile Ile Leu Asp Asp Glu Leu Ile Gln Trp Lys
245 250 255
Arg Arg Gln Gln Leu Ala Gly Asn Gly Gly Pro Pro Glu Gly Ser Leu
260 265 270
Asp Val Leu Gln Ser Trp Cys Glu Lys Leu Ala Glu Ile Ile Trp Gln
275 280 285
Asn Arg Gln Gln Ile Arg Arg Ala Glu His Leu Cys Gln Gln Leu Pro
290 295 300
Ile Pro Gly Pro Val Glu Glu Met Leu Ala Glu Val Asn Ala Thr Ile
305 310 315 320
Thr Asp Ile Ile Ser Ala Leu Val Thr Ser Thr Phe Ile Ile Glu Lys
325 330 335
Gln Pro Pro Gln Val Leu Lys Thr Gln Thr Lys Phe Ala Ala Thr Val
340 345 350
Arg Leu Leu Va1 Gly Gly Lys Leu Asn Val His Met Asn Pro Pro Gln
355 360 365
Val Lys Ala Thr Ile Ile Ser Glu Gln Gln Ala Lys Ser Leu Leu Lys
370 375 380
Asn Glu Asn Thr Arg Asn Glu Cys Ser Gly Glu Ile Leu Asn Asn Cys
385 390 395 400
Cys Val Met Glu Tyr His Gln Ala Thr Gly Thr Leu Ser Ala His Phe
405 410 415
Arg Asn Met Ser Leu Lys Arg Ile Lys Arg Ala Asp Arg Arg Gly Ala
420 425 430
Glu Ser Val Thr Glu Glu Lys Phe Thr Val Leu Phe Glu Ser Gln Phe
435 440 445
Ser Val Gly Ser Asn Glu Leu Val Phe Gln Val Lys Thr Leu Ser Leu
CA 02450698 2003-12-23
176
450 455 460
Pro Val Val Val Ile Val His Gly Ser Gln Asp His Asn Ala Thr Ala
465 470 475 480
Thr Val Leu Trp Asp Asn Ala Phe Ala Glu Pro Gly Arg Val Pro Phe
485 490 495
Ala Val Pro Asp Lys Val Leu Trp Pro Gln Leu Cys Glu Ala Leu Asn
500 505 510
Met Lys Phe Lys Ala Glu Val Gln Ser Asn Arg Gly Leu Thr Lys Glu
515 520 525
Asn Leu Val Phe Leu Ala Gln Lys Leu Phe Asn Asn Ser Ser Ser His
530 535 540
Leu Glu Asp Tyr Ser Gly Leu Ser Val Ser Trp Ser Gln Phe Asn Arg
545 550 555 560
Glu Asn Leu Pro Gly Trp Asn Tyr Thr Phe Trp Gln Trp Phe Asp Gly
565 570 575
Val Met Glu Val Leu Lys Lys His His Lys Pro His Trp Asn Asp Gly
580 585 590
Ala Ile Leu Gly Phe Val Asn Lys Gln Gln Ala His Asp Leu Leu Ile
595 600 605
Asn Lys Pro Asp Gly Thr Phe Leu Leu Arg Phe Ser Asp Ser Glu Ile
610 615 620
Gly Gly Ile Thr Ile Ala Trp Lys Phe Asp Ser Pro Glu Arg Asn Leu
625 630 635 640
Trp Asn Leu Lys Pro Phe Thr Thr Arg Asp Phe Ser Ile Arg Ser Leu
645 650 655
Ala Asp Arg Leu Gly Asp Leu Ser Tyr Leu Ile Tyr Val Phe Pro Asp
660 665 670
Arg Pro Lys Asp Glu Val Phe Ser Lys Tyr Tyr Thr Pro Val Leu Ala
675 680 685
Lys Ala Val Asp Gly Tyr Val Lys Pro Gln Ile Lys Gln Val Val Pro
690 695 700
Glu Phe Val Asn Ala Ser Ala Asp Ala Gly Gly Ser Ser Ala Thr Tyr
705 710 715 720
Met Asp Gln Ala Pro Ser Pro Ala Val Cys Pro Gln Ala Pro Tyr Asn
725 730 735
Met Tyr Pro Gln Asn Pro Asp His Val Leu Asp Gln Asp Gly Glu Phe
740 745 750
Asp Leu Asp Glu Thr Met Asp Val Ala Arg His Val Glu Glu Leu Leu
755 760 765
Arg Arg Pro Met Asp Ser Leu Asp Ser Arg Leu Ser Pro Pro Ala Gly
770 775 780
Leu Phe Thr Ser Ala Arg Gly Sex Leu Ser Trp Val Pro Arg Ala Arg
785 790 795 800
Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr
805 810 815
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
820 825 830
Lys Phe Sex Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys
835 840 845
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
850 855 860
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg
865 870 875 880
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
885 890 895
Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
900 905 910
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
915 920 925
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
CA 02450698 2003-12-23
177
930 935 940
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met
945 950 955 960
Ala Asp Lys Gln Lys Asn Gly Ile Lys Va1 Asn Phe Lys Ile Arg His
965 970 975
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
980 985 990
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
995 1000 1005
Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
1010 1015 1020
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met
025 1030 1035 1040
Asp Glu Leu Tyr Lys
1045
(2) INFORMATION FOR SEQ ID N0:80:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:80:
TGGGATCCTC AGGCCGTGCT GCTGGCCG 28
(2) INFORMATION FOR SEQ ID N0:81:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:81:
GTCTCGAGGG AGCATGGGCA CCTTGCG 27
(2) INFORMATION FOR SEQ ID N0:82:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:82:
TGGGATCCGA GAAGTCTATA TCCCATC 27
(2) INFORMATION FOR SEQ ID N0:83:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
CA 02450698 2003-12-23
178
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:83:
TGGGATCCTT AGAAGTCTAT ATCCCATC 28
(2) INFORMATION FOR SEQ ID N0:84:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:84:
GTCTCGAGCC ATGAACGCCC CCGAGCGG 28
(2) INFORMATION FOR SEQ ID N0:85:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:85:
GTGAATTCTC GTCTGATTTC TGGCAGGAGG 30
(2) INFORMATION FOR SEQ ID N0:86:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:86:
GTGAATTCTT TACGTCTGAT TTCTGGCAGG 30
(2) INFORMATION FOR SEQ ID N0:87:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:87:
GTCTCGAGCC ATGGACGAAC TGTTCCCCCT CATC 34
CA 02450698 2003-12-23
179
(2) INFORMATION FOR SEQ ID N0:88:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 31 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:88:
GTGGATCCAA GGAGCTGATC TGACTCAGCA G 31
(2) INFORMATION FOR SEQ ID N0:89:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:89:
GTGGATCCTT AGGAGCTGAT CTGACTCAGC AG 32
(2) INFORMATION FOR SEQ ID N0:90:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:90:
CCTCCTAAGC TTATCATGGA CCATTATGAT TC 32
(2) INFORMATION FOR SEQ ID N0:91:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:91:
CCTCCTGGAT CCCTGCGCAG GATGATGGTC CAG 33
(2) INFORMATION FOR SEQ ID N0:92:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 45 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
CA 02450698 2003-12-23
180
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:92:
GGATGGAAGC TTCAATGGCT GCCATCCGGA AGAAACTGGT GATTG 45
(2) INFORMATION FOR SEQ ID N0:93:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 45 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:93:
GGATGGGGAT CCTCACAAGA CAAGGCAACC AGATTTTTTC TTCCC 45
(2) INFORMATION FOR SEQ ID N0:94:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:94:
GGGAAGCTTC CATGAGCGAG ACGGTCATC 29
(2) INFORMATION FOR SEQ ID N0:95:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:95:
CCCGGATCCT CAGGGAGAAC CCCGCTTC 28
(2) INFORMATION FOR SEQ ID N0:96:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:96:
GTGAATTCGA CCATGGAGCG GCCCCCGGGG 30
(2) INFORMATION FOR SEQ ID N0:97:
(i) SEQUENCE CHARACTERISTICS:
CA 02450698 2003-12-23
181
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:97:
GTGGTACCCA TTCTGTTAAC CAACTCC 27
(2) INFORMATION FOR SEQ ID N0:98:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:98:
GTGGTACCTC ATTCTGTTAA CCAACTCC 28
(2) INFORMATION FOR SEQ ID N0:99:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:99:
GTCTCGAGAG ATGCTGTCCC GTGGGTGG 28
(2) INFORMATION FOR SEQ ID NO:100:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:100:
GTGAATTCGC TTCCTCTTGA GGGAACC 27
(2) INFORMATION FOR SEQ ID NO:101:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 27 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:101:
CA 02450698 2003-12-23
182
GTGAATTCAC TTCCTCTTGA GGGAACC 27
(2) INFORMATION FOR SEQ ID N0:102:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:102:
GTCTCGAGCC ATGGAGAACT TCCAAAAGG 2g
(2) INFORMATION FOR SEQ ID N0:103:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 28 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:103:
GTGGATCCCA GAGTCGAAGA TGGGGTAC 2g
(2) INFORMATION FOR SEQ ID N0:104:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 29 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:104:
GTGGATCCTC AGAGTCGAAG ATGGGGTAC 29
(2) INFORMATION FOR SEQ ID N0:105:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 30 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:105:
GTGAATTCGG CGATGCCAGA CCCCGCGGCG 30
(2) INFORMATION FOR SEQ ID N0:106:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 32 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
CA 02450698 2003-12-23
183
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:106:
GTGGATCCCA GGCACAGGCA GCCTCAGCCT TC 32
(2) INFORMATION FOR SEQ ID N0:107:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 33 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:107:
GTGGATCCTC AGGCACAGGC AGCCTCAGCC TTC 33
(2) INFORMATION FOR SEQ ID N0:108:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2616 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2613
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:108:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CA 02450698 2003-12-23
184
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TCG GCG ATG CCA GAC CSC 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Ala Met Pro Asp Pro
245 250 255
GCG GCG CAC CTG CCC TTC TTC TAC GGC AGC ATC TCG CGT GCC GAG GCC 816
Ala Ala His Leu Pro Phe Phe Tyr Gly Ser Ile Ser Arg Ala Glu Ala
260 265 270
GAG GAG CAC CTG AAG CTG GCG GGC ATG GCG GAC GGG CTC TTC CTG CTG 864
Glu Glu His Leu Lys Leu Ala Gly Met Ala Asp Gly Leu Phe Leu Leu
275 280 285
CGC CAG TGC CTG CGC TCG CTG GGC GGC TAT GTG CTG TCG CTC GTG CAC 912
Arg Gln Cys Leu Arg Ser Leu Gly Gly Tyr Val Leu Ser Leu Val His
290 295 300
GAT GTG CGC TTC CAC CAC TTT CCC ATC GAG CGC CAG CTC AAC GGC ACC 960
Asp Val Arg Phe His His Phe Pro Ile Glu Arg Gln Leu Asn Gly Thr
305 310 315 320
TAC GCC ATT GCC GGC GGC AAA GCG CAC TGT GGA CCG GCA GAG CTC TGC 1008
Tyr Ala Ile Ala Gly Gly Lys Ala His Cys Gly Pro Ala Glu Leu Cys
325 330 335
CA 02450698 2003-12-23
185
GAG TTC TAC TCG CGC GAC CCC GAC GGG CTG CCC TGC AAC CTG CGC AAG 1056
Glu Phe Tyr Ser Arg Asp Pro Asp Gly Leu Pro Cys Asn Leu Arg Lys
340 345 350
CCG TGC AAC CGG CCG TCG GGC CTC GAG CCG CAG CCG GGG GTC TTC GAC 1104
Pro Cys Asn Arg Pro Ser Gly Leu Glu Pro Gln Pro Gly Val Phe Asp
355 360 365
TGC CTG CGA GAC GCC ATG GTG CGT GAC TAC GTG CGC CAG ACG TGG AAG 1152
Cys Leu Arg Asp Ala Met Val Arg Asp Tyr Val Arg Gln Thr Trp Lys
370 375 380
CTG GAG GGC GAG GCC CTG GAG CAG GCC ATC ATC AGC CAG GCC CCG CAG 1200
Leu Glu Gly Glu Ala Leu Glu Gln Ala Ile Ile Ser Gln Ala Pro Gln
385 390 395 400
GTG GAG AAG CTC ATT GCT ACG ACG GCC CAC GAG CGG ATG CCC TGG TAC 1248
Val Glu Lys Leu Ile Ala Thr Thr Ala His Glu Arg Met Pro Trp Tyr
405 410 415
CAC AGC AGC CTG ACG CGT GAG GAG GCC GAG CGC AAA CTT TAC TCT GGG 1296
His Ser Ser Leu Thr Arg Glu Glu Ala Glu Arg Lys Leu Tyr Ser Gly
420 425 430
GCG CAG ACC GAC GGC AAG TTC CTG CTG AGG CCG CGG AAG GAG CAG GGC 1344
Ala Gln Thr Asp Gly Lys Phe Leu Leu Arg Pro Arg Lys Glu Gln Gly
435 440 445
ACA TAC GCC CTG TCC CTC ATC TAT GGG AAG ACG GTG TAC CAC TAC CTC 1392
Thr Tyr Ala Leu Ser Leu Ile Tyr Gly Lys Thr Val Tyr His Tyr Leu
450 455 460
ATC AGC CAA GAC AAG GCG GGC AAG TAC TGC ATT CCC GAG GGC ACC AAG 1440
Ile Ser Gln Asp Lys Ala Gly Lys Tyr Cys Ile Pro Glu Gly Thr Lys
465 470 475 480
TTT GAC ACG CTC TGG CAG CTG GTG GAG TAT CTG AAG CTG AAG GCG GAC 1488
Phe Asp Thr Leu Trp Gln Leu Val Glu Tyr Leu Lys Leu Lys Ala Asp
485 490 495
GGG CTC ATC TAC TGC CTG AAG GAG GCC TGC CCC AAC AGC AGT GCC AGC 1536
Gly Leu Ile Tyr Cys Leu Lys Glu Ala Cys Pro Asn Ser Ser Ala Ser
500 505 510
AAC GCC TCA GGG GCT GCT GCT CCC ACA CTC CCA GCC CAC CCA TCC ACG 1584
Asn Ala Ser Gly Ala Ala Ala Pro Thr Leu Pro Ala His Pro Ser Thr
515 520 525
TTG ACT CAT CCT CAG AGA CGA ATC GAC ACC CTC AAC TCA GAT GGA TAC 1632
Leu Thr His Pro Gln Arg Arg Tle Asp Thr Leu Asn Ser Asp Gly Tyr
530 535 540
ACC CCT GAG CCA GCA CGC ATA ACG TCC CCA GAC AAA CCG CGG CCG ATG 1680
Thr Pro Glu Pro Ala Arg Ile Thr Ser Pro Asp Lys Pro Arg Pro Met
545 550 555 560
CCC ATG GAC ACG AGC GTG TAT GAG AGC CCC TAC AGC GAC CCA GAG GAG 1728
Pro Met Asp Thr Ser Val Tyr Glu Ser Pro Tyr Ser Asp Pro Glu Glu
565 570 575
CA 02450698 2003-12-23
186
CTC AAG GAC AAG AAG CTC TTC CTG AAG CGC GAT AAC CTC CTC ATA GCT 1776
Leu Lys Asp Lys Lys Leu Phe Leu Lys Arg Asp Asn Leu Leu Ile Ala
580 585 590
GAC ATT GAA CTT GGC TGC GGC AAC TTT GGC TCA GTG CGC CAG GGC GTG 1824
Asp Ile G1u Leu Gly Cys Gly Asn Phe Gly Ser Val Arg Gln Gly Val
595 600 605
TAC CGC ATG CGC AAG AAG CAG ATC GAC GTG GCC ATC AAG GTG CTG AAG 1872
Tyr Arg Met Arg Lys Lys Gln Ile Asp Val Ala Ile Lys Val Leu Lys
610 615 620
CAG GGC ACG GAG AAG GCA GAC ACG GAA GAG ATG ATG CGC GAG GCG CAG 1920
Gln Gly Thr Glu Lys Ala Asp Thr Glu Glu Met Met Arg Glu Ala Gln
625 630 635 640
ATC ATG CAC CAG CTG GAC AAC CCC TAC ATC GTG CGG CTC ATT GGC GTC 1968
Ile Met His Gln Leu Asp Asn Pro Tyr Ile Val Arg Leu Ile Gly Val
645 650 655
TGC CAG GCC GAG GCC CTC ATG CTG GTC ATG GAG ATG GCT GGG GGC GGG 2016
Cys Gln Ala Glu Ala Leu Met Leu Val Met Glu Met Ala Gly Gly Gly
660 665 670
CCG CTG CAC AAG TTC CTG GTC GGC AAG AGG GAG GAG ATC CCT GTG AGC 2064
Pro Leu His Lys Phe Leu Val Gly Lys Arg Glu Glu Ile Pro Val Ser
675 680 685
AAT GTG GCC GAG CTG CTG CAC CAG GTG TCC ATG GGG ATG AAG TAC CTG 2112
Asn Val Ala Glu Leu Leu His Gln Val Ser Met Gly Met Lys Tyr Leu
690 695 700
GAG GAG AAG AAC TTT GTG CAC CGT GAC CTG GCG GCC CGC AAC GTC CTG 2160
Glu Glu Lys Asn Phe Val His Arg Asp Leu Ala Ala Arg Asn Val Leu
705 710 715 720
CTG GTT AAC CGG CAC TAC GCC AAG ATC AGC GAC TTT GGC CTC TCC AAA 2208
Leu Val Asn Arg His Tyr Ala Lys Ile Ser Asp Phe Gly Leu Ser Lys
725 730 735
GCA CTG GGT GCC GAC GAC AGC TAC TAC ACT GCC CGC TCA GCA GGG AAG 2256
Ala Leu Gly Ala Asp Asp Ser Tyr Tyr Thr Ala Arg Ser Ala Gly Lys
740 745 750
TGG CCG CTC AAG TGG TAC GCA CCC GAA TGC ATC AAC TTC CGC AAG TTC 2304
Trp Pro Leu Lys Trp Tyr Ala Pro Glu Cys Ile Asn Phe Arg Lys Phe
755 760 765
TCC AGC CGC AGC GAT GTC TGG AGC TAT GGG GTC ACC ATG TGG GAG GCC 2352
Ser Ser Arg Ser Asp Val Trp Ser Tyr Gly Val Thr Met Trp Glu Ala
770 775 780
TTG TCC TAC GGC CAG AAG CCC TAC AAG AAG ATG AAA GGG CCG GAG GTC 2400
Leu Ser Tyr Gly Gln Lys Pro Tyr Lys Lys Met Lys Gly Pro Glu Val
785 790 795 800
ATG GCC TTC ATC GAG CAG GGC AAG CGG ATG GAG TGC CCA CCA GAG TGT 2448
Met Ala Phe Ile Glu Gln Gly Lys Arg Met Glu Cys Pro Pro Glu Cys
805 810 815
CA 02450698 2003-12-23
187
CCA CCC GAA CTG TAC GCA CTC ATG AGT GAC TGC TGG ATC TAC AAG TGG 2496
Pro Pro Glu Leu Tyr Ala Leu Met Ser Asp Cys Trp Ile Tyr Lys Trp
820 825 830
GAG GAT CGC CCC GAC TTC CTG ACC GTG GAG CAG CGC ATG CGA GCC TGT 2544
Glu Asp Arg Pro Asp Phe Leu Thr Val Glu Gln Arg Met Arg Ala Cys
835 840 845
TAC TAC AGC CTG GCC AGC AAG GTG GAA GGG CCC CCA GGC AGC ACA CAG 2592
Tyr Tyr Ser Leu Ala Ser Lys Val Glu Gly Pro Pro Gly Ser Thr Gln
850 855 860
AAG GCT GAG GCT GCC TGT GCC TGA 2616
Lys Ala Glu Ala Ala Cys Ala
865 870
(2) INFORMATION FOR SEQ ID N0:109:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 871 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:109:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Sex Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
CA 02450698 2003-12-23
188
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Ala Met Pro Asp Pro
245 250 255
Ala Ala His Leu Pro Phe Phe Tyr Gly Ser Ile Ser Arg Ala Glu Ala
260 265 270
Glu Glu His Leu Lys Leu Ala Gly Met Ala Asp Gly Leu Phe Leu Leu
275 280 285
Arg Gln Cys Leu Arg Ser Leu Gly Gly Tyr Val Leu Ser Leu Val His
290 295 300
Asp Val Arg Phe His His Phe Pro Ile Glu Arg Gln Leu Asn Gly Thr
305 310 315 320
Tyr Ala Ile Ala Gly Gly Lys Ala His Cys Gly Pro Ala Glu Leu Cys
325 330 335
Glu Phe Tyr Ser Arg Asp Pro Asp Gly Leu Pro Cys Asn Leu Arg Lys
340 345 350
Pro Cys Asn Arg Pro Ser Gly Leu Glu Pro Gln Pro Gly Val Phe Asp
355 360 365
Cys Leu Arg Asp Ala Met Val Arg Asp Tyr Val Arg Gln Thr Trp Lys
370 375 380
Leu Glu Gly Glu Ala Leu Glu Gln Ala Ile Ile Ser Gln Ala Pro Gln
385 390 395 400
Val Glu Lys Leu Ile Ala Thr Thr Ala His Glu Arg Met Pro Trp Tyr
405 410 415
His Ser Ser Leu Thr Arg Glu Glu Ala Glu Arg Lys Leu Tyr Ser Gly
420 425 430
Ala Gln Thr Asp Gly Lys Phe Leu Leu Arg Pro Arg Lys Glu Gln Gly
435 440 445
Thr Tyr Ala Leu Ser Leu Ile Tyr Gly Lys Thr Val Tyr His Tyr Leu
450 455 460
Ile Ser Gln Asp Lys Ala Gly Lys Tyr Cys Ile Pro Glu Gly Thr Lys
465 470 475 480
Phe Asp Thr Leu Trp Gln Leu Val Glu Tyr Leu Lys Leu Lys Ala Asp
485 490 495
Gly Leu Ile Tyr Cys Leu Lys Glu Ala Cys Pro Asn Ser Ser Ala Ser
500 505 510
Asn Ala Ser Gly Ala Ala Ala Pro Thr Leu Pro Ala His Pro Ser Thr
515 520 525
Leu Thr His Pro Gln Arg Arg Ile Asp Thr Leu Asn Ser Asp Gly Tyr
530 535 540
Thr Pro Glu Pro Ala Arg Ile Thr Ser Pro Asp Lys Pro Arg Pro Met
545 550 555 560
Pro Met Asp Thr Ser Val Tyr Glu Ser Pro Tyr Ser Asp Pro Glu Glu
565 570 575
Leu Lys Asp Lys Lys Leu Phe Leu Lys Arg Asp Asn Leu Leu Ile Ala
580 585 590
Asp Ile Glu Leu Gly Cys Gly Asn Phe Gly Ser Val Arg Gln Gly Val
595 600 605
Tyr Arg Met Arg Lys Lys Gln Ile Asp Val Ala Ile Lys Val Leu Lys
610 615 620
Gln Gly Thr Glu Lys Ala Asp Thr Glu Glu Met Met Arg Glu Ala Gln
625 630 635 640
Ile Met His Gln Leu Asp Asn Pro Tyr Ile Val Arg Leu Ile Gly Val
645 650 655
Cys Gln Ala Glu Ala Leu Met Leu Val Met Glu Met Ala Gly Gly Gly
660 665 670
Pro Leu His Lys Phe Leu Val Gly Lys Arg Glu Glu Ile Pro Val Ser
675 680 685
Asn Val Ala Glu Leu Leu His Gln Val Ser Met Gly Met Lys Tyr Leu
690 695 700
Glu Glu Lys Asn Phe Val His Arg Asp Leu Ala Ala Arg Asn Val Leu
CA 02450698 2003-12-23
189
705 710 715 720
Leu Val Asn Arg His Tyr Ala Lys Ile Ser Asp Phe Gly Leu Ser Lys
725 730 735
Ala Leu Gly Ala Asp Asp Ser Tyr Tyr Thr Ala Arg Ser Ala G1y Lys
740 745 750
Trp Pro Leu Lys Trp Tyr Ala Pro Glu Cys Ile Asn Phe Arg Lys Phe
755 760 765
Ser Ser Arg Ser Asp Val Trp Ser Tyr Gly Val Thr Met Trp G1u Ala
770 775 780
Leu Ser Tyr Gly Gln Lys Pro Tyr Lys Lys Met Lys Gly Pro Glu Val
785 790 795 800
Met Ala Phe Ile Glu Gln Gly Lys Arg Met Glu Cys Pro Pro Glu Cys
805 810 815
Pro Pro Glu Leu Tyr Ala Leu Met Ser Asp Cys Trp Ile Tyr Lys Trp
820 825 830
Glu Asp Arg Pro Asp Phe Leu Thr Val Glu Gln Arg Met Arg Ala Cys
835 840 845
Tyr Tyr Ser Leu Ala Ser Lys Val Glu Gly Pro Pro Gly Ser Thr Gln
850 855 860
Lys Ala Glu Ala Ala Cys Ala
865 870
(2) INFORMATION FOR SEQ ID NO:110:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2598 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2595
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:110:
ATG CCA GAC CCC GCG GCG CAC CTG CCC TTC TTC TAC GGC AGC ATC TCG 48
Met Pro Asp Pro Ala Ala His Leu Pro Phe Phe Tyr Gly Ser Ile Ser
1 5 10 15
CGT GCC GAG GCC GAG GAG CAC CTG AAG CTG GCG GGC ATG GCG GAC GGG 96
Arg Ala Glu Ala Glu Glu His Leu Lys Leu Ala Gly Met Ala Asp Gly
20 25 30
CTC TTC CTG CTG CGC CAG TGC CTG CGC TCG CTG GGC GGC TAT GTG CTG 144
Leu Phe Leu Leu Arg Gln Cys Leu Arg Ser Leu Gly Gly Tyr Val Leu
35 40 45
TCG CTC GTG CAC GAT GTG CGC TTC CAC CAC TTT CCC ATC GAG CGC CAG 192
Ser Leu Val His Asp Val Arg Phe His His Phe Pro Ile Glu Arg Gln
50 55 60
CTC AAC GGC ACC TAC GCC ATT GCC GGC GGC AAA GCG CAC TGT GGA CCG 240
Leu Asn Gly Thr Tyr Ala Ile Ala Gly G1y Lys Ala His Cys Gly Pro
65 70 75 80
GCA GAG CTC TGC GAG TTC TAC TCG CGC GAC CCC GAC GGG CTG CCC TGC 288
CA 02450698 2003-12-23
190
Ala Glu Leu Cys Glu Phe Tyr Ser Arg Asp Pro Asp Gly Leu Pro Cys
85 90 95
AAC CTG CGC AAG CCG TGC AAC CGG CCG TCG GGC CTC GAG CCG CAG CCG 336
Asn Leu Arg Lys Pro Cys Asn Arg Pro Ser Gly Leu Glu Pro Gln Pro
100 105 110
GGG GTC TTC GAC TGC CTG CGA GAC GCC ATG GTG CGT GAC TAC GTG CGC 384
Gly Val Phe Asp Cys Leu Arg Asp Ala Met Val Arg Asp Tyr Val Arg
115 120 125
CAG ACG TGG AAG CTG GAG GGC GAG GCC CTG GAG CAG GCC ATC ATC AGC 432
Gln Thr Trp Lys Leu Glu Gly Glu Ala Leu Glu Gln Ala Ile Ile Ser
130 135 140
CAG GCC CCG CAG GTG GAG AAG CTC ATT GCT ACG ACG GCC CAC GAG CGG 480
Gln Ala Pro Gln Val Glu Lys Leu Ile Ala Thr Thr Ala His Glu Arg
145 150 155 160
ATG CCC TGG TAC CAC AGC AGC CTG ACG CGT GAG GAG GCC GAG CGC AAA 528
Met Pro Trp Tyr His Ser Ser Leu Thr Arg G1u Glu Ala Glu Arg Lys
165 170 175
CTT TAC TCT GGG GCG CAG ACC GAC GGC AAG TTC CTG CTG AGG CCG CGG 576
Leu Tyr Ser Gly Ala Gln Thr Asp Gly Lys Phe Leu Leu Arg Pro Arg
180 185 190
AAG GAG CAG GGC ACA TAC GCC CTG TCC CTC ATC TAT GGG AAG ACG GTG 624
Lys Glu Gln Gly Thr Tyr Ala Leu Ser Leu Ile Tyr Gly Lys Thr Val
195 200 205
TAC CAC TAC CTC ATC AGC CAA GAC AAG GCG GGC AAG TAC TGC ATT CCC 672
Tyr His Tyr Leu Ile Ser Gln Asp Lys Ala Gly Lys Tyr Cys Ile Pro
210 215 220
GAG GGC ACC AAG TTT GAC ACG CTC TGG CAG CTG GTG GAG TAT CTG AAG 720
Glu Gly Thr Lys Phe Asp Thr Leu Trp Gln Leu Val Glu Tyr Leu Lys
225 230 235 240
CTG AAG GCG GAC GGG CTC ATC TAC TGC CTG AAG GAG GCC TGC CCC AAC 768
Leu Lys Ala Asp Gly Leu Ile Tyr Cys Leu Lys Glu Ala Cys Pro Asn
245 250 255
AGC AGT GCC AGC AAC GCC TCA GGG GCT GCT GCT CCC ACA CTC CCA GCC 816
Ser Ser Ala Ser Asn Ala Ser Gly Ala Ala Ala Pro Thr Leu Pro Ala
260 265 270
CAC CCA TCC ACG TTG ACT CAT CCT CAG AGA CGA ATC GAC ACC CTC AAC 864
His Pro Ser Thr Leu Thr His Pro Gln Arg Arg Ile Asp Thr Leu Asn
275 280 285
TCA GAT GGA TAC ACC CCT GAG CCA GCA CGC ATA ACG TCC CCA GAC AAA 912
Ser Asp Gly Tyr Thr Pro Glu Pro Ala Arg Ile Thr Ser Pro Asp Lys
290 295 300
CCG CGG CCG ATG CCC ATG GAC ACG AGC GTG TAT GAG AGC CCC TAC AGC 960
Pro Arg Pro Met Pro Met Asp Thr Ser Val Tyr Glu Ser Pro Tyr Ser
305 310 315 320
GAC CCA GAG GAG CTC AAG GAC AAG AAG CTC TTC CTG AAG CGC GAT AAC 1008
CA 02450698 2003-12-23
191
Asp Pro Glu Glu Leu Lys Asp Lys Lys Leu Phe Leu Lys Arg Asp Asn
325 330 335
CTC CTC ATA GCT GAC ATT GAA CTT GGC TGC GGC AAC TTT GGC TCA GTG 1056
Leu Leu Ile Ala Asp Ile Glu Leu Gly Cys Gly Asn Phe Gly Ser Val
340 345 350
CGC CAG GGC GTG TAC CGC ATG CGC AAG AAG CAG ATC GAC GTG GCC ATC 1104
Arg Gln Gly Val Tyr Arg Met Arg Lys Lys Gln Ile Asp Val Ala Ile
355 360 365
AAG GTG CTG AAG CAG GGC ACG GAG AAG GCA GAC ACG GAA GAG ATG ATG 1152
Lys Val Leu Lys Gln Gly Thr Glu Lys Ala Asp Thr Glu Glu Met Met
370 375 380
CGC GAG GCG CAG ATC ATG CAC CAG CTG GAC AAC CCC TAC ATC GTG CGG 1200
Arg Glu Ala Gln Ile Met His Gln Leu Asp Asn Pro Tyr Ile Val Arg
385 390 395 400
CTC ATT GGC GTC TGC CAG GCC GAG GCC CTC ATG CTG GTC ATG GAG ATG 1248
Leu Ile Gly Val Cys Gln Ala Glu Ala Leu Met Leu Val Met Glu Met
405 410 415
GCT GGG GGC GGG CCG CTG CAC AAG TTC CTG GTC GGC AAG AGG GAG GAG 1296
Ala Gly Gly Gly Pro Leu His Lys Phe Leu Val Gly Lys Arg Glu Glu
420 425 430
ATC CCT GTG AGC AAT GTG GCC GAG CTG CTG CAC CAG GTG TCC ATG GGG 1344
Ile Pro Val Ser Asn Val Ala Glu Leu Leu His Gln Val Ser Met Gly
435 440 445
ATG AAG TAC CTG GAG GAG AAG AAC TTT GTG CAC CGT GAC CTG GCG GCC 1392
Met Lys Tyr Leu Glu Glu Lys Asn Phe Val His Arg Asp Leu Ala Ala
450 455 460
CGC AAC GTC CTG CTG GTT AAC CGG CAC TAC GCC AAG ATC AGC GAC TTT 1440
Arg Asn Val Leu Leu Val Asn Arg His Tyr Ala Lys Ile Ser Asp Phe
465 470 475 480
GGC CTC TCC AAA GCA CTG GGT GCC GAC GAC AGC TAC TAC ACT GCC CGC 1488
Gly Leu Ser Lys Ala Leu Gly Ala Asp Asp Ser Tyr Tyr Thr Ala Arg
485 490 495
TCA GCA GGG AAG TGG CCG CTC AAG TGG TAC GCA CCC GAA TGC ATC AAC 1536
Ser Ala Gly Lys Trp Pro Leu Lys Trp Tyr Ala Pro Glu Cys Ile Asn
500 505 510
TTC CGC AAG TTC TCC AGC CGC AGC GAT GTC TGG AGC TAT GGG GTC ACC 1584
Phe Arg Lys Phe Ser Ser Arg Ser Asp Val Trp Ser Tyr Gly Val Thr
515 520 525
ATG TGG GAG GCC TTG TCC TAC GGC CAG AAG CCC TAC AAG AAG ATG AAA 1632
Met Trp Glu Ala Leu Ser Tyr Gly Gln Lys Pro Tyr Lys Lys Met Lys
530 535 540
GGG CCG GAG GTC ATG GCC TTC ATC GAG CAG GGC AAG CGG ATG GAG TGC 1680
Gly Pro Glu Val Met Ala Phe Ile Glu Gln Gly Lys Arg Met Glu Cys
545 550 555 560
CCA CCA GAG TGT CCA CCC GAA CTG TAC GCA CTC ATG AGT GAC TGC TGG 1728
CA 02450698 2003-12-23
192
Pro Pro Glu Cys Pro Pro Glu Leu Tyr Ala Leu Met Ser Asp Cys Trp
565 570 575
ATC TAC AAG TGG GAG GAT CGC CCC GAC TTC CTG ACC GTG GAG CAG CGC 1776
Ile Tyr Lys Trp Glu Asp Arg Pro Asp Phe Leu Thr Val Glu Gln Arg
580 585 590
ATG CGA GCC TGT TAC TAC AGC CTG GCC AGC AAG GTG GAA GGG CCC CCA 1824
Met Arg Ala Cys Tyr Tyr Ser Leu Ala Ser Lys Val Glu Gly Pro Pro
595 600 605
GGC AGC ACA CAG AAG GCT GAG GCT GCC TGT GCC TGG GAT CCA CCG GTC 1872
Gly Ser Thr Gln Lys Ala Glu Ala Ala Cys Ala Trp Asp Pro Pro Val
610 615 620
GCC ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC 1920
Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro
625 630 635 640
ATC CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG 1968
Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val
645 650 655
TCC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG 2016
Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys
660 665 670
TTC ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG 2064
Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val
675 680 685
ACC ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC 2112
Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His
690 695 700
ATG AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC 2160
Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val
705 710 715 720
CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC 2208
Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg
725 730 735
GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG 2256
Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu
740 745 750
AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG 2304
Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu
755 760 765
GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG 2352
Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln
770 775 780
AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC 2400
Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile G1u Asp
785 790 795 800
GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC 2448
CA 02450698 2003-12-23
193
Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly
805 810 815
GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC 2496
Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser
820 825 830
GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG 2544
Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu
835 840 845
GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC 2592
Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr
850 855 860
AAG TAA 2598
Lys
865
(2) INFORMATION FOR SEQ ID NO:111:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 865 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:111:
Met Pro Asp Pro Ala Ala His Leu Pro Phe Phe Tyr Gly Ser Ile Ser
1 5 10 15
Arg Ala Glu Ala Glu Glu His Leu Lys Leu Ala Gly Met Ala Asp Gly
20 25 30
Leu Phe Leu Leu Arg Gln Cys Leu Arg Ser Leu Gly Gly Tyr Val Leu
35 40 45
Ser Leu Val His Asp Val Arg Phe His His Phe Pro Ile Glu Arg Gln
50 55 60
Leu Asn Gly Thr Tyr Ala Ile Ala Gly Gly Lys Ala His Cys Gly Pro
65 70 75 80
Ala Glu Leu Cys Glu Phe Tyr Ser Arg Asp Pro Asp Gly Leu Pro Cys
85 90 95
Asn Leu Arg Lys Pro Cys Asn Arg Pro Sex Gly Leu Glu Pro Gln Pro
100 105 110
Gly Val Phe Asp Cys Leu Arg Asp Ala Met Val Arg Asp Tyr Val Arg
115 120 125
Gln Thr Trp Lys Leu Glu Gly Glu Ala Leu Glu Gln Ala Ile Ile Ser
130 135 140
Gln Ala Pro Gln Val Glu Lys Leu Ile Ala Thr Thr Ala His Glu Arg
145 150 155 160
Met Pro Trp Tyr His Ser Ser Leu Thr Arg Glu Glu Ala Glu Arg Lys
165 170 175
Leu Tyr Ser Gly Ala Gln Thr Asp Gly Lys Phe Leu Leu Arg Pro Arg
180 185 190
Lys Glu Gln Gly Thr Tyr Ala Leu Ser Leu Ile Tyr Gly Lys Thr Val
195 200 205
Tyr His Tyr Leu Ile Ser Gln Asp Lys Ala Gly Lys Tyr Cys I1e Pro
CA 02450698 2003-12-23
194
210 215 220
Glu Gly Thr Lys Phe Asp Thr Leu Trp Gln Leu Val Glu Tyr Leu Lys
225 230 235 240
Leu Lys Ala Asp Gly Leu Ile Tyr Cys Leu Lys Glu Ala Cys Pro Asn
245 250 255
Ser Ser Ala Ser Asn Ala Ser Gly Ala Ala Ala Pro Thr Leu Pro Ala
260 265 270
His Pro Ser Thr Leu Thr His Pro Gln Arg Arg Ile Asp Thr Leu Asn
275 280 285
Ser Asp Gly Tyr Thr Pro Glu Pro Ala Arg Ile Thr Ser Pro Asp Lys
290 295 300
Pro Arg Pro Met Pro Met Asp Thr Ser Val Tyr Glu Ser Pro Tyr Ser
305 310 315 320
Asp Pro Glu Glu Leu Lys Asp Lys Lys Leu Phe Leu Lys Arg Asp Asn
325 330 335
Leu Leu Ile Ala Asp Ile Glu Leu Gly Cys Gly Asn Phe Gly Ser Val
340 345 350
Arg Gln Gly Val Tyr Arg Met Arg Lys Lys Gln Ile Asp Val Ala Ile
355 360 365
Lys Val Leu Lys Gln Gly Thr Glu Lys Ala Asp Thr Glu Glu Met Met
370 375 380
Arg Glu Ala Gln Ile Met His Gln Leu Asp Asn Pro Tyr Ile Val Arg
385 390 395 400
Leu Ile Gly Val Cys Gln Ala Glu Ala Leu Met Leu Val Met Glu Met
405 410 415
Ala Gly Gly Gly Pro Leu His Lys Phe Leu Val Gly Lys Arg Glu Glu
420 425 430
Ile Pro Val Ser Asn Val Ala Glu Leu Leu His Gln Val Ser Met Gly
435 440 445
Met Lys Tyr Leu Glu Glu Lys Asn Phe Val His Arg Asp Leu Ala Ala
450 455 460
Arg Asn Val Leu Leu Val Asn Arg His Tyr Ala Lys Tle Ser Asp Phe
465 470 475 480
Gly Leu Ser Lys Ala Leu Gly Ala Asp Asp Ser Tyr Tyr Thr Ala Arg
485 490 495
Ser Ala Gly Lys Trp Pro Leu Lys Trp Tyr Ala Pro Glu Cys Ile Asn
500 505 510
Phe Arg Lys Phe Ser Ser Arg Ser Asp Val Trp Ser Tyr Gly Val Thr
515 520 525
Met Trp Glu Ala Leu Ser Tyr Gly Gln Lys Pro Tyr Lys Lys Met Lys
530 535 540
Gly Pro Glu Val Met Ala Phe Ile Glu Gln Gly Lys Arg Met Glu Cys
545 550 555 560
Pro Pro Glu Cys Pro Pro Glu Leu Tyr Ala Leu Met Ser Asp Cys Trp
565 570 575
Ile Tyr Lys Trp Glu Asp Arg Pro Asp Phe Leu Thr Val Glu Gln Arg
580 585 590
Met Arg Ala Cys Tyr Tyr Ser Leu Ala Ser Lys Val Glu Gly Pro Pro
595 600 605
Gly Ser Thr Gln Lys Ala Glu Ala Ala Cys Ala Trp Asp Pro Pro Val
610 615 620
Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro
625 630 635 640
Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val
645 650 655
Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys
660 665 670
Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val
675 680 685
Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His
CA 02450698 2003-12-23
195
690 695 700
Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val
705 710 715 720
Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg
725 730 735
Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu
740 745 750
Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu
755 760 765
Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln
770 775 780
Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp
785 790 795 800
Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly
805 810 815
Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser
820 825 830
Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu
835 840 845
Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr
850 855 860
Lys
865
(2) INFORMATION FOR SEQ ID N0:112:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1635 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1632
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:112:
ATG GAG AAC TTC CAA AAG GTG GAA AAG ATC GGA GAG GGC ACG TAC GGA 48
Met Glu Asn Phe Gln Lys Val Glu Lys Ile Gly Glu Gly Thr Tyr Gly
1 5 10 15
GTT GTG TAC AAA GCC AGA AAC AAG TTG ACG GGA GAG GTG GTG GCG CTT 96
Val Val Tyr Lys Ala Arg Asn Lys Leu Thr Gly Glu Val Val Ala Leu
20 25 30
AAG AAA ATC CGC CTG GAC ACT GAG ACT GAG GGT GTG CCC AGT ACT GCC 144
Lys Lys Ile Arg Leu Asp Thr Glu Thr Glu Gly Val Pro Ser Thr Ala
35 40 45
ATC CGA GAG ATC TCT CTG CTT AAG GAG CTT AAC CAT CCT AAT ATT GTC 192
Ile Arg Glu Ile Ser Leu Leu Lys Glu Leu Asn His Pro Asn Ile Val
50 55 60
AAG CTG CTG GAT GTC ATT CAC ACA GAA AAT AAA CTC TAC CTG GTT TTT 240
Lys Leu Leu Asp Val Ile His Thr Glu Asn Lys Leu Tyr Leu Val Phe
65 70 75 80
CA 02450698 2003-12-23
196
GAA TTT CTG CAC CAA GAT CTC AAG AAA TTC ATG GAT GCC TCT GCT CTC 288
Glu Phe Leu His Gln Asp Leu Lys Lys Phe Met Asp Ala Ser Ala Leu
85 90 95
ACT GGC ATT CCT CTT CCC CTC ATC AAG AGC TAT CTG TTC CAG CTG CTC 336
Thr Gly Ile Pro Leu Pro Leu Ile Lys Ser Tyr Leu Phe Gln Leu Leu
100 105 110
CAG GGC CTA GCT TTC TGC CAT TCT CAT CGG GTC CTC CAC CGA GAC CTT 384
Gln Gly Leu Ala Phe Cys His Ser His Arg Val Leu His Arg Asp Leu
115 120 125
AAA CCT CAG AAT CTG CTT ATT AAC ACA GAG GGG GCC ATC AAG CTA GCA 432
Lys Pro Gln Asn Leu Leu Ile Asn Thr Glu Gly Ala Ile Lys Leu Ala
130 135 140
GAC TTT GGA CTA GCC AGA GCT TTT GGA GTC CCT GTT CGT ACT TAC ACC 480
Asp Phe Gly Leu Ala Arg Ala Phe Gly Val Pro Val Arg Thr Tyr Thr
145 150 155 160
CAT GAG GTG GTG ACC CTG TGG TAC CGA GCT CCT GAA ATC CTC CTG GGC 528
His Glu Val Val Thr Leu Trp Tyr Arg Ala Pro Glu Ile Leu Leu Gly
165 170 175
TCG AAA TAT TAT TCC ACA GCT GTG GAC ATC TGG AGC CTG GGC TGC ATC 576
Ser Lys Tyr Tyr Ser Thr Ala Val Asp Ile Trp Ser Leu Gly Cys Ile
180 185 190
TTT GCT GAG ATG GTG ACT CGC CGG GCC CTG TTC CCT GGA GAT TCT GAG 624
Phe Ala Glu Met Val Thr Arg Arg Ala Leu Phe Pro Gly Asp Ser Glu
195 200 205
ATT GAC CAG CTC TTC CGG ATC TTT CGG ACT CTG GGG ACC CCA GAT GAG 672
Ile Asp Gln Leu Phe Arg Ile Phe Arg Thr Leu Gly Thr Pro Asp Glu
210 215 220
GTG GTG TGG CCA GGA GTT ACT TCT ATG CCT GAT TAC AAG CCA AGT TTC 720
Val Val Trp Pro Gly Val Thr Ser Met Pro Asp Tyr Lys Pro Ser Phe
225 230 235 240
CCC AAG TGG GCC CGG CAA GAT TTT AGT AAA GTT GTA CCT CCC CTG GAT 768
Pro Lys Trp Ala Arg Gln Asp Phe Ser Lys Val Val Pro Pro Leu Asp
245 250 255
GAA GAT GGA CGG AGC TTG TTA TCG CAA ATG CTG CAC TAC GAC CCT AAC 816
Glu Asp Gly Arg Ser Leu Leu Ser Gln Met Leu His Tyr Asp Pro Asn
260 265 270
AAG CGG ATT TCG GCC AAG GCA GCC CTG GCT CAC CCT TTC TTC CAG GAT 864
Lys Arg Ile Ser Ala Lys Ala Ala Leu Ala His Pro Phe Phe Gln Asp
275 280 285
GTG ACC AAG CCA GTA CCC CAT CTT CGA CTC TGG GAT CCA CCG GTC GCC 912
Val Thr Lys Pro Val Pro His Leu Arg Leu Trp Asp Pro Pro Val Ala
290 295 300
ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC 960
Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile
305 310 315 320
CA 02450698 2003-12-23
197
CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC 1008
Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser
325 330 335
GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC 1056
Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe
340 345 350
ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC 1104
Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr
355 360 365
ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG 1152
Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met
370 375 380
AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG 1200
Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln
385 390 395 400
GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC 1248
Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala
405 410 415
GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG 1296
Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys
420 425 430
GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG 1344
Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu
435 440 445
TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG 1392
Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys
450 455 460
AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC 1440
Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly
465 470 475 480
AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC 1488
Ser Val Gln Leu Ala Asp His Tyr Gln Gln Ann Thr Pro Ile Gly Asp
485 490 495
GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC 1536
Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala
500 505 510
CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG 1584
Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu
515 520 525
TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG T 1633
Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
530 535 540
AA 1635
(2) INFORMATION FOR SEQ ID N0:113:
CA 02450698 2003-12-23
198
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 544 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:113:
Met Glu Asn Phe Gln Lys Val Glu Lys Ile Gly Glu Gly Thr Tyr Gly
1 5 10 15
Val Val Tyr Lys Ala Arg Asn Lys Leu Thr Gly Glu Val Val Ala Leu
20 25 30
Lys Lys Ile Arg Leu Asp Thr Glu Thr Glu Gly Val Pro Ser Thr Ala
35 40 45
Ile Arg Glu Ile Ser Leu Leu Lys Glu Leu Asn His Pro Asn Ile Val
50 55 60
Lys Leu Leu Asp Val Ile His Thr Glu Asn Lys Leu Tyr Leu Val Phe
65 70 75 80
Glu Phe Leu His Gln Asp Leu Lys Lys Phe Met Asp Ala Ser Ala Leu
85 90 95
Thr Gly Ile Pro Leu Pro Leu Ile Lys Ser Tyr Leu Phe Gln Leu Leu
100 105 110
Gln Gly Leu Ala Phe Cys His Ser His Arg Val Leu His Arg Asp Leu
115 120 125
Lys Pro Gln Asn Leu Leu Ile Asn Thr Glu Gly Ala Ile Lys Leu Ala
130 135 140
Asp Phe Gly Leu Ala Arg Ala Phe Gly Val Pro Val Arg Thr Tyr Thr
145 150 155 160
His Glu Val Val Thr Leu Trp Tyr Arg Ala Pro Glu Ile Leu Leu Gly
165 170 175
Ser Lys Tyr Tyr Ser Thr Ala Val Asp Ile Trp Ser Leu Gly Cys Ile
180 185 190
Phe Ala Glu Met Val Thr Arg Arg Ala Leu Phe Pro Gly Asp Ser Glu
195 200 205
Ile Asp Gln Leu Phe Arg Ile Phe Arg Thr Leu Gly Thr Pro Asp Glu
210 215 220
Val Val Trp Pro Gly Val Thr Ser Met Pro Asp Tyr Lys Pro Ser Phe
225 230 235 240
Pro Lys Trp Ala Arg Gln Asp Phe Ser Lys Val Val Pro Pro Leu Asp
245 250 255
Glu Asp Gly Arg Ser Leu Leu Ser Gln Met Leu His Tyr Asp Pro Asn
260 265 270
Lys Arg Ile Ser Ala Lys Ala Ala Leu Ala His Pro Phe Phe Gln Asp
275 280 285
Val Thr Lys Pro Val Pro His Leu Arg Leu Trp Asp Pro Pro Val Ala
290 295 300
Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile
305 310 315 320
Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser
325 330 335
G1y Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe
340 345 350
Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr
355 360 365
Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met
370 375 380
CA 02450698 2003-12-23
199
Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln
385 390 395 400
Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala
405 410 415
Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys
420 425 430
Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu
435 440 445
Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys
450 455 460
Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly
465 470 475 480
Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp
485 490 495
Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala
500 505 510
Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu
515 520 525
Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
530 535 540
(2) INFORMATION FOR SEQ ID N0:114:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1635 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAMEjKEY: Coding Sequence
(H) LOCATION: 1...1632
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:114:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
CA 02450698 2003-12-23
200
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Fhe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Va1 Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCC ATG GAG AAC TTC CAA AAG GTG GAA AAG ATC 768
Gly Leu Arg Ser Arg Ala Met Glu Asn Phe Gln Lys Val Glu Lys Ile
245 250 255
GGA GAG GGC ACG TAC GGA GTT GTG TAC AAA GCC AGA AAC AAG TTG ACG 816
Gly Glu Gly Thr Tyr Gly Val Val Tyr Lys Ala Arg Asn Lys Leu Thr
260 265 270
GGA GAG GTG GTG GCG CTT AAG AAA ATC CGC CTG GAC ACT GAG ACT GAG 864
Gly Glu Val Val Ala Leu Lys Lys Ile Arg Leu Asp Thr Glu Thr Glu
275 280 285
GGT GTG CCC AGT ACT GCC ATC CGA GAG ATC TCT CTG CTT AAG GAG CTT 912
Gly Val Pro Ser Thr Ala Ile Arg Glu Ile Ser Leu Leu Lys Glu Leu
290 295 300
AAC CAT CCT AAT ATT GTC AAG CTG CTG GAT GTC ATT CAC ACA GAA AAT 960
Asn His Pro Asn Ile Val Lys Leu Leu Asp Val Ile His Thr Glu Asn
305 310 315 320
AAA CTC TAC CTG GTT TTT GAA TTT CTG CAC CAA GAT CTC AAG AAA TTC 1008
Lys Leu Tyr Leu Val Phe Glu Phe Leu His Gln Asp Leu Lys Lys Phe
CA 02450698 2003-12-23
201
325 330 335
ATG GAT GCC TCT GCT CTC ACT GGC ATT CCT CTT CCC CTC ATC AAG AGC 1056
Met Asp Ala Ser Ala Leu Thr Gly Ile Pro Leu Pro Leu Ile Lys Ser
340 345 350
TAT CTG TTC CAG CTG CTC CAG GGC CTA GCT TTC TGC CAT TCT CAT CGG 1104
Tyr Leu Phe Gln Leu Leu Gln G1y Leu Ala Phe Cys His Ser His Arg
355 360 365
GTC CTC CAC CGA GAC CTT AAA CCT CAG AAT CTG CTT ATT AAC ACA GAG 1152
Val Leu His Arg Asp Leu Lys Pro Gln Asn Leu Leu Ile Asn Thr Glu
370 375 380
GGG GCC ATC AAG CTA GCA GAC TTT GGA CTA GCC AGA GCT TTT GGA GTC 1200
Gly Ala Ile Lys Leu Ala Asp Phe Gly Leu Ala Arg Ala Phe Gly Val
385 390 395 400
CCT GTT CGT ACT TAC ACC CAT GAG GTG GTG ACC CTG TGG TAC CGA GCT 1248
Pro Val Arg Thr Tyr Thr His Glu Val Val Thr Leu Trp Tyr Arg Ala
405 410 415
CCT GAA ATC CTC CTG GGC TCG AAA TAT TAT TCC ACA GCT GTG GAC ATC 1296
Pro Glu Ile Leu Leu Gly Ser Lys Tyr Tyr Ser Thr Ala Val Asp Ile
420 425 430
TGG AGC CTG GGC TGC ATC TTT GCT GAG ATG GTG ACT CGC CGG GCC CTG 1344
Trp Ser Leu Gly Cys Ile Phe Ala Glu Met Val Thr Arg Arg Ala Leu
435 440 445
TTC CCT GGA GAT TCT GAG ATT GAC CAG CTC TTC CGG ATC TTT CGG ACT 1392
Phe Pro Gly Asp Ser Glu Ile Asp Gln Leu Phe Arg Ile Phe Arg Thr
450 455 460
CTG GGG ACC CCA GAT GAG GTG GTG TGG CCA GGA GTT ACT TCT ATG CCT 1440
Leu Gly Thr Pro Asp Glu Val Val Trp Pro Gly Val Thr Ser Met Pro
465 470 475 480
GAT TAC AAG CCA AGT TTC CCC AAG TGG GCC CGG CAA GAT TTT AGT AAA 1488
Asp Tyr Lys Pro Ser Phe Pro Lys Trp Ala Arg Gln Asp Phe Ser Lys
485 490 495
GTT GTA CCT CCC CTG GAT GAA GAT GGA CGG AGC TTG TTA TCG CAA ATG 1536
Val Val Pro Pro Leu Asp Glu Asp Gly Arg Ser Leu Leu Ser Gln Met
500 505 510
CTG CAC TAC GAC CCT AAC AAG CGG ATT TCG GCC AAG GCA GCC CTG GCT 1584
Leu His Tyr Asp Pro Asn Lys Arg Ile Ser Ala Lys Ala Ala Leu Ala
515 520 525
CAC CCT TTC TTC CAG GAT GTG ACC AAG CCA GTA CCC CAT CTT CGA CTC T 1633
His Pro Phe Phe Gln Asp Val Thr Lys Pro Val Pro His Leu Arg Leu
530 535 540
GA 1635
(2) INFORMATION FOR SEQ ID N0:115:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 544 amino acids
CA 02450698 2003-12-23
202
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:115:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Met Glu Asn Phe Gln Lys Val Glu Lys Ile
245 250 255
Gly Glu Gly Thr Tyr Gly Val Val Tyr Lys Ala Arg Asn Lys Leu Thr
260 265 270
Gly Glu Val Val Ala Leu Lys Lys Ile Arg Leu Asp Thr Glu Thr Glu
275 280 285
Gly Val Pro Ser Thr Ala Ile Arg Glu Ile Ser Leu Leu Lys Glu Leu
290 295 300
Asn His Pro Asn Ile Val Lys Leu Leu Asp Val Ile His Thr Glu Asn
305 310 315 320
Lys Leu Tyr Leu Val Phe Glu Phe Leu His Gln Asp Leu Lys Lys Phe
325 330 335
Met Asp Ala Ser Ala Leu Thr Gly Ile Pro Leu Pro Leu Ile Lys Ser
340 345 350
Tyr Leu Phe Gln Leu Leu Gln Gly Leu Ala Phe Cys His Ser His Arg
355 360 365
Val Leu His Arg Asp Leu Lys Pro Gln Asn Leu Leu Ile Asn Thr Glu
370 375 380
Gly A1a Ile Lys Leu Ala Asp Phe Gly Leu Ala Arg Ala Phe Gly Val
385 390 395 400
Pro Val Arg Thr Tyr Thr His Glu Val Val Thr Leu Trp Tyr Arg Ala
CA 02450698 2003-12-23
203
405 410 415
Pro Glu Ile Leu Leu Gly Ser Lys Tyr Tyr Ser Thr Ala Val Asp Ile
420 425 430
Trp Ser Leu Gly Cys Ile Phe Ala Glu Met Val Thr Arg Arg Ala Leu
435 440 445
Phe Pro Gly Asp Ser Glu Ile Asp Gln Leu Phe Arg Ile Phe Arg Thr
450 455 460
Leu Gly Thr Pro Asp Glu Val Val Trp Pro Gly Val Thr Ser Met Pro
465 470 475 480
Asp Tyr Lys Pro Ser Phe Pro Lys Trp Ala Arg Gln Asp Phe Ser Lys
485 490 495
Val Val Pro Pro Leu Asp Glu Asp Gly Arg Ser Leu Leu Ser Gln Met
500 505 510
Leu His Tyr Asp Pro Asn Lys Arg Ile Ser Ala Lys Ala Ala Leu Ala
515 520 525
His Pro Phe Phe Gln Asp Val Thr Lys Pro Val Pro His Leu Arg Leu
530 535 540
(2) INFORMATION FOR SEQ ID N0:116:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2532 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2529
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:116:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly G1u Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
CA 02450698 2003-12-23
204
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Va1 Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu G1y Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GAG ATG CTG TCC CGT GGG TGG TTT CAC CGA GAC 768
Gly Leu Arg Ser Arg Glu Met Leu Ser Arg Gly Trp Phe His Arg Asp
245 250 255
CTC AGT GGG CTG GAT GCA GAG ACC CTG CTC AAG GGC CGA GGT GTC CAC 816
Leu Ser Gly Leu Asp Ala Glu Thr Leu Leu Lys Gly Arg Gly Val His
260 265 270
GGT AGC TTC CTG GCT CGG CCC AGT CGC AAG AAC CAG GGT GAC TTC TCG 864
Gly Ser Phe Leu Ala Arg Pro Ser Arg Lys Asn Gln Gly Asp Phe Ser
275 280 285
CTC TCC GTC AGG GTG GGG GAT CAG GTG ACC CAT ATT CGG ATC CAG AAC 912
Leu Ser Val Arg Val Gly Asp Gln Val Thr His Ile Arg Ile Gln Asn
290 295 300
TCA GGG GAT TTC TAT GAC CTG TAT GGA GGG GAG AAG TTT GCG ACT CTG 960
Ser Gly Asp Phe Tyr Asp Leu Tyr Gly Gly Glu Lys Phe Ala Thr Leu
305 310 315 320
ACA GAG CTG GTG GAG TAC TAC ACT CAG CAG CAG GGT GTC CTG CAG GAC 1008
Thr Glu Leu Val Glu Tyr Tyr Thr Gln Gln Gln Gly Val Leu Gln Asp
325 330 335
CGC GAC GGC ACC ATC ATC CAC CTC AAG TAC CCG CTG AAC TGC TCC GAT 1056
CA 02450698 2003-12-23
205
Arg Asp Gly Thr Ile Ile His Leu Lys Tyr Pro Leu Asn Cys Ser Asp
340 345 350
CCC ACT AGT GAG AGG TGG TAC CAT GGC CAC ATG TCT GGC GGG CAG GCA 1104
Pro Thr Ser Glu Arg Trp Tyr His Gly His Met Ser Gly Gly Gln Ala
355 360 365
GAG ACG CTG CTG CAG GCC AAG GGC GAG CCC TGG ACG TTT CTT GTG CGT 1152
Glu Thr Leu Leu Gln Ala Lys Gly Glu Pro Trp Thr Phe Leu Val Arg
370 375 380
GAG AGC CTC AGC CAG CCT GGA GAC TTC GTG CTT TCT GTG CTC AGT GAC 1200
Glu Sex Leu Ser Gln Pro Gly Asp Phe Val Leu Ser Val Leu Ser Asp
385 390 395 400
CAG CCC AAG GCT GGC CCA GGC TCC CCG CTC AGG GTC ACC CAC ATC AAG 1248
Gln Pro Lys Ala Gly Pro Gly Ser Pro Leu Arg Val Thr His Ile Lys
405 410 415
GTC ATG TGC GAG GGT GGA CGC TAC ACA GTG GGT GGT TTG GAG ACC TTC 1296
Val Met Cys Glu Gly Gly Arg Tyr Thr Val Gly Gly Leu Glu Thr Phe
420 425 430
GAC AGC CTC ACG GAC CTG GTA GAG CAT TTC AAG AAG ACG GGG ATT GAG 1344
Asp Ser Leu Thr Asp Leu Val Glu His Phe Lys Lys Thr Gly Ile Glu
435 440 445
GAG GCC TCA GGC GCC TTT GTC TAC CTG CGG CAG CCG TAC TAT GCC ACG 1392
Glu Ala Ser Gly Ala Phe Val Tyr Leu Arg Gln Pro Tyr Tyr Ala Thr
450 455 460
AGG GTG AAT GCG GCT GAC ATT GAG AAC CGA GTG TTG GAA CTG AAC AAG 1440
Arg Val Asn Ala Ala Asp Ile Glu Asn Arg Val Leu Glu Leu Asn Lys
465 470 475 480
AAG CAGGAGTCC GAGGATACA GCCAAGGCTGGC TTCTGG GAGGAGTTT 1488
Lys GlnGluSer GluAspThr AlaLysAlaGly PheTrp GluGluPhe
485 490 495
GAG AGTTTGCAG AAGCAGGAG GTGAAGAACTTG CACCAG CGTCTGGAA 1536
Glu SerLeuGln LysGlnGlu ValLysAsnLeu HisGln ArgLeuGlu
500 505 510
GGG CAGCGGCCA GAGAACAAG GGCAAGAACCGC TACAAG AACATTCTC 1584
Gly GlnArgPro GluAsnLys GlyLysAsnArg TyrLys AsnIleLeu
515 520 525
CCC TTTGACCAC AGCCGAGTG ATCCTGCAGGGA CGGGAC AGTAACATC 1632
Pro PheAspHis SerArgVal IleLeuGlnGly ArgAsp SerAsnIle
530 535 540
CCC GGGTCCGAC TACATCAAT GCCAACTACATC AAGAAC CAGCTGCTA 1680
Pro GlySerAsp TyrIleAsn AlaAsnTyrIle LysAsn GlnLeuLeu
545 550 555 560
GGC CCTGATGAG AACGCTAAG ACCTACATCGCC AGCCAG GGCTGTCTG 1728
Gly ProAspGlu AsnAlaLys ThrTyrIleAla SerGln GlyCysLeu
565 570 575
GAG GCCACGGTC AATGACTTC TGGCAGATGGCG TGGCAG GAGAACAGC 1776
CA 02450698 2003-12-23
206
Glu Ala Thr Val Asn Asp Phe Trp Gln Met Ala Trp Gln Glu Asn Ser
580 585 590
CGT GTC ATC GTC ATG ACC ACC CGA GAG GTG GAG AAA GGC CGG AAC AAA 1824
Arg Val Ile Val Met Thr Thr Arg Glu Val Glu Lys Gly Arg Asn Lys
595 600 605
TGC GTC CCA TAC TGG CCC GAG GTG GGC ATG CAG CGT GCT TAT GGG CCC 1872
Cys Val Pro Tyr Trp Pro Glu Val Gly Met Gln Arg Ala Tyr Gly Pro
610 615 620
TAC TCT GTG ACC AAC TGC GGG GAG CAT GAC ACA ACC GAA TAC AAA CTC 1920
Tyr Ser Val Thr Asn Cys Gly Glu His Asp Thr Thr Glu Tyr Lys Leu
625 630 635 640
CGT ACC TTA CAG GTC TCC CCG CTG GAC AAT GGA GAC CTG ATT CGG GAG 1968
Arg Thr Leu Gln Val Ser Pro Leu Asp Asn Gly Asp Leu Ile Arg Glu
645 650 655
ATC TGG CAT TAC CAG TAC CTG AGC TGG CCC GAC CAT GGG GTC CCC AGT 2016
Ile Trp His Tyr Gln Tyr Leu Ser Trp Pro Asp His Gly Val Pro Ser
660 665 670
GAG CCT GGG GGT GTC CTC AGC TTC CTG GAC CAG ATC AAC CAG CGG CAG 2064
Glu Pro Gly Gly Val Leu Ser Phe Leu Asp Gln Ile Asn Gln Arg Gln
675 680 685
GAA AGT CTG CCT CAC GCA GGG CCC ATC ATC GTG CAC TGC AGC GCC GGC 2112
Glu Ser Leu Pro His Ala Gly Pro Ile I1e Val His Cys Ser Ala Gly
690 695 700
ATC GGC CGC ACA GGC ACC ATC ATT GTC ATC GAC ATG CTC ATG GAG AAC 2160
Ile Gly Arg Thr Gly Thr Ile Ile Val Ile Asp Met Leu Met Glu Asn
705 710 715 720
ATC TCC ACC AAG GGC CTG GAC TGT GAC ATT GAC ATC CAG AAG ACC ATC 2208
Ile Ser Thr Lys Gly Leu Asp Cys Asp Ile Asp Ile Gln Lys Thr Ile
725 730 735
CAG ATG GTG CGG GCG CAG CGC TCG GGC ATG GTG CAG ACG GAG GCG CAG 2256
Gln Met Val Arg Ala Gln Arg Ser Gly Met Val Gln Thr Glu Ala Gln
740 745 750
TAC AAG TTC ATC TAC GTG GCC ATC GCC CAG TTC ATT GAA ACC ACT AAG 2304
Tyr Lys Phe Ile Tyr Val Ala Ile Ala Gln Phe Ile Glu Thr Thr Lys
755 760 765
AAG AAG CTG GAG GTC CTG CAG TCG CAG AAG GGC CAG GAG TCG GAG TAC 2352
Lys Lys Leu Glu Val Leu Gln Ser Gln Lys Gly Gln Glu Ser Glu Tyr
770 775 780
GGG AAC ATC ACC TAT CCC CCA GCC ATG AAG AAT GCC CAT GCC AAG GCC 2400
Gly Asn Ile Thr Tyr Pro Pro Ala Met Lys Asn Ala His Ala Lys Ala
785 790 795 800
TCC CGC ACC TCG TCC AAA CAC AAG GAG GAT GTG TAT GAG AAC CTG CAC 2448
Ser Arg Thr Ser Ser Lys His Lys Glu Asp Val Tyr Glu Asn Leu His
805 810 815
ACT AAG AAC AAG AGG GAG GAG AAA GTG AAG AAG CAG CGG TCA GCA GAC 2496
CA 02450698 2003-12-23
207
Thr Lys Asn Lys Arg Glu Glu Lys Val Lys Lys Gln Arg Ser Ala Asp
820 825 830
AAG GAG AAG AGC AAG GGT TCC CTC AAG AGG AAG TGA 2532
Lys Glu Lys Ser Lys Gly Ser Leu Lys Arg Lys
835 840
(2) INFORMATION FOR SEQ ID N0:117:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 843 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:117:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Tle Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Glu Met Leu Ser Arg Gly Trp Phe His Arg Asp
245 250 255
Leu Ser Gly Leu Asp Ala Glu Thr Leu Leu Lys Gly Arg Gly Val His
260 265 270
Gly Ser Phe Leu Ala Arg Pro Ser Arg Lys Asn Gln Gly Asp Phe Ser
275 280 285
Leu Ser Val Arg Val Gly Asp Gln Val Thr His Ile Arg Ile Gln Asn
290 295 300
Ser Gly Asp Phe Tyr Asp Leu Tyr Gly Gly Glu Lys Phe Ala Thr Leu
CA 02450698 2003-12-23
208
305 310 315 320
Thr Glu Leu Val Glu Tyr Tyr Thr Gln Gln Gln Gly Val Leu Gln Asp
325 330 335
Arg Asp Gly Thr Ile Ile His Leu Lys Tyr Pro Leu Asn Cys Ser Asp
340 345 350
Pro Thr Ser Glu Arg Trp Tyr His Gly His Met Ser Gly Gly Gln Ala
355 360 365
Glu Thr Leu Leu Gln Ala Lys Gly Glu Pro Trp Thr Phe Leu Val Arg
370 375 380
Glu Ser Leu Ser Gln Pro Gly Asp Phe Val Leu Ser Val Leu Sex Asp
385 390 395 400
Gln Pro Lys Ala Gly Pro Gly Ser Pro Leu Arg Val Thr His Ile Lys
405 410 415
Val Met Cys Glu Gly Gly Arg Tyr Thr Val Gly Gly Leu Glu Thr Phe
420 425 430
Asp Ser Leu Thr Asp Leu Val Glu His Phe Lys Lys Thr Gly Ile Glu
435 440 445
Glu Ala Ser Gly Ala Phe Val Tyr Leu Arg Gln Pro Tyr Tyr Ala Thr
450 455 460
Arg Val Asn Ala Ala Asp Ile Glu Asn Arg Val Leu Glu Leu Asn Lys
465 470 475 480
Lys Gln Glu Ser Glu Asp Thr Ala Lys Ala G1y Phe Trp Glu Glu Phe
485 490 495
Glu Ser Leu Gln Lys Gln Glu Val Lys Asn Leu His Gln Arg Leu Glu
500 505 510
Gly Gln Arg Pro Glu Asn Lys Gly Lys Asn Arg Tyr Lys Asn Ile Leu
515 520 525
Pro Phe Asp His Ser Arg Val Ile Leu Gln Gly Arg Asp Ser Asn Ile
530 535 540
Pro Gly Ser Asp Tyr Ile Asn Ala Asn Tyr Ile Lys Asn Gln Leu Leu
545 550 555 560
Gly Pro Asp Glu Asn Ala Lys Thr Tyr I1e Ala Ser Gln Gly Cys Leu
565 570 575
Glu Ala Thr Va1 Asn Asp Phe Trp Gln Met Ala Trp Gln Glu Asn Ser
580 585 590
Arg Val Ile Val Met Thr Thr Arg Glu Val Glu Lys Gly Arg Asn Lys
595 600 605
Cys Val Pro Tyr Trp Pro Glu Val Gly Met Gln Arg Ala Tyr Gly Pro
610 615 620
Tyr Ser Val Thr Asn Cys Gly Glu His Asp Thr Thr Glu Tyr Lys Leu
625 630 635 640
Arg Thr Leu Gln Val Ser Pro Leu Asp Asn Gly Asp Leu Ile Arg Glu
645 650 655
Ile Trp His Tyr Gln Tyr Leu Ser Trp Pro Asp His Gly Val Pro Ser
660 665 670
Glu Pro Gly Gly Val Leu Ser Phe Leu Asp Gln Ile Asn Gln Arg Gln
675 680 685
Glu Ser Leu Pro His Ala Gly Pro Ile Ile Val His Cys Ser Ala Gly
690 695 700
Ile Gly Arg Thr Gly Thr Ile Ile Val Ile Asp Met Leu Met Glu Asn
705 710 715 720
Ile Ser Thr Lys Gly Leu Asp Cys Asp Ile Asp Ile Gln Lys Thr Ile
725 730 735
Gln Met Val Arg Ala Gln Arg Ser Gly Met Val Gln Thr Glu Ala Gln
740 745 750
Tyr Lys Phe Ile Tyr Val Ala Ile Ala Gln Phe Ile Glu Thr Thr Lys
755 760 765
Lys Lys Leu Glu Val Leu Gln Ser Gln Lys Gly Gln Glu Ser Glu Tyr
770 775 780
Gly Asn Ile Thr Tyr Pro Pro Ala Met Lys Asn Ala His Ala Lys Ala
CA 02450698 2003-12-23
209
785 790 795 800
Ser Arg Thr Ser Ser Lys His Lys Glu Asp Val Tyr Glu Asn Leu His
805 810 815
Thr Lys Asn Lys Arg Glu Glu Lys Val Lys Lys Gln Arg Ser Ala Asp
820 825 830
Lys Glu Lys Ser Lys Gly Ser Leu Lys Arg Lys
835 840
(2) INFORMATION FOR SEQ ID N0:118:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2562 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2559
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:118:
ATG CTG TCC CGT GGG TGG TTT CAC CGA GAC CTC AGT GGG CTG GAT GCA 48
Met Leu Ser Arg Gly Trp Phe His Arg Asp Leu Ser Gly Leu Asp Ala
1 5 10 15
GAG ACC CTG CTC AAG GGC CGA GGT GTC CAC GGT AGC TTC CTG GCT CGG 96
Glu Thr Leu Leu Lys Gly Arg Gly Val His Gly Ser Phe Leu Ala Arg
20 25 30
CCC AGT CGC AAG AAC CAG GGT GAC TTC TCG CTC TCC GTC AGG GTG GGG 144
Pro Ser Arg Lys Asn Gln Gly Asp Phe Ser Leu Ser Val Arg Val Gly
35 40 45
GAT CAG GTG ACC CAT ATT CGG ATC CAG AAC TCA GGG GAT TTC TAT GAC 192
Asp Gln Val Thr His Ile Arg Ile Gln Asn Ser Gly Asp Phe Tyr Asp
50 55 60
CTG TAT GGA GGG GAG AAG TTT GCG ACT CTG ACA GAG CTG GTG GAG TAC 240
Leu Tyr Gly Gly Glu Lys Phe A1a Thr Leu Thr Glu Leu Val Glu Tyr
65 70 75 80
TAC ACT CAG CAG CAG GGT GTC CTG CAG GAC CGC GAC GGC ACC ATC ATC 288
Tyr Thr Gln Gln Gln Gly Val Leu Gln Asp Arg Asp Gly Thr Ile Ile
85 90 95
CAC CTC AAG TAC CCG CTG AAC TGC TCC GAT CCC ACT AGT GAG AGG TGG 336
His Leu Lys Tyr Pro Leu Asn Cys Ser Asp Pro Thr Ser Glu Arg Trp
100 105 110
TAC CAT GGC CAC ATG TCT GGC GGG CAG GCA GAG ACG CTG CTG CAG GCC 384
Tyr His Gly His Met Ser Gly Gly Gln Ala Glu Thr Leu Leu Gln Ala
115 120 125
AAG GGC GAG CCC TGG ACG TTT CTT GTG CGT GAG AGC CTC AGC CAG CCT 432
Lys Gly Glu Pro Trp Thr Phe Leu Val Arg Glu Ser Leu Sex Gln Pro
130 135 140
CA 02450698 2003-12-23
210
GGA GAC TTC GTG CTT TCT GTG CTC AGT GAC CAG CCC AAG GCT GGC CCA 480
Gly Asp Phe Val Leu Ser Val Leu Ser Asp Gln Pro Lys Ala Gly Pro
145 150 155 160
GGC TCC CCG CTC AGG GTC ACC CAC ATC AAG GTC ATG TGC GAG GGT GGA 528
Gly Ser Pro Leu Arg Val Thr His Ile Lys Val Met Cys Glu Gly Gly
165 170 175
CGC TAC ACA GTG GGT GGT TTG GAG ACC TTC GAC AGC CTC ACG GAC CTG 576
Arg Tyr Thr Val Gly Gly Leu Glu Thr Phe Asp Ser Leu Thr Asp Leu
180 185 190
GTA GAG CAT TTC AAG AAG ACG GGG ATT GAG GAG GCC TCA GGC GCC TTT 624
Val Glu His Phe Lys Lys Thr Gly Ile Glu Glu Ala Ser Gly Ala Phe
195 200 205
GTC TAC CTG CGG CAG CCG TAC TAT GCC ACG AGG GTG AAT GCG GCT GAC 672
Val Tyr Leu Arg Gln Pro Tyr Tyr Ala Thr Arg Val Asn Ala Ala Asp
210 215 220
ATT GAG AAC CGA GTG TTG GAA CTG AAC AAG AAG CAG GAG TCC GAG GAT 720
Ile Glu Asn Arg Val Leu Glu Leu Asn Lys Lys Gln Glu Ser Glu Asp
225 230 235 240
ACA GCC AAG GCT GGC TTC TGG GAG GAG TTT GAG AGT TTG CAG AAG CAG 768
Thr Ala Lys Ala Gly Phe Trp Glu Glu Phe Glu Ser Leu Gln Lys Gln
245 250 255
GAG GTG AAG AAC TTG CAC CAG CGT CTG GAA GGG CAG CGG CCA GAG AAC 816
Glu Val Lys Asn Leu His Gln Arg Leu Glu Gly Gln Arg Pro Glu Asn
260 265 270
AAG GGC AAG AAC CGC TAC AAG AAC ATT CTC CCC TTT GAC CAC AGC CGA 864
Lys Gly Lys Asn Arg Tyr Lys Asn Ile Leu Pro Phe Asp His Ser Arg
275 280 285
GTG ATC CTG CAG GGA CGG GAC AGT AAC ATC CCC GGG TCC GAC TAC ATC 912
Val Ile Leu Gln G1y Arg Asp Ser Asn Ile Pro Gly Ser Asp Tyr Ile
290 295 300
AAT GCC AAC TAC ATC AAG AAC CAG CTG CTA GGC CCT GAT GAG AAC GCT 960
Asn ATa Asn Tyr Ile Lys Asn Gln Leu Leu Gly Pro Asp Glu Asn Ala
305 310 315 320
AAG ACC TAC ATC GCC AGC CAG GGC TGT CTG GAG GCC ACG GTC AAT GAC 1008
Lys Thr Tyr Ile Ala Ser Gln Gly Cys Leu Glu Ala Thr Val Asn Asp
325 330 335
TTC TGG CAG ATG GCG TGG CAG GAG AAC AGC CGT GTC ATC GTC ATG ACC 1056
Phe Trp Gln Met Ala Trp Gln Glu Asn Ser Arg Val Ile Val Met Thr
340 345 350
ACC CGA GAG GTG GAG AAA GGC CGG AAC AAA TGC GTC CCA TAC TGG CCC 1104
Thr Arg Glu Val Glu Lys Gly Arg Asn Lys Cys Val Pro Tyr Trp Pro
355 360 365
GAG GTG GGC ATG CAG CGT GCT TAT GGG CCC TAC TCT GTG ACC AAC TGC 1152
Glu Val Gly Met Gln Arg Ala Tyr Gly Pro Tyr Ser Val Thr Asn Cys
370 375 380
CA 02450698 2003-12-23
211
GGGGAG CATGACACA ACCGAA AAA CTCCGT ACCTTACAG GTCTCC 1200
TAC
GlyGlu HisAspThr ThrGluTyrLys LeuArg ThrLeuGln ValSer
385 390 395 400
CCGCTG GACAATGGA GACCTGATTCGG GAGATC TGGCATTAC CAGTAC 1248
ProLeu AspAsnGly AspLeuIleArg GluIle TrpHisTyr GlnTyr
405 410 415
CTGAGC TGGCCCGAC CATGGGGTCCCC AGTGAG CCTGGGGGT GTCCTC 1296
LeuSer TrpProAsp HisGlyValPro SerGlu ProGlyGly ValLeu
420 425 430
AGCTTC CTGGACCAG ATCAACCAGCGG CAGGAA AGTCTGCCT CACGCA 1344
SerPhe LeuAspGln IleAsnGlnArg GlnGlu SerLeuPro HisAla
435 440 445
GGGCCC ATCATCGTG CACTGCAGCGCC GGCATC GGCCGCACA GGCACC 1392
GlyPro IleIleVal HisCysSerAla GlyIle GlyArgThr GlyThr
450 455 460
ATCATT GTCATCGAC ATGCTCATGGAG AACATC TCCACCAAG GGCCTG 1440
IleIle ValIleAsp MetLeuMetGlu AsnIle SerThrLys GlyLeu
465 470 475 480
GACTGT GACATTGAC ATCCAGAAGACC ATCCAG ATGGTGCGG GCGCAG 1488
AspCys AspIleAsp IleGlnLysThr IleGln MetValArg AlaGln
485 490 495
CGCTCG GGCATGGTG CAGACGGAGGCG CAGTAC AAGTTCATC TACGTG 1536
ArgSer GlyMetVal GlnThrGluAla GlnTyr LysPheIle TyrVal
500 505 510
GCCATC GCCCAGTTC ATTGAAACCACT AAGAAG AAGCTGGAG GTCCTG 1584
AlaIle AlaGlnPhe IleGluThrThr LysLys LysLeuGlu ValLeu
515 520 525
CAGTCG CAGAAGGGC CAGGAGTCGGAG TACGGG AACATCACC TATCCC 1632
GlnSer GlnLysGly GlnGluSerGlu TyrGly AsnIleThr TyrPro
530 535 540
CCA ATG AAGAATGCC CATGCCAAG GCCTCCCGC ACCTCG TCCAAA 1680
GCC
ProAlaMet LysAsnAla HisAlaLys AlaSerArg ThrSer SerLys
545 550 555 560
CACAAGGAG GATGTGTAT GAGAACCTG CACACTAAG AACAAG AGGGAG 1728
HisLysGlu AspValTyr GluAsnLeu HisThrLys AsnLys ArgGlu
565 570 5?5
GAGAAAGTG AAGAAGCAG CGGTCAGCA GACAAGGAG AAGAGC AAGGGT 1776
GluLysVal LysLysGln ArgSerAla AspLysGlu LysSer LysGly
580 585 590
TCCCTCAAG AGGAAGCGA ATTCTGCAG TCGACGGTA CCGCGG GCCCGG 1824
SerLeuLys ArgLysArg IleLeuGln SerThrVal ProArg AlaArg
595 600 605
GATCCACCG GTCGCCACC ATGGTGAGC AAGGGCGAG GAGCTG TTCACC 1872
AspProPro ValAlaThr MetValSer LysGlyGlu GluLeu PheThr
610 615 620
CA 02450698 2003-12-23
212
GGG GTG GTG CCC ATC CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC 1920
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
625 630 635 640
AAG TTC AGC GTG TCC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG 1968
Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys
645 650 655
CTG ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG 2016
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
660 665 670
CCC ACC CTC GTG ACC ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC 2064
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg
675 680 685
TAC CCC GAC CAC ATG AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC 2112
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
690 695 700
GAA GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC 2160
Glu G1y Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
705 710 715 720
TAC AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC 2208
Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn
725 730 735
CGC ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG 2256
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
740 745 750
GGG CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG 2304
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Va1 Tyr Ile Met
755 760 765
GCC GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC 2352
Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His
770 775 780
AAC ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC 2400
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
785 790 795 800
ACC CCC ATC GGC GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG 2448
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
805 810 815
AGC ACC CAG TCC GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC 2496
Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
820 825 830
ATG GTC CTG CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG 2544
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met
835 840 845
GAC GAG CTG TAC AAG TAA 2562
Asp Glu Leu Tyr Lys
850
CA 02450698 2003-12-23
213
(2) INFORMATION FOR SEQ ID N0:119:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 853 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:119:
Met Leu Ser Arg Gly Trp Phe His Arg Asp Leu Ser Gly Leu Asp Ala
1 5 10 15
Glu Thr Leu Leu Lys Gly Arg Gly Va1 His Gly Ser Phe Leu Ala Arg
20 25 30
Pro Ser Arg Lys Asn Gln Gly Asp Phe Ser Leu Ser Val Arg Val Gly
35 40 45
Asp Gln Val Thr His Ile Arg Ile Gln Asn Ser Gly Asp Phe Tyr Asp
50 55 60
Leu Tyr Gly Gly Glu Lys Phe Ala Thr Leu Thr Glu Leu Val Glu Tyr
65 70 75 80
Tyr Thr Gln Gln Gln Gly Val Leu Gln Asp Arg Asp Gly Thr Ile Ile
85 90 95
His Leu Lys Tyr Pro Leu Asn Cys Ser Asp Pro Thr Ser Glu Arg Trp
100 105 110
Tyr His Gly His Met Ser Gly Gly Gln Ala Glu Thr Leu Leu Gln Ala
115 120 125
Lys Gly Glu Pro Trp Thr Phe Leu Val Arg Glu Ser Leu Ser Gln Pro
130 135 140
Gly Asp Phe Val Leu Ser Val Leu Ser Asp Gln Pro Lys Ala Gly Pro
145 150 155 160
G1y Ser Pro Leu Arg Val Thr His Ile Lys Val Met Cys Glu Gly Gly
165 170 175
Arg Tyr Thr Val Gly Gly Leu Glu Thr Phe Asp Ser Leu Thr Asp Leu
180 185 190
Val Glu His Phe Lys Lys Thr Gly Ile Glu Glu Ala Ser Gly Ala Phe
195 200 205
Val Tyr Leu Arg Gln Pro Tyr Tyr Ala Thr Arg Val Asn Ala Ala Asp
210 215 220
Ile Glu Asn Arg Val Leu Glu Leu Asn Lys Lys Gln Glu Ser Glu Asp
225 230 235 240
Thr Ala Lys Ala Gly Phe Trp Glu Glu Phe Glu Ser Leu Gln Lys Gln
245 250 255
Glu Val Lys Asn Leu His Gln Arg Leu Glu Gly Gln Arg Pro Glu Asn
260 265 270
Lys Gly Lys Asn Arg Tyr Lys Asn Ile Leu Pro Phe Asp His Ser Arg
275 280 285
Val Ile Leu Gln Gly Arg Asp Ser Asn Ile Pro Gly Ser Asp Tyr Ile
290 295 300
Asn Ala Asn Tyr Ile Lys Asn Gln Leu Leu Gly Pro Asp Glu Asn Ala
305 310 315 320
Lys Thr Tyr Ile Ala Ser Gln Gly Cys Leu Glu Ala Thr Val Asn Asp
325 330 335
Phe Trp Gln Met Ala Trp Gln Glu Asn Ser Arg Val Ile Val Met Thr
340 345 350
Thr Arg Glu Val Glu Lys Gly Arg Asn Lys Cys Val Pro Tyr Trp Pro
CA 02450698 2003-12-23
214
355 360 365
Glu Val Gly Met Gln Arg Ala Tyr Gly Pro Tyr Ser Val Thr Asn Cys
370 375 380
Gly Glu His Asp Thr Thr Glu Tyr Lys Leu Arg Thr Leu Gln Val Ser
385 390 395 400
Pro Leu Asp Asn Gly Asp Leu Ile Arg Glu Ile Trp His Tyr Gln Tyr
405 410 415
Leu Ser Trp Pro Asp His Gly Val Pro Ser Glu Pro Gly Gly Val Leu
420 425 430
Ser Phe Leu Asp Gln Ile Asn Gln Arg Gln Glu Ser Leu Pro His Ala
435 440 445
Gly Pro Ile Ile Val His Cys Ser Ala Gly Ile Gly Arg Thr Gly Thr
450 455 460
Ile Ile Val Ile Asp Met Leu Met Glu Asn Ile Ser Thr Lys Gly Leu
465 470 475 480
Asp Cys Asp Ile Asp Ile Gln Lys Thr Ile Gln Met Val Arg Ala Gln
485 490 495
Arg Ser Gly Met Val Gln Thr Glu Ala Gln Tyr Lys Phe Ile Tyr Val
500 505 510
Ala Ile Ala Gln Phe Ile Glu Thr Thr Lys Lys Lys Leu Glu Val Leu
515 520 525
Gln Ser Gln Lys Gly Gln Glu Ser Glu Tyr Gly Asn Ile Thr Tyr Pro
530 535 540
Pro Ala Met Lys Asn Ala His Ala Lys Ala Ser Arg Thr Ser Ser Lys
545 550 555 560
His Lys Glu Asp Val Tyr Glu Asn Leu His Thr Lys Asn Lys Arg Glu
565 570 575
Glu Lys Val Lys Lys Gln Arg Ser Ala Asp Lys Glu Lys Ser Lys Gly
580 585 590
Ser Leu Lys Arg Lys Arg Ile Leu Gln Ser Thr Val Pro Arg Ala Arg
595 600 605
Asp Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr
610 615 620
Gly Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His
625 630 635 640
Lys Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys
645 650 655
Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp
660 665 670
Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg
675 680 685
Tyr Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro
690 695 700
Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn
705 710 715 720
Tyr Lys Thr Arg Ala Glu Va1 Lys Phe Glu Gly Asp Thr Leu Val Asn
725 730 735
Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu
740 745 750
Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met
755 760 765
Ala Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His
7?0 775 780
Asn Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn
785 790 795 800
Thr Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu
805 810 815
Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His
820 825 830
Met Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met
CA 02450698 2003-12-23
215
835 840 845
Asp Glu Leu Tyr Lys
850
(2) INFORMATION FOR SEQ ID N0:120:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2994 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2991
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:120:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Tzp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
CA 02450698 2003-12-23
216
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCT CAA GCT TCG AAT TCG ACC ATG GAG CGG CCC 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Asn Ser Thr Met Glu Arg Pro
245 250 255
CCG GGG CTG CGG CCG GGC GCG GGC GGG CCC TGG GAG ATG CGG GAG CGG 816
Pro Gly Leu Arg Pro Gly Ala Gly Gly Pro Trp Glu Met Arg Glu Arg
260 265 270
CTG GGC ACC GGC GGC TTC GGG AAC GTC TGT CTG TAC CAG CAT CGG GAA 864
Leu Gly Thr Gly Gly Phe Gly Asn Val Cys Leu Tyr Gln His Arg Glu
275 280 285
CTT GAT CTC AAA ATA GCA ATT AAG TCT TGT CGC CTA GAG CTA AGT ACC 912
Leu Asp Leu Lys Ile A1a I1e Lys Ser Cys Arg Leu Glu Leu Ser Thr
290 295 300
AAA AAC AGA GAA CGA TGG TGC CAT GAA ATC CAG ATT ATG AAG AAG TTG 960
Lys Asn Arg Glu Arg Trp Cys His Glu Ile Gln Ile Met Lys Lys Leu
305 310 315 320
AAC CAT GCC AAT GTT GTA AAG GCC TGT GAT GTT CCT GAA GAA TTG AAT 1008
Asn His A1a Asn Val Val Lys Ala Cys Asp Val Pro Glu Glu Leu Asn
325 330 335
ATT TTG ATT CAT GAT GTG CCT CTT CTA GCA ATG GAA TAC TGT TCT GGA 1056
Ile Leu Ile His Asp Val Pro Leu Leu Ala Met Glu Tyr Cys Ser Gly
340 345 350
GGA GAT CTC CGA AAG CTG CTC AAC AAA CCA GAA AAT TGT TGT GGA CTT 1104
Gly Asp Leu Arg Lys Leu Leu Asn Lys Pro Glu Asn Cys Cys Gly Leu
355 360 365
AAA GAA AGC CAG ATA CTT TCT TTA CTA AGT GAT ATA GGG TCT GGG ATT 1152
Lys Glu Ser Gln Ile Leu Ser Leu Leu Ser Asp Ile Gly Ser Gly Ile
370 375 380
CGA TAT TTG CAT GAA AAC AAA ATT ATA CAT CGA GAT CTA AAA CCT GAA 1200
Arg Tyr Leu His Glu Asn Lys Ile Ile His Arg Asp Leu Lys Pro Glu
385 390 395 400
CA 02450698 2003-12-23
217
AAC ATA GTT CTT CAG GAT GTT GGT GGA AAG ATA ATA CAT AAA ATA ATT 1248
Asn Ile Val Leu Gln Asp Val Gly Gly Lys Ile Ile His Lys Ile Ile
405 410 415
GAT CTG GGA TAT GCC AAA GAT GTT GAT CAA GGA AGT CTG TGT ACA TCT 1296
Asp Leu Gly Tyr Ala Lys Asp Val Asp Gln Gly Ser Leu Cys Thr Ser
420 425 430
TTT GTG GGA ACA CTG CAG TAT CTG GCC CCA GAG CTC TTT GAG AAT AAG 1344
Phe Val Gly Thr Leu Gln Tyr Leu Ala Pro Glu Leu Phe Glu Asn Lys
435 440 445
CCT TAC ACA GCC ACT GTT GAT TAT TGG AGC TTT GGG ACC ATG GTA TTT 1392
Pro Tyr Thr Ala Thr Val Asp Tyr Trp Ser Phe Gly Thr Met Val Phe
450 455 460
GAA TGT ATT GCT GGA TAT AGG CCT TTT TTG CAT CAT CTG CAG CCA TTT 1440
Glu Cys Ile Ala Gly Tyr Arg Pro Phe Leu His His Leu Gln Pro Phe
465 470 475 480
ACC TGG CAT GAG AAG ATT AAG AAG AAG GAT CCA AAG TGT ATA TTT GCA 1488
Thr Trp His Glu Lys Ile Lys Lys Lys Asp Pro Lys Cys Ile Phe Ala
485 490 495
TGT GAA GAG ATG TCA GGA GAA GTT CGG TTT AGT AGC CAT TTA CCT CAA 1536
Cys Glu Glu Met Ser Gly Glu Val Arg Phe Ser Ser His Leu Pro Gln
500 505 510
CCA AAT AGC CTT TGT AGT TTA ATA GTA GAA CCC ATG GAA AAC TGG CTA 1584
Pro Asn Ser Leu Cys Ser Leu Ile Val Glu Pro Met Glu Asn Trp Leu
515 520 525
CAG TTG ATG TTG AAT TGG GAC CCT CAG CAG AGA GGA GGA CCT GTT GAC 1632
Gln Leu Met Leu Asn Trp Asp Pro Gln Gln Arg Gly Gly Pro Val Asp
530 535 540
CTT ACT TTG AAG CAG CCA AGA TGT TTT GTA TTA ATG GAT CAC ATT TTG 1680
Leu Thr Leu Lys Gln Pro Arg Cys Phe Val Leu Met Asp His Ile Leu
545 550 555 560
AAT TTG AAG ATA GTA CAC ATC CTA AAT ATG ACT TCT GCA AAG ATA ATT 1728
Asn Leu Lys Ile Val His Ile Leu Asn Met Thr Ser Ala Lys Ile Ile
565 570 575
TCT TTT CTG TTA CCA CCT GAT GAA AGT CTT CAT TCA CTA CAG TCT CGT 1776
Ser Phe Leu Leu Pro Pro Asp Glu Ser Leu His Ser Leu Gln Ser Arg
580 585 590
ATT GAG CGT GAA ACT GGA ATA AAT ACT GGT TCT CAA GAA CTT CTT TCA 1824
Ile Glu Arg Glu Thr Gly Ile Asn Thr Gly Ser Gln Glu Leu Leu Ser
595 600 605
GAG ACA GGA ATT TCT CTG GAT CCT CGG AAA CCA GCC TCT CAA TGT GTT 1872
Glu Thr Gly Ile Ser Leu Asp Pro Arg Lys Pro Ala Ser Gln Cys Val
610 615 620
CTA GAT GGA GTT AGA GGC TGT GAT AGC TAT ATG GTT TAT TTG TTT GAT 1920
Leu Asp Gly Val Arg Gly Cys Asp Ser Tyr Met Val Tyr Leu Phe Asp
625 630 635 640
CA 02450698 2003-12-23
218
AAA AGT AAA ACT GTA TAT GAA GGG CCA TTT GCT TCC AGA AGT TTA TCT 1968
Lys Ser Lys Thr Val Tyr Glu Gly Pro Phe Ala Ser Arg Ser Leu Ser
645 650 655
GAT TGT GTA AAT TAT ATT GTA CAG GAC AGC AAA ATA CAG CTT CCA ATT 2016
Asp Cys Val Asn Tyr Ile Val Gln Asp Ser Lys Ile Gln Leu Pro Ile
660 665 670
ATA CAG CTG CGT AAA GTG TGG GCT GAA GCA GTG CAC TAT GTG TCT GGA 2064
Ile Gln Leu Arg Lys Val Trp Ala Glu Ala Val His Tyr Val Ser Gly
675 680 685
CTA AAA GAA GAC TAT AGC AGG CTC TTT CAG GGA CAA AGG GCA GCA ATG 2112
Leu Lys Glu Asp Tyr Ser Arg Leu Phe Gln Gly Gln Arg Ala Ala Met
690 695 700
TTA AGT CTT CTT AGA TAT AAT GCT AAC TTA ACA AAA ATG AAG AAC ACT 2160
Leu Ser Leu Leu Arg Tyr Asn Ala Asn Leu Thr Lys Met Lys Asn Thr
705 710 715 720
TTG ATC TCA GCA TCA CAA CAA CTG AAA GCT AAA TTG GAG TTT TTT CAC 2208
Leu Ile Ser Ala Ser Gln Gln Leu Lys Ala Lys Leu Glu Phe Phe His
725 730 735
AAA AGC ATT CAG CTT GAC TTG GAG AGA TAC AGC GAG CAG ATG ACG TAT 2256
Lys Ser Ile Gln Leu Asp Leu Glu Arg Tyr Ser Glu Gln Met Thr Tyr
740 745 750
GGG ATA TCT TCA GAA AAA ATG CTA AAA GCA TGG AAA GAA ATG GAA GAA 2304
Gly Ile Ser Ser Glu Lys Met Leu Lys Ala Trp Lys Glu Met Glu Glu
755 760 765
AAG GCC ATC CAC TAT GCT GAG GTT GGT GTC ATT GGA TAC CTG GAG GAT 2352
Lys Ala Ile His Tyr Ala Glu Val Gly Val Ile Gly Tyr Leu Glu Asp
770 775 780
CAG ATT ATG TCT TTG CAT GCT GAA ATC ATG GGG CTA CAG AAG AGC CCC 2400
Gln Ile Met Ser Leu His Ala Glu Ile Met Gly Leu Gln Lys Ser Pro
785 790 795 800
TAT GGA AGA CGT CAG GGA GAC TTG ATG GAA TCT CTG GAA CAG CGT GCC 2448
Tyr Gly Arg Arg Gln Gly Asp Leu Met Glu Ser Leu Glu Gln Arg Ala
805 810 815
ATT GAT CTA TAT AAG CAG TTA AAA CAC AGA CCT TCA GAT CAC TCC TAC 2496
Ile Asp Leu Tyr Lys Gln Leu Lys His Arg Pro Ser Asp His Ser Tyr
820 825 830
AGT GAC AGC ACA GAG ATG GTG AAA ATC ATT GTG CAC ACT GTG CAG AGT 2544
Ser Asp Ser Thr Glu Met Val Lys Ile Ile Val His Thr Val Gln Ser
835 840 845
CAG GAC CGT GTG CTC AAG GAG CTG TTT GGT CAT TTG AGC AAG TTG TTG 2592
Gln Asp Arg Val Leu Lys Glu Leu Phe Gly His Leu Ser Lys Leu Leu
850 855 860
GGC TGT AAG CAG AAG ATT ATT GAT CTA CTC CCT AAG GTG GAA GTG GCC 2640
Gly Cys Lys Gln Lys Ile Ile Asp Leu Leu Pro Lys Val Glu Val Ala
865 870 875 880
CA 02450698 2003-12-23
219
CTC AGT AAT ATC AAA GAA GCT GAC AAT ACT GTC ATG TTC ATG CAG GGA 2688
Leu Ser Asn Ile Lys Glu Ala Asp Asn Thr Val Met Phe Met Gln Gly
885 890 895
AAA AGG CAG AAA GAA ATA TGG CAT CTC CTT AAA ATT GCC TGT ACA CAG 2736
Lys Arg Gln Lys Glu Ile Trp His Leu Leu Lys Ile Ala Cys Thr Gln
900 905 910
AGT TCT GCC CGC TCT CTT GTA GGA TCC AGT CTA GAA GGT GCA GTA ACC 2784
Ser Ser Ala Arg Ser Leu Val Gly Ser Ser Leu Glu Gly Ala Val Thr
915 920 925
CCT CAG ACA TCA GCA TGG CTG CCC CCG ACT TCA GCA GAA CAT GAT CAT 2832
Pro Gln Thr Ser Ala Trp Leu Pro Pro Thr Ser Ala Glu His Asp His
930 935 940
TCT CTG TCA TGT GTG GTA ACT CCT CAA GAT GGG GAG ACT TCA GCA CAA 2880
Ser Leu Ser Cys Val Val Thr Pro Gln Asp Gly Glu Thr Ser Ala Gln
945 950 955 960
ATG ATA GAA GAA AAT TTG AAC TGC CTT GGC CAT TTA AGC ACT ATT ATT 2928
Met Ile Glu Glu Asn Leu Asn Cys Leu Gly His Leu Ser Thr Ile Ile
965 970 975
CAT GAG GCA AAT GAG GAA CAG GGC AAT AGT ATG ATG AAT CTT GAT TGG 2976
His Glu Ala Asn Glu Glu Gln Gly Asn Ser Met Met Asn Leu Asp Trp
980 985 990
AGT TGG TTA ACA GAA TGA 2994
Ser Trp Leu Thr Glu
995
(2) INFORMATION FOR SEQ ID N0:121:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 997 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:121:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr G1y Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr I1e Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
CA 02450698 2003-12-23
220
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Sex Asn Ser Thr Met Glu Arg Pro
245 250 255
Pro Gly Leu Arg Pro Gly Ala Gly Gly Pro Trp Glu Met Arg Glu Arg
260 265 270
Leu Gly Thr Gly Gly Phe Gly Asn Val Cys Leu Tyr Gln His Arg Glu
275 280 285
Leu Asp Leu Lys Ile Ala Ile Lys Ser Cys Arg Leu Glu Leu Ser Thr
290 295 300
Lys Asn Arg Glu Arg Trp Cys His Glu I1e Gln Ile Met Lys Lys Leu
305 310 315 320
Asn His Ala Asn Val Val Lys Ala Cys Asp Val Pro Glu Glu Leu Asn
325 330 335
Ile Leu Ile His Asp Val Pro Leu Leu Ala Met Glu Tyr Cys Ser Gly
340 345 350
Gly Asp Leu Arg Lys Leu Leu Asn Lys Pro Glu Asn Cys Cys Gly Leu
355 360 365
Lys Glu Ser Gln Ile Leu Ser Leu Leu Ser Asp Ile Gly Ser Gly Ile
370 375 380
Arg Tyr Leu His Glu Asn Lys Ile Ile His Arg Asp Leu Lys Pro Glu
385 390 395 400
Asn Ile Val Leu Gln Asp Val Gly Gly Lys Ile Ile His Lys Ile Ile
405 410 415
Asp Leu Gly Tyr Ala Lys Asp Va1 Asp Gln Gly Ser Leu Cys Thr Ser
420 425 430
Phe Val Gly Thr Leu Gln Tyr Leu Ala Pro Glu Leu Phe Glu Asn Lys
435 440 445
Pro Tyr Thr Ala Thr Val Asp Tyr Trp Ser Phe Gly Thr Met Val Phe
450 455 460
Glu Cys Ile Ala Gly Tyr Arg Pro Phe Leu His His Leu Gln Pro Phe
465 470 475 480
Thr Trp His Glu Lys Ile Lys Lys Lys Asp Pro Lys Cys Ile Phe Ala
485 490 495
Cys Glu Glu Met Ser Gly Glu Val Arg Phe Ser Ser His Leu Pro Gln
500 505 510
Pro Asn Ser Leu Cys Ser Leu Ile Val Glu Pro Met Glu Asn Trp Leu
515 520 525
Gln Leu Met Leu Asn Trp Asp Pro Gln Gln Arg Gly Gly Pro Val Asp
530 535 540
Leu Thr Leu Lys Gln Pro Arg Cys Phe Val Leu Met Asp His Ile Leu
545 550 555 560
Asn Leu Lys Ile Val His Ile Leu Asn Met Thr Ser Ala Lys Ile Ile
565 570 575
Ser Phe Leu Leu Pro Pro Asp Glu Ser Leu His Ser Leu Gln Ser Arg
CA 02450698 2003-12-23
221
580 585 590
Ile Glu Arg Glu Thr Gly Ile Asn Thr Gly Ser Gln Glu Leu Leu Ser
595 600 605
Glu Thr Gly Ile Ser Leu Asp Pro Arg Lys Pro Ala Ser Gln Cys Val
610 615 620
Leu Asp Gly Val Arg Gly Cys Asp Ser Tyr Met Val Tyr Leu Phe Asp
625 630 635 640
Lys Ser Lys Thr Val Tyr Glu Gly Pro Phe Ala Ser Arg Ser Leu Ser
645 650 655
Asp Cys Val Asn Tyr Ile Val Gln Asp Ser Lys Ile Gln Leu Pro Ile
660 665 670
Ile Gln Leu Arg Lys Val Trp Ala Glu Ala Val His Tyr Val Ser Gly
675 680 685
Leu Lys Glu Asp Tyr Ser Arg Leu Phe Gln Gly Gln Arg Ala Ala Met
690 695 700
Leu Ser Leu Leu Arg Tyr Asn Ala Asn Leu Thr Lys Met Lys Asn Thr
705 710 715 720
Leu Ile Ser Ala Ser Gln Gln Leu Lys Ala Lys Leu Glu Phe Phe His
725 730 735
Lys Ser Ile Gln Leu Asp Leu Glu Arg Tyr Ser Glu Gln Met Thr Tyr
740 745 750
Gly Ile Ser Ser Glu Lys Met Leu Lys Ala Trp Lys Glu Met Glu Glu
755 760 765
Lys Ala Ile His Tyr Ala Glu Val Gly Val Ile Gly Tyr Leu Glu Asp
770 775 780
Gln Ile Met Ser Leu His Ala Glu Ile Met Gly Leu Gln Lys Ser Pro
785 790 795 800
Tyr Gly Arg Arg Gln Gly Asp Leu Met Glu Ser Leu Glu Gln Arg Ala
805 810 815
Ile Asp Leu Tyr Lys Gln Leu Lys His Arg Pro Ser Asp His Ser Tyr
820 825 830
Ser Asp Ser Thr Glu Met Val Lys Ile Ile Val His Thr Val Gln Ser
835 840 845
Gln Asp Arg Val Leu Lys Glu Leu Phe Gly His Leu Ser Lys Leu Leu
850 855 860
Gly Cys Lys Gln Lys Ile Ile Asp Leu Leu Pro Lys Val Glu Val Ala
865 870 875 880
Leu Ser Asn Ile Lys Glu Ala Asp Asn Thr Val Met Phe Met Gln Gly
885 890 895
Lys Arg Gln Lys Glu Ile Trp His Leu Leu Lys Ile Ala Cys Thr Gln
900 905 910
Ser Ser Ala Arg Ser Leu Val Gly Ser Ser Leu Glu Gly Ala Val Thr
915 920 925
Pro Gln Thr Ser Ala Trp Leu Pro Pro Thr Ser Ala Glu His Asp His
930 935 940
Ser Leu Ser Cys Val Val Thr Pro Gln Asp Gly Glu Thr Ser Ala Gln
945 950 955 960
Met Ile Glu Glu Asn Leu Asn Cys Leu Gly His Leu Ser Thr Ile Ile
965 970 975
His Glu Ala Asn Glu Glu Gln Gly Asn Ser Met Met Asn Leu Asp Trp
980 985 990
Ser Trp Leu Thr Glu
995
(2) INFORMATION FOR SEQ ID N0:122:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2991 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
CA 02450698 2003-12-23
222
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...2988
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:122:
ATG GAG CGG CCC CCG GGG CTG CGG CCG GGC GCG GGC GGG CCC TGG GAG 48
Met Glu Arg Pro Pro Gly Leu Arg Pro Gly Ala Gly Gly Pro Trp Glu
1 5 10 15
ATG CGG GAG CGG CTG GGC ACC GGC GGC TTC GGG AAC GTC TGT CTG TAC 96
Met Arg Glu Arg Leu Gly Thr Gly Gly Phe Gly Asn Val Cys Leu Tyr
20 25 30
CAG CAT CGG GAA CTT GAT CTC AAA ATA GCA ATT AAG TCT TGT CGC CTA 144
Gln His Arg Glu Leu Asp Leu Lys Ile Ala Ile Lys Ser Cys Arg Leu
35 40 45
GAG CTA AGT ACC AAA AAC AGA GAA CGA TGG TGC CAT GAA ATC CAG ATT 192
Glu Leu Ser Thr Lys Asn Arg Glu Arg Trp Cys His Glu Ile Gln Ile
50 55 60
ATG AAG AAG TTG AAC CAT GCC AAT GTT GTA AAG GCC TGT GAT GTT CCT 240
Met Lys Lys Leu Asn His Ala Asn Val Val Lys Ala Cys Asp Val Pro
65 70 75 80
GAA GAA TTG AAT ATT TTG ATT CAT GAT GTG CCT CTT CTA GCA ATG GAA 288
Glu Glu Leu Asn Ile Leu Ile His Asp Val Pro Leu Leu Ala Met Glu
85 90 95
TAC TGT TCT GGA GGA GAT CTC CGA AAG CTG CTC AAC AAA CCA GAA AAT 336
Tyr Cys Ser Gly Gly Asp Leu Arg Lys Leu Leu Asn Lys Pro Glu Asn
100 105 110
TGT TGT GGA CTT AAA GAA AGC CAG ATA CTT TCT TTA CTA AGT GAT ATA 384
Cys Cys Gly Leu Lys Glu Ser Gln Ile Leu Ser Leu Leu Ser Asp Ile
115 120 125
GGG TCT GGG ATT CGA TAT TTG CAT GAA AAC AAA ATT ATA CAT CGA GAT 432
Gly Ser Gly Ile Arg Tyr Leu His Glu Asn Lys Ile Ile His Arg Asp
130 135 140
CTA AAA CCT GAA AAC ATA GTT CTT CAG GAT GTT GGT GGA AAG ATA ATA 480
Leu Lys Pro Glu Asn Ile Val Leu Gln Asp Val Gly Gly Lys Ile Ile
145 150 155 160
CAT AAA ATA ATT GAT CTG GGA TAT GCC AAA GAT GTT GAT CAA GGA AGT 528
His Lys Ile Ile Asp Leu Gly Tyr Ala Lys Asp Val Asp Gln Gly Ser
165 170 175
CTG TGT ACA TCT TTT GTG GGA ACA CTG CAG TAT CTG GCC CCA GAG CTC 576
Leu Cys Thr Ser Phe Val Gly Thr Leu Gln Tyr Leu Ala Pro Glu Leu
180 185 190
TTT GAG AAT AAG CCT TAC ACA GCC ACT GTT GAT TAT TGG AGC TTT GGG 624
CA 02450698 2003-12-23
223
Phe Glu Asn Lys Pro Tyr Thr Ala Thr Val Asp Tyr Trp Ser Phe Gly
195 200 205
ACC ATG GTA TTT GAA TGT ATT GCT GGA TAT AGG CCT TTT TTG CAT CAT 672
Thr Met Val Phe Glu Cys Ile Ala Gly Tyr Arg Pro Phe Leu His His
210 215 220
CTG CAG CCA TTT ACC TGG CAT GAG AAG ATT AAG AAG AAG GAT CCA AAG 720
Leu Gln Pro Phe Thr Trp His Glu Lys Ile Lys Lys Lys Asp Pro Lys
225 230 235 240
TGT ATA TTT GCA TGT GAA GAG ATG TCA GGA GAA GTT CGG TTT AGT AGC 768
Cys Ile Phe Ala Cys Glu Glu Met Ser Gly Glu Va1 Arg Phe Ser Ser
245 250 255
CAT TTA CCT CAA CCA AAT AGC CTT TGT AGT TTA ATA GTA GAA CCC ATG 816
His Leu Pro Gln Pro Asn Ser Leu Cys Ser Leu Ile Val Glu Pro Met
260 265 270
GAA AAC TGG CTA CAG TTG ATG TTG AAT TGG GAC CCT CAG CAG AGA GGA 864
Glu Asn Trp Leu Gln Leu Met Leu Asn Trp Asp Pro Gln Gln Arg Gly
275 280 285
GGA CCT GTT GAC CTT ACT TTG AAG CAG CCA AGA TGT TTT GTA TTA ATG 912
Gly Pro Val Asp Leu Thr Leu Lys Gln Pro Arg Cys Phe Val Leu Met
290 295 300
GAT CAC ATT TTG AAT TTG AAG ATA GTA CAC ATC CTA AAT ATG ACT TCT 960
Asp His Ile Leu Asn Leu Lys Ile Val His Ile Leu Asn Met Thr Ser
305 310 315 320
GCA AAG ATA ATT TCT TTT CTG TTA CCA CCT GAT GAA AGT CTT CAT TCA 1008
Ala Lys Ile Ile Ser Phe Leu Leu Pro Pro Asp Glu Ser Leu His Ser
325 330 335
CTA CAG TCT CGT ATT GAG CGT GAA ACT GGA ATA AAT ACT GGT TCT CAA 1056
Leu Gln Ser Arg Ile Glu Arg Glu Thr Gly Ile Asn Thr Gly Ser Gln
340 345 350
GAA CTT CTT TCA GAG ACA GGA ATT TCT CTG GAT CCT CGG AAA CCA GCC 1104
Glu Leu Leu Ser Glu Thr Gly Ile Ser Leu Asp Pro Arg Lys Pro Ala
355 360 365
TCT CAA TGT GTT CTA GAT GGA GTT AGA GGC TGT GAT AGC TAT ATG GTT 1152
Ser Gln Cys Val Leu Asp Gly Val Arg Gly Cys Asp Ser Tyr Met Val
370 375 380
TAT TTG TTT GAT AAA AGT AAA ACT GTA TAT GAA GGG CCA TTT GCT TCC 1200
Tyr Leu Phe Asp Lys Ser Lys Thr Val Tyr Glu Gly Pro Phe Ala Ser
385 390 395 400
AGA AGT TTA TCT GAT TGT GTA AAT TAT ATT GTA CAG GAC AGC AAA ATA 1248
Arg Ser Leu Ser Asp Cys Val Asn Tyr Ile Val Gln Asp Ser Lys Ile
405 410 415
CAG CTT CCA ATT ATA CAG CTG CGT AAA GTG TGG GCT GAA GCA GTG CAC 1296
Gln Leu Pro Ile Ile Gln Leu Arg Lys Val Trp Ala Glu Ala Val His
420 425 430
TAT GTG TCT GGA CTA AAA GAA GAC TAT AGC AGG CTC TTT CAG GGA CAA 1344
CA 02450698 2003-12-23
224
Tyr Val Ser Gly Leu Lys Glu Asp Tyr Ser Arg Leu Phe Gln Gly Gln
435 440 445
AGG GCA GCA ATG TTA AGT CTT CTT AGA TAT AAT GCT AAC TTA ACA AAA 1392
Arg Ala Ala Met Leu Ser Leu Leu Arg Tyr Asn Ala Asn Leu Thr Lys
450 455 460
ATG AAG AAC ACT TTG ATC TCA GCA TCA CAA CAA CTG AAA GCT AAA TTG 1440
Met Lys Asn Thr Leu Ile Ser Ala Ser Gln Gln Leu Lys Ala Lys Leu
465 470 475 480
GAG TTT TTT CAC AAA AGC ATT CAG CTT GAC TTG GAG AGA TAC AGC GAG 1488
Glu Phe Phe His Lys Ser Ile Gln Leu Asp Leu Glu Arg Tyr Ser Glu
485 490 495
CAG ATG ACG TAT GGG ATA TCT TCA GAA AAA ATG CTA AAA GCA TGG AAA 1536
Gln Met Thr Tyr Gly Ile Ser Ser Glu Lys Met Leu Lys Ala Trp Lys
500 505 510
GAA ATG GAA GAA AAG GCC ATC CAC TAT GCT GAG GTT GGT GTC ATT GGA 1584
Glu Met Glu Glu Lys Ala Ile His Tyr Ala Glu Val Gly Val Ile Gly
515 520 525
TAC CTG GAG GAT CAG ATT ATG TCT TTG CAT GCT GAA ATC ATG GGG CTA 1632
Tyr Leu Glu Asp Gln Ile Met Ser Leu His Ala Glu Ile Met Gly Leu
530 535 540
CAG AAG AGC CCC TAT GGA AGA CGT CAG GGA GAC TTG ATG GAA TCT CTG 1680
Gln Lys Ser Pro Tyr Gly Arg Arg Gln Gly Asp Leu Met Glu Ser Leu
545 550 555 560
GAA CAG CGT GCC ATT GAT CTA TAT AAG CAG TTA AAA CAC AGA CCT TCA 1728
Glu Gln Arg Ala Ile Asp Leu Tyr Lys Gln Leu Lys His Arg Pro Ser
565 570 575
GAT CAC TCC TAC AGT GAC AGC ACA GAG ATG GTG AAA ATC ATT GTG CAC 1776
Asp His Ser Tyr Ser Asp Ser Thr Glu Met Val Lys Ile Ile Val His
580 585 590
ACT GTG CAG AGT CAG GAC CGT GTG CTC AAG GAG CTG TTT GGT CAT TTG 1824
Thr Val Gln Ser Gln Asp Arg Val Leu Lys Glu Leu Phe Gly His Leu
595 600 605
AGC AAG TTG TTG GGC TGT AAG CAG AAG ATT ATT GAT CTA CTC CCT AAG 1872
Ser Lys Leu Leu Gly Cys Lys Gln Lys Ile Ile Asp Leu Leu Pro Lys
610 615 620
GTG GAA GTG GCC CTC AGT AAT ATC AAA GAA GCT GAC AAT ACT GTC ATG 1920
Val Glu Val Ala Leu Ser Asn Ile Lys Glu Ala Asp Asn Thr Val Met
625 630 635 640
TTC ATG CAG GGA AAA AGG CAG AAA GAA ATA TGG CAT CTC CTT AAA ATT 1968
Phe Met Gln Gly Lys Arg Gln Lys Glu Ile Trp His Leu Leu Lys Ile
645 650 655
GCC TGT ACA CAG AGT TCT GCC CGC TCT CTT GTA GGA TCC AGT CTA GAA 2016
Ala Cys Thr Gln Ser Ser Ala Arg Ser Leu Val Gly Ser Ser Leu Glu
660 665 670
GGT GCA GTA ACC CCT CAG ACA TCA GCA TGG CTG CCC CCG ACT TCA GCA 2064
CA 02450698 2003-12-23
225
Gly Ala Val Thr Pro Gln Thr Ser Ala Trp Leu Pro Pro Thr Ser Ala
675 680 685
GAA CAT GAT CAT TCT CTG TCA TGT GTG GTA ACT CCT CAA GAT GGG GAG 2112
Glu His Asp His Ser Leu Ser Cys Val Val Thr Pro Gln Asp Gly Glu
690 695 700
ACT TCA GCA CAA ATG ATA GAA GAA AAT TTG AAC TGC CTT GGC CAT TTA 2160
Thr Ser Ala Gln Met Ile Glu Glu Asn Leu Asn Cys Leu Gly His Leu
705 710 715 720
AGC ACT ATT ATT CAT GAG GCA AAT GAG GAA CAG GGC AAT AGT ATG ATG 2208
Ser Thr Ile Ile His Glu Ala Asn Glu Glu Gln Gly Asn Ser Met Met
725 730 735
AAT CTT GAT TGG AGT TGG TTA ACA GAA TGG GTA CCG CGG GCC CGG GAT 2256
Asn Leu Asp Trp Ser Trp Leu Thr Glu Trp Val Pro Arg Ala Arg Asp
740 745 750
CCA CCG GTC GCC ACC ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG 2304
Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly
755 760 765
GTG GTG CCC ATC CTG GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG 2352
Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys
770 775 780
TTC AGC GTG TCC GGC GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG 2400
Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu
785 790 795 800
ACC CTG AAG TTC ATC TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC 2448
Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro
805 810 815
ACC CTC GTG ACC ACC CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC 2496
Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr
820 825 830
CCC GAC CAC ATG AAG CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA 2544
Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu
835 840 845
GGC TAC GTC CAG GAG CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC 2592
Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr
850 855 860
AAG ACC CGC GCC GAG GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC 2640
Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg
865 870 875 880
ATC GAG CTG AAG GGC ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG 2688
Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly
885 890 895
CAC AAG CTG GAG TAC AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC 2736
His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala
900 905 910
GAC AAG CAG AAG AAC GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC 2784
CA 02450698 2003-12-23
226
Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn
915 920 925
ATC GAG GAC GGC AGC GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC 2832
Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr
930 935 940
CCC ATC GGC GAC GGC CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC 2880
Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser
945 950 955 960
ACC CAG TCC GCC CTG AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG 2928
Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met
965 970 975
GTC CTG CTG GAG TTC GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC 2976
Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp
980 985 990
GAG CTG TAC AAG TAA 2991
Glu Leu Tyr Lys
995
(2) INFORMATION FOR SEQ ID N0:123:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 996 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:123:
Met Glu Arg Pro Pro Gly Leu Arg Pro Gly Ala Gly Gly Pro Trp Glu
1 5 10 15
Met Arg Glu Arg Leu Gly Thr Gly Gly Phe Gly Asn Val Cys Leu Tyr
20 25 30
Gln His Arg Glu Leu Asp Leu Lys Ile Ala Ile Lys Ser Cys Arg Leu
35 40 45
Glu Leu Ser Thr Lys Asn Arg Glu Arg Trp Cys His Glu Ile Gln Ile
50 55 60
Met Lys Lys Leu Asn His Ala Asn Val Val Lys Ala Cys Asp Val Pro
65 70 75 80
Glu Glu Leu Asn Ile Leu Ile His Asp Val Pro Leu Leu Ala Met Glu
85 90 95
Tyr Cys Ser Gly Gly Asp Leu Arg Lys Leu Leu Asn Lys Pro Glu Asn
100 105 110
Cys Cys Gly Leu Lys Glu Ser Gln Ile Leu Ser Leu Leu 5er Asp Ile
115 120 125
Gly Ser Gly Ile Arg Tyr Leu His Glu Asn Lys Ile Ile His Arg Asp
130 135 140
Leu Lys Pro Glu Asn Ile Val Leu Gln Asp Val Gly Gly Lys Ile Ile
145 150 155 160
His Lys Ile Ile Asp Leu Gly Tyr Ala Lys Asp Val Asp Gln Gly Ser
165 170 175
Leu Cys Thr Ser Phe Val Gly Thr Leu Gln Tyr Leu Ala Pro Glu Leu
CA 02450698 2003-12-23
227
180 185 190
Phe Glu Asn Lys Pro Tyr Thr Ala Thr Val Asp Tyr Trp Ser Phe Gly
195 200 205
Thr Met Val Phe Glu Cys Ile Ala Gly Tyr Arg Pro Phe Leu His His
210 215 220
Leu Gln Pro Phe Thr Trp His Glu Lys Ile Lys Lys Lys Asp Pro Lys
225 230 235 240
Cys Ile Phe Ala Cys Glu Glu Met Ser Gly Glu Val Arg Phe Ser Ser
245 250 255
His Leu Pro Gln Pro Asn Ser Leu Cys Ser Leu Ile Val Glu Pro Met
260 265 270
Glu Asn Trp Leu Gln Leu Met Leu Asn Trp Asp Pro Gln Gln Arg Gly
275 280 285
Gly Pro Val Asp Leu Thr Leu Lys Gln Pro Arg Cys Phe Val Leu Met
290 295 300
Asp His Ile Leu Asn Leu Lys Ile Val His Ile Leu Asn Met Thr Ser
305 310 315 320
Ala Lys Ile Ile Ser Phe Leu Leu Pro Pro Asp Glu Ser Leu His Ser
325 330 335
Leu Gln Ser Arg Ile Glu Arg Glu Thr Gly Ile Asn Thr Gly Ser Gln
340 345 350
Glu Leu Leu Ser Glu Thr Gly Ile Ser Leu Asp Pro Arg Lys Pro Ala
355 360 365
Ser Gln Cys Val Leu Asp Gly Val Arg Gly Cys Asp Ser Tyr Met Val
370 375 380
Tyr Leu Phe Asp Lys Ser Lys Thr Val Tyr Glu Gly Pro Phe Ala Ser
385 390 395 400
Arg Ser Leu Ser Asp Cys Val Asn Tyr Ile Val Gln Asp Ser Lys Ile
405 410 415
Gln Leu Pro Ile Ile Gln Leu Arg Lys Val Trp Ala Glu Ala Val His
420 425 430
Tyr Val Ser Gly Leu Lys Glu Asp Tyr Ser Arg Leu Phe Gln Gly Gln
435 440 445
Arg Ala Ala Met Leu Ser Leu Leu Arg Tyr Asn Ala Asn Leu Thr Lys
450 455 460
Met Lys Asn Thr Leu Ile Ser Ala Ser Gln Gln Leu Lys Ala Lys Leu
465 470 475 480
Glu Phe Phe His Lys Ser Ile Gln Leu Asp Leu Glu Arg Tyr Ser Glu
485 490 495
Gln Met Thr Tyr Gly Ile Ser Ser Glu Lys Met Leu Lys Ala Trp Lys
500 505 510
Glu Met Glu Glu Lys Ala Ile His Tyr Ala Glu Val Gly Val Ile Gly
515 520 525
Tyr Leu Glu Asp Gln Ile Met Ser Leu His Ala Glu Ile Met Gly Leu
530 535 540
Gln Lys Ser Pro Tyr Gly Arg Arg Gln Gly Asp Leu Met Glu Ser Leu
545 550 555 560
Glu Gln Arg Ala Ile Asp Leu Tyr Lys Gln Leu Lys His Arg Pro Ser
565 570 575
Asp His Ser Tyr Ser Asp Ser Thr Glu Met Val Lys Ile Ile Val His
580 585 590
Thr Val Gln Ser Gln Asp Arg Val Leu Lys Glu Leu Phe Gly His Leu
595 600 605
Ser Lys Leu Leu Gly Cys Lys Gln Lys Ile Ile Asp Leu Leu Pro Lys
610 615 620
Val Glu Val Ala Leu Ser Asn Ile Lys Glu Ala Asp Asn Thr Val Met
625 630 635 640
Phe Met Gln Gly Lys Arg Gln Lys Glu Ile Trp His Leu Leu Lys Ile
645 650 655
Ala Cys Thr Gln Ser Ser Ala Arg Ser Leu Val Gly Ser Ser Leu Glu
CA 02450698 2003-12-23
228
660 665 670
Gly Ala Val Thr Pro Gln Thr Ser Ala Trp Leu Pro Pro Thr Ser Ala
675 680 685
Glu His Asp His Ser Leu Ser Cys Val Val Thr Pro Gln Asp Gly Glu
690 695 700
Thr Ser Ala Gln Met Ile Glu Glu Asn Leu Asn Cys Leu Gly His Leu
705 710 715 720
Ser Thr Ile Ile His Glu Ala Asn Glu Glu Gln Gly Asn Ser Met Met
725 730 735
Asn Leu Asp Tzp Ser Trp Leu Thr Glu Trp Val Pro Arg Ala Arg Asp
740 745 750
Pro Pro Val Ala Thr Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly
755 760 765
Val Val Pro Ile Leu Val Glu Leu Asp Gly Asp Val Asn Gly His Lys
770 775 780
Phe Ser Val Ser Gly Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu
785 790 795 800
Thr Leu Lys Phe Ile Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro
805 810 815
Thr Leu Val Thr Thr Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr
820 825 830
Pro Asp His Met Lys Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu
835 840 845
Gly Tyr Val Gln Glu Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr
850 855 860
Lys Thr Arg Ala Glu Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg
865 870 875 880
Ile Glu Leu Lys Gly Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly
885 890 895
His Lys Leu Glu Tyr Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala
900 905 910
Asp Lys Gln Lys Asn Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn
915 920 925
Ile Glu Asp Gly Ser Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr
930 935 940
Pro Ile Gly Asp Gly Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser
945 950 955 960
Thr Gln Ser Ala Leu Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met
965 970 975
Val Leu Leu Glu Phe Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp
980 985 990
Glu Leu Tyr Lys
995
(2) INFORMATION FOR SEQ ID N0:124:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1908 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1905
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:124:
CA 02450698 2003-12-23
229
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
CA 02450698 2003-12-23
230
GGA CTC AGA TCT CGA GCT CAA GCT TCC ATG AGC GAG ACG GTC ATC ATG 768
Gly Leu Arg Ser Arg Ala Gln Ala Ser Met Ser Glu Thr Val Ile Met
245 250 255
AGC GAG ACG GTC ATC TGT TCC AGC CGG GCC ACT GTG ATG CTT TAT GAT 816
Ser Glu Thr Val Ile Cys Ser Ser Arg Ala Thr Val Met Leu Tyr Asp
260 265 270
GAT GGC AAC AAG CGA TGG CTC CCT GCT GGC ACG GGT CCC CAG GCC TTC 864
Asp Gly Asn Lys Arg Trp Leu Pro Ala Gly Thr Gly Pro Gln Ala Phe
275 280 285
AGC CGC GTC CAG ATC TAC CAC AAC CCC ACG GCC AAT TCC TTT CGC GTC 912
Ser Arg Val Gln Ile Tyr His Asn Pro Thr Ala Asn Ser Phe Arg Val
290 295 300
GTG GGC CGG AAG ATG CAG CCC GAC CAG CAG GTG GTC ATC AAC TGT GCC 960
Val Gly Arg Lys Met Gln Pro Asp Gln Gln Val Val Ile Asn Cys Ala
305 310 315 320
ATC GTC CGG GGT GTC AAG TAT AAC CAG GCC ACC CCC AAC TTC CAT CAG 1008
Ile Val Arg Gly Val Lys Tyr Asn Gln Ala Thr Pro Asn Phe His Gln
325 330 335
TGG CGC GAC GCT CGC CAG GTC TGG GGC CTC AAC TTC GGC AGC AAG GAG 1056
Trp Arg Asp Ala Arg Gln Val Trp Gly Leu Asn Phe Gly Ser Lys Glu
340 345 350
GAT GCG GCC CAG TTT GCC GCC GGC ATG GCC AGT GCC CTA GAG GCG TTG 1104
Asp Ala Ala Gln Phe Ala Ala Gly Met Ala Ser Ala Leu Glu Ala Leu
355 360 365
GAA GGA GGT GGG CCC CCT CCA CCC CCA GCA CTT CCC ACC TGG TCG GTC 1152
Glu Gly Gly Gly Pro Pro Pro Pro Pro Ala Leu Pro Thr Trp Ser Val
370 375 380
CCG AAC GGC CCC TCC CCG GAG GAG GTG GAG CAG CAG AAA AGG CAG CAG 1200
Pro Asn Gly Pro Ser Pro Glu Glu Val Glu Gln Gln Lys Arg Gln Gln
385 390 395 400
CCC GGC CCG TCG GAG CAC ATA GAG CGC CGG GTC TCC AAT GCA GGA GGC 1248
Pro Gly Pro Ser Glu His Ile Glu Arg Arg Val Ser Asn Ala Gly Gly
405 410 415
CCA CCT GCT CCC CCC GCT GGG GGT CCA CCC CCA CCA CCA GGA CCT CCC 1296
Pro Pro Ala Pro Pro Ala Gly Gly Pro Pro Pro Pro Pro Gly Pro Pro
420 425 430
CCT CCT CCA GGT CCC CCC CCA CCC CCA GGT TTG CCC CCT TCG GGG GTC 1344
Pro Pro Pro Gly Pro Pro Pro Pro Pro Gly Leu Pro Pro Ser Gly Val
435 440 445
CCA GCT GCA GCG CAC GGA GCA GGG GGA GGA CCA CCC CCT GCA CCC CCT 1392
Pro Ala Ala Ala His Gly Ala Gly Gly Gly Pro Pro Pro Ala Pro Pro
450 455 460
CTC CCG GCA GCA CAG GGC CCT GGT GGT GGG GGA GCT GGG GCC CCA GGC 1440
Leu Pro Ala Ala Gln Gly Pro Gly Gly Gly Gly Ala Gly Ala Pro Gly
465 470 475 480
CA 02450698 2003-12-23
231
CTG GCC GCA GCT ATT GCT GGA GCC AAA CTC AGG AAA GTC AGC AAG CAG 1488
Leu Ala Ala Ala Ile Ala Gly Ala Lys Leu Arg Lys Val Ser Lys Gln
485 490 495
GAG GAG GCC TCA GGG GGG CCC ACA GCC CCC AAA GCT GAG AGT GGT CGA 1536
Glu Glu Ala Ser Gly Gly Pro Thr Ala Pro Lys Ala Glu Ser Gly Arg
500 505 510
AGC GGA GGT GGG GGA CTC ATG GAA GAG ATG AAC GCC ATG CTG GCC CGG 1584
Ser Gly Gly Gly Gly Leu Met Glu Glu Met Asn Ala Met Leu Ala Arg
515 520 525
AGA AGG AAA GCC ACG CAA GTT GGG GAG AAA ACC CCC AAG GAT GAA TCT 1632
Arg Arg Lys Ala Thr Gln Val Gly Glu Lys Thr Pro Lys Asp Glu Ser
530 535 540
GCC AAT CAG GAG GAG CCA GAG GCC AGA GTC CCG GCC CAG AGT GAA TCT 1680
Ala Asn Gln Glu Glu Pro Glu Ala Arg Val Pro Ala Gln Ser Glu Ser
545 550 555 560
GTG CGG AGA CCC TGG GAG AAG AAC AGC ACA ACC TTG CCA AGG ATG AAG 1728
Val Arg Arg Pro Trp Glu Lys Asn Ser Thr Thr Leu Pro Arg Met Lys
565 570 575
TCG TCT TCT TCG GTG ACC ACT TCC GAG ACC CAA CCC TGC ACG CCC AGC 1776
Ser Ser Ser Ser Val Thr Thr Ser Glu Thr Gln Pro Cys Thr Pro Ser
580 585 590
TCC AGT GAT TAC TCG GAC CTA CAG AGG GTG AAA CAG GAG CTT CTG GAA 1824
Ser Ser Asp Tyr Ser Asp Leu Gln Arg Val Lys Gln Glu Leu Leu Glu
595 600 605
GAG GTG AAG AAG GAA TTG CAG AAA GTG AAA GAG GAA ATC ATT GAA GCC 1872
Glu Val Lys Lys Glu Leu Gln Lys Val Lys Glu Glu Ile Ile Glu Ala
610 615 620
TTC GTC CAG GAG CTG AGG AAG CGG GGT TCT CCC TGA 1908
Phe Val Gln Glu Leu Arg Lys Arg Gly Ser Pro
625 630 635
(2) INFORMATION FOR SEQ ID N0:125:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 635 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:125:
Met Val Sex Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
CA 02450698 2003-12-23
232
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Met Ser Glu Thr Val Ile Met
245 250 255
Ser Glu Thr Val Ile Cys Ser Ser Arg Ala Thr Val Met Leu Tyr Asp
260 265 270
Asp Gly Asn Lys Arg Trp Leu Pro Ala Gly Thr Gly Pro Gln Ala Phe
275 280 285
Ser Arg Val Gln Ile Tyr His Asn Pro Thr Ala Asn Ser Phe Arg Val
290 295 300
Val Gly Arg Lys Met Gln Pro Asp Gln Gln Val Val Ile Asn Cys Ala
305 310 315 320
Ile Val Arg Gly Val Lys Tyr Asn Gln Ala Thr Pro Asn Phe His Gln
325 330 335
Trp Arg Asp Ala Arg Gln Val Trp Gly Leu Asn Phe Gly Ser Lys Glu
340 345 350
Asp Ala Ala Gln Phe Ala Ala Gly Met Ala Ser Ala Leu Glu Ala Leu
355 360 365
Glu Gly Gly Gly Pro Pro Pro Pro Pro Ala Leu Pro Thr Trp Ser Val
370 375 380
Pro Asn Gly Pro Ser Pro Glu Glu Val Glu Gln Gln Lys Arg Gln Gln
385 390 395 400
Pro Gly Pro Ser Glu His Ile Glu Arg Arg Val Ser Asn Ala Gly Gly
405 410 415
Pro Pro Ala Pro Pro Ala Gly Gly Pro Pro Pro Pro Pro Gly Pro Pro
420 425 430
Pro Pro Pro Gly Pro Pro Pro Pro Pro Gly Leu Pro Pro Ser Gly Val
435 440 445
Pro Ala Ala Ala His Gly Ala Gly Gly Gly Pro Pro Pro Ala Pro Pro
450 455 460
Leu Pro Ala Ala Gln Gly Pro Gly Gly Gly Gly Ala Gly Ala Pro Gly
465 470 475 480
Leu Ala Ala Ala Ile Ala Gly Ala Lys Leu Arg Lys Val Ser Lys Gln
485 490 495
Glu Glu Ala Ser Gly Gly Pro Thr Ala Pro Lys Ala Glu Ser Gly Arg
500 505 510
Ser Gly Gly Gly Gly Leu Met Glu Glu Met Asn Ala Met Leu Ala Arg
CA 02450698 2003-12-23
233
515 520 525
Arg Arg Lys Ala Thr Gln Val Gly Glu Lys Thr Pro Lys Asp Glu Ser
530 535 540
Ala Asn Gln Glu Glu Pro Glu Ala Arg Val Pro Ala Gln Ser Glu Ser
545 550 555 560
Val Arg Arg Pro Trp Glu Lys Asn Ser Thr Thr Leu Pro Arg Met Lys
565 570 575
Ser Ser Ser Ser Val Thr Thr Ser Glu Thr Gln Pro Cys Thr Pro Ser
580 585 590
Ser Ser Asp Tyr Ser Asp Leu Gln Arg Val Lys Gln Glu Leu Leu Glu
595 600 605
Glu Val Lys Lys Glu Leu Gln Lys Val Lys Glu Glu Ile Ile Glu Ala
610 615 620
Phe Val Gln Glu Leu Arg Lys Arg Gly Ser Pro
625 630 635
(2) INFORMATION FOR SEQ ID N0:126:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1329 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1326
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:126:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC.AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
CA 02450698 2003-12-23
234
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGCAAA CCCAAC GAGAAGCGC GATCACATG GTCCTGCTG GAGTTC 672
GAC
SerLys AspProAsn GluLysArg AspHisMet ValLeuLeu GluPhe
210 215 220
GTGACC GCCGCCGGG ATCACTCTC GGCATGGAC GAGCTGTAC AAGTCC 720
ValThr AlaAlaGly IleThrLeu GlyMetAsp GluLeuTyr LysSer
225 230 235 240
GGACTC AGATCTCGA GCTCAAGCT TCAATGGCT GCCATCCGG AAGAAA 768
GlyLeu ArgSerArg AlaGlnAla SerMetAla AlaIleArg LysLys
245 250 255
CTGGTG ATTGTTGGT GATGGAGCC TGTGGAAAG ACATGCTTG CTCATA 816
LeuVal IleValGly AspGlyAla CysGlyLys ThrCysLeu LeuIle
260 265 270
GTC TTC AGC AAG GAC CAG TTC CCA GAG GTG TAT GTG CCC ACA GTG TTT 864
Val Phe Ser Lys Asp Gln Phe Pro Glu Val Tyr Val Pro Thr Val Phe
275 280 285
GAG AAC TAT GTG GCA GAT ATC GAG GTG GAT GGA AAG CAG GTA GAG TTG 912
Glu Asn Tyr Val Ala Asp Ile Glu Val Asp Gly Lys Gln Val Glu Leu
290 295 300
GCT TTG TGG GAC ACA GCT GGG CAG GAA GAT TAT GAT CGC CTG AGG CCC 960
Ala Leu Trp Asp Thr Ala Gly Gln Glu Asp Tyr Asp Arg Leu Arg Pro
305 310 315 320
CTC TCC TAC CCA GAT ACC GAT GTT ATA CTG ATG TGT TTT TCC ATC GAC 1008
Leu Ser Tyr Pro Asp Thr Asp Val Ile Leu Met Cys Phe Ser Ile Asp
325 330 335
AGC CCT GAT AGT TTA GAA AAC ATC CCA GAA AAG TGG ACC CCA GAA GTC 1056
Ser Pro Asp Ser Leu Glu Asn Ile Pro Glu Lys Trp Thr Pro Glu Val
340 345 350
CA 02450698 2003-12-23
235
AAG CAT TTC TGT CCC AAC GTG CCC ATC ATC CTG GTT GGG AAT AAG AAG 1104
Lys His Phe Cys Pro Asn Val Pro Ile Ile Leu Val Gly Asn Lys Lys
355 360 365
GAT CTT CGG AAT GAT GAG CAC ACA AGG CGG GAG CTA GCC AAG ATG AAG 1152
Asp Leu Arg Asn Asp Glu His Thr Arg Arg Glu Leu Ala Lys Met Lys
370 375 380
CAG GAG CCG GTG AAA CCT GAA GAA GGC AGA GAT ATG GCA AAC AGG ATT 1200
Gln Glu Pro Val Lys Pro Glu Glu Gly Arg Asp Met Ala Asn Arg Ile
385 390 395 400
GGC GCT TTT GGG TAC ATG GAG TGT TCA GCA AAG ACC AAA GAT GGA GTG 1248
Gly Ala Phe Gly Tyr Met Glu Cys Ser Ala Lys Thr Lys Asp Gly Val
405 410 415
AGA GAG GTT TTT GAA ATG GCT ACG AGA GCT GCT CTG CAA GCT AGA CGT 1296
Arg Glu Val Phe Glu Met Ala Thr Arg Ala Ala Leu Gln Ala Arg Arg
420 425 430
GGG AAG AAA AAA TCT GGT TGC CTT GTC TTG TGA 1329
Gly Lys Lys Lys Ser Gly Cys Leu Val Leu
435 440
(2) INFORMATION FOR SEQ ID N0:127:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 442 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:127:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met A1a Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
CA 02450698 2003-12-23
236
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Gln Ala Ser Met Ala Ala Ile Arg Lys Lys
245 250 255
Leu Val Ile Val Gly Asp Gly Ala Cys Gly Lys Thr Cys Leu Leu Ile
260 265 270
Val Phe Ser Lys Asp Gln Phe Pro Glu Val Tyr Va1 Pro Thr Val Phe
275 280 285
Glu Asn Tyr Va1 Ala Asp Ile Glu Val Asp Gly Lys Gln Va1 Glu Leu
290 295 300
Ala Leu Trp Asp Thr Ala Gly Gln Glu Asp Tyr Asp Arg Leu Arg Pro
305 310 315 320
Leu Ser Tyr Pro Asp Thr Asp Val Ile Leu Met Cys Phe Ser Ile Asp
325 330 335
Ser Pro Asp Ser Leu Glu Asn Ile Pro Glu Lys Trp Thr Pro Glu Val
340 345 350
Lys His Phe Cys Pro Asn Val Pro Ile Ile Leu Val Gly Asn Lys Lys
355 360 365
Asp Leu Arg Asn Asp Glu His Thr Arg Arg Glu Leu Ala Lys Met Lys
370 375 380
Gln Glu Pro Val Lys Pro Glu Glu Gly Arg Asp Met Ala Asn Arg Ile
385 390 395 400
Gly Ala Phe Gly Tyr Met Glu Cys Ser Ala Lys Thr Lys Asp Gly Val
405 410 415
Arg Glu Val Phe Glu Met Ala Thr Arg Ala Ala Leu Gln Ala Arg Arg
420 425 430
Gly Lys Lys Lys Ser Gly Cys Leu Val Leu
435 440
(2) INFORMATION FOR SEQ ID N0:128:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1140 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAME/KEY: Coding Sequence
(B) LOCATION: 1...1137
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:128:
ATG GAC CAT TAT GAT TCT CAG CAA ACC AAC GAT TAC ATG CAG CCA GAA 48
Met Asp His Tyr Asp Ser Gln Gln Thr Asn Asp Tyr Met Gln Pro Glu
1 5 10 15
GAG GAC TGG GAC CGG GAC CTG CTC CTG GAC CCG GCC TGG GAG AAG CAG 96
Glu Asp Trp Asp Arg Asp Leu Leu Leu Asp Pro Ala Trp Glu Lys Gln
20 25 30
CA 02450698 2003-12-23
237
CAGAGAAAG ACG GCA TGT AACTCCCAC CTCCGGAAG GCG 144
ACA TGG
TTC
GlnArgLys ThrPheThr AlaTrpCys AsnSerHis LeuArgLys Ala
35 40 45
GGGACACAG ATCGAGAAC ATCGAAGAG GACTTCCGG GATGGCCTG AAG 192
GlyThrGln IleGluAsn IleGluGlu AspPheArg AspGlyLeu Lys
50 55 60
CTCATGCTG CTGCTGGAG GTCATCTCA GGTGAACGC TTGGCCAAG CCA 240
LeuMetLeu LeuLeuG1u ValIleSer GlyGluArg LeuAlaLys Pro
65 70 75 80
GAGCGAGGC AAGATGAGA GTGCACAAG ATCTCCAAC GTCAACAAG GCC 288
GluArgGly LysMetArg ValHisLys IleSerAsn ValAsnLys Ala
85 90 95
CTGGATTTC ATAGCCAGC AAAGGCGTC AAACTGGTG TCCATCGGA GCC 336
LeuAspPhe IleAlaSer LysGlyVal LysLeuVal SerIleGly Ala
100 105 110
GAAGAAATC GTGGATGGG AATGTGAAG ATGACCCTG GGCATGATC TGG 384
GluGluIle ValAspGly AsnValLys MetThrLeu GlyMetIle Trp
115 120 125
ACCATCATC CTGCGCAGG GATCCACCG GTCGCCACC ATGGTGAGC AAG 432
ThrIleIle LeuArgArg AspProPro ValAlaThr MetValSer Lys
130 135 140
GGCGAGGAG CTGTTCACC GGGGTGGTG CCCATCCTG GTCGAGCTG GAC 480
GlyGluGlu LeuPheThr GlyValVal ProIleLeu ValGluLeu Asp
145 150 155 160
GGCGACGTA AACGGCCAC AAGTTCAGC GTGTCCGGC GAGGGCGAG GGC 528
GlyAspVal AsnGlyHis LysPheSer ValSerGly GluGlyGlu Gly
165 170 175
GATGCCACC TACGGCAAG CTGACCCTG AAGTTCATC TGCACCACC GGC 576
AspAlaThr TyrGlyLys LeuThrLeu LysPheIle CysThrThr Gly
180 185 190
AAGCTGCCC GTGCCCTGG CCCACCCTC GTGACCACC CTGACCTAC GGC 624
LysLeuPro ValProTrp ProThrLeu ValThrThr LeuThrTyr Gly
195 200 205
GTGCAGTGC TTCAGCCGC TACCCCGAC CACATGAAG CAGCACGAC TTC 672
ValGlnCys PheSerArg TyrProAsp HisMetLys GlnHisAsp Phe
210 215 220
TTCAAGTCC GCCATGCCC GAAGGCTAC GTCCAGGAG CGCACCATC TTC 720
PheLysSer AlaMetPro GluGlyTyr ValGlnGlu ArgThrIle Phe
225 230 235 240
TTCAAGGAC GACGGCAAC TACAAGACC CGCGCCGAG GTGAAGTTC GAG 768
PheLysAsp AspGlyAsn TyrLysThr ArgAlaGlu ValLysPhe Glu
245 250 255
GGCGACACC CTGGTGAAC CGCATCGAG CTGAAGGGC ATCGACTTC AAG 816
GlyAspThr LeuValAsn ArgIleGlu LeuLysGly IleAspPhe Lys
260 265 270
CA 02450698 2003-12-23
238
GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC AAC TAC AAC AGC 864
Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser
275 280 285
CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC GGC ATC AAG GTG 912
His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val
290 295 300
AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC GTG CAG CTC GCC 960
Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala
305 310 315 320
GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC CCC GTG CTG CTG 1008
Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu
325 330 335
CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG AGC AAA GAC CCC 1056
Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro
340 345 350
AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC GTG ACC GCC GCC ll04
Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala Ala
355 360 365
GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TAA 1140
Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
370 375
(2) INFORMATION FOR SEQ ID N0:129:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 379 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:129:
Met Asp His Tyr Asp Ser Gln Gln Thr Asn Asp Tyr Met Gln Pro Glu
1 5 10 15
Glu Asp Trp Asp Arg Asp Leu Leu Leu Asp Pro Ala Trp Glu Lys Gln
20 25 30
Gln Arg Lys Thr Phe Thr Ala Trp Cys Asn Ser His Leu Arg Lys Ala
35 40 45
Gly Thr Gln Ile Glu Asn Tle Glu Glu Asp Phe Arg Asp Gly Leu Lys
50 55 60
Leu Met Leu Leu Leu Glu Val Ile Ser Gly Glu Arg Leu Ala Lys Pro
65 ?0 75 80
Glu Arg Gly Lys Met Arg Val His Lys Ile Ser Asn Val Asn Lys Ala
85 90 95
Leu Asp Phe Ile Ala Ser Lys Gly Val Lys Leu Val Sex Ile Gly Ala
100 105 110
Glu Glu Ile Val Asp Gly Asn Val Lys Met Thr Leu Gly Met Ile Trp
115 120 125
Thr Ile Ile Leu Arg Arg Asp Pro Pro Val Ala Thr Met Val Ser Lys
CA 02450698 2003-12-23
239
130 135 140
Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu Asp
145 150 155 160
Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly Glu Gly Glu Gly
165 170 175
Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile Cys Thr Thr Gly
180 185 190
Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Thr Tyr Gly
195 200 205
Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp Phe
210 215 220
Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile Phe
225 230 235 240
Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe Glu
245 250 255
Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe Lys
260 265 270
Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Tyr Asn Ser
275 280 285
His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn Gly Ile Lys Val
290 295 300
Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu Ala
305 310 315 320
Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu Leu
325 330 335
Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu Ser Lys Asp Pro
340 345 350
Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala Ala
355 360 365
Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys
370 375
(2) INFORMATION FOR SEQ ID N0:130:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 3516 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: cDNA
(ix) FEATURE:
(A) NAMEjKEY: Coding Sequence
(B) LOCATION: 1...3513
(D) OTHER INFORMATION:
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:130:
ATG GTG AGC AAG GGC GAG GAG CTG TTC ACC GGG GTG GTG CCC ATC CTG 48
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
GTC GAG CTG GAC GGC GAC GTA AAC GGC CAC AAG TTC AGC GTG TCC GGC 96
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
GAG GGC GAG GGC GAT GCC ACC TAC GGC AAG CTG ACC CTG AAG TTC ATC 144
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
CA 02450698 2003-12-23
240
TGC ACC ACC GGC AAG CTG CCC GTG CCC TGG CCC ACC CTC GTG ACC ACC 192
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
CTG ACC TAC GGC GTG CAG TGC TTC AGC CGC TAC CCC GAC CAC ATG AAG 240
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
CAG CAC GAC TTC TTC AAG TCC GCC ATG CCC GAA GGC TAC GTC CAG GAG 288
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
CGC ACC ATC TTC TTC AAG GAC GAC GGC AAC TAC AAG ACC CGC GCC GAG 336
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
GTG AAG TTC GAG GGC GAC ACC CTG GTG AAC CGC ATC GAG CTG AAG GGC 384
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
ATC GAC TTC AAG GAG GAC GGC AAC ATC CTG GGG CAC AAG CTG GAG TAC 432
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
AAC TAC AAC AGC CAC AAC GTC TAT ATC ATG GCC GAC AAG CAG AAG AAC 480
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
GGC ATC AAG GTG AAC TTC AAG ATC CGC CAC AAC ATC GAG GAC GGC AGC 528
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
GTG CAG CTC GCC GAC CAC TAC CAG CAG AAC ACC CCC ATC GGC GAC GGC 576
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
CCC GTG CTG CTG CCC GAC AAC CAC TAC CTG AGC ACC CAG TCC GCC CTG 624
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
AGC AAA GAC CCC AAC GAG AAG CGC GAT CAC ATG GTC CTG CTG GAG TTC 672
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
GTG ACC GCC GCC GGG ATC ACT CTC GGC ATG GAC GAG CTG TAC AAG TCC 720
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
GGA CTC AGA TCT CGA GCC ATG AAC GCC CCC GAG CGG CAG CCC CAA CCC 768
Gly Leu Arg Ser Arg Ala Met Asn Ala Pro Glu Arg Gln Pro Gln Pro
245 250 255
GAC GGC GGG GAC GCC CCA GGC CAC GAG CCT GGG GGC AGC CCC CAA GAC 816
Asp Gly Gly Asp Ala Pro Gly His Glu Pro Gly Gly Ser Pro Gln Asp
260 265 270
GAG CTT GAC TTC TCC ATC CTC TTC GAC TAT GAG TAT TTG AAT CCG AAC 864
Glu Leu Asp Phe Ser Ile Leu Phe Asp Tyr Glu Tyr Leu Asn Pro Asn
275 280 285
CA 02450698 2003-12-23
241
GAA GAA GAG CCG AAT GCA CAT AAG GTC GCC AGC CCA CCC TCC GGA CCC 912
Glu Glu Glu Pro Asn Ala His Lys Val Ala Ser Pro Pro Ser Gly Pro
290 295 300
GCA TACCCCGATGAT GTAATGGAC TATGGCCTC AAGCCA TACAGCCCC 960
Ala TyrProAspAsp ValMetAsp TyrGlyLeu LysPro TyrSerPro
305 310 315 320
CTT GCTAGTCTCTCT GGCGAGCCC CCCGGCCGA TTCGGA GAGCCGGAT 1008
Leu AlaSerLeuSer GlyGluPro ProGlyArg PheGly GluProAsp
325 330 335
AGG GTAGGGCCGCAG AAGTTTCTG AGCGCGGCC AAGCCA GCAGGGGCC 1056
Arg ValGlyProGln LysPheLeu SerAlaAla LysPro AlaGlyAla
340 345 350
TCG GGCCTGAGCCCT CGGATCGAG ATCACTCCG TCCCAC GAACTGATC 1104
Ser GlyLeuSerPro ArgIleGlu IleThrPro SerHis GluLeuIle
355 360 365
CAG GCAGTGGGGCCC CTCCGCATG AGAGACGCG GGCCTC CTGGTGGAG 1152
Gln AlaValGlyPro LeuArgMet ArgAspAla GlyLeu LeuValGlu
370 375 380
CAG CCTCCCCTGGCC GGGGTGGCC GCCAGCCCG AGGTTC ACCCTGCCC 1200
Gln ProProLeuAla GlyValAla AlaSerPro ArgPhe ThrLeuPro
385 390 395 400
GTG CCCGGCTTCGAG GGCTACCGC GAGCCGCTT TGCTTG AGCCCCGCT 1248
Va1 ProGlyPheGlu GlyTyrArg GluProLeu CysLeu SerProAla
405 410 415
AGC AGCGGCTCCTCT GCCAGCTTC ATTTCTGAC ACCTTC TCCCCCTAC 1296
Ser SerGlySerSer AlaSerPhe IleSerAsp ThrPhe SerProTyr
420 425 430
ACC TCGCCCTGCGTC TCGCCCAAT AACGGCGGG CCCGAC GACCTGTGT 1344
Thr SerProCysVal SerProAsn AsnGlyGly ProAsp AspLeuCys
435 440 445
CCG CAGTTTCAAAAC ATCCCTGCT CATTATTCC CCCAGA ACCTCGCCA 1392
Pro GlnPheGlnAsn IleProAla HisTyrSer ProArg ThrSerPro
450 455 460
ATA ATGTCACCTCGA ACCAGCCTC GCCGAGGAC AGCTGC CTGGGCCGC 1440
Ile MetSerProArg ThrSerLeu AlaGluAsp SerCys LeuGlyArg
465 470 475 480
CAC TCGCCCGTGCCC CGTCCGGCC TCCCGCTCC TCATCG CCTGGTGCC 1488
His SerProValPro ArgProAla SerArgSer SerSer ProGlyAla
485 490 495
AAG CGGAGGCATTCG TGCGCCGAG GCCTTGGTT GCCCTG CCGCCCGGA 1536
Lys ArgArgHisSer CysAlaGlu AlaLeuVal AlaLeu ProProGly
500 505 510
GCC TCACCCCAGCGC TCCCGGAGC CCCTCGCCG CAGCCC TCATCTCAC 1584
Ala SerProGlnArg SerArgSer ProSerPro GlnPro SerSerHis
515 520 525
CA 02450698 2003-12-23
242
GTG GCA CCC CAG GAC CAC GGC TCC CCG GCT GGG TAC CCC CCT GTG GCT 1632
Val Ala Pro Gln Asp His Gly Ser Pro Ala Gly Tyr Pro Pro Val Ala
530 535 540
GGC TCT GCC GTG ATC ATG GAT GCC CTG AAC AGC CTC GCC ACG GAC TCG 1680
Gly Ser Ala Val Ile Met Asp Ala Leu Asn Ser Leu Ala Thr Asp Ser
545 550 555 560
CCT TGT GGG ATC CCC CCC AAG ATG TGG AAG ACC AGC CCT GAC CCC TCG 1728
Pro Cys Gly Ile Pro Pro Lys Met Trp Lys Thr Ser Pro Asp Pro Ser
565 570 575
CCG GTG TCT GCC GCC CCA TCC AAG GCC GGC CTG CCT CGC CAC ATC TAC 1776
Pro Val Ser Ala Ala Pro Ser Lys Ala Gly Leu Pro Arg His Ile Tyr
580 585 590
CCG GCC GTG GAG TTC CTG GGG CCC TGC GAG CAG GGC GAG AGG AGA AAC 1824
Pro Ala Val Glu Phe Leu Gly Pro Cys Glu Gln Gly Glu Arg Arg Asn
595 600 605
TCG GCT CCA GAA TCC ATC CTG CTG GTT CCG CCC ACT TGG CCC AAG CCG 1872
Ser Ala Pro Glu Ser Ile Leu Leu Val Pro Pro Thr Trp Pro Lys Pro
610 615 620
CTG GTG CCT GCC ATT CCC ATC TGC AGC ATC CCA GTG ACT GCA TCC CTC 1920
Leu Val Pro Ala Ile Pro Ile Cys Ser Ile Pro Val Thr Ala Ser Leu
625 630 635 640
CCT CCA CTT GAG TGG CCG CTG TCC AGT CAG TCA GGC TCT TAC GAG CTG 1968
Pro Pro Leu Glu Trp Pro Leu Ser Ser Gln Ser Gly Ser Tyr Glu Leu
645 650 655
CGG ATC GAG GTG CAG CCC AAG CCA CAT CAC CGG GCC CAC TAT GAG ACA 2016
Arg Ile Glu Val Gln Pro Lys Pro His His Arg Ala His Tyr Glu Thr
660 665 670
GAA GGC AGC CGA GGG GCT GTC AAA GCT CCA ACT GGA GGC CAC CCT GTG 2064
Glu Gly Ser Arg Gly Ala Val Lys Ala Pro Thr Gly Gly His Pro Val
675 680 685
GTT CAG CTC CAT GGC TAC ATG GAA AAC AAG CCT CTG GGA CTT CAG ATC 2112
Val Gln Leu His Gly Tyr Met Glu Asn Lys Pro Leu Gly Leu Gln Ile
690 695 700
TTC ATT GGG ACA GCT GAT GAG CGG ATC CTT AAG CCG CAC GCC TTC TAC 2160
Phe Ile Gly Thr Ala Asp Glu Arg Ile Leu Lys Pro His Ala Phe Tyr
705 710 715 720
CAG GTG CAC CGA ATC ACG GGG AAA ACT GTC ACC ACC ACC AGC TAT GAG 2208
Gln Val His Arg Ile Thr Gly Lys Thr Val Thr Thr Thr Ser Tyr Glu
725 730 735
AAG ATA GTG GGC AAC ACC AAA GTC CTG GAG ATC CCC TTG GAG CCC AAA 2256
Lys Ile Val Gly Asn Thr Lys Val Leu Glu Ile Pro Leu Glu Pro Lys
740 745 750
AAC AAC ATG AGG GCA ACC ATC GAC TGT GCG GGG ATC TTG AAG CTT AGA 2304
Asn Asn Met Arg Ala Thr Ile Asp Cys Ala Gly Ile Leu Lys Leu Arg
755 760 765
CA 02450698 2003-12-23
243
AAC GCC GAC ATT GAG CTG CGG AAA GGC GAG ACG GAC ATT GGA AGA AAG 2352
Asn Ala Asp Ile Glu Leu Arg Lys Gly Glu Thr Asp Ile Gly Arg Lys
770 775 780
AAC ACG CGG GTG AGA CTG GTT TTC CGA GTT CAC ATC CCA GAG TCC AGT 2400
Asn Thr Arg Val Arg Leu Val Phe Arg Val His Ile Pro Glu Ser Ser
785 790 795 800
GGC AGA ATC GTC TCT TTA CAG ACT GCA TCT AAC CCC ATC GAG TGC TCC 2448
Gly Arg Ile Val Ser Leu Gln Thr Ala Ser Asn Pro Ile Glu Cys Ser
805 810 815
CAG CGA TCT GCT CAC GAG CTG CCC ATG GTT GAA AGA CAA GAC ACA GAC 2496
Gln Arg Ser Ala His Glu Leu Pro Met Val Glu Arg Gln Asp Thr Asp
820 825 830
AGC TGC CTG GTC TAT GGC GGC CAG CAA ATG ATC CTC ACG GGG CAG AAC 2544
Ser Cys Leu Val Tyr Gly Gly Gln Gln Met Ile Leu Thr Gly Gln Asn
835 840 845
TTT ACA TCC GAG TCC AAA GTT GTG TTT ACT GAG AAG ACC ACA GAT GGA 2592
Phe Thr Ser Glu Ser Lys Val Val Phe Thr Glu Lys Thr Thr Asp Gly
850 855 860
CAG CAA ATT TGG GAG ATG GAA GCC ACG GTG GAT AAG GAC AAG AGC CAG 2640
Gln Gln Ile Trp Glu Met Glu Ala Thr Val Asp Lys Asp Lys Ser Gln
865 870 875 880
CCC AAC ATG CTT TTT GTT GAG ATC CCT GAA TAT CGG AAC AAG CAT ATC 2688
Pro Asn Met Leu Phe Val Glu Ile Pro Glu Tyr Arg Asn Lys His Ile
885 890 895
CGC ACA CCT GTA AAA GTG AAC TTC TAC GTC ATC AAT GGG AAG AGA AAA 2736
Arg Thr Pro Val Lys Val Asn Phe Tyr Val Ile Asn Gly Lys Arg Lys
900 905 910
CGA AGT CAG CCT CAG CAC TTT ACC TAC CAC CCA GTC CCA GCC ATC AAG 2784
Arg Ser Gln Pro Gln His Phe Thr Tyr His Pro Val Pro Ala Ile Lys
915 920 925
ACG GAG CCC ACG GAT GAA TAT GAC CCC ACT CTG ATC TGC AGC CCC ACC 2832
Thr Glu Pro Thr Asp Glu Tyr Asp Pro Thr Leu Ile Cys Ser Pro Thr
930 935 940
CAT GGA GGC CTG GGG AGC CAG CCT TAC TAC CCC CAG CAC CCG ATG GTG 2880
His Gly Gly Leu Gly Ser Gln Pro Tyr Tyr Pro Gln His Pro Met Val
945 950 955 960
GCC GAG TCC CCC TCC TGC CTC GTG GCC ACC ATG GCT CCC TGC CAG CAG 2928
Ala Glu Ser Pro Ser Cys Leu Val Ala Thr Met Ala Pro Cys Gln Gln
965 970 975
TTC CGC ACG GGG CTC TCA TCC CCT GAC GCC CGC TAC CAG CAA CAG AAC 2976
Phe Arg Thr Gly Leu Ser Ser Pro Asp Ala Arg Tyr Gln Gln Gln Asn
980 985 990
CCA GCG GCC GTA CTC TAC CAG CGG AGC AAG AGC CTG AGC CCC AGC CTG 3024
Pro Ala Ala Val Leu Tyr Gln Arg Ser Lys Ser Leu Ser Pro Ser Leu
995 1000 1005
CA 02450698 2003-12-23
244
CTG GGC TAT CAG CAG CCG GCC CTC ATG GCC GCC CCG CTG TCC CTT GCG 3072
Leu Gly Tyr Gln Gln Pro Ala Leu Met Ala Ala Pro Leu Ser Leu Ala
1010 1015 1020
GAC GCT CAC CGC TCT GTG CTG GTG CAC GCC GGC TCC CAG GGC CAG AGC 3120
Asp Ala His Arg Ser Val Leu Val His Ala Gly Ser Gln Gly Gln Ser
1025 1030 1035 1040
TCA GCC CTG CTC CAC CCC TCT CCG ACC AAC CAG CAG GCC TCG CCT GTG 3168
Ser Ala Leu Leu His Pro Ser Pro Thr Asn Gln Gln Ala Ser Pro Val
1045 1050 1055
ATC CAC TAC TCA CCC ACC AAC CAG CAG CTG CGC TGC GGA AGC CAC CAG 3216
Ile His Tyr Ser Pro Thr Asn Gln Gln Leu Arg Cys Gly Ser His Gln
1060 1065 1070
GAG TTC CAG CAC ATC ATG TAC TGC GAG AAT TTC GCA CCA GGC ACC ACC 3264
Glu Phe Gln His Ile Met Tyr Cys Glu Asn Phe Ala Pro Gly Thr Thr
1075 1080 1085
AGA CCT GGC CCG CCC CCG GTC AGT CAA GGT CAG AGG CTG AGC CCG GGT 3312
Arg Pro Gly Pro Pro Pro Val Ser Gln Gly Gln Arg Leu Ser Pro Gly
1090 1095 1100
TCC TAC CCC ACA GTC ATT CAG CAG CAG AAT GCC ACG AGC CAA AGA GCC 3360
Ser Tyr Pro Thr Val Ile Gln Gln Gln Asn Ala Thr Ser Gln Arg Ala
1105 1110 1115 1120
GCC AAA AAC GGA CCC CCG GTC AGT GAC CAA AAG GAA GTA TTA CCT GCG 3408
Ala Lys Asn Gly Pro Pro Val Ser Asp Gln Lys Glu Val Leu Pro Ala
1125 1130 1135
GGG GTG ACC ATT AAA CAG GAG CAG AAC TTG GAC CAG ACC TAC TTG GAT 3456
Gly Val Thr Ile Lys Gln Glu Gln Asn Leu Asp Gln Thr Tyr Leu Asp
1140 1145 1150
GAT GTT AAT GAA ATT ATC AGG AAG GAG TTT TCA GGA CCT CCT GCC AGA 3504
Asp Val Asn Glu Ile Ile Arg Lys Glu Phe Ser Gly Pro Pro Ala Arg
1155 1160 1165
AAT CAG ACG TAA 3516
Asn Gln Thr
1170
(2) INFORMATION FOR SEQ ID N0:131:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1171 amino acids
(B) TYPE: amino acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: protein
(v) FRAGMENT TYPE: internal
(xi) SEQUENCE DESCRIPTION: SEQ ID N0:131:
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
CA 02450698 2003-12-23
245
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Ser Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Gln His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Ile Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Tyr Asn Ser His Asn Val Tyr Ile Met Ala Asp Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Val Asn Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Ser Ala Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe
210 215 220
Val Thr Ala Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys Ser
225 230 235 240
Gly Leu Arg Ser Arg Ala Met Asn Ala Pro Glu Arg Gln Pro Gln Pro
245 250 255
Asp Gly Gly Asp Ala Pro Gly His Glu Pro Gly Gly Ser Pro Gln Asp
260 265 270
Glu Leu Asp Phe Ser Ile Leu Phe Asp Tyr Glu Tyr Leu Asn Pro Asn
275 280 285
Glu Glu Glu Pro Asn Ala His Lys Val Ala Ser Pro Pro Ser Gly Pro
290 295 300
Ala Tyr Pro Asp Asp Val Met Asp Tyr Gly Leu Lys Pro Tyr Ser Pro
305 310 315 320
Leu Ala Ser Leu Ser Gly Glu Pro Pro Gly Arg Phe Gly Glu Pro Asp
325 330 335
Arg Val Gly Pro Gln Lys Phe Leu Ser Ala Ala Lys Pro Ala Gly Ala
340 345 350
Ser Gly Leu Ser Pro Arg Ile Glu Ile Thr Pro Ser His Glu Leu Ile
355 360 365
Gln Ala Val Gly Pro Leu Arg Met Arg Asp Ala Gly Leu Leu Val Glu
370 375 380
Gln Pro Pro Leu Ala Gly Val Ala Ala Ser Pro Arg Phe Thr Leu Pro
385 390 395 400
Val Pro Gly Phe Glu Gly Tyr Arg Glu Pro Leu Cys Leu Ser Pro Ala
405 410 415
Ser Ser Gly Ser Ser Ala Ser Phe Ile Ser Asp Thr Phe Ser Pro Tyr
420 425 430
Thr Ser Pro Cys Val Ser Pro Asn Asn Gly Gly Pro Asp Asp Leu Cys
435 440 445
Pro Gln Phe Gln Asn Ile Pro Ala His Tyr Ser Pro Arg Thr Ser Pro
450 455 460
Ile Met Ser Pro Arg Thr Ser Leu Ala Glu Asp Ser Cys Leu Gly Arg
465 470 475 480
His Ser Pro Val Pro Arg Pro Ala Ser Arg Ser Ser Ser Pro Gly Ala
CA 02450698 2003-12-23
246
485 490 495
Lys Arg Arg His Ser Cys Ala Glu Ala Leu Val Ala Leu Pro Pro Gly
500 505 510
Ala Ser Pro Gln Arg Ser Arg Ser Pro Ser Pro Gln Pro Ser Ser His
515 520 525
Val Ala Pro Gln Asp His Gly Ser Pro Ala Gly Tyr Pro Pro Val Ala
530 535 540
Gly Ser Ala Val Ile Met Asp Ala Leu Asn Ser Leu Ala Thr Asp Ser
545 550 555 560
Pro Cys Gly Ile Pro Pro Lys Met Trp Lys Thr Ser Pro Asp Pro Ser
565 570 575
Pro Val Ser Ala Ala Pro Ser Lys Ala Gly Leu Pro Arg His Ile Tyr
580 585 590
Pro Ala Val Glu Phe Leu Gly Pro Cys Glu Gln Gly Glu Arg Arg Asn
595 600 605
Ser Ala Pro Glu Ser Ile Leu Leu Val Pro Pro Thr Trp Pro Lys Pro
610 615 620
Leu Val Pro Ala Ile Pro Ile Cys Ser Ile Pro Val Thr Ala Ser Leu
625 630 635 640
Pro Pro Leu Glu Trp Pro Leu Ser Ser Gln Ser Gly Ser Tyr Glu Leu
645 650 655
Arg Ile Glu Val Gln Pro Lys Pro His His Arg Ala His Tyr Glu Thr
660 665 670
Glu Gly Ser Arg Gly Ala Val Lys Ala Pro Thr Gly Gly His Pro Val
675 680 685
Val Gln Leu His Gly Tyr Met Glu Asn Lys Pro Leu Gly Leu Gln Ile
690 695 700
Phe Ile Gly Thr Ala Asp Glu Arg Ile Leu Lys Pro His Ala Phe Tyr
705 710 715 720
Gln Val His Arg Ile Thr Gly Lys Thr Val Thr Thr Thr Ser Tyr Glu
725 730 735
Lys Ile Val Gly Asn Thr Lys Val Leu Glu Ile Pro Leu Glu Pro Lys
740 745 750
Asn Asn Met Arg Ala Thr Ile Asp Cys Ala Gly Ile Leu Lys Leu Arg
755 760 765
Asn Ala Asp Ile Glu Leu Arg Lys Gly Glu Thr Asp Ile Gly Arg Lys
770 775 780
Asn Thr Arg Val Arg Leu Val Phe Arg Val His Ile Pro Glu Ser Ser
785 790 795 800
Gly Arg Ile Val Ser Leu Gln Thr Ala Ser Asn Pro Ile Glu Cys Ser
805 810 815
Gln Arg Ser Ala His Glu Leu Pro Met Val Glu Arg Gln Asp Thr Asp
820 825 830
Ser Cys Leu Val Tyr Gly Gly Gln Gln Met Ile Leu Thr Gly Gln Asn
835 840 845
Phe Thr Ser Glu Ser Lys Val Val Phe Thr Glu Lys Thr Thr Asp Gly
850 855 860
Gln Gln Ile Trp Glu Met Glu Ala Thr Val Asp Lys Asp Lys Ser Gln
865 870 875 880
Pro Asn Met Leu Phe Val Glu Ile Pro Glu Tyr Arg Asn Lys His Ile
885 890 895
Arg Thr Pro Val Lys Val Asn Phe Tyr Val Ile Asn Gly Lys Arg Lys
900 905 910
Arg Ser Gln Pro Gln His Phe Thr Tyr His Pro Val Pro Ala Ile Lys
915 920 925
Thr Glu Pro Thr Asp Glu Tyr Asp Pro Thr Leu Ile Cys Ser Pro Thr
930 935 940
His Gly Gly Leu Gly Ser Gln Pro Tyr Tyr Pro Gln His Pro Met Val
945 950 955 960
Ala Glu Ser Pro Ser Cys Leu Val Ala Thr Met Ala Pro Cys Gln Gln
CA 02450698 2003-12-23
DEMANDES OU BREVETS VOLUMINEUX
LA PRESENTE PARTIE DE CETTE DEMANDE OU CE BREVETS
COMPREND PLUS D'UN TOME.
CECI EST LE TOME I DE
NOTE: Pour les tomes additionels, veillez contacter 1e Bureau Canadien des
Brevets.
JUMBO APPLICATIONS / PATENTS
THIS SECTION OF THE APPLICATION / PATENT CONTAINS MORE
THAN ONE VOLUME.
THIS IS VOLUME ~ OF
NOTE: For additional volumes please contact the Canadian Patent Office.
